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Zusammenfassung	  
	  Theorien	   zur	   Ätiologie	   der	   Aufmerksamkeitsdefizit-­‐/	   Hyperaktivitätsstö-­‐rung	   (ADHS)	   konzentrieren	   sich	   oft	   auf	   defizitäre	   Prozesse	   der	  Verhaltensinhibition,	   die	   wiederum	   zu	   Defiziten	   der	   Exekutivfunktionen	   (EF)	  führen.	   Übereinstimmend	   mit	   diesen	   Beeinträchtigungen	   berichteten	  Neuroimaging-­‐Studien	   von	  Hypoaktivierung	   im	   frontoparietalen	  Netzwerk	   sowie	  Hyperaktivierung	   im	   dorsalen	   Aufmerksamkeitsnetzwerk.	   Studien	   zur	   Wirkung	  von	   Stimulanzien	   zeigten	   eine	   Verbesserung	   von	   EF-­‐Maßen	   einschließlich	   des	  Arbeitsgedächtnisses	   sowie	   eine	   Hochregulierung	   des	   aufgabenpositiven/	  frontoparietalen	  Netzwerks	   durch	  Methylphenidat	   (MPH).	   Bis	   jetzt	   untersuchten	  nur	   wenige	   Studien	   die	   Auswirkungen	   von	   ADHS	   auf	   neurophysiologische	   und	  Verhaltensmaße	   der	   EF	   sowie	   den	   Effekt	   von	   länger	   andauernder	  Stimulanziengabe	  bei	  erwachsenen	  Patienten.	  	  Die	   Wichtigkeit	   des	   Enzyms	   Catechol-­‐O-­‐Methyltransferase	   (COMT)	   für	  subkortikale	   und	   kortikale	   dopaminerge	   und	   noradrenerge	   Funktionen	   führte	  darüber	   hinaus	   zu	   Studien,	   die	   eine	   potentielle	   Interaktion	   in	   der	   Wirkung	   des	  
COMT	  Genotyps	  und	  ADHS	  auf	  neuropsychologische	  Funktionen	  und	  insbesondere	  auf	   das	   Arbeitsgedächtnis	   untersuchten.	   Die	   Ergebnisse	   dieser	   Studien	   waren	  recht	  heterogen.	  Da	  zudem	  keine	  der	  Studien	  die	  Ergebnisse	  der	  ADHS-­‐Patienten	  mit	   denen	   einer	   gesunden	   Kontrollgruppe	   verglich,	   konnten	   möglicherweise	  vorhandene	   unterschiedliche	   Einflüsse	   von	   COMT	   bei	   Patienten	   und	   gesunden	  Kontrollprobanden	  nicht	  angemessen	  ermittelt	  werden.	  	  Das	   Ziel	   dieser	   Dissertation	   waren	   zunächst	   die	   Untersuchung	   von	  selektiven	  Aufmerksamkeitsprozessen,	  die	  durch	  die	  Zentrale	  Exekutive	  vermittelt	  werden,	   sowie	  die	  Übertragung	  der	  dazu	  verwendeten	  Arbeitsgedächtnisaufgabe	  ins	  fMRT.	  Eine	  dritte	  Studie	  strebte	  die	  Untersuchung	  der	  Auswirkungen	  von	  ADHS	  bei	  Erwachsenen	  (aADHS),	  MPH	  und	  COMT	  Genotyp	  auf	  das	  Arbeitsgedächtnis	  an.	  Ein	   besonderer	   Fokus	   bei	   der	   Analyse	   der	   fMRT-­‐Daten	   lag	   hierbei	   auf	   der	  Aktivierung	  des	  aufgabenpositiven	  Netzwerks.	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Die	   erste	   Studie	   (EEG)	   konnte	  bisherige	  Forschungsergebnisse	   replizieren	  und	   erweitern.	   Zudem	   konnte	   diese	   Studie	   die	   Gesamtaktivierung	   in	   frontalen	  Bereichen	  mit	  der	  Unterdrückungseffizienz	   in	  posterioren	  visuellen	  Bereichen	   in	  Verbindung	   bringen	   sowie	   einen	   Einfluss	   von	   hyperaktiv/	   impulsiver	   ADHS-­‐Symptomatik	   auf	   die	   Verhaltensleistung	   feststellen.	   Die	   zweite	   Studie	   (fMRT)	  zeigte	   eine	   erfolgreiche	   Übertragung	   des	   Paradigmas	   auf	   das	   fMRT	   und	   eine	  weitergehende	   Replizierung	   und	   Erweiterung	   vorheriger	   Forschungsergebnisse.	  Es	   konnte	   außerdem	   die	   Sensitivität	   der	   Aufgabe	   für	   die	   Effekte	   des	   COMT	  Genotyps	  gezeigt	  werden.	  Die	  dritte	  Studie	  (fMRT)	  war	  eine	  der	  ersten	  Studien,	  die	  exploratorisch	  die	  Effekte	  von	  COMT	  in	  einer	  Stichprobe	  von	  aADHS-­‐Patienten	  und	  einer	   vergleichbaren	  gesunden	  Kontrollgruppe	  untersuchte.	  Hier	   zeigte	   sich	   eine	  Interaktion	   von	   COMT	   Genotyp	   und	   aADHS	   auf	   die	   erhobenen	  neuropsychologischen	   Maße	   sowie	   auf	   die	   fMRT-­‐Aktivierung	   während	   einer	   n-­‐back	   Arbeitsgedächtnisaufgabe.	   Die	   Aufgabe	   führte	   zu	   mehr	   Aktivierung	   im	  aufgabenpositiven	  Netzwerk	  der	  aADHS-­‐Gruppe	  im	  Vergleich	  zur	  Kontrollgruppe.	  Da	  keine	  Leistungsunterschiede	  zwischen	  den	  Gruppen	  zu	  erkennen	  waren,	  weist	  diese	   Hyperaktivierung	   auf	   eine	   kompensatorische	   Aktivierung	   in	   der	   aADHS-­‐Gruppe	   hin.	   Zudem	   zeigte	   sich	   eine	   erhöhte	   Aktivierung	   im	   Frontalkortex	   bei	  Patienten,	  die	  MPH	  statt	  einem	  Placebo	  einnahmen.	  Die	   fMRT-­‐Daten	  der	  Aufgabe	  zur	  selektiven	  Aufmerksamkeit	  zeigten	  außerdem	  eine	  reduzierte	  Aktivierung	   im	  rechten	   DLPFC	   der	   Patientengruppe,	   die	   über	   alle	   Probanden	   hinweg	   mit	   einer	  reduzierten	  Unterdrückungseffizienz	  assoziiert	  war.	  Der	  klinische	  Effekt	  von	  MPH	  in	   der	   Patientenstichprobe	   war	   sichtbar,	   erreichte	   aber	   keine	   Signifikanz,	   was	  vermutlich	  auf	  eine	  zu	  geringe	  experimentelle	  Power	  zurückzuführen	  ist.	  Die	   Studien	   in	   dieser	   Dissertation	   konnten	   vorherige	   Befunde	   erfolgreich	  replizieren	  und	  erweitern.	  Ein	  Ziel	  für	  zukünftige	  Studien	  sollte	  die	  weitergehende	  Untersuchung	  dieser	  Fragestellungen	  sein.	  Vor	  allem	  in	  Bezug	  auf	  eine	  Interaktion	  von	   COMT	   Genotyp	   und	   aADHS	   auf	   neuropsychologische	   Testergebnisse	   und	  fMRT-­‐Aktivierung,	   aber	   auch	   auf	  Medikamenten-­‐Response	   und	   Nebenwirkungen	  ist	  dies	  von	  großer	  Bedeutung.	  Die	  Übernahme	  einer	  Netzwerkperspektive	  bei	  der	  Analyse	  von	  fMRT-­‐Daten	  scheint	  zudem	  der	  beste	  Weg,	  existierende	  Unterschiede	  zwischen	  den	  Gruppen	  zu	  finden.	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Abstract	  
	  Theories	  of	  attention	  deficit	  hyperactivity	  disorder	  (ADHD)	  aetiology	  have	  placed	  a	  focus	  on	  impaired	  behavioural	  inhibition	  presumably	  leading	  to	  executive	  function	   (EF)	   deficits.	   Neuroimaging	   studies	   report	   neurophysiological	   findings	  consistent	  with	   these	  hypothesised	   impairments,	  and	   investigations	  of	   functional	  brain	   activation	   from	   a	   network	   perspective	   report	   hypoactivation	   in	   the	  frontoparietal	  network	  as	  well	  as	  hyperactivation	  in	  the	  dorsal	  attention	  network.	  Studies	   investigating	   the	   acute	   effects	   of	   stimulant	   medication	   on	   EF	   show	   an	  improvement	  on	  behavioural	  EF	  measures	  including	  working	  memory.	  In	  addition,	  methylphenidate	   (MPH)	   was	   shown	   to	   up-­‐regulate	   the	   task-­‐positive/	  frontoparietal	   network	   in	   children	   and	   adolescents	  with	  ADHD.	   So	   far,	   there	   are	  only	   few	   studies	   investigating	   the	   impact	   of	   ADHD	   on	   behavioural	   and	  neurophysiological	  EF	  measures	  as	  well	  as	  the	  effect	  of	  several	  weeks	  of	  stimulant	  medication	  in	  adult	  patients.	  	  The	   importance	   of	   the	   catechol-­‐O-­‐methyltransferase	   (COMT)	   enzyme	   for	  subcortical	  and	  cortical	  dopaminergic	  and	  noradrenergic	  functioning	  furthermore	  led	   to	   studies	   investigating	   a	  potential	   interactive	   impact	   of	  COMT	   genotype	   and	  ADHD	   on	   neuropsychological	   functioning,	   with	   a	   particular	   focus	   on	   working	  memory.	   The	   results	   of	   these	   studies	   were	   very	   heterogeneous.	   In	   addition,	   as	  none	  of	   the	   studies	   compared	   the	   results	  of	  ADHD	  patients	   to	   those	  of	   a	  healthy	  control	  group,	  possible	  differential	  effects	  of	  COMT	  in	  patients	  and	  healthy	  controls	  could	  not	  be	  examined.	  	  The	  aim	  of	  this	  dissertation	  was	  to	  investigate	  selective	  attention	  properties	  of	  the	  central	  executive	  component	  during	  a	  working	  memory	  task	  and	  to	  transfer	  this	  task	  to	  fMRI.	  A	  third	  study	  then	  aimed	  to	  investigate	  the	  effects	  of	  adult	  ADHD	  (aADHD),	  MPH,	  and	  COMT	  genotype	  on	  working	  memory	  with	  a	  particular	   focus	  on	  activation	  of	  the	  task-­‐positive	  network	  during	  the	  analysis	  of	  the	  fMRI	  data.	  	  The	  first	  study	  (EEG)	  could	  replicate	  and	  extend	  the	  results	  from	  previous	  research.	   This	   study	   could	   furthermore	   connect	   the	   overall	   activation	   in	   frontal	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areas	   to	   suppression	   efficiency	   in	   posterior	   visual	   areas	   as	  well	   as	   establish	   the	  impact	   of	   hyperactive/	   impulsive	   ADHD	   symptoms	   on	   task	   performance.	   The	  second	  study	  (fMRI)	  allowed	  the	  successful	  transfer	  of	  the	  paradigm	  to	  fMRI,	  and	  the	   further	   replication	  and	  extension	  of	  previous	   findings.	   In	  addition,	   this	   study	  showed	  the	  sensitivity	  of	   the	   task	   to	   the	  effects	  of	   the	  COMT	   genotype.	  The	   third	  study	  (fMRI)	  was	  one	  of	  the	  first	  studies	  that	  exploratorily	  investigated	  the	  effects	  
COMT	  in	  a	  sample	  of	  aADHD	  patients	  and	  a	  comparable	  healthy	  control	  group.	  This	  study	   showed	   an	   interactive	   effect	   of	   these	   two	   factors	   on	   neuropsychological	  measures	  as	  well	   as	  on	   fMRI	  activation	  during	  a	   classic	  n-­‐back	  working	  memory	  task.	  In	  addition,	  this	  task	  led	  to	  more	  activation	  in	  the	  task-­‐positive	  network	  of	  the	  aADHD	  group	  compared	  to	  a	  healthy	  control	  group	  in	  the	  absence	  of	  performance	  differences,	   pointing	   towards	   compensatory	   activation	   in	   the	   aADHD	   group.	  Furthermore,	  activation	  in	  the	  frontal	  cortex	  was	  increased	  in	  patients	  taking	  MPH	  compared	  to	  a	  placebo.	  The	  fMRI	  data	  from	  the	  selective	  attention	  task	  moreover	  showed	  decreased	  activation	   in	   the	   right	  DLPFC	  of	   the	  patient	  group,	  which	  was	  associated	  with	  reduced	  suppression	  efficiency	  across	  all	  participants.	  The	  clinical	  effect	  of	  MPH	  in	  the	  third	  study	  was	  visible	  but	  did	  not	  reach	  significance,	  which	  is	  probably	  attributable	  to	  a	  lack	  of	  experimental	  power.	  The	   studies	   in	   this	   dissertation	   could	   successfully	   replicate	   and	   extend	  previous	   findings.	  A	  goal	   for	   future	  studies	  should	  be	   the	   further	   investigation	  of	  the	   interactive	   effects	   of	  COMT	   genotype	   and	   aADHD	  on	   neuropsychological	   test	  results	  and	  fMRI	  activation,	  but	  also	  on	  medication	  response	  and	  adverse	  effects.	  In	  this	  context,	  the	  adaptation	  of	  a	  network	  perspective	  during	  the	  analysis	  of	  fMRI	  data	  seems	  to	  be	  the	  best	  way	  to	  detect	  existing	  between-­‐group	  differences.	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1 Introduction	  
	  People	  with	  ADHD	  are	  difficult	  to	  deal	  with.	  They	  are	  hard	  on	  everybody	  else,	  and	  they	  are	  especially	  hard	  on	  themselves,	  even	  if	   they	  do	  seem	  to	  be	   nothing	   more	   than	   hedonistic	   fun-­‐seekers.	   Too	   many	   internalize	   the	  feeling	   held	   by	   others	   that	   they	   are	   incorrigibly	   flawed,	   deficient,	  disposable	  people	  with	  little	  to	  offer	  to	  society.	  Too	  many	  are	  abandoned	  to	   inadequate	   educational	   systems	   and	   parental	   support	   networks	   and	  grow	  up	  to	  become	  unsocialized,	  unqualified,	  problematic	  and	  emotionally	  erratic	  adults.	  Too	  many	  spend	  their	  lives	  hurting	  themselves	  and	  others,	  endlessly	   apologizing	   for	   their	   actions	   in	   the	   hope	   that	   the	   apology	  will	  dismiss	   the	  behavior	   that	   caused	   the	  pain	  as	   if	   it	  were	  a	  bad	  dream	  that	  never	  happened.	  But	  it	  did.	  And	  it	  will	  not	  go	  away.	  Ever.	  Richard	  Kuendig	  in	  ADHD:	  An	  Autobiography	  of	  Survival	  (2003,	  p.15).	  	  These	  words	  by	  Richard	  Kuendig,	  a	  clinical	  psychologist	  who	  himself	  suffers	  from	  adult	  attention	  deficit/	  hyperactivity	  disorder	  (aADHD)	  dramatically	  describe	  the	   long-­‐term	   consequences	   of	   a	   disorder	   that	   was	   once	   thought	   to	   subside	   in	  adolescence.	   The	   conception	   of	   ADHD	   as	   a	   childhood	   disorder	   that	   you	   just	  ‘outgrow’	   is	  still	  widespread	  and	  research	  has	  only	  relatively	  recently	  recognized	  that	  this	  might	  not	  be	  the	  case	  for	  most	  of	  the	  affected	  children.	  ADHD	  is	  in	  fact	  a	  disorder	  that	  subtly	  and	  pervasively	  affects	  neurophysiological	  functioning	  leading	  to	  altered	  attentional	  and	  emotional	  processes.	  While	  research	  on	  childhood	  ADHD	  abounds,	  much	  work	  remains	  to	  be	  done	  on	  how	  this	  disorder	  affects	  adults,	  and	  few	   studies	   exist	   on	   the	   influence	   of	   pharmacological	   treatment	   on	   adult	   brain	  function.	   This	   dissertation	   therefore	   aims	   to	   contribute	   to	   the	   understanding	   of	  attentional	  processes	   in	   aADHD,	   the	  pharmacological	   treatment	  of	   its	   symptoms,	  and	  the	  possible	  interaction	  of	  aADHD	  and	  a	  common	  variation	  of	  the	  COMT	  gene,	  which	  might	  ameliorate	  or	  exacerbate	  existing	  symptoms.	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1.1 Adult	  ADHD	  and	  Its	  Treatment	  
 Diagnosis,	  Prevalence,	  and	  Persistence	  1.1.1
The	   first	  well-­‐known	  description	  of	  ADHD	   in	  children	  dates	  back	  as	   far	  as	  1845	   (Lange,	   Reichl,	   Lange,	   Tucha,	  &	   Tucha,	   2010):	  Heinrich	  Hoffman	   described	  two	   children,	   with	   one	   –	   Fidgety	   Phil	   –	   exhibiting	   severe	   symptoms	   of	  hyperactivity	   with	   an	   inability	   to	   sit	   still,	   and	   the	   other	   –	   Johnny	   Head-­‐in-­‐Air	   –	  showing	  pronounced	  symptoms	  of	  inattention.	  The	  disorder	  now	  known	  as	  ADHD	  was	   subsequently	   described	   as	   a	   “defect	   in	   moral	   control”,	   “postencephalitic	  behavior	  disorder”,	  “hyperkinetic	  disease	  of	  infancy”,	  “minimal	  brain	  damage”,	  and	  “minimal	   brain	   dysfunction”	   before	   the	   second	   edition	   of	   the	   Diagnostic	   and	  Statistical	  Manual	  of	  Mental	  Disorders	  (DSM-­‐II)	  (American	  Psychiatric	  Association,	  1968)	  introduced	  the	  condition	  as	  “Hyperkinetic	  Reaction	  of	  Childhood”.	  In	  1980,	  the	   DSM-­‐III	   (American	   Psychiatric	   Association)	   changed	   the	   focus	   from	  hyperkinesis	   to	   attentional	   dysfunction	   by	   specifying	   the	   diagnostic	   criteria	   for	  attention	   deficit	   disorder	   (ADD),	   with	   and	   without	   hyperactivity.	   However,	   the	  revision	   of	   this	   edition	   (DSM-­‐III-­‐R)	   (American	   Psychiatric	   Association,	   1987)	  provided	   an	   equal	   focus	   on	   symptoms	   of	   both	   inattention	   and	   hyperactivity/	  impulsivity	   by	   naming	   the	   condition	   attention	   deficit/	   hyperactivity	   disorder	  (ADHD)	  for	  the	  first	  time,	  before	  the	  DSM-­‐IV-­‐TR	  (American	  Psychiatric	  Association,	  2000)	  described	  the	  current	  symptoms	  and	  provided	  further	  diagnostic	  specificity	  by	   distinguishing	   between	   three	   different	   subtypes	   based	   on	   the	   individual	  distribution	  of	  symptoms	  (see	  Table	  1.1).	  The	   recently	   published	   latest	   revision,	   DSM-­‐5	   (American	   Psychiatric	  Association,	   2013),	   only	  makes	   slight	   changes	   to	   these	   criteria.	  However,	   special	  efforts	   were	   undertaken	   to	   better	   include	   adult	   presentations	   of	   ADHD	   in	   the	  definition	  of	  the	  disorder.	  While	  the	  diagnostic	  criteria	  remain	  the	  same,	  examples	  now	  specify	  how	  symptoms	  may	  present	  in	  adolescence	  and	  adulthood,	  e.g.	  instead	  of	   inappropriately	   leaving	   their	   seats,	  older	  adolescents	  and	  adults	  may	  be	  more	  likely	  to	  endure	  a	  distressing	  subjective	  feeling	  of	  restlessness	  in	  situations	  where	  they	  are	  expected	  to	  remain	  seated	  for	  a	  lengthy	  amount	  of	  time.	  Emotional	  lability	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as	  an	  impairment	  that	  is	  rather	  common	  in	  aADHD	  and	  independent	  of	  underlying	  comorbid	   conditions	   (Skirrow	  &	  Asherson,	   2013)	  was,	   however,	   not	   included	   in	  the	   new	   symptoms	   list.	   The	   DSM-­‐5	   (2013)	   also	   slightly	   lowers	   the	   diagnostic	  threshold	  for	  adults	  over	  the	  age	  of	  17	  years	  and	  now	  only	  requires	  five	  symptoms	  from	  one	  (or	  both)	  of	  the	  categories	  for	  a	  diagnosis.	  	  
	  





Hyperactivity/	  Impulsivity	  Careless	  mistakes	   Fidgeting	  or	  squirming	  Difficulty	  sustaining	  attention	   Leaving	  one’s	  seat	  Not	  listening	   Inappropriate	  running	  or	  climbing	  Failure	  to	  finish	  tasks	   Difficulty	  playing	  quietly	  Difficulty	  organizing	  tasks	   Often	  ‘on	  the	  go’	  	  Dislike	  of	  sustained	  mental	  effort	   Excessive	  talking	  Loss	  of	  necessary	  things	   Blurting	  out	  Easily	  distracted	   Difficulty	  awaiting	  turn	  Forgetful	   Interrupting	  or	  intruding	  	  Six	  or	  more	  symptoms:	  
!	  Predominantly	  inattentive	  type	  
	  Six	  or	  more	  symptoms:	  	  
!	  Predominantly	  hyperactive-­‐impulsive	  type	  	  Criteria	  for	  both	  subtypes	  are	  met:	  
!	  Combined	  type	  	  Necessary	  preconditions:	  	  
• Symptoms	  persist	  for	  at	  least	  six	  months.	  
• Some	  symptoms	  are	  present	  before	  the	  age	  of	  seven	  years.	  
• Symptoms	  cause	  some	  impairment	  in	  two	  or	  more	  settings.	  	  
• Clear	  evidence	  of	  significant	  impairment	  in	  social,	  academic,	  or	  occupational	  functioning.	  	  While	  there	  are	  numerous	  studies	  investigating	  the	  prevalence	  of	  ADHD	  in	  children	   and	   adolescents,	   studies	   of	   ADHD	   prevalence	   in	   adults	   are	   still	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comparably	   rare.	   A	   German	   study	   reports	   a	   prevalence	   rate	   of	   4.7	  %	   in	   a	   large	  population	   sample	   aged	   18	   to	   64	   years	   (de	   Zwaan	   et	   al.,	   2012).	   Younger	  participants	  met	  criteria	   for	  ADHD	  more	  often	  than	  older	  participants	  and	  ADHD	  symptoms	  were	  associated	  with	  lower	  education,	  unemployment,	  depression,	  and	  anxiety,	   but	  not	  with	   gender.	  An	  Australian	   study	  of	   a	   large	  middle-­‐aged	   sample	  with	  a	  mean	  age	  of	  50	  years	   reports	  a	   slightly	  higher	  ADHD	  prevalence	  of	  6.2	  %	  (Das,	   Cherbuin,	   Butterworth,	   Anstey,	   &	   Easteal,	   2012).	   As	   in	   the	   German	   study,	  there	   was	   no	   gender	   difference,	   and	   participants	   with	   more	   ADHD	   symptoms	  suffered	   from	   higher	   depression	   and	   anxiety	   and	   scored	   lower	   on	   measures	   of	  employment,	   financial	   and	   general	  well-­‐being,	   relationship	  quality,	   and	  health.	  A	  Dutch	  study	  investigated	  a	  sample	  of	  older	  adults	  aged	  60	  to	  94	  years	  (Michielsen	  et	  al.,	  2012).	  These	  researchers	  found	  that	  2.8	  %	  of	  participants	  met	  full	  diagnostic	  criteria	  of	  ADHD	  with	  an	  additional	  4.2	  %	  showing	  four	  or	  more	  symptoms	  of	  any	  one	   of	   the	   three	   subtypes.	   As	   in	   the	   previous	   studies,	   ADHD	   symptoms	  declined	  with	  increasing	  age.	  A	  recent	  meta-­‐analysis	  puts	  the	  prevalence	  of	  ADHD	  according	  to	  DSM-­‐IV	  (2000)	  at	  5.9	  %	  to	  7.1	  %	  for	  children	  and	  adolescents,	  and	  at	  5.0	  %	  for	  young	  adults	  (Willcutt,	  2012).	  Importantly,	  these	  researchers	  found	  no	  significant	  differences	  in	  the	  prevalence	  rates	  for	  different	  regions	  or	  countries.	  This	  finding	  supports	  ADHD	  as	  a	  valid	  diagnostic	  construct.	  	  Studies	  furthermore	  indicate	  a	  substantial	  stability	  of	  ADHD	  symptoms	  over	  time:	   A	   ten-­‐year	   follow-­‐up	   study	   of	   children	   aged	   6	   to	   17	   years	   at	   the	   first	  assessment	   points	   to	   a	   substantial	   persistence	   of	   ADHD	   symptoms	   (Biederman,	  Petty,	   Evans,	   Small,	   &	   Faraone,	   2010).	   While	   35	  %	   of	   participants	   still	   met	   full	  diagnostic	  criteria	  at	  follow-­‐up,	  another	  43	  %	  still	  showed	  subthreshold	  symptoms	  or	   functional	   impairment.	   These	   participants	   also	   presented	   with	   increased	  psychiatric	   comorbidity	   and	   stronger	   educational	   and	   interpersonal	   impairment.	  Furthermore,	  a	  Swedish	  study	  showed	  that	  53.3	  %	  of	  older	  adults	  (aged	  65	  to	  80	  years)	   who	   were	   retrospectively	   diagnosed	   with	   childhood	   ADHD	   still	   scored	  above	  the	  cut-­‐off	  on	  a	  present-­‐day	  rating	  scale	  (Guldberg-­‐Kjar,	  Sehlin,	  &	  Johansson,	  2013).	   A	   meta-­‐analysis	   of	   follow-­‐up	   studies	   of	   children	   with	   ADHD	   reports	  persistence	  rates	  of	  around	  15	  %	  at	  age	  25	  years	  when	  full	  diagnostic	  criteria	  had	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to	  be	  fulfilled,	  but	  of	  around	  65	  %	  when	  also	  partially	  remitted	  cases	  were	  included	  (Faraone,	  Biederman,	  &	  Mick,	  2006).	  	  In	   addition,	   longitudinal	   studies	   of	   participants	   diagnosed	   with	   ADHD	   in	  childhood	   or	   adolescence	   support	   the	   association	   of	   ADHD	   and	   worsened	   life	  outcomes:	  A	  study	  following	  a	  community	  sample	  of	  adolescents	  over	  twenty	  years	  found	  an	  association	  of	  ADHD	  symptoms	  in	  adolescence	  and	  impaired	  physical	  and	  mental	  health,	  lower	  work	  performance,	  and	  increased	  financial	  stress	  in	  later	  life	  (Brook,	  Brook,	  Zhang,	  Seltzer,	  &	  Finch,	  2013).	  A	  16-­‐year	  longitudinal	  study	  reports	  higher	   lifetime	   rates	   of	   psychiatric	   disorders	   and	   increased	   impairment	   in	  psychosocial	   and	   educational	   functioning	   in	   adults	   originally	   diagnosed	   with	  childhood	   ADHD	   compared	   to	   a	   case-­‐control	   group	   (Biederman	   et	   al.,	   2012).	   In	  addition,	  a	  study	  of	  an	  adult	  patient	  sample	  found	  significantly	  lower	  educational	  attainment	   and	   a	   lower	   level	   of	   employment	   than	   in	   the	   general	   population	  (Gjervan,	  Torgersen,	  Nordahl,	  &	  Rasmussen,	  2012).	   Interestingly,	  a	   later	  begin	  of	  stimulant	  treatment	  was	  associated	  with	  worse	  employment	  outcomes.	  	  	  
 Pharmacological	  Treatment	  1.1.2
The	   first	   treatment	   attempt	   of	   children	   with	   ADHD	   using	   stimulant	  medication	   was	   implemented	   by	   Charles	   Bradley	   in	   the	   1930s	   (Conners,	   2000;	  Lange	   et	   al.,	   2010).	   He	   had	   administered	   the	   strong	   stimulant	   Benzedrine	   to	  hospitalized	   children	   for	   medical	   reasons	   and	   noted	   a	   paradoxical	   effect	   of	  improved	  school	  performance	  and	  decreased	  motor	  activity	  in	  some	  of	  the	  treated	  children.	  According	  to	   the	   findings	  of	  a	  subsequent	  more	  systematic	  clinical	   trial,	  the	   most	   improved	   children	   were	   those	   who	   exhibited	   what	   would	   today	   be	  considered	   typical	   symptoms	   of	   ADHD:	   attentional	   problems,	   hyperactivity/	  impulsivity,	  and	  emotional	  instability.	   In	  1944,	  Leandro	  Panizzon	  synthesized	  the	  stimulant	  drug	  methylphenidate	  (MPH),	  which	  he	  named	  Ritalin	   in	  honour	  of	  his	  wife	   (Lange	   et	   al.,	   2010).	   MPH	   turned	   out	   to	   be	   very	   effective	   in	   treating	   the	  symptoms	  of	  ADHD	  and	  –	  unlike	  Benzedrine	  –	  is	  still	  widely	  used	  today.	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The	  stimulant	  properties	  of	  MPH	  are	  attributed	  to	  its	  capability	  to	  block	  the	  functioning	  of	  the	  dopamine	  transporter	  (DAT)	  (Schweri	  et	  al.,	  1985;	  Volkow	  et	  al.,	  2001;	  Volkow	  et	  al.,	  1998)	  and	  the	  norepinephrine	  transporter	  (NET)	  as	  well	  as	  –	  to	   a	   lesser	   extent	   –	   to	   inhibit	   monoamine	   oxidase,	   an	   enzyme	   deactivating	  catecholamine	   neurotransmitters	   like	   dopamine	   and	   norepinephrine	   (Pliszka,	  2005).	   DAT	   are	   located	   at	   the	   terminal	   button	   of	   axons	   and	   act	   by	   transporting	  excess	  dopamine	  from	  the	  synaptic	  cleft	  back	  into	  the	  neuron,	  thereby	  decreasing	  extracellular	  dopamine	  concentrations.	  Their	  main	  expression	  site	  is	  the	  striatum	  with	  only	   scarce	  expression	   in	  other	  areas	   (Lewis	  et	  al.,	  2001;	  Sesack,	  Hawrylak,	  Matus,	   Guido,	   &	   Levey,	   1998).	   A	   landmark	   positron	   emission	   tomography	   (PET)	  study	  by	  Volkow	  and	  colleagues	   (Volkow	  et	  al.,	   1998)	   could	   show	   that	  MPH	  was	  extremely	   effective	   at	   blocking	   the	   DAT,	   occupying	   more	   than	   fifty	   per	   cent	   of	  transporters	   in	  the	  striatum	  at	   therapeutic	  doses.	  These	   findings	  were	  confirmed	  in	   adult	   patients	   with	   ADHD	   who	   showed	   increased	   DAT	   availability	   in	   the	  striatum,	   with	   methylphenidate	   acting	   by	   lowering	   this	   availability	   and	   thereby	  increasing	   synaptic	   dopamine	   concentrations	   (Krause,	   Dresel,	   Krause,	   Kung,	   &	  Tatsch,	  2000;	  Krause,	  Dresel,	  Krause,	  la	  Fougere,	  &	  Ackenheil,	  2003;	  Volkow	  et	  al.,	  2007).	  	  In	   contrast	   to	   DAT,	   NET	   is	   also	   expressed	   in	   the	   cortex	   and	   can	   take	   up	  norepinephrine	   as	   well	   as	   dopamine,	   thereby	   playing	   an	   important	   role	   in	   the	  regulation	   of	   dopamine	   levels	   in	   the	   prefrontal	   cortex	   (PFC)	   (Pliszka,	   2005).	  Unfortunately,	   the	   PET	   and	   single-­‐photon	   emission	   computed	   tomography	  (SPECT)	  imaging	  used	  to	  investigate	  the	  subcortical	  action	  of	  stimulant	  medication	  is	   not	   sensitive	   enough	   to	   detect	   changes	   in	   cortical	   catecholamine	  neurotransmission	  (Arnsten,	  2006).	  The	  precise	  impact	  of	  stimulant	  medication	  in	  this	   region	   is	   therefore	   still	   somewhat	  unclear.	  However,	   an	   in	   vivo	   study	   in	   rats	  demonstrated	   that	   therapeutic	   doses	   of	   MPH	   caused	   a	   significant	   increase	   in	  norepinephrine	   and	  dopamine	   release	   in	   the	  PFC	  while	   improving	   attention	   and	  working	  memory	  (Berridge	  et	  al.,	  2006).	  	  The	  efficiency	  of	  stimulants	  to	  increase	  both	  dopamine	  and	  norepinephrine	  concentrations	   in	   the	   synaptic	   cleft	   can	   also	   be	   related	   to	   Grace’s	   (1991)	   tonic-­‐phasic	  model	  of	  dopaminergic	  function	  (see	  also	  1.2.1)	  (Pliszka,	  2005).	  According	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to	  the	  tonic-­‐phasic	  model	  of	  dopaminergic	  function,	  increased	  tonic	  (background)	  neurotransmitter	   release	   of	   dopamine	   (and	   norepinephrine)	   leads	   to	   increased	  synaptic	   concentrations	   of	   this	   neurotransmitter,	   which	   in	   turn	   activates	   the	  neurons’	   auto-­‐receptors.	   These	   auto-­‐receptors	   then	   down-­‐regulate	   the	  responsivity	   of	   the	   neurotransmitter	   system	   to	   external	   events	   by	   inducing	   a	  decrease	   of	   phasic	   (event-­‐related)	   activity	   (Grace,	   1991).	   In	   the	   case	   of	   ADHD,	  medication	  might	  operate	  to	  increase	  tonic	  neurotransmitter	  release	  and	  thereby	  reduce	   the	   activity	   of	   an	   overly	   active	   and	   therefore	   unstable	   and	   disorganised	  phasic	  dopaminergic	   (and	  noradrenergic)	   system	   (Arnsten,	   2006;	  Pliszka,	   2005).	  As	   the	   dopaminergic	   and	   noradrenergic	   neurotransmitter	   systems	   are	   closely	  linked,	  the	  individual	   impact	  of	  these	  two	  systems	  on	  cognition	  can	  currently	  not	  be	   separated.	   It	   is,	   however,	   notable	   that	  medications	  which	   primarily	   influence	  the	  dopaminergic	  system	  so	  far	  showed	  no	  effectiveness	  in	  the	  treatment	  of	  ADHD	  (Pliszka,	  2005).	  Studies	   investigating	  MPH	  treatment	   in	  aADHD	  patients	  vary	  considerably	  in	  terms	  of	  design,	  medication	  schedule,	  MPH	  formulation,	  and	  employed	  symptom	  ratings:	  A	  recent	   long-­‐term	  double-­‐blind	  placebo-­‐controlled	  study	  tested	  efficacy,	  tolerability,	  and	  safety	  of	   long-­‐acting	  osmotic-­‐release	  oral	  system	  (OROS)	  MPH	  in	  223	   adults	   diagnosed	  with	  ADHD	   (Biederman,	  Mick,	   et	   al.,	   2010).	   In	   order	   to	   be	  included	   in	   the	   study,	   participants	   had	   to	   fulfil	   diagnostic	   criteria	   for	   ADHD	  according	   to	  DSM-­‐IV-­‐TR	   (2000)	   and	   be	  without	   an	   adequate	   trial	   of	  MPH	   in	   the	  past.	   The	   authors	   randomly	   assigned	   participants	   to	   either	   MPH	   or	   placebo	  treatment	   and	   used	   a	   free	   dose	   titration	   schedule.	   In	   this	   schedule,	   medication	  dose	   could	   be	   flexibly	   adjusted	   based	   on	   patients’	   reports	   of	   subjective	  improvement	  and	  adverse	  effects.	  The	  maximum	  allowed	  dose	  was	  1.3	  mg/kg	  per	  day	   and	   a	   mean	   daily	   dose	   of	   78.4	  ±	  31.7	  mg	   was	   achieved	   after	   six	   weeks	   of	  treatment.	   ADHD	   symptoms	   were	   assessed	   using	   the	   Adult	   ADHD	   Investigator	  Symptom	  Rating	  Scale	  (AISRS),	  a	  semi-­‐structured	  interview	  (Spencer	  et	  al.,	  2010).	  After	   six	  weeks	   of	   either	  MPH	   or	   placebo	   treatment,	   patients	   in	   the	  MPH	   group	  showed	  significantly	  more	  improvement	  with	  significantly	  more	  responders	  in	  this	  group	   than	   in	   the	   placebo	   group	   (67	  %	   versus	   37	  %).	   A	   following	   24-­‐week	   trial	  with	  the	  responders	  from	  both	  groups	  showed	  no	  difference	  between	  the	  MPH	  and	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the	  placebo	  group	  with	  regard	  to	  stability	  of	  the	  response.	  MPH	  responders	  were	  subsequently	   randomised	   to	   a	   4-­‐week	   discontinuation	   trial,	   where	   they	   were	  assigned	   either	   their	   previous	   MPH	   medication	   or	   were	   switched	   to	   a	   placebo.	  Interestingly,	   although	   the	   placebo	   group	   showed	   a	   slight	   worsening	   of	   their	  symptoms	  and	   the	  MPH	  group	  showed	  some	   further	   improvement,	   there	  was	  no	  significant	  difference	  with	  regard	  to	  relapse	  rate	  between	  the	  two	  groups.	  	  A	  double-­‐blind	  forced	  titration	  trial	  over	  six	  weeks	  yielded	  similar	  results:	  Spencer	  and	  colleagues	  (2005)	  investigated	  MPH	  treatment	  in	  146	  aADHD	  patients	  and	  report	  significantly	  higher	  response	  rates	  of	  the	  MPH	  group	  compared	  to	  the	  placebo	  group	  based	  on	  investigator	  ratings,	  but	  also	  slightly	  more	  adverse	  effects	  the	   form	   of	   appetite	   suppression,	   dry	   mouth,	   moodiness,	   and	   weight	   loss.	   The	  immediate-­‐release	  (IR)	  MPH	  medication	  used	  in	  this	  study	  was	  prescribed	  up	  to	  a	  maximum	   dose	   of	   1.3	  mg/kg	   per	   day	  with	   a	  mean	   dose	   of	   82	  ±	  22	  mg	   achieved	  after	  six	  weeks.	  The	  MPH	  medication	  used	  in	  this	  study	  was	  supplied	  by	  Novartis	  Pharmaceuticals	  Corporation	  and	  was	  most	  likely	  Ritalin®.	  The	  company	  does	  not	  give	  any	  explicit	  recommendations	  for	  maximum	  daily	  dosage	  in	  adults,	  but	  states	  that	   the	   average	   dosage	   is	   20	  mg	   to	   30	  mg	   per	   day	   (Novartis	   Pharmaceuticals	  Corporation),	   which	   makes	   the	   average	   daily	   dosage	   used	   in	   this	   study	   appear	  rather	  high.	  Medori	   and	   colleagues	   (2008)	   report	   the	   results	   of	   a	   double-­‐blind	   fixed	  dose	  trial	  with	  401	  aADHD	  patients.	  Patients	  received	  either	  a	  daily	  dose	  of	  18	  mg,	  36	  mg,	   or	   72	  mg	   MPH	   or	   a	   placebo,	   with	   72	  mg/day	   being	   the	   maximum	  recommended	   adult	   dose	   of	   Concerta®,	   the	   extended-­‐release	   MPH	   medication	  used	   in	   this	   study	   (Janssen	  Pharmaceuticals).	   This	   trial	   also	   yielded	   significantly	  more	  improvement	  in	  the	  three	  MPH	  groups	  compared	  to	  the	  placebo	  group	  with	  effect	   sizes	   of	   .38,	   .43,	   and	   .72,	   respectively.	   There	   were	   also	   significantly	  more	  responders	   in	   the	   MPH	   groups	   (between	   48.5	  %	   and	   59.6	  %)	   compared	   to	   the	  placebo	  group	  (27.4	  %)	  when	  observer	  ratings	  on	  the	  Conners’	  Adult	  ADHD	  Rating	  Scales	  (CAARS)	  (Conners,	  Erhardt,	  &	  Sparrow,	  1999)	  were	  examined.	  When	  CAARS	  self-­‐report	   ratings	  were	   considered,	   the	   placebo	   group	   also	   showed	   significantly	  less	  improvement	  than	  the	  72	  mg/day	  MPH	  group	  across	  the	  scales	  incorporating	  adult	  symptoms	  as	  well	  as	  on	  the	  total	  and	  index	  score	  scales,	  but	  differences	  were	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less	   stable	   when	   the	   placebo	   group	   was	   compared	   to	   the	   18	  mg/day	   and	  36	  mg/day	  MPH	  groups.	  In	  addition,	  all	  MPH	  groups	  showed	  more	  adverse	  effects	  in	   the	   form	   of	   decreased	   appetite,	   headache,	   and	   insomnia	   with	   some	   of	   these	  effects	  being	  dose-­‐dependent.	  	  A	   large	   German	   multi-­‐centre	   study	   of	   extended-­‐release	   MPH	   medication	  investigated	   359	   aADHD	   patients	   for	   24	   weeks	   in	   a	   double-­‐blind	   placebo-­‐controlled	   design	   (Rösler	   et	   al.,	   2009).	   Although	   the	   maximum	   daily	   dose	   of	  60	  mg/day	   as	  well	   as	   the	  mean	   daily	   dose	   of	   0.55	  mg/kg	  were	   comparably	   low,	  these	  authors	  also	  report	  significantly	  more	  responders	  in	  the	  MPH	  group	  (61	  %)	  than	  in	  the	  placebo	  group	  (42	  %).	  	  A	  very	  recent	  meta-­‐analysis	  (Castells,	  Cunill,	  &	  Capella,	  2013)	  combined	  the	  results	  of	  twelve	  medication	  studies	  with	  over	  2,000	  adult	  patients	  diagnosed	  with	  ADHD	   according	   to	   DSM-­‐IV-­‐TR	   (2000).	   The	   authors	   found	   that	   all	   MPH	  formulations	  were	  more	  effective	  than	  placebo	  in	  reducing	  ADHD	  symptoms,	  with	  some	   heterogeneity	   between	   studies.	   However,	   patients	   medicated	   with	   MPH	  (particularly	   with	   the	   OROS	   formulation)	   were	   more	   likely	   to	   discontinue	  treatment	   than	   patients	   receiving	   placebo.	   The	   authors	   also	   point	   to	   a	   potential	  bias	  of	  the	  included	  studies	  caused	  by	  possible	  blinding	  failure	  of	  the	  investigators	  due	  to	  the	  visible	  behavioural	  and	  hemodynamic	  effects	  of	  methylphenidate.	  These	  effects	  might	   allow	   trained	   clinical	   investigators	   to	   distinguish	   between	   patients	  receiving	  MPH	  and	  patients	  receiving	  placebo,	  even	  if	  they	  are	  formally	  blind	  to	  the	  intervention.	  	  To	   summarise,	   double-­‐blind	   placebo-­‐controlled	   trials	   seem	   to	   indicate	   a	  superiority	   of	   MPH	   treatment	   over	   placebo	   in	   aADHD,	   both	   when	   symptom	  reduction	  and	  response	  rates	  are	  considered.	  There	   is,	  however,	   some	   indication	  that	  treatment	  effects	  might	  be	  more	  pronounced	  in	  fixed	  dose	  or	  forced	  titration	  trials	   than	   in	  more	   externally	   valid	   flexible	   dose	   titration	   trials,	  with	   the	   overall	  daily	  dosage	  in	  some	  of	  the	  studies	  being	  rather	  high.	  In	  addition,	  effects	  might	  be	  more	   visible	   on	   investigator	   ratings	   compared	   to	   patient	   self-­‐reports,	   with	   the	  potential	   for	   blinding	   failures	   due	   to	   visible	   consequences	   of	  MPH	   treatment	   for	  the	  trained	  clinician.	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 Higher	  Order	  Cognitive	  Functioning	  	  1.1.3
(1) Theories	  	  
Besides	   the	   well-­‐known	   deficits	   in	   the	   regulation	   of	   activity,	   behavioural	  impulses,	  and	  attention,	  research	  interest	  also	  focused	  on	  a	  potential	   impairment	  of	   higher	   order	   cognitive	   functioning	   in	   ADHD.	   In	   1997,	   Barkley	   proposed	   an	  extremely	  influential	  theory	  that	  shifted	  the	  focus	  away	  from	  deficient	  attentional	  processes	   and	   linked	   the	   behavioural	   inhibition	   deficit	   observed	   in	   the	  predominantly	   hyperactive-­‐impulsive	   and	   the	   combined	   type	   ADHD	   to	   impaired	  executive	   functioning	   and	   motor	   control	   (see	   Figure	   1.1	   for	   a	   schematic	   of	   this	  model).	  	  	  	  
	  Figure	  1.1:	  Schematic	  of	   the	  model	   linking	  the	  behavioural	   inhibition	  deficit	   in	  ADHD	  to	   impaired	  executive	  functioning	  and	  motor	  control	  (Barkley,	  1997).	  The	  figure	  was	  modified	  from	  the	  original	  to	  improve	  legibility.	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ADHD	  of	   the	   predominantly	   inattentive	   type	  was	   explicitly	   excluded	   from	  this	  model,	  as	  Barkley	  (1997)	  proposed	  that	  the	  attentional	  deficits	  of	  this	  subtype	  were	   related	   to	   deficient	   attentional	   focus	   and	   speed	   of	   information	   processing	  and	   thereby	   qualitatively	   different	   from	   the	   attentional	   deficits	   related	   to	  persistence	   and	   distractibility	   observed	   in	   the	   two	   other	   subtypes.	   Importantly,	  although	   many	   adults	   with	   ADHD	   might	   present	   with	   the	   predominantly	  inattentive	   type	   due	   to	   a	   reduction	   of	   hyperactivity	  with	   increasing	   age,	   Barkley	  notes	  that	  the	  model	  should	  still	  be	  valid	  for	  those	  adults	  suffering	  from	  ADHD	  of	  the	  predominantly	  hyperactive-­‐impulsive	  or	  combined	  type	  in	  childhood.	  	  According	   to	   this	  model,	   the	  core	  deficit	   in	  ADHD	   is	   impaired	  behavioural	  inhibition.	  This	  central	  deficit	  leads	  to	  impairment	  in	  the	  executive	  functions	  (EF)	  that	  rely	  on	  behavioural	  inhibition	  –	  working	  memory,	  self-­‐regulation,	  internalised	  speech,	   and	   reconstitution.	   These	   EF	   normally	   act	   to	   bring	   behaviour	   under	   the	  control	   of	   internally	   represented	   information	   and	   are	   thus	   necessary	   for	   goal-­‐directed	  action	  and	  task	  persistence,	  both	  of	  which	  are	  impaired	  in	  ADHD.	  Barkley	  (1997)	  reports	  empirical	  evidence	  for	  an	  impairment	  of	  behavioural	  inhibition	  and	  its	  subcomponents,	  of	  the	  EF	  of	  working	  memory	  and	  self-­‐regulation,	  and	  of	  motor	  control,	  with	  research	  of	  internalised	  speech	  and	  reconstitution	  in	  ADHD	  being	  still	  scarce.	  	  A	   meta-­‐analysis	   of	   studies	   investigating	   EF	   deficits	   in	   children	   and	  adolescents	  with	   ADHD	   confirmed	   an	   overall	   impairment	   in	   the	   investigated	   EF	  domains	  of	  response	  inhibition,	  vigilance,	  set-­‐shifting,	  planning/	  organization,	  and	  verbal	   as	   well	   as	   spatial	   working	   memory	   (Willcutt,	   Doyle,	   Nigg,	   Faraone,	   &	  Pennington,	   2005).	   The	   authors	   report	   a	  medium	  effect	   size	   across	   the	   different	  paradigms	   with	   lower	   effects	   for	   measures	   of	   set-­‐shifting,	   Stroop	   interference	  control,	   and	   visuospatial	   attention	   orienting.	   Interestingly,	   there	   was	   some	  evidence	  of	  an	  association	  of	  inattention	  but	  not	  hyperactivity/	  impulsivity	  with	  EF	  deficits,	  contradicting	  Barkley’s	  (1997)	  assumptions	  and	  raising	  the	  possibility	  of	  the	   predominantly	   hyperactive-­‐impulsive	   type	   as	   an	   aetiologically	   distinct	  disorder.	  Still,	  based	  on	  the	  much	  smaller	  effect	  sizes	   for	  EF	  dysfunction	  than	  for	  ADHD	  symptoms	   in	   the	   reviewed	  studies,	   the	  authors	   conclude	   that	   although	  EF	  seem	  to	  be	  impaired	  in	  ADHD,	  deficient	  behavioural	  inhibition	  and	  EF	  dysfunction	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are	   “neither	   necessary	   nor	   sufficient	   to	   cause	   all	   cases	   of	   ADHD”	   (p.	  1336).	   This	  result	  was	  confirmed	  by	  a	  meta-­‐analysis	  of	  studies	  with	  aADHD	  patients	  (Boonstra,	  Oosterlaan,	   Sergeant,	  &	  Buitelaar,	   2005).	   The	   authors	   found	  medium	  effect	   sizes	  for	   different	   EF	   tasks	   (verbal	   fluency,	   inhibition,	   set-­‐shifting),	   but	   also	   for	   tasks	  classified	  as	  non-­‐EF	  (response	  consistency,	  word	  reading,	  colour	  naming)	  leading	  them	   to	   question	   the	   assumption	   of	   EF	   dysfunction	   as	   an	   exclusive	   underlying	  cause	  of	  ADHD.	  A	  meta-­‐analysis	  examining	  working	  memory	  research	  in	  children	  and	   adolescents	  with	  ADHD	   furthermore	   reports	   a	   significant	   impairment	   in	   the	  ADHD	  group	  compared	  to	  a	  control	  group	  (Martinussen,	  Hayden,	  Hogg-­‐Johnson,	  &	  Tannock,	  2005).	  These	  deficits	  were	  particularly	  pronounced	  in	  the	  areas	  of	  spatial	  information	   storage	   and	   manipulation,	   but	   were	   also	   significant	   for	   the	   verbal	  domain.	  	  The	  fact	  that	  EF	  impairment	  in	  ADHD	  is	  clearly	  visible	  on	  a	  group	  level,	  but	  is	   not	   necessarily	   on	   an	   individual	   level	   led	   researchers	   to	   investigate	   plausible	  alternatives.	   Another	   very	   influential	   model	   was	   proposed	   by	   Sonuga-­‐Barke	  (2005).	   He	   suggested	   that	   ADHD	   might	   result	   from	   impaired	   reward-­‐related	  motivational	   processes	   mediated	   by	   frontoventral	   striatal	   and	   mesolimbic	  dopaminergic	   functioning	   (for	   a	   recent	   review	   see	   Plichta	   &	   Scheres,	   2013)	   in	  addition	  to	  executive	  dysfunction	  that	  resulted	  from	  deficient	  frontodorsal	  striatal	  and	   mesocortical	   dopaminergic	   functioning.	   In	   a	   further	   development	   of	   this	  model,	   an	   abandonment	   of	   the	   notion	   of	   one	   core	   deficit	   underlying	   ADHD	  was	  suggested	   and	   the	   alternative	   possibility	   of	   different	   neurophysiological	   and	  developmental	   pathways	   leading	   to	   the	   same	   disorder	   was	   considered	  (Castellanos,	   Sonuga-­‐Barke,	   Milham,	   &	   Tannock,	   2006).	   It	   was	   proposed	   to	  distinguish	   between	   ‘cool’	   EF,	  which	  were	   necessary	   to	   solve	   abstract	   tasks	   like	  working	  memory	  or	  interference	  control,	  and	  ‘hot’	  EF	  needed	  for	  affectively	  loaded	  problems	   like	   delay	   discounting.	   As	   supported	   by	   previous	   research,	   ‘cool’	   EF	  should	   be	   related	   to	   the	   inattention	   dimension	   of	   ADHD	  whereas	   ‘hot’	   EF	   were	  hypothesised	   to	   be	   specific	   for	   the	   hyperactivity/	   impulsivity	   dimension.	   In	  addition,	   while	   ‘cool’	   EF	   were	   proposed	   to	   be	   linked	   to	   functioning	   of	   the	  dorsolateral	   prefrontal	   cortex	   (DLPFC)	   and	   the	   dorsal	   anterior	   cingulate	   cortex	  (dACC),	   ‘hot’	  EF	  should	  be	  mediated	  by	  the	  orbital	  and	  medial	  PFC	  as	  well	  as	  the	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ventral	   striatum	   and	   the	   nucleus	   accumbens.	   According	   to	   this	   model,	   an	  impairment	   of	   ‘cool’	   and	   ‘hot’	   EF	   can	   be	   expected	   on	   a	   group	   level,	   but	   the	  individual	   ADHD	   patient	   may	   show	   deficiencies	   in	   ‘cool’	   EF,	   ‘hot‘	   EF,	   or	   both,	  depending	  on	  his	  or	  her	  symptomatology.	  	  It	  has	   to	  be	  noted	   that	   the	  development	  of	   the	  above-­‐described	  models	  as	  well	   as	   their	   empirical	   support	   are	   almost	   exclusively	   based	   on	   studies	  investigating	  children	  and	  adolescents	  with	  ADHD.	  However,	  given	  the	  stability	  of	  cognitive	  deficits	  over	  time,	  they	  should	  nevertheless	  also	  be	  applicable	  to	  an	  adult	  population	  (Castellanos	  et	  al.,	  2006).	  	  	  
(2) Neuroimaging	  Research	  
Recent	  neuroimaging	  studies	  succeeded	  to	  link	  the	  hypothesis	  of	  altered	  EF	  in	  ADHD	   to	   functional	  differences	  between	  aADHD	  patients	   and	  healthy	   controls	  during	   task	   completion.	   A	   functional	   magnetic	   resonance	   imaging	   (fMRI)	   study	  (Valera	   et	   al.,	   2010)	   investigated	   aADHD	   patients	   and	  matched	   healthy	   controls	  using	   the	   classic	   n-­‐back	   task	   (J.	   D.	   Cohen	   et	   al.,	   1994).	   The	   researchers	   found	  significantly	   less	   prefrontal	   activation	   in	   the	   aADHD	   group	   than	   in	   the	   healthy	  control	  group	   in	  the	  absence	  of	  behavioural	  performance	  differences.	  The	  results	  also	  indicated	  more	  pronounced	  differences	  for	  male	  than	  for	  female	  participants	  and	   a	   differential	   association	   of	   task-­‐related	   activation	   with	   hyperactive/	  impulsive	  and	  inattentive	  symptomatology	  for	  men	  and	  for	  women.	  A	  similar	  fMRI	  study	   with	   a	   sample	   of	   medication-­‐naïve	   aADHD	   patients	   found	   an	   overall	  decreased	   activation	   pattern	   in	   the	   task-­‐positive	   network	   when	   task-­‐related	  activation	  of	  the	  aADHD	  group	  was	  visually	  compared	  to	  a	  matched	  control	  group	  (Bayerl	  et	  al.,	  2010).	  However,	   the	  only	  significant	  between-­‐group	  difference	  was	  found	  in	  the	  right	  parietal	  cortex.	  An	  fMRI	  study	  using	  a	  variant	  of	  the	  Stroop	  task	  (Stroop,	  1935)	  also	  found	  widespread	  activation	  differences	  with	  healthy	  controls	  showing	  more	  activation	  than	  aADHD	  patients	  in	  DLPFC,	  anterior	  cingulate	  cortex	  (ACC),	   posterior	   parietal	   cortex,	   and	   right	   inferior	   frontal	   cortex	   (Banich	   et	   al.,	  2009).	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Given	  the	  observation	  of	  altered	  activation	  patterns	  in	  patients	  with	  ADHD,	  research	   has	   also	   focused	   on	   the	   investigation	   of	   these	   patterns.	   An	   older	  meta-­‐analysis	   of	   16	   neuroimaging	   studies	   in	   children,	   adolescents,	   and	   adults	   with	  ADHD	   used	   activation	   likelihood	   estimation	   (ALE)	   and	   identified	   a	   pattern	   of	  hypoactivation	  in	  ADHD	  patients	  compared	  to	  healthy	  controls	  (Dickstein,	  Bannon,	  Castellanos,	  &	  Milham,	  2006).	  Patients	  showed	  significantly	  lower	  activation	  in	  the	  left	   ventral	   PFC	   and	  DLPFC,	   ACC,	   and	   bilateral	   parietal	   cortex,	  with	   significantly	  higher	   activation	   only	   in	   the	   left	   insular	   and	  middle	   frontal	   gyrus.	   These	   results	  were	  confirmed	  by	  a	  more	  recent	  meta-­‐analysis,	  which	  used	  the	  same	  method	  to	  analyse	  39	  fMRI	  studies	  of	  children	  and	  adolescents	  with	  ADHD,	  and	  16	  studies	  of	  adults	  (Cortese	  et	  al.,	  2012).	  This	  meta-­‐analysis	  reports	  hypoactivation	  in	  children	  with	  ADHD	  compared	  to	  controls	  in	  bilateral	  frontal	  areas	  and	  the	  putamen	  as	  well	  as	  in	  right	  parietal	  and	  temporal	  areas.	  Hyperactivation	  was	  found	  in	  the	  posterior	  cingulate	  cortex	  (PCC)	  and	  the	  midcingulate	  cortex.	  In	  contrast,	  adults	  with	  ADHD	  showed	  significant	  hypoactivation	   in	  the	  right	  central	  and	  precentral	  gyri	  as	  well	  as	   in	   the	  right	  middle	   frontal	  gyrus,	  and	  hyperactivation	   in	   the	  right	  angular	  and	  middle	  occipital	  gyri.	  This	  meta-­‐analysis	  also	  tried	  to	  link	  the	  identified	  activation	  clusters	  to	  previously	  defined	  neurophysiological	  networks.	  Interestingly,	  children	  with	   ADHD	   showed	   most	   hypoactivation	   in	   the	   frontoparietal	   network,	   while	  hyperactivation	  was	   found	   in	   the	   default	  mode	   and	   somatomotor	   networks.	   The	  ventral	   attention	   network	  was	   associated	  with	   hypo-­‐	   but	   to	   a	   lesser	   extent	   also	  with	   hyperactivation.	   In	   contrast,	   adults	   with	   ADHD	   showed	   the	   strongest	  hypoactivation	   in	   the	   frontoparietal	   network,	   with	   some	   hyperactivation	   in	   the	  visual,	   dorsal	   attention,	   and	   default	   mode	   networks.	   Results	   were	   similar	   when	  only	   studies	   with	   medication-­‐naïve	   participants	   were	   considered.	   The	   authors	  note,	  however,	   that	   the	   lack	  of	   results	   for	   the	  dorsal	   attention	  network	  might	  be	  caused	   by	   the	   selection	   of	   studies,	   which	   were	   mostly	   investigating	   inhibition	  processes	  subserved	  by	  the	  ventral	  attention	  network.	  	  In	   addition,	   a	   recent	   fMRI	   study	   showed	   altered	   connectivity	   in	   adult	  patients	   with	   ADHD:	   A	   complex	   parametric	   verbal	   working	   memory	   task	   that	  required	   the	  maintenance	  and	  manipulation	  of	  one,	   two,	  or	   three	   letters	   showed	  no	  behavioural	  performance	  differences	  between	  a	  group	  of	  aADHD	  patients	  and	  a	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healthy	  control	  group	  (Wolf	  et	  al.,	  2009).	  However,	  during	  the	  delay	  period	  of	  the	  task,	   aADHD	   patients’	   connectivity	   in	   a	   network	   consisting	   of	   bilateral	   lateral	  prefrontal	  cortex,	  striatum,	  and	  cingulate	  cortex	  differed	  significantly	  from	  that	  of	  healthy	  controls	  with	  decreased	  connectivity	   in	  bilateral	  ventrolateral	  prefrontal,	  anterior	  cingulate,	  and	  superior	  parietal	  areas,	  but	  increased	  connectivity	  in	  right	  prefrontal,	  and	  left	  dorsal	  cingulate	  and	  occipital	  regions.	  	  To	   summarise,	   the	   deficient	   EF	   found	   on	   a	   behavioural	   level	  when	  ADHD	  patients	  were	   compared	   to	   healthy	   controls	   appears	   to	   have	   an	   equivalent	   on	   a	  neurophysiological	   level	   as	   assessed	   with	   fMRI.	   This	   altered	   neurophysiological	  functioning	  in	  ADHD	  seems	  to	  be	  more	  visible	  when	  activation	  patterns	  instead	  of	  cluster	   differences	   are	   examined.	   Studies	   linking	   the	   location	   of	   observed	  differences	   to	   hypothesised	   neurophysiological	   network	   activation	   in	   aADHD	  showed	   hypoactivation	   in	   the	   frontoparietal	   network	   and	   hyperactivation	   in	   the	  default	  mode	  and	  (as	  a	  potential	  compensation	  mechanism)	  in	  the	  dorsal	  attention	  network.	  	  	  
(3) Effects	  of	  Stimulant	  Medication	  
Neuropsychological	   and	   imaging	   studies	   also	   investigated	   the	   impact	   of	  MPH	   treatment	   on	   the	   behavioural	   performance	   of	   participants	   with	   ADHD.	   An	  open-­‐label	  trial	  of	  OROS	  MPH	  showed	  a	  significant	  improvement	  of	  test	  scores	  on	  the	  Stroop	  as	  well	  as	  on	  the	  Working	  Memory	  Index	  comprising	  the	  Arithmetic	  and	  Digit	  Span	  subtests	  of	  the	  Wechsler	  Adult	  Intelligence	  Scale	  3rd	  Edition	  (WAIS-­‐III)	  (Wechsler,	   1997)	   in	   aADHD	  patients	   after	  38	  days	  of	  medication	   (Fallu,	  Richard,	  Prinzo,	   &	   Binder,	   2006).	   In	   contrast,	   a	   similar	   placebo-­‐controlled	   study	   of	   OROS	  MPH	  reports	  no	  behavioural	  effects	  on	  a	  modified	  version	  of	   the	  Stroop	  (Bush	  et	  al.,	  2008).	  The	  fMRI	  data,	  however,	  showed	  a	  significant	   interaction	  of	  group	  and	  time	  of	   scan	  with	   the	  MPH	  group	  displaying	   increased	   activation	   in	   the	  dACC	   as	  well	  as	   in	  the	  left	  DLPFC	  and	  bilateral	  parietal	   lobe	  at	  the	  second	  scan.	  A	  double-­‐blind	   placebo-­‐controlled	   single	   dose	   cross-­‐over	   fMRI	   study	   investigating	  interference	  inhibition	  in	  a	  sample	  of	  boys	  with	  ADHD	  found	  reduced	  activation	  in	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several	  task-­‐related	  areas	  with	  MPH	  increasing	  activation	  in	  the	  right	  DLPFC	  and	  striatothalamic	  regions	  to	  the	  level	  found	  in	  healthy	  controls	  (Rubia	  et	  al.,	  2011).	  A	  similar	   study	   using	   a	   parametric	   n-­‐back	   task	   found	   worse	   performance	   and	  significant	   hypoactivation	   of	   the	   bilateral	   DLPFC	   during	   the	   2-­‐back	   condition	   in	  boys	   with	   ADHD	   compared	   to	   healthy	   controls	   (Cubillo	   et	   al.,	   2013).	   Patients	  taking	   MPH	   showed	   higher	   activation	   of	   the	   left	   DPLFC	   during	   the	   2-­‐back	  condition,	   leading	   the	   authors	   to	   propose	   an	   up-­‐regulation	   of	   the	   task-­‐positive	  network	   through	  MPH.	  A	  naturalistic	  cross-­‐over	  study	  of	  adolescents	  with	  ADHD	  examined	   fMRI	   activation	   during	   a	  working	  memory	   task	  with	   patients	   both	   on	  and	   off	   their	   usual	   stimulant	   medication	   (Wong	   &	   Stevens,	   2012).	   The	   authors	  report	   increased	   activation	   in	   frontoparietal	   networks	   after	   stimulant	   intake	   as	  well	  as	  increased	  functional	  connectivity	  throughout	  the	  brain.	  	  A	   very	   recent	   meta-­‐analysis	   examined	   placebo-­‐controlled	   studies	   which	  investigated	   the	   effects	   of	   MPH	   on	   behavioural	   EF	   and	   non-­‐EF	   measures	   in	  children	  diagnosed	  with	  ADHD	  (Coghill	  et	  al.,	  2013).	  MPH	  was	  found	  to	  improve	  all	  of	   the	   examined	   functions,	   with	   a	   small	   effect	   on	   working	   memory	   measures	  requiring	   manipulation	   of	   the	   maintained	   material	   and	   a	   medium	   effect	   on	  working	   memory	   measures	   requiring	   simple	   storage	   and	   reproduction.	   No	  negative	   effects	   of	   MPH	   were	   found	   for	   any	   of	   the	   investigated	   measures.	  Interestingly,	   the	   effect	   sizes	   reported	   for	   the	   different	   cognitive	   domains	   were	  smaller	  than	  the	  effect	  sizes	  usually	  found	  in	  treatment	  studies	  focusing	  on	  ADHD	  symptom	  reduction.	  This	  might	  be	  the	  result	  of	  EF	  studies	  only	  recruiting	  patients	  with	   neuropsychological	   functioning	   within	   the	   normal	   range	   or,	   as	   described	  under	   1.1.3	   (1),	   it	   might	   be	   a	   further	   indication	   of	   the	   heterogeneous	  neuropsychological	   profiles	   found	   in	   ADHD	   (Coghill	   et	   al.,	   2013).	   However,	   this	  difference	  might	   also	   be	   caused	   by	   the	   greater	   objectivity	   of	   neuropsychological	  tests	   compared	   to	   the	   investigator	   or	   self-­‐report	   ratings	   of	   ADHD	   symptoms	  normally	  used	  in	  treatment	  studies.	  	  To	  conclude,	  behavioural	  studies	  show	  a	  robust	  positive	  effect	  of	  stimulant	  medication	   on	   EF	   as	  well	   as	   non-­‐EF	  measures.	   In	   line	  with	   these	   findings,	   fMRI	  studies	   of	   working	   memory	   and	   interference	   control	   show	   increased	   activation	  particularly	  in	  the	  DLPFC,	  but	  also	  in	  parietal	  and	  striatal	  regions	  after	  the	  intake	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of	   stimulant	   medication.	   Studies	   employing	   a	   network	   perspective	   furthermore	  report	   an	   upregulation	   of	   task-­‐positive/	   frontoparietal	   networks.	   It	   should	   be	  noted,	   however,	   that	   almost	   all	   of	   these	   studies	   rely	   on	   children	   or	   adolescents	  with	   ADHD,	   and	   that	   network	   activation	   patterns	   might	   change	   somewhat	   with	  increasing	  age	  and	  the	  accompanying	  decline	  in	  hyperactive	  behaviour	  (Cortese	  et	  al.,	  2012).	  In	  addition,	  there	  is	  a	  scarcity	  of	  investigations	  using	  placebo-­‐controlled	  designs	   spanning	   several	   weeks,	   with	  most	   studies	   relying	   on	   dispensing	   single	  doses	  of	  medication	  or	  using	  a	  naturalistic	  on/off	  design.	  	  	  	  
1.2 The	  COMT	  Gene	  
 Val158Met	  Single-­‐Nucleotide	  Polymorphism	  1.2.1
In	   1958,	   researchers	   described	   an	   enzyme	   that	   they	   called	   “catechol	  O-­‐methyl	  transferase”	  (Axelrod	  &	  Tomchick).	  This	  enzyme	  could	  transfer	  a	  methyl	  group	  to	  the	  phenolic	  hydroxyl	  group	  in	  epinephrine	  as	  well	  as	  in	  other	  catechols.	  The	  O-­‐methylation	  catalysed	  by	  this	  enzyme	  was	  hypothesized	  to	  play	  a	  major	  role	  in	  the	  metabolism	  of	  catecholamines	  and	  was	  later	  linked	  to	  the	  inactivation	  of	  the	  catecholamine	   neurotransmitters	   norepinephrine,	   epinephrine,	   and	   dopamine	  (Ball,	  Breuer,	  Haupt,	  &	  Knuppen,	  1972;	  Guldberg	  &	  Marsden,	  1975).	  More	  than	  one	  decade	   later,	   researchers	   found	   evidence	   for	   one	   single	   gene	   located	   on	  chromosome	   22q11.1-­‐q11.2	   coding	   the	   catechol-­‐O-­‐methyltransferase	   (COMT)	  enzyme	   (Bertocci	   et	   al.,	   1991;	   Grossman,	   Emanuel,	   &	   Budarf,	   1992;	   Lundström,	  Salminen,	   Jalanko,	   Savolainen,	  &	  Ulmanen,	   1991).	   This	   gene	   comprises	   six	   exons	  with	   the	   third	   exon	   containing	   two	   different	   promoters	   that	   are	   responsible	   for	  initiating	  translation	  of	  the	  soluble	  as	  well	  as	  the	  membrane-­‐bound	  form	  of	  COMT	  (Tenhunen	   et	   al.,	   1994).	   The	   membrane-­‐bound	   form	   of	   COMT	   contains	   an	  additional	   50	   amino	   acids	   that	   are	   responsible	   for	   its	   hydrophobic	   properties	  (Lundström	   et	   al.,	   1991).	   The	   predominantly	   translated	   form	   of	   COMT	   depends	  greatly	   on	   the	   investigated	   tissue,	  with	  membrane-­‐bound	  COMT	   constituting	   the	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vast	  majority	   of	   all	   COMT	   enzymes	   found	   in	   the	   brain	   (Hong,	   Shu-­‐Leong,	   Tao,	  &	  Lap-­‐Ping,	  1998;	  Tenhunen	  et	  al.,	  1994).	  	  In	  1995,	   researchers	   realized	   that	   two	  previously	  published	  human	  COMT	  sequences	  specified	  different	  amino	  acids	  (valine	  and	  methionine,	  respectively)	  at	  position	  108	  for	  the	  soluble	  COMT	  form	  due	  to	  a	  single-­‐nucleotide	  polymorphism	  (SNP)	  in	  the	  responsible	  gene.	  Although	  this	  difference	  did	  not	  affect	  functionality	  of	   the	   resulting	   enzyme,	   the	   methionine	   (met)	   variant	   proved	   to	   be	   more	  thermolabile	   leading	   to	  already	  reduced	  activity	  at	  physiological	   temperatures	  of	  as	   little	   as	   37°C	   (Lotta	   et	   al.,	   1995).	   Biochemical	   simulations	   showed	   that	   the	  substitution	  of	  valine	  (val)	  with	  the	   larger	  met	  residue	  caused	  inefficient	  packing	  of	   the	   resulting	   enzyme	   and	   thereby	   decreased	   enzyme	   stability	   while	   not	  impairing	  functionality	  (Rutherford,	  Bennion,	  Parson,	  &	  Daggett,	  2006).	  The	  same	  SNP	   of	   the	   COMT	   gene	   (rs4680)	   exists	   for	   the	   membrane-­‐bound	   form	   of	   the	  enzyme	  at	  codon	  158	  (val158met	  polymorphism)	  (Lachman	  et	  al.,	  1996),	  with	  two	  val-­‐alleles	   causing	   three	   to	   four	   times	  more	   COMT	   activity	   than	   two	  met-­‐alleles	  and	   heterozygosis	   leading	   to	   intermediate	   activity	   (Chen	   et	   al.,	   2004;	  Weinshilboum,	  Otterness,	  &	  Szumlanski,	  1999).	  The	  distribution	  of	  the	  two	  COMT	  alleles	  varies	  widely	  across	  different	  populations:	  While	  frequencies	  of	  the	  val-­‐	  and	  met-­‐allele	   are	   nearly	   equal	   in	   European	   populations,	   most	   African	   and	   Asian	  populations	   show	   a	  much	   higher	   frequency	   of	   the	   val-­‐allele	   (Palmatier,	   Kang,	   &	  Kidd,	  1999).	  	  Due	  to	  the	  low	  expression	  of	  the	  DAT	  in	  the	  PFC,	  COMT	  plays	  a	  critical	  role	  in	   clearing	   dopamine	   from	   the	   synaptic	   cleft	   in	   this	   area	   (Dickinson	   &	   Elvevag,	  2009;	   Lewis	   et	   al.,	   2001;	   Lewis,	   Sesack,	   Levey,	   &	   Rosenberg,	   1997;	   Meyer-­‐Lindenberg	   &	   Weinberger,	   2006;	   Tunbridge,	   Bannerman,	   Sharp,	   &	   Harrison,	  2004).	   The	   significance	   of	   the	   COMT	   enzyme	   for	   regulating	   dopaminergic	  transmission	   in	   the	   PFC	   therefore	   provides	   a	   direct	   link	   of	   the	   val158met	  polymorphism	   to	   higher	   order	   cognitive	   functions.	   Bilder	   and	   colleagues	   (2004)	  proposed	  an	  influence	  of	  COMT	  on	  cortical	  as	  well	  as	  subcortical	  dopamine	  levels	  by	   drawing	   on	   the	   tonic-­‐phasic	   hypothesis	   of	   dopaminergic	   functioning.	   The	  original	   tonic-­‐phasic	   model,	   which	   was	   developed	   to	   explain	   symptoms	   of	  schizophrenia,	   held	   that	   dopaminergic	   transmission	   in	   subcortical	   regions	   was	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regulated	  by	   tonic	   as	  well	   as	   phasic	  dopamine	   release	   (Grace,	   1991).	  The	  phasic	  dopamine	   response	   is	   hypothesised	   to	   consist	   of	   a	   sudden	   transient	   release	   of	  dopamine	   in	   the	   striatum	   in	   response	   to	   behaviourally	   relevant	   stimuli.	   This	  dopaminergic	   action	   is	   then	   equally	   suddenly	   terminated	   by	   rapid	   re-­‐uptake	   of	  dopamine	   from	   the	   synaptic	   cleft.	   In	   contrast,	   tonic	   dopamine	   levels	   are	  hypothesised	   to	   be	   mediated	   by	   glutamatergic	   neurons,	   which	   stimulate	   the	  continuous	   release	   of	   low	   amounts	   of	   dopamine	   in	   the	   striatum.	   These	  glutamatergic	   neurons	  most	   likely	   originate	   in	   the	   PFC	   as	  well	   as	   other	   cortical	  regions,	   allowing	   subcortical	   dopamine	   levels	   to	   be	   influenced	   by	   cortical	  processes.	  Tonic	  dopamine	   release	   is	  hypothesised	   to	  be	  much	   slower	   and	  more	  prolonged	   than	   phasic	   release	   and	   to	   mainly	   influence	   extracellular	   dopamine	  levels.	   Tonic	   dopamine	   levels	   might	   thus	   affect	   the	   responsivity	   of	   the	   entire	  dopamine	   system	   by	   stimulating	   dopamine	   autoreceptors	   which	   in	   turn	   control	  the	  amplitude	  of	  the	  phasic	  dopamine	  response	  (Grace,	  1991).	  	  In	   their	   refined	  version	  of	   this	  model,	  Bilder	  and	  colleagues	   (2004)	   stress	  the	  importance	  of	  COMT	  for	  subcortical	  tonic	  dopamine	  levels.	  Phasically	  released	  dopamine	  is	  rapidly	  taken	  up	  from	  the	  synaptic	  cleft	  by	  the	  DAT.	  However,	  this	  re-­‐uptake	  process	  does	  not	  affect	  continuously	  released	  low	  levels	  of	  tonic	  dopamine,	  which	   can	  escape	   the	   synaptic	   cleft	   and	   thereby	   contribute	   to	   extracellular	   tonic	  dopamine	  levels.	  As	  hypothesised	  by	  the	  original	  model	  (Grace,	  1991),	  high	  levels	  of	   tonic	   dopamine	   suppress	   the	   phasic	   dopamine	   response	   by	   stimulating	   D1	  autoreceptors.	   According	   to	   Bilder	   and	   colleagues	   (2004),	   this	   is	   where	   the	  different	   versions	   of	   COMT	   gain	   importance:	   The	   highly	   active	   COMT	   version	  coded	  by	  the	  val-­‐allele	  maintains	  low	  tonic	  dopamine	  levels	  thereby	  increasing	  the	  amplitude	  of	  phasic	  dopaminergic	  transmission.	  In	  contrast,	  the	  low	  active	  version	  coded	  by	  the	  met-­‐allele	  leads	  to	  high	  levels	  of	  tonic	  dopamine	  thereby	  decreasing	  phasic	  dopamine	  transmission.	  	  The	  impact	  of	  COMT	  becomes	  even	  more	  pronounced	  in	  the	  PFC	  where	  the	  phasically	  as	  well	  as	   the	   tonically	   released	  dopamine	  diffuses	  out	  of	   the	  synaptic	  cleft.	   In	   this	   area,	   carriers	   of	   two	   met-­‐alleles	   therefore	   show	   much	   higher	  concentrations	   of	   cortical	   dopamine	   than	   val-­‐allele	   carriers	   (Bilder	   et	   al.,	   2004).	  With	   regard	   to	   cognitive	   functions,	   the	   constantly	   increased	   D1	   stimulation	   in	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met/met	  carriers	  is	  hypothesised	  to	  lead	  to	  increased	  stability	  of	  neural	  networks	  underlying	  working	  memory	   functions,	  while	   the	  more	   transiently	   increased	  D2	  stimulation	   in	   val/val	   carriers	   should	   support	   increased	   flexibility	   of	   these	  networks	  (Bilder	  et	  al.,	  2004;	  Levy,	  2007).	  Met/met	  carriers	  should	  therefore	  show	  superior	  performance	  on	  “stable”	  working	  memory	  tasks	  that	  require	  maintenance	  processes	   or	   sustained	   executions	   of	   fixed	   response	   sets.	   In	   contrast,	   val/val	  carriers	   should	   be	   superior	   on	   “flexible”	   working	   memory	   tasks,	   e.g.	   tasks	  demanding	   constant	   updating	   of	   working	   memory	   content	   or	   switching	   of	  response	  sets	  (Bilder	  et	  al.,	  2004).	  Since	  the	  COMT	  allele	  is	  codominant	  (Spielman,	  Weinshilboum,	  &	  Opitz,	  1981),	  val/met	  carriers	  should	  place	  intermediate	  on	  all	  of	  these	  variables.	  	  
 Impact	  on	  Attention	  and	  Working	  Memory	  1.2.2
The	   hypothesised	   influence	   of	   the	   COMT	   polymorphism	   on	   higher	   order	  cognitive	   functioning	   was	   previously	   explored	   in	   numerous	   studies:	   Egan	   and	  colleagues	   (2001)	   used	   the	   Wisconsin	   Card	   Sorting	   Test	   (WCST)	   as	   a	   broad	  measure	  of	  EF.	  In	  this	  test,	  participants	  have	  to	  identify	  the	  response	  category	  by	  which	  to	  sort	  an	  extended	  set	  of	  ambiguous	  cards	  (Heaton,	  Chelune,	  Talky,	  Kay,	  &	  Curtiss,	  1993).	  After	  the	  participant	  has	  sorted	  ten	  consecutive	  cards	  correctly,	  the	  response	   category	   is	   suddenly	   switched	   without	   informing	   the	   participant.	  Performance	   measures	   usually	   take	   perseverative	   errors,	   which	   occur	   after	  switching	   of	   the	   response	   category,	   as	   well	   as	   the	   amount	   of	   trials	   required	   to	  obtain	  a	  stable	  representation	  of	  the	  new	  correct	  response	  category	  into	  account.	  This	   complex	   test	   seemed	   to	   favour	   met-­‐allele	   carriers	   with	   the	   met-­‐allele	  positively	  influencing	  performance	  in	  an	  allele	  dosage	  fashion	  (Egan	  et	  al.,	  2001).	  However,	   a	   recent	   meta-­‐analysis	   pointed	   out	   that	   while	   the	   met-­‐allele	   might	  indeed	  be	  associated	  with	  slightly	  better	  WCST	  performance,	  this	  effect	  was	  most	  pronounced	  in	  early	  studies	  and	  might	  therefore	  be	  overrated	  (Barnett,	  Scoriels,	  &	  Munafo,	  2008;	  Dickinson	  &	  Elvevag,	  2009).	  In	  addition,	  the	  WCST	  requires	  a	  wide	  range	   of	   mental	   abilities	   –	   concept	   formation,	   mental	   flexibility,	   performance	  monitoring,	   and	   performance	   adjustment	   –	   that	   are	   subsumed	   under	   the	   broad	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term	  of	  EF	  but	  that	  must	  in	  fact	  be	  classified	  as	  containing	  stable	  as	  well	  as	  flexible	  working	   memory	   components	   (Bilder	   et	   al.,	   2004;	   Dickinson	   &	   Elvevag,	   2009).	  Since	   stable	   and	   flexible	   task	   requirements	   are	   thought	   to	   differentially	   benefit	  met-­‐	   and	   val-­‐allele	   carriers,	   conflicting	   findings	   are	   to	   be	   expected	   (Bilder	   et	   al.,	  2004).	  Given	  the	  ambiguous	  findings	  obtained	  with	  the	  WCST,	  researchers	  tried	  to	  implement	   a	   task	   that	   more	   clearly	   taxed	   either	   stable	   or	   flexible	   aspects	   of	  working	  memory,	  thereby	  allowing	  a	  priori	  predictions	  as	  to	  what	  allele	  might	  be	  favourable	   to	   overall	   performance.	   The	   n-­‐back	   task	   seemed	   to	   fulfil	   these	  conditions:	   In	   its	   original	   form,	   this	   task	   requires	   participants	   to	   hold	   in	   mind	  several	   sequentially	   presented	   numbers	   and	   to	   indicate	   whenever	   a	   number	   is	  identical	  to	  the	  number	  presented	  “n”	  (usually	  one,	  two,	  or	  three)	  trials	  before	  (J.	  D.	   Cohen	   et	   al.,	   1994).	   A	  modified	   version	   of	   this	   task	   developed	  by	  Weinberger	  and	   colleagues	   (Goldberg	   et	   al.,	   2003)	   uses	   similar	   instructions	   but	   requires	  participants	   to	   constantly	   indicate	   the	   number	   seen	   “n”	   trials	   earlier,	   thereby	  increasing	   demands	   on	   EF	  while	   still	   allowing	   a	   parametric	   increase	   of	  working	  memory	   load.	   As	   this	   task	   requires	   a	   stable	   representation	   of	   the	   presented	  numbers	   (Goldberg	   &	   Weinberger,	   2004),	   it	   was	   expected	   to	   favour	   met-­‐allele	  carriers.	   This	   hypothesis	  was	   confirmed	  by	   an	   early	   study	  using	   the	  modified	  n-­‐back	   paradigm:	   Val/val	   carriers	   gave	   significantly	   fewer	   correct	   responses	   than	  met/met	   carriers	   in	   both	   the	   1-­‐back	   and	   the	   2-­‐back	   condition	   with	   val/met	  carriers	   tending	   to	  perform	   in	  between	  (Goldberg	  et	  al.,	  2003).	   In	  another	  study,	  val/val	   carriers	   showed	   less	   efficient	   functioning	   of	   frontal	   areas	   than	  met/met	  carriers,	   as	   indicated	   by	   more	   fMRI	   activation	   in	   the	   absence	   of	   performance	  differences,	   with	   val/met	   carriers	   showing	   intermediate	   activation	   (Egan	   et	   al.,	  2001).	  	  However,	   a	  meta-­‐analysis	   of	   studies	   using	   the	   n-­‐back	   task	   found	   that	   the	  val-­‐allele	  was	   actually	   associated	  with	   better	   performance	   (Barnett	   et	   al.,	   2008),	  although	   there	  was	   evidence	   that	   this	   association	  was	   reversed	   in	   schizophrenic	  patients	   and	   results	   indicated	   a	   substantial	   heterogeneity	   between	   studies.	   In	  addition,	  effect	  sizes	  in	  the	  investigated	  samples	  increased	  with	  a	  greater	  number	  of	  female	  participants	  and	  also	  with	  increasing	  sample	  age.	  Still,	  it	  has	  to	  be	  noted	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that	  this	  meta-­‐analysis	  analysed	  studies	  that	  used	  different	  versions	  of	  the	  n-­‐back	  task.	   Visual	   inspection	   of	   the	   individual	   results	   shows	   that	   the	   modified	   n-­‐back	  task	  might	  actually	  slightly	  benefit	  met/met	  carriers	  (see	  Figure	  1.2),	  which	  would	  be	  in	  line	  with	  the	  results	  of	  Goldberg	  and	  colleagues	  (2003)	  that	  are	  not	  included	  in	  this	  analysis.	  	  	  
	  Figure	  1.2:	  Results	  of	  the	  meta-­‐analysis	  by	  Barnett	  and	  colleagues	  (2008).	  The	  figure	  was	  modified	  from	  the	  original	  graph	  to	  show	  which	  paradigm	  was	  used	  by	  the	  respective	  study.	  ‘CL’	  denotes	  the	  classic	   n-­‐back	   paradigm	   as	   described	   in	   Cohen	   et	   al.	   (1994),	   ‘MOD’	   denotes	   the	  modified	   n-­‐back	  task	  used	  by	  Weinberger’s	  group	  (e.g.	  Goldberg	  et	  al.,	  2003).	  	  	  While	   findings	   on	   the	   behavioural	   effects	   of	   different	   COMT	   alleles	   thus	  show	  no	  clear	  benefit	  of	  one	  allele	  over	  the	  other,	  the	  initial	  finding	  of	  less	  efficient	  frontal	  functioning	  in	  val-­‐allele	  carriers	  reported	  by	  Egan	  et	  al.	  (2001)	  seems	  to	  be	  more	  robust.	  A	  meta-­‐analysis	  of	  studies	  investigating	  the	  effect	  of	  COMT	  genotype	  on	  fMRI	  activation	  during	  cognitive	  processing	  found	  an	  overall	  greater	  prefrontal	  activation	   in	   val-­‐allele	   carriers,	   pointing	   to	   less	   efficient	   frontal	   lobe	   functioning	  caused	  by	   this	   allele	   (Mier,	  Kirsch,	  &	  Meyer-­‐Lindenberg,	  2010).	   Importantly,	   this	  effect	   seems	   to	  persist	  when	  only	   the	  studies	  using	   the	  modified	  n-­‐back	   task	  are	  considered	  (see	  Figure	  1.3).	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  Figure	   1.3:	   Results	   of	   the	  meta-­‐analysis	   by	  Mier	   and	   colleagues	   (2010).	   The	   figure	  was	  modified	  from	   the	   original	   graph	   to	   show	  only	   those	   studies	   that	   employed	   the	  modified	  n-­‐back	   task	   (e.g.	  Goldberg	  et	  al.,	  2003).	  	  	  A	  study	  by	  Mattay	  and	  colleagues	  (2003)	  showed	  that	  efficient	  frontal	  lobe	  functioning	  was	  indeed	  connected	  to	  dopamine	  levels	  in	  this	  region,	  and	  that	  these	  levels	  were	   in	   turn	   influenced	   by	   participants’	   COMT	   genotype.	   The	   researchers	  measured	   frontal	   lobe	   efficiency	   in	   participants	   homozygous	   for	   the	   COMT	  genotype	   during	   the	   modified	   n-­‐back	   task.	   Participants	   were	   given	   either	  amphetamine	   –	   a	   substance	   known	   to	   increase	   synaptic	   and	   extracellular	  dopamine	   levels	   (Schiffer	   et	   al.,	   2006)	   –	   or	   a	   placebo.	   During	   the	   simple	   1-­‐back	  condition,	  all	  groups	  showed	  the	  same	  level	  of	  activation	  in	  a	  region	  of	  interest	  in	  the	   left	   PFC.	   As	   difficulty	   increased,	   val/val	   participants	   showed	   less	   efficient	  frontal	   lobe	  functioning	  only	  after	  the	   intake	  of	  placebo.	  All	  participants	  who	  had	  been	   assigned	   to	   take	   amphetamine	   showed	   similar	   activation	   that	   was	  independent	  of	  their	  genotype.	  Interestingly,	  this	  pattern	  was	  reversed	  in	  the	  most	  difficult	   3-­‐back	   condition.	   Here,	   val/val	   carriers	   showed	   the	   least	   efficient	  activation	  after	  placebo	  intake,	  but	  the	  most	  efficient	  activation	  after	  the	  intake	  of	  amphetamine.	  The	  opposite	  was	  true	  for	  met/met	  carriers.	  The	  authors	  concluded	  that	   their	   results	   provide	   evidence	   for	   an	   inverted	   U-­‐shaped	   cortical	   response	  function	   to	  dopamine	   in	   the	  PFC:	  While	   increased	  dopamine	   associated	  with	   the	  intake	   of	   amphetamine	  moved	   val/val	   carriers	   towards	   the	   peak	   of	   the	   function	  (i.e.	  towards	  optimal	  efficiency),	  met/met	  carriers	  were	  pushed	  to	  the	  far	  right	  of	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the	   function,	   resulting	   in	   a	   decrease	   of	   cortical	   efficiency	   caused	  by	   an	   excess	   of	  cortical	  dopamine.	  	  To	   conclude,	   while	   most	   studies	   investigating	   higher	   cognitive	   functions	  and	   COMT	   show	   no	   behavioural	   differences	   among	   the	   three	   genotypes,	   fMRI	  studies	   fairly	   consistently	   point	   to	   increased	   cortical	   activation	   in	   participants	  homozygous	  for	  the	  val-­‐allele.	  Participants	  homozygous	  for	  the	  met-­‐allele	  typically	  show	   the	   lowest	   –	   presumably	   most	   efficient	   –	   activation,	   with	   heterozygous	  participants	   usually	   located	   in	   between	   these	   two	   groups.	   Interestingly,	   this	  pattern	  of	  results	  can	  be	  reversed	  when	  the	  amount	  of	  available	  cortical	  dopamine	  is	   increased:	   While	   a	   pharmaceutically	   induced	   increase	   in	   cortical	   dopamine	  benefitted	  val/val	  carriers,	  it	  was	  actually	  harmful	  for	  met/met	  carriers,	  providing	  evidence	  for	  an	  association	  of	  the	  inverted	  U-­‐shaped	  cortical	  response	  function	  to	  dopamine	  and	  efficient	  cortical	  activation	  in	  the	  PFC.	  	  	  
 COMT	  Genotype	  and	  ADHD	  	  1.2.3
Given	   the	   implication	   of	   COMT	   in	   PFC	   noradrenergic	   and	   dopaminergic	  neurotransmission	  and	  the	  impact	  of	   its	  polymorphism	  on	  higher	  order	  cognitive	  functioning,	  the	  COMT	  genotype	  was	  investigated	  as	  a	  possible	  candidate	  gene	  for	  ADHD.	   The	   high	   estimated	   heritability	   of	   ADHD	   of	   around	   70	  %	   (Faraone	   et	   al.,	  2005)	   led	   many	   studies	   to	   search	   for	   common	   genetic	   variants	   causing	   the	  disorder	  –	  with	  disappointing	  results.	  A	  meta-­‐analysis	  of	  genome-­‐wide	  association	  studies	  (GWAS)	  of	  almost	  3,000	  children	  with	  ADHD	  did	  not	  reveal	  any	  significant	  associations	   and	   the	   authors	   concluded	   that	   either	   several	   common	   genetic	  variants	  with	  extremely	  small	  contributions	  or	  not	   investigated	  rare	  variants	   like	  copy	   number	   variants	  might	   be	   involved	   in	   the	   aetiology	   of	   ADHD	   (Neale	   et	   al.,	  2010).	   Although	   no	   gene	   reached	   genome-­‐wide	   significance,	   the	   most	   likely	  associated	  genes	  were	  found	  on	  chromosomes	  7,	  8,	  11,	  and	  20	  with	  many	  of	  these	  genes	   having	   still	   unknown	   effects	   in	   the	   brain.	   An	   analysis	   of	   a	   priori	   defined	  candidate	  genes	  also	  did	  not	  yield	  any	  results	  with	  genome-­‐wide	  significance.	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A	   meta-­‐analysis	   of	   research	   on	   candidate	   genes	   revealed	   significant	  associations	   of	   the	   dopaminergic	   genes	   DAT1,	   DRD4,	   and	   DRD5	   with	   childhood	  ADHD	  (Gizer,	  Ficks,	  &	  Waldman,	  2009).	  Significant	  heterogeneity	   in	  study	  results	  was	   found	   for	  DAT1,	  DRD4,	   and	  DRD5,	   but	  also	   for	   the	  noradrenergic	  genes	  DBH	  and	   ADRA2A,	   which	   the	   authors	   interpreted	   as	   potentially	   indicating	   the	  investigation	   of	   dissimilar	   groups	   –	   like	   gender	   or	   ADHD	   subtype	   –	   who	   have	  differing	   genetic	   contributions	   to	   their	   ADHD	   symptoms.	   This	   inclusion	   of	  dissimilar	  subgroups	  in	  genetic	  analyses	  might	  furthermore	  be	  partly	  responsible	  for	   the	   overall	   small	   associations	   found	   in	   this	   study.	   The	   authors	   found	   no	  indication	   for	   an	   association	   of	   COMT	   genotype	   (with	   val	   being	   generally	  considered	   the	   risk	   allele)	   and	   ADHD,	   although	   they	   pointed	   to	   the	   slight	  possibility	  of	  a	  sexually	  dimorphic	  effect	  of	  COMT	  with	  met	  being	  the	  risk	  allele	  for	  boys	  and	  val	  being	  the	  risk	  allele	  for	  girls.	  	  In	   addition,	   although	   a	   recent	   review	   gave	   some	   indication	   of	   different	  genes	   being	   partly	   responsible	   for	   ADHD	   in	   children	   and	   in	   adults,	   the	   authors	  concluded	   that	   sample	   sizes	  must	   still	   be	   vastly	   increased	   before	   GWAS	   studies	  could	  possibly	   find	  any	  significant	  associations	  (Franke	  et	  al.,	  2012).	  The	  authors	  furthermore	   stressed	   the	   importance	   of	   focussing	   research	   on	   intermediate	  phenotypes	   –	   so-­‐called	   endophenotypes	   –	   that	   are	   classified	   based	   on	  neuroimaging	   results	   and	   neuropsychological	   testing.	   The	   thereby	   obtained	  “purer”	   samples	   should	   share	  more	   similar	   profiles	   of	   strength	   and	  weaknesses	  and	  thereby	  stronger	  associations	  with	  possibly	  responsible	  genetic	  variants	  than	  more	  heterogeneous	  samples.	  	  Several	   studies	   investigated	   the	   impact	   of	   COMT	   genotype	   on	  neuropsychological	   endophenotypes	   in	  ADHD	  (Kebir	  &	   Joober,	  2011).	  A	   study	  of	  124	   children	   with	   ADHD	   found	   no	   effect	   of	   COMT	   genotype	   on	   EF	   measures	   of	  working	  memory,	  attention,	  and	  response	  inhibition	  (Mills	  et	  al.,	  2004).	  A	  sample	  of	  118	  children	  with	  ADHD	  also	  showed	  no	  association	  of	  COMT	  genotype	  and	  EF	  tasks	  historically	  used	  to	  assess	  frontal	  lobe	  damage,	  namely	  the	  WCST,	  the	  Tower	  of	  London,	  and	   the	  Self-­‐Ordered	  Pointing	  Task	  (Taerk	  et	  al.,	  2004).	   In	  contrast,	  a	  third	   study	   used	   a	   delayed-­‐match-­‐to-­‐sample	   task	   and	   reports	   a	   negative	  association	  of	  val/val	  genotype	  and	  working	  memory	  performance	  in	  children	  with	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ADHD	  (Matthews	  et	  al.,	  2012),	  while	  a	  fourth	  study	  found	  a	  negative	  association	  of	  the	  met-­‐allele	  and	  a	  measure	  of	  sustained	  attention	  in	  ADHD	  children	  (Bellgrove	  et	  al.,	   2005).	   So	   far,	   only	   one	   study	   examined	   a	   sample	   of	   adults	   with	   ADHD.	   This	  study	   found	   a	   positive	   association	   of	   the	   val/met	   genotype	   and	   full-­‐scale	   IQ	   as	  assessed	   with	   the	  WAIS-­‐III	   (Boonstra	   et	   al.,	   2008).	   The	   authors	   report	   no	  main	  effect	   of	  COMT	  genotype	  on	   the	  WAIS	   subtests	  Digit	   Span	  Forward	   or	  Digit	   Span	  
Backward	   or	   the	   Stroop	   Color	   Word	   Test.	   None	   of	   these	   studies	   investigated	   a	  healthy	  control	  group.	  	  As	   both	   COMT	   genotype	   and	   MPH	   are	   thought	   to	   influence	   prefrontal	  cortical	  and	  subcortical	  dopamine	  and	  noradrenaline	  levels	  (Berridge	  et	  al.,	  2006;	  Bilder	  et	  al.,	  2004)	  research	  also	  focused	  on	  the	  question	  whether	  COMT	  genotype	  might	  influence	  the	  medication	  response	  in	  ADHD.	  Based	  on	  the	  assumption	  of	  an	  inverted	   U-­‐shaped	   cortical	   response	   function	   to	   dopamine	   in	   the	   PFC	   (see	   also	  Mattay	   et	   al.,	   2003)	   it	   was	   hypothesised	   that	   the	   optimal	   dose	   of	   stimulant	  medication	   should	   vary	   depending	   on	   patients’	   COMT	   genotype	   with	   met/met	  patients	   requiring	   considerably	   lower	   doses	   than	   val/val	   patients,	   with	   val/met	  patients	   in	   between	   (Levy,	   2007,	   2009).	   This	   hypothesis	  was	   confirmed	   by	   a	   6-­‐month	  medication	  study	  of	  122	  children	  with	  ADHD,	  which	  classified	  significantly	  more	   children	   with	   val/val	   than	   with	   met/met	   genotype	   as	   responders,	   with	  val/met	  genotype	  children	  showing	  an	   intermediate	  response	  rate	   (Kereszturi	  et	  al.,	   2008).	   COMT	   genotype	   was	   also	   found	   to	   significantly	   interact	   with	  hyperactive-­‐impulsive	   symptom	   severity,	   with	   val/val	   children	   presenting	   with	  significantly	   fewer	   symptoms	   than	   met/met	   children	   after	   the	   treatment.	   An	   8-­‐week	   trial	  with	  128	  Korean	  children	   reports	   similar	   (albeit	  weaker)	   results	  with	  val/val	   children’s	   treatment	   response	   being	   rated	   as	   better	   than	   met/met	  children’s	  in	  the	  absence	  of	  medication	  dose	  differences	  (Cheon,	  Jun,	  &	  Cho,	  2008).	  It	  has	  to	  be	  noted,	  however,	  that	  the	  proportion	  of	  children	  with	  met/met	  genotype	  in	  both	  studies	  was	  rather	  low	  (14	  and	  eight,	  respectively),	  somewhat	  limiting	  the	  conclusions	  that	  can	  be	  drawn	  from	  the	  obtained	  results.	  A	  double-­‐blind	  placebo-­‐controlled	   fixed-­‐dose	   cross-­‐over	   trial	   with	   children	   and	   adolescents	   reports	   an	  association	  of	  MPH	  response	  and	  COMT	  genotype	  as	  well	   (McGough	  et	  al.,	  2009),	  although	  only	  on	  a	  trend	  level.	  In	  contrast,	  a	  study	  investigating	  MPH	  response	  in	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adults	  with	  ADHD	   found	  no	   indication	   for	   an	   association	   of	  COMT	   genotype	   and	  medication	  response	  (Contini	  et	  al.,	  2012).	   It	   is	  potentially	  problematic,	  however,	  that	  this	  study	  collapsed	  the	  data	  of	  met-­‐allele	  carriers	  (met/met	  and	  val/met).	  As	  children	  with	   val/met	   genotype	  were	   previously	   reported	   to	   show	   intermediate	  response	  rates,	  this	  analysis	  strategy	  may	  have	  diluted	  any	  existing	  effects.	  	  Overall,	  GWAS	  as	  well	  as	  candidate	  gene	  studies	  do	  not	  point	  to	  COMT	  as	  a	  risk	   gene	   for	   the	   development	   of	   ADHD,	   and	   studies	   on	   the	   neuropsychological	  impact	  of	  COMT	  in	  ADHD	  patients	  show	  greatly	  differing	  results	  that	  might	  depend	  heavily	   on	   the	   type	   of	   working	   memory	   measure	   used.	   In	   addition,	   as	   COMT	  becomes	  more	  important	  with	  increasing	  age	  (Barnett	  et	  al.,	  2008;	  Levy,	  2007)	  its	  functional	   impact	   on	   PFC	   mediated	   cognitive	   functions	   may	   be	   more	   visible	   in	  adults	  than	  it	  is	  in	  children.	  Research	  on	  the	  impact	  of	  COMT	  genotype	  on	  response	  to	   treatment	   with	   stimulant	   medication	   also	   yielded	   conflicting	   results,	   with	  studies	   showing	   a	   possible	   association	   of	   good	   treatment	   response	   and	   the	   val-­‐allele	  in	  a	  gene	  dosage	  fashion	  in	  children,	  while	  a	  study	  of	  adult	  patients	  showed	  no	  association	  of	  treatment	  response	  and	  the	  met-­‐allele.	  	  	  
1.3 Working	  Memory	  	  
 Theories	  1.3.1
Nearly	  forty	  years	  ago,	  Hitch	  and	  Baddeley	  (1976)	  proposed	  the	  concept	  of	  working	  memory	   as	   a	   new	   system	   separate	   from	   short-­‐	   and	   long-­‐term	  memory,	  which	  took	  the	  form	  of	  a	  general	  executive.	  This	  executive	  processing	  system	  was	  proposed	   to	   have	   limited	   capacity	   and	   to	   operate	   as	   short-­‐term	   storage	   for	  memory	   items	   during	   complex	   cognitive	   tasks.	   Over	   the	   years,	   the	   basic	   model	  grew	  increasingly	  refined	  and	  16	  years	  later,	  working	  memory	  was	  described	  as	  “a	  brain	  system	  that	  provides	  temporary	  storage	  and	  manipulation	  of	  the	  information	  necessary	   for	   […]	   complex	   cognitive	   tasks”	   (Baddeley,	   1992,	   p.	   556).	   Working	  memory	  was	  now	  proposed	  to	  consist	  of	  a	  central	  executive,	  whose	  main	  function	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was	   to	   coordinate	   information	   input	   from	   and	   attention	   allocation	   to	   two	   visual	  and	  speech-­‐related	  slave	  systems,	  the	  visuospatial	  sketch	  pad	  and	  the	  phonological	  loop.	  	   Given	  this	  very	  influential	  theory,	  much	  research	  has	  focused	  on	  finding	  the	  neural	   correlates	   of	   working	   memory.	   In	   a	   ground-­‐breaking	   study,	   researchers	  measured	   single-­‐cell	   activity	   in	   monkeys’	   PFC	   and	   frontal	   eye	   fields	   while	   the	  monkeys	  performed	  a	  visual	  delayed-­‐response	  task	  (Funahashi,	  Bruce,	  &	  Goldman-­‐Rakic,	   1989).	   The	   researchers	   found	   that	   many	   of	   the	   investigated	   neurons	  continued	   to	  exhibit	  directional	  activity	  changes	  during	   the	  delay	  period	  –	   in	   the	  absence	   of	   a	   physical	   stimulus	   –	   which	   stopped	   as	   soon	   as	   the	   behavioural	  response	   was	   executed.	   These	   results	   were	   interpreted	   as	   evidence	   for	   the	  DLPFC’s	   role	   in	   working	  memory.	   However,	   as	   each	   neuron	   seemed	   to	   respond	  maximally	   to	   a	   specific	   spatial	   location,	   the	   firing	  was	   construed	   as	   a	  mnemonic	  process	   with	   each	   neuron	   possessing	   a	   so-­‐called	   “memory	   field”	   where	   its	  responsiveness	  was	  highest	  (Goldman-­‐Rakic,	  1995).	  	  In	   contrast	   to	   this	   view	   of	   the	   PFC	   as	   subserving	   specific	   memory	   –	   i.e.	  storage	  –	  functions,	  Postle	  (2006)	  proposed	  working	  memory	  to	  be	  an	  “emergent	  property”	   of	   the	   nervous	   system.	   In	   this	   model,	   working	   memory	   functions	  “emerged”	  whenever	  attention	  was	  directed	  to	  a	  specific	  kind	  of	  information	  that	  required	  shot-­‐term	  retention.	  According	  to	  this	  theory,	  the	  brain	  regions	  originally	  involved	  in	  the	  processing	  of	  a	  given	  stimulus	  accomplished	  the	  short-­‐term	  storage	  of	   this	   information.	   Since	   PFC	   activity	  was	   seen	   across	   a	  wide	   array	   of	   different	  working	  memory	  tasks,	  the	  author	  proposed	  that	  its	  activity	  might	  serve	  to	  control	  interference	  from	  internal	  and	  external	  sources,	  to	  maintain	  a	  given	  task-­‐set,	  and/	  or	  to	  provide	  attentional	  monitoring	  and	  selection	  during	  a	  given	  task.	  In	  a	  recent	  summary	   of	   his	  work,	   Baddeley	   (2012)	   similarly	   described	   the	  main	   role	   of	   the	  central	  executive	  as	  affording	  attentional	  control	  of	  action.	  He	  proposed	  the	  central	  executive	   to	   be	   especially	   involved	   in	   attentionally	   demanding	  working	  memory	  tasks	   and	   to	   focus	   attention	   in	   the	   presence	   of	   distracting	   stimuli	   as	   well	   as	   to	  divide	   attention	   if	   two	   stimuli	  were	   equally	   important	   for	   the	   task	   at	   hand.	   The	  central	  executive’s	  originally	  assumed	  second	  role	  as	  providing	  short-­‐term	  storage	  of	   information	  was	  moved	   to	   a	   separate	   component	   (the	   episodic	   buffer),	  which	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was	  hypothesised	  to	  be	  under	  the	  control	  of	  the	  central	  executive.	  The	  main	  focus	  of	  the	  central	  executive	  was	  now	  seen	  in	  modulating	  attentional	  processes.	  	  	  
 Working	  Memory	  and	  Selective	  Attention1	  1.3.2
Since	   theoretical	   models	   of	   working	   memory	   started	   to	   assume	   an	  important	  role	  of	  selective	  attention	  for	  the	  sound	  functioning	  of	  working	  memory,	  much	   research	   has	   focused	   on	   this	   interface	   of	   working	   memory	   and	   selective	  attention.	  An	   influential	   study	  using	  a	  delayed	  recognition	  paradigm	   investigated	  neural	   activity	   in	   visual	   regions	   involved	   in	   the	   processing	   of	   face	   and	   house	  stimuli	  (Gazzaley,	  Cooney,	  McEvoy,	  Knight,	  &	  D'Esposito,	  2005).	  The	  authors	  found	  a	  suppression	  of	  visual	  processing	  when	  a	  stimulus	  was	  not	  task	  relevant	  and	  an	  enhancement	  when	  it	  was:	  FMRI	  data	  showed	  changing	  activation	  in	  fusiform	  and	  parahippocampal	   regions	   of	   interest	   (ROIs)	   depending	   on	   task	   relevance.	  Electroencephalography	  (EEG)	  data	  recorded	  from	  the	  same	  participants	  revealed	  longer	  peak	   latencies	   and	   reduced	  peak	  amplitudes	  of	   an	  event-­‐related	  potential	  (ERP)	   of	   early	   visual	   processing	   particularly	   sensitive	   to	   facial	   stimuli	   (N170)	  (Bentin,	  Allison,	  Puce,	  Perez,	  &	  McCarthy,	  1996)	  when	  task	  irrelevant	  face	  stimuli	  were	  presented.	  In	  contrast,	  an	  ERP	  especially	  sensitive	  to	  spatial	  attention	  (P100)	  (Hillyard	   &	   Anllo-­‐Vento,	   1998;	   Mangun	   &	   Hillyard,	   1991)	   was	   not	   significantly	  influenced.	   Another	   EEG	   study	   examined	   the	   N170	   in	   a	   delayed	   recognition	  paradigm	  with	   distractors	   placed	   in	   between	   a	   to-­‐be-­‐remembered	   stimulus	   and	  the	   to-­‐be-­‐recognized	   item	   (Sreenivasan	  &	   Jha,	   2007).	   This	   study	   found	   a	   greater	  reduction	  of	  amplitudes	  when	  a	  distractor	  was	  from	  the	  same	  category	  as	  the	  to-­‐be-­‐remembered	   stimulus	   indicating	   that	   the	   more	   similar	   a	   distractor	   was	   to	   a	  target	  stimulus	  the	  more	  its	  processing	  was	  suppressed.	  	  The	   finding	   of	   reduced	   N170	   amplitudes	   for	   task	   irrelevant	   face	   stimuli	  could	  also	  be	  generalized	  to	  a	  variation	  of	  the	  classic	  n-­‐back	  task	  which	  presented	  relevant	   stimuli	   interspersed	   with	   irrelevant	   stimuli	   (Schreppel,	   Pauli,	   Ellgring,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Parts	  of	  this	  section	  are	  published	  in	  BMC	  Neuroscience	  (Biehl	  et	  al.,	  2013). 
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Fallgatter,	  &	  Herrmann,	  2008).	  This	  study	  also	   found	  enhanced	  N170	  amplitudes	  for	   task	   relevant	   stimuli.	   Moreover,	   task	   relevance	   seemed	   to	   influence	   P100	  amplitudes,	  with	  task	  relevant	  stimuli	  leading	  to	  higher	  amplitudes	  than	  passively	  viewed	  stimuli.	  This	  effect	  of	  task	  relevance	  on	  P100	  amplitude	  was	  replicated	  in	  another	   study	   and	   seemed	   to	   be	   connected	   to	   working	   memory	   performance	  (Rutman,	  Clapp,	  Chadick,	  &	  Gazzaley,	  2010).	  Drawing	  on	  the	  models	  of	  working	  memory	  described	  above	  this	  processing	  modulation	  might	  be	  induced	  by	  the	  PFC	  central	  executive,	  which	  could	  modulate	  attention	   to	   stimuli	   depending	   on	   their	   task	   relevance.	   Egner	   and	  Hirsch	   (2005)	  point	   to	   a	   model	   originally	   stemming	   from	   research	   on	   error	   processing	   (J.	   D.	  Cohen,	  Botvinick,	  &	  Carter,	  2000).	  This	  model	  suggests	  a	  processing	  system,	  which	  regulates	   attentional	   resources	  by	  drawing	  on	   two	  distinct	   components:	   ‘conflict	  monitoring’	  and	  ‘cognitive	  control’.	  Conflict	  monitoring	  is	  mediated	  by	  the	  ACC	  and	  serves	   to	   detect	   response	   conflict	   in	   on-­‐going	   tasks.	   Once	   a	   conflict	   is	   detected,	  Cohen	  and	  colleagues	   (2000)	  propose	   the	   implication	  of	   two	  different	  processes:	  The	   first	   process	   is	   mediated	   by	   the	   ACC	   and	   affects	   the	   preparation	   of	   future	  responses.	   The	   second	   process,	   however,	   is	   delegated	   to	   the	   cognitive	   control	  system,	  which	  is	  located	  in	  the	  DLPFC	  and	  corresponds	  to	  the	  central	  executive	  in	  Baddeley’s	   (2012)	  model.	   This	   control	   system	   is	   hypothesised	   to	   use	   long-­‐range	  projections	   to	   visual	   areas	   to	   increase	   selective	   attention	   by	   influencing	   the	  processing	  of	  relevant	  and	  of	  distracting	  information.	  	  This	   model	   has	   since	   been	   confirmed	   by	   findings	   from	   neuroimaging	  research	   (MacDonald,	   Cohen,	   Stenger,	   &	   Carter,	   2000),	   and	   several	   studies	  investigated	  the	  involvement	  of	  frontal	  areas	  in	  distractor	  processing	  (for	  reviews	  see	  Gazzaley	  &	  Nobre,	  2012;	  Miller	  &	  D'Esposito,	  2005).	  Increased	  PFC	  activation	  was	  found	  in	  a	  delayed	  recognition	  task	  when	  only	  some	  of	  the	  presented	  stimuli	  were	  task	  relevant	  (Gazzaley	  et	  al.,	  2007),	  and	  when	  a	  distractor	  presented	  during	  the	   delay	   was	   from	   the	   same	   category	   as	   the	   to-­‐be-­‐remembered	   stimulus	   (Jha,	  Fabian,	   &	   Aguirre,	   2004).	   Investigations	   of	   functional	   connectivity	   furthermore	  revealed	  activity	  correlations	  between	  visual	  association	  cortices	  and	  PFC	  regions	  if	  the	  task	  demanded	  a	  modulation	  of	  stimulus	  processing	  (Gazzaley	  et	  al.,	  2007).	  In	  addition,	  EEG	  studies	  investigating	  patients	  with	  DLPFC	  lesions	  report	  increased	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cortical	  responses	  to	  task	  irrelevant	  stimuli	  in	  these	  patients	  (Barcelo,	  Suwazono,	  &	  Knight,	  2000;	  Chao	  &	  Knight,	  1998).	  Furthermore,	  there	  appears	  to	  be	  increased	  processing	   of	   irrelevant	   and	   distracting	   stimuli	   with	   increasing	   age	   (Boehm,	  Dering,	  &	  Thierry,	  2011;	  Clapp	  &	  Gazzaley,	  2012;	  Gazzaley	  et	  al.,	  2008),	  which	  has	  been	  associated	  with	  a	  substantial	  decline	  in	  prefrontal	  grey	  matter	  volume	  (Raz	  et	  al.,	  1997).	  	  To	  summarise,	  there	  is	  evidence	  of	  early	  visual	  processing	  being	  influenced	  by	   the	   task	   relevance	   on	   the	   processed	   stimulus.	   This	   processing	  modulation	   is	  most	   likely	   induced	  by	   the	   allocation	   of	   selective	   attention	   to	   task	   relevant	   (and	  away	   from	   task	   irrelevant)	   stimuli.	   Previous	   research	   located	   the	   source	   of	   this	  instance	  of	  central	  executive	  or	  cognitive	  control	  in	  the	  PFC	  and	  there	  seems	  to	  be	  a	   direct	   association	   of	   activation	   in	   this	   area	   and	   the	   measured	   processing	  modulation	  based	  on	  the	  task	  relevance	  of	  a	  stimulus.	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2 Summary	  and	  Rationale	  
	  Although	   studies	   indicate	   that	   the	   prevalence	   of	   ADHD	   in	   the	   general	  population	  declines	  with	   increasing	  age	   (de	  Zwaan	  et	   al.,	   2012;	  Michielsen	  et	   al.,	  2012),	   about	   5	  %	   of	   young	   adults	   meet	   full	   diagnostic	   criteria	   for	   this	   disorder	  (Willcutt,	  2012).	  Symptoms	  were	  shown	  to	  be	  stable	  over	  time	  with	  about	  15	  %	  of	  diagnosed	   children	   still	   meeting	   full	   diagnostic	   criteria	   after	   several	   years	   and	  about	  65	  %	  of	  patients	  showing	  only	  partial	  remission	  (Faraone	  et	  al.,	  2006).	  This	  has	   far-­‐reaching	   implications,	   as	   ADHD	   is	   consistently	   associated	   with	   lower	  educational	   and	   professional	   achievement	   as	  well	   as	  worse	  mental	   and	   physical	  health	  (Biederman,	  Petty,	  et	  al.,	  2010;	  Biederman	  et	  al.,	  2012;	  Brook	  et	  al.,	  2013;	  Gjervan	   et	   al.,	   2012).	   In	   this	   context,	   the	   efficient	   treatment	   of	   ADHD	   symptoms	  gains	   great	   importance.	   Studies	   reliably	   showed	   higher	   response	   rates	   and	  increased	  symptom	  reduction	  when	  patients	  were	  treated	  with	  MPH	  –	  a	  stimulant	  blocking	   the	   dopamine	   and	   the	   norepinephrine	   transporter	   and	   inhibiting	  monoamine	  oxidase	  –	  compared	  to	  a	  placebo	  (Castells	  et	  al.,	  2013).	  	  Theories	   of	   ADHD	   aetiology	   placed	   a	   focus	   on	   impaired	   behavioural	  inhibition	   presumably	   leading	   to	   EF	   deficits	   (Barkley,	   1997).	   In	   fact,	   EF	  impairment	  in	  ADHD	  patients	  is	  clearly	  visible	  on	  a	  group	  level,	  both	  for	  children	  (Willcutt	  et	  al.,	  2005)	  and	  for	  adults	  (Boonstra	  et	  al.,	  2005)	  with	  effect	  sizes	  in	  the	  medium	   range.	   Specific	   impairment	   was	   also	   found	   for	   measures	   of	   working	  memory	  (Martinussen	  et	  al.,	  2005),	  which	  is	  considered	  an	  important	  component	  of	   higher	   order	   cognitive	   functioning.	   Neuroimaging	   studies	   report	  neurophysiological	   findings	   consistent	   with	   the	   described	   behavioural	  impairments:	   Researchers	   investigating	   functional	   brain	   activity	   in	   unmedicated	  aADHD	   patients	   from	   a	   network	   perspective	   report	   hypoactivation	   in	   the	  frontoparietal	  network	  as	  well	  as	  hyperactivation	  in	  the	  default	  mode	  network	  and	  –	   as	   a	   potential	   compensatory	   mechanism	   –	   in	   the	   dorsal	   attention	   network	  (Cortese	  et	  al.,	  2012).	  Past	  treatment	  with	  stimulant	  medication	  had	  little	  effect	  on	  the	  observed	  activation	  patterns.	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Studies	   investigating	  the	  acute	  effects	  of	  stimulant	  medication	  on	  EF	  show	  an	   improvement	   on	   behavioural	   EF	   measures	   including	   working	   memory	  manipulation	  and	  storage	  with	  small	  and	  medium	  effect	  sizes,	  respectively	  (Coghill	  et	   al.,	   2013).	   In	   addition,	   MPH	   was	   shown	   to	   up-­‐regulate	   the	   task-­‐positive/	  frontoparietal	   network	   in	   children	   and	   adolescents	   with	   ADHD	   (Cubillo	   et	   al.,	  2013;	  Wong	  &	  Stevens,	  2012).	  So	   far,	  only	   few	  studies	   investigated	  the	   impact	  of	  ADHD	  on	  behavioural	  and	  neurophysiological	  EF	  measures	  in	  adults	  as	  well	  as	  the	  effect	   of	   several	   weeks	   of	   stimulant	   medication	   in	   a	   double-­‐blind	   placebo-­‐controlled	  design.	  	  The	   val158met	   SNP	   of	   the	  COMT	   gene	   is	   a	   common	   genetic	   polymorphism	  found	   to	   have	   a	   substantial	   impact	   on	   subcortical	   and	   cortical	   dopamine	   and	  norepinephrine	   concentrations	   with	   met/met	   carriers	   exhibiting	   higher	   cortical	  neurotransmitter	  levels	  than	  val/met	  carriers	  and	  much	  higher	  levels	  than	  val/val	  carriers	  (Bilder	  et	  al.,	  2004;	  Chen	  et	  al.,	  2004;	  Weinshilboum	  et	  al.,	  1999).	  This	  was	  hypothesised	   to	   have	   a	   profound	   influence	   on	   higher	   cognitive	   functions	   where	  met/met	  carriers	  should	  benefit	  from	  working	  memory	  tasks	  demanding	  stability	  of	   neural	   networks	   and	   val/val	   carriers	   should	   benefit	   from	   tasks	   demanding	  flexibility	  of	  these	  networks	  (Bilder	  et	  al.,	  2004;	  Levy,	  2007).	  Studies	  investigating	  the	   effect	   of	   this	   polymorphism	   on	   the	   behavioural	   performance	   of	   working	  memory	  tasks	  found	  weak	  indications	  for	  a	  possible	  behavioural	  advantage	  of	  val-­‐allele	   carriers	   (Barnett	   et	   al.,	   2008).	   In	   contrast,	   val-­‐allele	   carriers	   fairly	  consistently	   showed	   less	   efficient	   prefrontal	   cortical	   functioning	   when	   fMRI	  studies	   of	  working	  memory	  were	   considered	   (Mier	   et	   al.,	   2010).	   Interestingly,	   a	  pharmacological	  study	   indicated	  that	   increasing	  the	  amount	  of	  cortical	  dopamine	  (and	   norepinephrine)	   can	   reverse	   this	   efficiency	   pattern	   (Mattay	   et	   al.,	   2003):	  While	  an	  increase	  in	  cortical	  dopamine	  benefitted	  val/val	  carriers,	   it	  was	  actually	  harmful	  for	  met/met	  carriers,	  providing	  evidence	  for	  an	  association	  of	  the	  inverted	  U-­‐shaped	  cortical	  response	  function	  to	  dopamine	  and	  efficient	  cortical	  activation	  in	  the	  PFC.	  	  The	   importance	   of	   the	   COMT	   enzyme	   for	   subcortical	   and	   cortical	  dopaminergic	   and	   noradrenergic	   functioning	   led	   researchers	   to	   extensively	  investigate	   COMT	   as	   a	   potential	   candidate	   gene	   for	   ADHD.	   Contrary	   to	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expectations,	  neither	  GWAS	  nor	  candidate	  gene	  studies	  found	  any	  evidence	  for	  an	  hypothesised	   increased	   ADHD	   risk	   transferred	   by	   the	   val-­‐allele	   (Franke	   et	   al.,	  2012;	   Gizer	   et	   al.,	   2009;	   Neale	   et	   al.,	   2010).	   The	   effect	   of	   this	   polymorphism	   on	  higher	   order	   cognitive	   functioning	   also	   led	   to	   studies	   investigating	   a	   potential	  interactive	  impact	  of	  COMT	  genotype	  and	  ADHD	  on	  neuropsychological	  functioning	  with	  a	  particular	  focus	  on	  working	  memory	  (Bellgrove	  et	  al.,	  2005;	  Matthews	  et	  al.,	  2012;	  Mills	  et	  al.,	  2004;	  Taerk	  et	  al.,	  2004).	  The	   results	  of	   these	   studies	  are	  very	  heterogeneous,	   with	   some	   studies	   finding	   no	   interaction	   and	   others	   finding	   a	  disadvantage	  for	  val/val	  carriers	  or	  for	  carriers	  of	  the	  met-­‐allele,	  likely	  depending	  on	  the	  type	  of	  working	  memory	  measure	  used	  (Matthews	  et	  al.,	  2012).	  Until	  now,	  there	  is	  only	  one	  study	  of	  adults	  with	  ADHD,	  which	  found	  the	  val/met	  genotype	  to	  be	  most	  beneficial	  (Boonstra	  et	  al.,	  2008).	  As	  none	  of	  these	  studies	  compared	  the	  results	  of	  ADHD	  patients	  to	  those	  of	  a	  healthy	  control	  group,	  a	  possible	  differential	  effect	  of	  COMT	  in	  patients	  compared	  to	  healthy	  controls	  might	  have	  been	  missed.	  	  The	  three	  studies	  presented	  in	  this	  dissertation	  aimed	  to	  accomplish	  several	  goals.	  The	  first	  goal	  was	  to	  further	  refine	  an	  experimental	  paradigm	  hypothesised	  to	  tax	  selective	  attention	  mediated	  by	  the	  central	  executive	  component	  of	  working	  memory,	   as	   specified	   in	   Baddeley’s	   (2012)	   model.	   Since	   neurophysiological	  research	  previously	   implicated	   the	  PFC	  as	  subserving	  central	  executive	   functions	  (Funahashi	   et	   al.,	   1989;	   Goldman-­‐Rakic,	   1995;	   Postle,	   2006),	   we	   further	  investigated	   whether	   subclinical	   symptoms	   of	   aADHD	   and	   the	   COMT	   genotype,	  respectively,	   might	   have	   an	   impact	   on	   performance	   and	   neurophysiological	  functioning	   during	   this	   task.	   In	   a	   third	   study,	   performance	   and	   functional	   brain	  activity	  in	  aADHD	  patients	  and	  healthy	  controls	  during	  this	  selective	  attention	  task	  as	  well	   as	  during	  a	   standard	  working	  memory	   task	  were	   compared.	  A	  particular	  focus	  was	  placed	  on	  activity	  in	  the	  task-­‐positive/	  attention	  network.	  Furthermore,	  working	   memory	   and	   interference	   control	   were	   examined	   using	   three	   well-­‐established	   neuropsychological	   tests.	   The	   impact	   of	   stimulant	   treatment	   on	  functional	   activation	   and	   behavioural	   performance	   during	   these	   tasks	   was	  investigated	  in	  a	  6-­‐week	  placebo-­‐controlled	  double-­‐blind	  clinical	  trial	  with	  MPH	  or	  a	   placebo	   being	   dispensed	   to	   the	   participating	   aADHD	   patients	   in	   an	   externally	  valid	   free	   titration	   design.	   Given	   the	   scarcity	   of	   previous	   research	   on	   this	   topic,	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possible	  interactive	  effects	  of	  COMT	  genotype	  and	  aADHD	  on	  the	  above-­‐mentioned	  tasks	  were	  also	  explored.	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3 Study	  1:	  EEG	  Parameters	  of	  Selective	  Attention2	  
3.1 Introduction	  
As	   described	   under	   1.3.2,	   several	   studies	   previously	   focused	   on	   the	  contribution	   of	   central	   executive	   control	   to	   successful	   performance	   of	   working	  memory	   tasks	   that	   require	   selective	  attention	   in	   the	   face	  of	  distraction.	  EEG	  and	  fMRI	   studies	   employed	   a	  wide	   variety	   of	   paradigms	  with	   task	   relevant	   and	   task	  irrelevant	  stimuli	  from	  either	  the	  same	  or	  different	  categories,	  thereby	  varying	  the	  degree	   of	   distraction	   the	   task	   irrelevant	   stimuli	   produced	   (Gazzaley	   et	   al.,	   2005;	  Jha	   et	   al.,	   2004;	   Rutman	   et	   al.,	   2010;	   Schreppel	   et	   al.,	   2008;	   Sreenivasan	   &	   Jha,	  2007;	   Zanto	   &	   Gazzaley,	   2009).	   For	   all	   of	   these	   studies,	   relevance-­‐induced	  processing	  differences	  were	  fairly	  consistent	  across	  paradigms.	  Most	  EEG	  studies	  showed	   peak	   amplitude	   differences	   for	   the	   N170,	   with	   relevance-­‐induced	   peak	  latency	  differences	  apparently	  less	  consistent	  across	  the	  different	  paradigms.	  Peak	  amplitudes	   were	   reported	   to	   be	   enhanced	   (Schreppel	   et	   al.,	   2008)	   and/or	  suppressed	   (Gazzaley	   et	   al.,	   2005;	   Polk,	   Drake,	   Jonides,	   Smith,	   &	   Smith,	   2008;	  Sreenivasan	  &	  Jha,	  2007;	  Zanto	  &	  Gazzaley,	  2009),	  depending	  on	  the	  relevance	  of	  the	   processed	   stimulus.	   Results	   regarding	   frontal	   EEG	   components	   possibly	  reflecting	   DLPFC	   activity	   are	   scarce	   and	   more	   conflicting:	   One	   study	   used	   a	  continuous	  n-­‐back	  design	  and	  reports	  more	  positive	  amplitudes	  for	  task	  relevant	  stimuli	   compared	   to	   task	   irrelevant	  or	  passively	  viewed	  stimuli	   (Schreppel	  et	  al.,	  2008).	   In	   contrast,	   another	   study	   investigated	   the	   slightly	   different	   topic	   of	  recovery	   from	   interference	   and	   found	   significantly	   higher	   amplitudes	   after	   the	  presentation	  of	  a	  distracting	  stimulus	  than	  after	  no	  distraction	  (K.	  Kessler	  &	  Kiefer,	  2005).	  All	  studies,	  however,	  differed	  greatly	  in	  the	  employed	  paradigm,	  with	  some	  studies	  relying	  on	  simultaneous	  presentation	  of	  both	  task	  relevant	  and	  distracting	  task	  irrelevant	  stimuli	  (Rutman	  et	  al.,	  2010),	  while	  others	  presented	  task	  relevant	  and	  task	  irrelevant	  stimuli	  in	  sequential	  order	  (Gazzaley	  et	  al.,	  2005;	  Schreppel	  et	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  Results	  from	  the	  following	  study	  are	  published	  in	  BMC	  Neuroscience	  (Biehl	  et	  al.,	  2013)	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al.,	  2008;	  Sreenivasan	  &	  Jha,	  2007;	  Zanto	  &	  Gazzaley,	  2009).	  The	  thereby	  created	  conditions	   were	   also	   dissimilar	   across	   studies:	   While	   all	   studies	   contained	   task	  relevant	  stimuli,	   the	   task	   irrelevant	  stimuli	  differed	   in	   their	  degree	  of	  distraction	  (Sreenivasan	   &	   Jha,	   2007),	   depending	   on	   whether	   the	   distracting	   stimuli	   were	  from	  the	  same	  or	  a	  different	  category	  as	  the	  task	  relevant	  stimuli	  (Gazzaley	  et	  al.,	  2005;	  Rutman	  et	  al.,	  2010;	  Schreppel	  et	  al.,	  2008).	   In	  addition,	  only	  some	  studies	  included	  a	  passive	  viewing	  control	  condition	  (Gazzaley	  et	  al.,	  2005;	  Rutman	  et	  al.,	  2010;	   Schreppel	   et	   al.,	   2008;	   Zanto	  &	  Gazzaley,	   2009),	  which	   appears	   to	   lead	   to	  somewhat	   intermediate	   activation.	   No	   study	   so	   far	   included	   both	   high	   and	   low	  distracting	  task	  irrelevant	  stimuli	  as	  well	  as	  a	  passive	  viewing	  control	  condition.	  	  In	  order	   to	  compare	  passively	  viewed	  stimuli	   to	   task	   relevant	  and	   to	  high	  and	  low	  distracting	  task	  irrelevant	  stimuli,	  several	  aspects	  of	  the	  above-­‐mentioned	  tasks	   were	   combined:	   We	   used	   a	   modified	   n-­‐back	   paradigm	   (J.	   D.	   Cohen	   et	   al.,	  1994)	   similar	   to	   the	   one	   employed	   by	   Schreppel	   and	   colleagues	   (2008)	   to	  investigate	  both	  P100	  and	  N170	  amplitudes,	  with	  task	  relevant	  and	  task	  irrelevant	  stimuli	   being	   alternately	   presented	   in	   sequential	   order.	   The	   structure	   of	   this	  paradigm	   provided	   by	   the	   underlying	   n-­‐back	   task	   allows	   for	   the	   examination	   of	  continuous	   attentional	   processes,	   which	   differentiates	   this	   paradigm	   from	  previous	   investigations	   using	   delayed	   recognition	   paradigms.	   The	   continuous	  nature	   of	   this	   modified	   n-­‐back	   task	   should	   be	   more	   conducive	   to	   a	   stable	  attentional	  set	  than	  the	  delayed	  recognition	  paradigm	  where	  attention	  necessarily	  fluctuates	   between	   trials.	   In	   addition,	   the	   behavioural	   data	   obtained	   with	   this	  paradigm	  can	  easily	  be	  related	  to	  both	  impulsivity	  (provided	  by	  the	  ‘false	  alarms’	  parameter)	  and	  inattention	  (provided	  by	  the	  ‘detected	  targets’	  parameter),	  which	  makes	   it	   especially	   suitable	   for	   the	   assessment	   of	   participants	   with	   deficits	   in	  attention	  regulation.	  The	  main	  goal	  of	  this	  study	  was	  the	  examination	  of	  EEG	  activity	  related	  to	  the	   early	   processing	   of	   task	   relevant	   and	   high	   as	   well	   as	   low	   distracting	   task	  irrelevant	   stimuli,	   and	   of	   frontal	   processes	   related	   to	   selective	   attention	   and	  recovery	  from	  interference	  (K.	  Kessler	  &	  Kiefer,	  2005;	  Schreppel	  et	  al.,	  2008).	  This	  task	   requires	   EF	   by	   drawing	   on	   working	   memory	   functions	   in	   the	   form	   of	   the	  central	   executive	   (selective	   attention)	   and	   short-­‐term	   storage	   of	   information	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(maintenance).	   Since	  both	  EF	  and	  working	  memory	  were	  previously	   found	   to	  be	  deficient	  in	  childhood	  as	  well	  as	  aADHD	  (Boonstra	  et	  al.,	  2005;	  Martinussen	  et	  al.,	  2005;	  Willcutt	  et	  al.,	  2005)	  subclinical	  symptoms	  of	  ADHD	  were	  assessed	  in	  order	  to	   explore	   whether	   distractor	   processing	   might	   vary	   systematically	   with	   the	  amount	  of	  reported	  ADHD	  symptoms.	  	  
3.2 Hypotheses	  
1.	   We	  expected	  task	  relevant	  stimuli	  to	   lead	  to	  enhanced	  amplitudes	  and	  high	   distracting	   task	   irrelevant	   stimuli	   to	   lead	   to	   reduced	   amplitudes	  relative	  to	  the	  passive	  viewing	  control	  condition	  (Gazzaley	  et	  al.,	  2005;	  Schreppel	  et	  al.,	  2008).	  	  2.	   In	   line	   with	   previous	   studies,	   low	   distracting	   task	   irrelevant	   stimuli	  should	   lead	   to	   significantly	   less	   suppression	   and	   thereby	   higher	  amplitudes	  than	  high	  distracting	  task	  irrelevant	  stimuli	  (Sreenivasan	  &	  Jha,	  2007).	  	  3.	   Regarding	  the	  frontal	  components,	  we	  expected	  higher	  amplitudes	  after	  the	  presentation	  of	  high	  distracting	  task	  irrelevant	  stimuli	  (K.	  Kessler	  &	  Kiefer,	  2005).	  	  4.	   In	  addition,	  we	  hypothesised	  that	  participants	  with	  pronounced	  ADHD	  symptoms	  would	  have	  higher	  N170	  amplitudes	  to	  high	  distracting	  task	  irrelevant	   stimuli	   –	   indicating	   increased	   processing	   because	   of	  increased	   distractibility	   –	   than	   participants	   with	   less	   pronounced	  symptoms.	  	  5.	   Given	   the	   increased	   distractibility	   and	   hyperactivity/	   impulsivity	  associated	  with	   ADHD	   and	   the	   connection	   of	   ADHD	  with	   problems	   of	  top-­‐down	   distractor	   suppression	   and	   executive	   (cognitive)	   control	  (Dramsdahl,	   Westerhausen,	   Haavik,	   Hugdahl,	   &	   Plessen,	   2011;	  Friedman-­‐Hill	   et	   al.,	   2010),	   we	   also	   expected	   a	   correlation	   of	  participants’	   scores	  on	   three	  CAARS	  DSM-­‐IV	  self-­‐report	  scales	  and	   the	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behavioural	   task	   performance	   parameters	   ‘false	   alarms’	   and	   ‘detected	  targets’.	  	  	  
3.3 Methods	  
 Experimental	  Paradigm3	  3.3.1
The	   experimental	   task	   consisted	   of	   a	   1-­‐back	   paradigm	   with	   alternately	  presented	  task	  relevant	  and	  task	  irrelevant	  stimuli.	  Our	  task	  employed	  pictures	  of	  neutral	  faces	  taken	  from	  the	  FERET	  database	  (Phillips,	  Wechsler,	  Huang,	  &	  Rauss,	  1998)	   and	   pictures	   of	   German	   houses	   without	   any	   prominent	   distinguishing	  features.	  For	  lack	  of	  an	  existing	  database,	  the	  house	  pictures	  were	  taken	  in	  a	  rural	  area	   in	   southeast	   Germany.	   All	   pictures	  were	   edited	   using	  Adobe®	  Photoshop®	  CS4	   (version	   11.0,	   Adobe	   Systems,	   Inc.,	   San	   Jose,	   USA)	   to	   remove	   any	   apparent	  distinguishing	  features.	  	  The	  experiment	  consisted	  of	  three	  conditions:	  Two	  experimental	  conditions	  (“houses	   relevant”	  and	   “faces	   relevant”)	  and	  a	  passive	  viewing	  control	   condition.	  Each	  condition	  was	  presented	  twice,	  yielding	  a	  total	  of	  six	  blocks	  containing	  eighty	  stimuli	  each.	  Of	  these	  eighty	  stimuli,	  forty	  (i.e.	  50	  %	  of	  all	  stimuli	  presented	  in	  the	  block)	   were	   task	   relevant	   and	   forty	   (i.e.	   another	   50	  %)	   were	   task	   irrelevant	  distractors.	  For	  the	  two	  experimental	  conditions,	  the	  forty	  relevant	  stimuli	  were	  all	  from	   the	  same	  category	   (i.e.	  100	  %	  “face”	  or	  100	  %	  “house”	   stimuli).	   In	   contrast,	  the	  forty	  task	  irrelevant	  stimuli	  were	  split	  evenly	  to	  be	  from	  the	  same	  category	  as	  the	   task	  relevant	   stimuli	   (yielding	   twenty	  high	  distracting	  stimuli,	   i.e.	  50	  %	  of	  all	  task	   irrelevant	   stimuli	  were	  high	  distracting)	   or	   from	  another	   category	   (yielding	  twenty	   low	   distracting	   stimuli,	   i.e.	   50	  %	   of	   all	   task	   irrelevant	   stimuli	   were	   low	  distracting).	  The	  passive	  viewing	   control	   condition	  always	   contained	   forty	  house	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  Portions	  of	   the	   research	   in	   this	   study	  use	   the	  FERET	  database	  of	   facial	   images	   collected	  under	   the	  FERET	  programme.	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stimuli	  (i.e.	  50	  %	  of	  all	  presented	  stimuli)	  and	  forty	  face	  stimuli	  (i.e.	  another	  50	  %),	  which	  –	  only	  in	  this	  condition	  –	  were	  presented	  in	  random	  order.	  	  During	   each	   “houses	   relevant”	   and	   “faces	   relevant”	   condition,	   five	   task	  relevant	   stimuli	   (i.e.	   12.5	  %	   of	   all	   task	   relevant	   stimuli	   presented	   in	   the	   block)	  were	   repeated	   in	   a	   1-­‐back	   fashion	   requiring	   a	   behavioural	   response.	   Three	   task	  relevant	  stimuli	   (i.e.	  7.5	  %	  of	  all	   task	  relevant	  stimuli)	  were	  repeated	   in	  a	  2-­‐back	  fashion	   not	   requiring	   a	   behavioural	   response.	   The	   2-­‐back	   repetitions	   were	  included	  to	  ensure	  that	  participants	  would	  not	  simply	  react	  to	  the	  familiarity	  of	  a	  stimulus.	   All	   repeated	   stimuli	  were	   excluded	   from	   later	   EEG	   data	   analysis.	   On	   a	  behavioural	   level,	  reaction	  times	  for	  correct	  responses	  as	  well	  as	  number	  of	  false	  alarms	   and	  number	   of	   detected	   target	   stimuli	  were	   recorded.	   Every	   picture	  was	  shown	   only	   once	   in	   one	   of	   the	   three	   conditions.	   Task	   irrelevant	   stimuli	   never	  required	  a	  behavioural	  response.	  	  
	  Figure	   3.1:	   The	   experimental	   paradigm.	  Vertical	   bars	  mark	   task	   relevant	   stimuli;	   horizontal	   bars	  mark	  task	   irrelevant	  stimuli.	  Participants	  were	  supposed	  to	   indicate	  when	  a	  task	  relevant	  picture	  was	  repeated	  1-­‐back	  while	  ignoring	  the	  interspersed	  task	  irrelevant	  distractors.	  	  Although	   task	   relevant	   and	   task	   irrelevant	   stimuli	   were	   presented	  alternately,	   the	   task	   relevance	   or	   task	   irrelevance	   of	   a	   stimulus	  was	   additionally	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indicated	   by	   two	   horizontal	   or	   vertical	   bars	   in	   each	   of	   the	   four	   corners	   of	   the	  display	   (see	   Figure	   3.1	   for	   an	   example	   of	   the	   “faces	   relevant”	   condition).	  Participants	  were	   instructed	  beforehand	  about	  the	  markings	  (e.g.	  horizontal	  bars	  marking	   task	   relevant	   stimuli	   and	  vertical	  bars	  marking	   task	   irrelevant	   stimuli	   –	  this	  was	  counterbalanced	  across	  participants)	  and	  markings	  were	  kept	  consistent	  across	   the	   entire	   experiment.	   All	   stimuli	   were	   presented	   for	   1,000	  ms	   with	   the	  interstimulus	  interval	  showing	  a	  grey	  fixation	  cross	  and	  ranging	  from	  1,750	  ms	  to	  2,750	  ms.	   This	   experimental	   set-­‐up	   led	   to	   four	   different	   relevance-­‐levels	   of	   the	  presented	   stimuli:	   task	   relevant	   stimuli,	   high	   distracting	   task	   irrelevant	   stimuli,	  low	  distracting	   task	   irrelevant	   stimuli,	   and	  passively	  viewed	  stimuli.	  Participants	  were	  seated	  50	  cm	   from	  the	  monitor	  and	  viewed	  stimuli	  of	  approximately	  10	  cm	  height	  by	  7.5	  cm	  width.	  The	  whole	  display	   including	   the	  markings	  was	  12	  cm	  by	  12	  cm,	  subtending	  14°	  of	  visual	  angle.	  	  	  
 Participants	  3.3.2
Fifty	   participants	   took	   part	   in	   this	   study.	   They	   were	   recruited	   from	   a	  previously	  established	  subject	  pool	  (see	  also	  Gschwendtner	  et	  al.,	  2012)	  as	  well	  as	  through	  university	  advertisement.	  Participants	  were	  mostly	  students	  and	  received	  12€	   as	   compensation	   for	   their	   participation.	   All	   participants	  were	   right-­‐handed,	  had	   normal	   or	   corrected-­‐to-­‐normal	   vision,	   and	   were	   free	   of	   neurological	   or	  psychiatric	  diseases.	  However,	  due	  to	  a	  technical	  mistake,	  a	  substantial	  part	  of	  the	  data	  was	  recorded	  with	  an	  erroneous	  filter,	  not	  allowing	  the	  implementation	  of	  the	  required	  high-­‐pass	   filter	  of	  0.1	  Hz	  during	  data	  analysis.	  Therefore,	  only	   forty	  per	  cent	  of	  the	  original	  sample	  (twenty	  participants)	  could	  be	  fully	  analysed	  (see	  Table	  3.1	   for	   ADHD	   symptoms,	   depressive	   symptoms	   and	   affectivity	   of	   that	   sample).	  Ethical	   approval	  was	   obtained	   through	   the	   Ethical	   Review	   Board	   of	   the	  medical	  faculty	  of	  the	  University	  of	  Würzburg;	  all	  procedures	  involved	  were	  in	  accordance	  with	  the	  2008	  Declaration	  of	  Helsinki.	  Participants	  gave	  written	  informed	  consent	  after	  full	  explanation	  of	  procedures.	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Table	   3.1:	   Mean	   (SD)	   of	   demographic	   data,	   CAARS	   DSM-­‐IV	   ADHD	   symptoms,	   BDI-­‐II	   depressive	  
symptoms,	  and	  PANAS	  affectivity	  for	  the	  analysed	  sample.	  	  
Age	  (years)	   25.4(4.1)	   Men/	  women	   5/15	  
CAARS	  (T-­‐scores)	   	   PANAS	   	  Inattentive	  Symptoms	   43.6(8.9)	   Positive	  affect	  	   19.7(6.3)	  Hyperactive/Imp.	  Symptoms	   42.1(9.7)	   Negative	  affect	   2.7(4.4)	  Total	  ADHD	  Symptoms	   42.0(10.3)	   BDI-­‐II	  (sum	  score)	   6.2(6.7)	  	  	  
 Psychological	  Assessment	  	  3.3.3
Participants	   completed	   three	   ADHD	   questionnaires	   to	   assess	   individual	  symptoms	  of	  both	  childhood	  and	  adult	  ADHD:	  The	  Adult	  ADHD	  Self-­‐Report	  Scale	  (ASRS)	   (R.	   C.	   Kessler	   et	   al.,	   2005)	   is	   an	   18-­‐item	   questionnaire	   assessing	   ADHD	  symptoms	   based	   on	   the	   DSM-­‐IV-­‐TR	   (2000).	   Participants	  were	   pre-­‐screened	   and	  selected	  based	  on	  their	  ASRS	  scores	  to	  ensure	  variability	  of	  ADHD	  symptoms	  in	  the	  sample.	  All	  participants	  had	  either	  a	  score	  of	  ten	  or	  lower	  on	  both	  the	  inattention	  and	  the	  hyperactivity/	  impulsivity	  scale	  or	  a	  score	  of	  at	  least	  15	  on	  any	  one	  of	  the	  two	   scales.	   The	   CAARS	   (Conners	   et	   al.,	   1999)	   is	   a	   more	   refined	   questionnaire,	  adding	  symptoms	  of	  aADHD	  to	  the	  core	  ADHD	  symptoms	  (Christiansen	  et	  al.,	  2012;	  Christiansen	  et	  al.,	  2011).	  To	  ensure	  that	  no	  participant	  met	  full	  diagnostic	  criteria	  of	   childhood	   ADHD	   as	   described	   in	   the	   DSM-­‐IV-­‐TR	   (2000),	   participants	   also	  completed	   the	   Wender	   Utah	   Rating	   Scale	   (WURS)	   (Ward,	   Wender,	   &	   Reimherr,	  1993).	  No	  participant	   scored	  above	   the	   cut-­‐off	   score	   for	   the	   short	  version	   (Retz-­‐Junginger	  et	   al.,	   2002)	  of	   this	  questionnaire.	  To	   control	   for	  affect	   and	  depressive	  symptoms,	   subjects	   furthermore	   completed	   the	   Positive	   and	   Negative	   Affect	  Schedule	   (PANAS)	   (Krohne,	   Egloff,	   Kohlmann,	   &	   Tausch,	   1996;	  Watson,	   Clark,	   &	  Tellegen,	  1988)	  and	  the	  Beck	  Depression	  Inventory	  (BDI-­‐II)	  (Hautzinger,	  Keller,	  &	  Kühner,	  2006).	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 Electrophysiological	  Recording	  and	  Data	  Analysis	  3.3.4
ERPs	  were	  recorded	  from	  28	  Ag/AgCl	  active	  electrodes,	  which	  were	  placed	  according	   to	   the	   10-­‐20	   guidelines	   (Jasper,	   1958)	   using	   the	   actiCap	   system	   (see	  Figure	   3.2).	   Additional	   electrodes	  were	   placed	   under	   the	   right	   eye	   as	  well	   as	   on	  both	  outer	  canthi	   to	  monitor	  eye	  movement.	  The	  ground	  electrode	  was	  placed	  at	  AFz.	  Impedance	  was	  kept	  below	  10	  kΩ	   for	  all	  electrodes.	  Data	  was	  recorded	  with	  the	  software	  Brain	  Vision	  Recorder	  1.20	  (Brain	  Products	  GmbH,	  Munich,	  Germany)	  in	  relation	  to	  a	  midline	  reference	  electrode	  placed	  at	  FCz	  with	  a	  sampling	  rate	  of	  1000	  Hz.	  	  The	   data	   was	   analysed	   with	   the	   software	   BrainVision	   Analyzer	   1	   (Brain	  Products	  GmbH).	  Band-­‐pass	  filters	  were	  set	  to	  0.1-­‐30	  Hz,	  with	  a	  50	  Hz	  notch	  filter.	  Eye	  movement	  artefacts	  were	  corrected	  (Gratton,	  Coles,	  &	  Donchin,	  1983)	  and	  the	  data	   was	   re-­‐referenced	   to	   an	   average	   recorded	   reference.	   Stimulus-­‐locked	   EEG	  epochs	   from	   –100	  ms	   to	   500	  ms	   were	   segmented	   for	   the	   different	   stimuli.	   All	  stimuli	  used	  for	  1-­‐	  or	  2-­‐back	  repetitions	  as	  well	  as	  segments	  containing	  false	  alarm	  responses	  were	  excluded	  from	  further	  analysis.	  The	  data	  was	  baseline	  corrected	  to	  the	  mean	  amplitude	   from	  –100	  ms	   to	  0	  ms.	  Epochs	   containing	   artefacts	  with	   the	  voltage	  in	  any	  channel	  exceeding	  ±100	  µV	  or	  showing	  drops	  or	  rises	  of	  more	  than	  100	  µV/ms	  were	  rejected	  and	  the	  remaining	  artefact-­‐free	  epochs	  were	  averaged.	  Based	   on	   the	   literature	   (Bentin	   et	   al.,	   1996;	   K.	   Kessler	   &	   Kiefer,	   2005;	  Rossion	  &	  Jacques,	  2008;	  Schreppel	  et	  al.,	  2008;	  Sreenivasan	  &	  Jha,	  2007)	  and	  on	  grand	  average	   topography,	   channels	  O1	  and	  O2	  were	   selected	   for	  P100	  analysis,	  channels	  P7/P8	  and	  PO9/PO10	  were	  chosen	  for	  analysis	  of	  the	  N170,	  and	  channels	  T7/T8	   and	   F7/F8	   were	   chosen	   for	   the	   analysis	   of	   the	   frontal	   components	   (see	  Figure	  3.2).	  	  Based	  on	  the	  grand	  average	  time	  course	  over	  all	  participants,	  the	  P100	  was	  defined	  as	  the	  most	  positive	  peak	  in	  the	  time	  window	  from	  70	  ms	  to	  140	  ms.	  The	  N170	  was	  defined	  as	  the	  most	  negative	  peak	  in	  the	  time	  window	  from	  140	  ms	  to	  210	  ms.	  Since	  the	   fixation	  cross	  appeared	  after	  1000	  ms	  of	  stimulus	  presentation	  and	   the	   effects	   of	   this	   visual	   stimulation	   change	   might	   be	   different	   across	  conditions,	   frontal	   components	  were	   exported	   as	  mean	   activity	   only	   in	   the	   time	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window	  from	  800	  ms	  to	  1000	  ms.	  Peaks	  were	  automatically	  detected	  and	  manually	  adjusted	  if	  necessary.	  Peak	  amplitudes	  were	  then	  exported	  for	  subsequent	  analysis	  with	  SPSS	  Statistics	  20	  (IBM®,	  New	  York,	  USA).	  
	  Figure	  3.2:	  Standard	  layout	  of	  the	  actiCap	  32	  channel	  system	  (the	  active	  electrodes	  used	  to	  record	  eye	  movement	   are	   not	   shown	  here).	   Channels	   used	   for	   P100	   analysis	   are	  marked	  blue,	   channels	  used	   for	   N170	   analysis	   are	   marked	   red,	   and	   channels	   used	   for	   the	   analysis	   of	   the	   frontal	  components	  are	  marked	  green.	  	  	  
 Statistical	  Analysis	  3.3.5
For	   the	   behavioural	   data,	   the	   percentage	   of	   correctly	   identified	   target	  stimuli	   (hits)	   and	   the	   number	   of	   false	   alarms	   were	   compared	   for	   the	   two	  categories	   (face	   and	   house	   stimuli)	   using	   paired	   sample	   t-­‐tests.	   In	   addition,	   an	  accuracy	   index	   incorporating	   both	   correct	   (non-­‐)responses	   and	   false	   alarm	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responses	   as	   described	   by	   Grimm	   et	   al.	   (2012)	   was	   calculated	   for	   the	   two	  categories.	  	  ERP	  amplitudes	  were	  analysed	  separately	   for	   the	  P100,	   the	  N170,	  and	  the	  frontal	   components	  by	  using	  a	   repeated	  measures	  analysis	  of	  variance	   (ANOVA).	  The	  ANOVA	   for	   the	  P100	   comprised	   the	  within-­‐subjects	   factors	  hemisphere	   (left,	  right),	   stimulus	   category	   (face,	   house),	   and	   task	   relevance	   (relevant,	   irrelevant	   –	  high	  distracting,	  irrelevant	  –	  low	  distracting,	  passively	  viewed).	  The	  ANOVA	  for	  the	  N170	   and	   the	   ANOVA	   for	   the	   frontal	   components	   included	   the	   within-­‐subjects	  factors	   hemisphere	   (left,	   right),	   channel	   group	   (P7/P8,	   PO9/PO10	   and	   T7/T8,	  F7/F8,	   respectively),	   stimulus	   category	   (face,	   house),	   and	   task	   relevance	   (task	  relevant,	   task	   irrelevant	   –	   high	   distracting,	   task	   irrelevant	   –	   low	   distracting,	  passively	  viewed).	  Hypotheses-­‐driven	  one-­‐sided	   t-­‐tests	  were	  used	   for	   the	   factors	  
task	   relevance	   and	   stimulus	   category;	   two-­‐tailed	   t-­‐tests	   were	   used	   for	   all	   other	  post-­‐hoc	   comparisons.	   To	   control	   for	   multiple	   comparisons,	   all	   post-­‐hoc	   t-­‐tests	  were	   Šidák-­‐corrected.	   If	   assumptions	   of	   sphericity	   were	   violated,	   degrees	   of	  freedom	  were	   adjusted	   according	   to	  Greenhouse-­‐Geisser	   (Greenhouse	  &	  Geisser,	  1959).	   However,	   to	   facilitate	   understanding	   only	   full	   degrees	   of	   freedom	   are	  reported	  below.	  	  In	  addition,	  the	  following	  correlation	  coefficients	  were	  calculated:	  The	  N170	  components	   for	   the	   four	   task	   conditions	   (task	   relevant,	   task	   irrelevant	   –	   high	  distracting,	   task	   irrelevant	   –	   low	   distracting,	   passively	   viewed)	   were	   correlated	  with	   the	   three	   CAARS	   DSM-­‐IV	   subscales	   ‘Inattentive	   Symptoms’,	   ‘Hyperactive/	  Impulsive	   Symptoms’,	   and	   ‘Total	   ADHD	   Symptoms’.	   The	   N170	   difference	  amplitude	   of	   task	   relevant	   minus	   high	   distracting	   task	   irrelevant	   stimuli	   was	  correlated	  with	   the	   same	   three	  CAARS	  subscales	  as	  well	   as	  with	   the	  behavioural	  measures	   ‘percentage	  of	  detected	   targets’	   and	   ‘number	  of	   false	  alarms’,	   and	  with	  mean	  frontal	  amplitudes.	  The	  behavioural	  measures	  were	  also	  correlated	  with	  the	  three	  above-­‐mentioned	  CAARS	  subscales.	  For	  all	  analyses,	  p-­‐values	  of	  α	  ≤	  .05	  were	  considered	  significant.	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3.4 Results	  
(1) Behavioural	  Data	  
All	  participants	  detected	  at	  least	  50	  %	  of	  the	  target	  trials.	  The	  average	  rate	  of	  detected	   targets	  was	  88.8	  %	   (SD	  =	  9.9),	   the	   average	   reaction	   time	  was	  741	  ms	  (SD	  =	  123;	   see	   Table	   3.2	   for	   further	   performance	   characteristics).	   The	   rates	   of	  correctly	  identified	  target	  trials	  and	  of	  false	  alarms	  as	  well	  as	  the	  average	  reaction	  time	  and	  the	  accuracy	  index	  were	  not	  significantly	  different	  for	  face	  versus	  house	  stimuli	  (all	  p	  >	  .1).	  	  
	  
Table	  3.2:	  Overview	  of	  mean	  per	  cent	  hits,	  reaction	  time,	  false	  alarms,	  accuracy	  index,	  and	  usable	  EEG	  






Number	  of	  usable	  epochs	  
	  	  %	  hits	   88.8(9.9)	   Task	  relevant	  stimuli2	  	   120.3(9.2)	  Reaction	  time1	   741(123)	   Task	  irrelevant,	  high	  distracting3	   77.6(4.7)	  False	  alarms	   5.4(3.5)	   Task	  irrelevant,	  low	  distracting3	   77.1(6.4)	  Accuracy	  index	   .98(.01)	   Passive	  viewing2	   78.4(3.4)	  
Note.	  1	  Reaction	  time	  is	  reported	  in	  milliseconds	  (ms);	  2	  out	  of	  128	  epochs;	  3	  out	  of	  80	  epochs;	  	  	  	  
(2) EEG	  Data	  	  
P100	   The	   repeated	   measures	   ANOVA	   with	   the	   factors	   hemisphere,	   stimulus	  
category,	  and	  task	  relevance	  yielded	  a	  significant	  main	  effect	  of	  stimulus	  category	  (F(1,19)	  =	  7.2,	   p	  =	  .02),	   with	   significantly	   higher	   amplitudes	   for	   face	   compared	   to	  house	   stimuli.	   The	   ANOVA	   showed	   no	   further	   significant	   main	   effects	   or	  interactions.	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N170	  	   The	  repeated	  measures	  ANOVA	  with	  the	  factors	  hemisphere,	  channel	  group,	  
stimulus	   category,	   and	   task	   relevance	   yielded	   a	   significant	   main	   effect	   of	   task	  relevance	  (F(3,57)	  =	  9.1,	  p	  <	  .001;	  see	  Figure	  3.3	  for	  time	  courses	  and	  topographies	  in	  the	  different	  conditions).	  	  	  
	  	  Figure	  3.3:	  N170	  grand	  average	  time	  courses	  over	  electrodes	  P7/P8	  and	  PO9/PO10	  (A.),	  and	  N170	  topographies	   for	   the	   different	   conditions	   (B.).	   Horizontal	   (HEOG)	   and	   vertical	   (VEOG)	  electrooculogram	  activity	  is	  displayed	  in	  the	  upper	  part	  of	  the	  figure	  showing	  that	  eye	  movements	  were	   insignificant	   and	   did	   not	   differ	   across	   conditions.	   Topographies	   are	   shown	   for	   the	   grand	  average	  peak	  in	  each	  condition.	  	  	  Across	  the	  channel	  groups,	   task	  relevant	  stimuli	   led	  to	  significantly	  higher	  peak	   amplitudes	   than	   high	   distracting	   task	   irrelevant	   stimuli	   (p	  <	  .001)	   and	  significantly	  higher	  peak	  amplitudes	   than	  passively	  viewed	  stimuli	   (p	  =	  .03).	  Low	  distracting	  task	  irrelevant	  stimuli	  yielded	  significantly	  higher	  amplitudes	  than	  high	  distracting	   task	   irrelevant	   stimuli	   (p	  =	  .03),	   but	   the	   amplitudes	   were	   not	  significantly	   different	   from	   task	   relevant	   stimuli	   (p	  =	  .28)	   and	   from	   passively	  viewed	  stimuli	  (p	  =	  .36).	  Amplitudes	  for	  high	  distracting	  task	  irrelevant	  stimuli	  and	  for	   passively	   viewed	   stimuli	   were	   also	   not	   significantly	   different	   (p	  =	  .12;	   see	  Figure	  3.4).	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  In	   addition,	   there	   was	   a	   significant	   main	   effect	   of	   stimulus	   category	  (F(1,19)	  =	  213.5,	  p	  <	  .001)	  with	   face	  stimuli	  yielding	  significantly	  higher	  amplitudes	  than	  house	  stimuli	  across	  all	  channels	  and	  conditions.	  A	  significant	   interaction	  of	  hemisphere	  and	  channel	  group	  yielded	  no	  significant	  post-­‐hoc	  differences.	  There	  was	   no	   significant	   interaction	   of	   channel	   group	   and	   task	   relevance	   (F(3,57)	  =	  2.5,	  
p	  =	  .07)	  or	  of	  stimulus	  category	  and	  task	  relevance	  (F(3,57)	  =	  2.4,	  p	  =	  .08).4	  The	  N170	  difference	  amplitude	  of	  task	  relevant	  minus	  high	  distracting	  task	  irrelevant	   stimuli	  was	   significantly	   correlated	  with	   the	  accuracy	   index	   that	   takes	  correct	  (non-­‐)responses	  as	  well	  as	  false	  alarm	  responses	  into	  account	  (r(18)	  =	  -­‐.56,	  
p	  =	  .01):	   The	   smaller	   the	   difference	   between	   the	   amplitudes	   (i.e.	   the	   less	  processing	   suppression	   for	   high	   distracting	   task	   irrelevant	   stimuli	   compared	   to	  task	  relevant	  stimuli),	  the	  lower	  overall	  accuracy	  (see	  Figure	  3.5).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	   This	   method	   first	   normalises	   the	   data	   for	   all	   subjects	   without	   changing	   the	   pattern	   of	   the	   effects.	   Since	  irrelevant	   between-­‐subjects	   differences	   are	   thereby	   removed,	   the	   standard	   error	   of	   measurement	   is	   then	  calculated	  as	  in	  between-­‐subjects	  designs.	  For	  a	  more	  detailed	  description	  of	  this	  method	  see	  Franz	  and	  Loftus	  (2012).	  	  
Figure	  3.4:	  Mean	  N170	  peak	  amplitudes	  for	  the	  different	   conditions.	   For	   the	   graph,	   data	   were	  normalised	   using	   the	   normalisation	   method	  described	   in	   Franz	   and	   Loftus	   (2012)4	   to	  remove	   irrelevant	   between-­‐subjects	  differences.	  Error	  bars	  denote	  standard	  error	  of	  the	  mean	  for	  the	  normalised	  scores	  (SEMnorm).
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   In	  addition,	  N170	  amplitudes	   for	   low	  distracting	   task	   irrelevant	  stimuli	  as	  well	  as	  for	  passively	  viewed	  stimuli	  were	  significantly	  correlated	  with	  the	  CAARS	  DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	   subscale	   (low	   distracting:	   r(18)	  =	  .55,	  
p	  =	  .01;	   passively	   viewed:	   r(18)	  =	  .53,	  p	  =	  .02)	   and	   the	   CAARS	  DSM-­‐IV	   Total	   ADHD	  Symptoms	   subscale	   (low	   distracting:	   r(18)	  =	  .51,	   p	  =	  .02;	   passively	   viewed:	  
r(18)	  =	  .48,	  p	  =	  .03).	  The	  more	  symptoms	  participants	  reported	  on	  these	  subscales,	  the	   lower	   their	   N170	   amplitudes	   in	   these	   conditions.	   In	   addition,	   the	   accuracy	  index	   was	   significantly	   correlated	   with	   both	   the	   CAARS	   DSM-­‐IV	   Hyperactive/	  Impulsive	  Symptoms	  subscale	  (r(18)	  =	  -­‐.46,	  p	  =	  .04)	  and	  CAARS	  DSM-­‐IV	  Total	  ADHD	  Symptoms	   subscale	   (r(18)	  =	  -­‐.45,	   p	  =	  .047).	   The	   more	   symptoms	   participants	  reported	  on	  these	  scales,	   the	   lower	  their	  accuracy	   indices.	  An	  examination	  of	   the	  individual	   components	   forming	   the	   accuracy	   index	   showed	   that	   this	   was	   likely	  caused	   by	   participants	   with	   high	   symptom	   detecting	   fewer	   targets	   than	  participants	   with	   lower	   symptoms	   (CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	  Symptoms	  and	  percentage	  of	  detected	   targets:	  r(18)	  =	  -­‐.52,	  p	  =	  .02;	  CAARS	  DSM-­‐IV	  Total	   ADHD	   Symptoms	   subscale	   and	   percentage	   of	   detected	   targets:	   r(18)	  =	  -­‐.48,	  
p	  =	  .03).	  	  
	   	  
Figure	   3.5:	   Scatter	   plot	   and	   linear	  regression	   line	   for	   accuracy	   index	   and	  N170	   difference	   amplitude.	   Each	   dot	  represents	  one	  participant.	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Frontal	  Components	  The	  repeated	  measures	  ANOVA	  with	  the	  within-­‐subjects	  factors	  hemisphere,	  
channel	   group,	   stimulus	   category,	   and	   task	   relevance	   yielded	   a	   significant	   main	  effect	  of	  task	  relevance	  (F(3,57)	  =	  8.65,	  p	  =	  .001)	  and	  a	  main	  effect	  of	  channel	  group	  (F(1,19)	  =	  12.51,	  p	  =	  .002).	  In	  addition,	  there	  was	  a	  significant	  interaction	  of	  channel	  group	  and	  stimulus	  category	  (F(1,19)	  =	  7.58,	  p	  =	  .01),	  with	  T-­‐electrodes	  (p	  =	  .04)	  but	  not	   F-­‐electrodes	   (p	  =	  .38)	   measuring	   more	   negative	   amplitudes	   for	   face	   stimuli	  compared	   to	  house	   stimuli.	  Because	  of	   a	   significant	   interaction	  of	   task	   relevance	  and	   channel	   group	   (F(3,57)	  =	  9.69,	   p	  <	  .001),	   post-­‐hoc	   repeated	  measures	   ANOVAs	  with	   the	   within-­‐subjects	   factor	   relevance	   were	   calculated	   separately	   for	   each	  channel	  group:	  For	  the	  T-­‐channel	  group,	  there	  was	  a	  trend	  level	  main	  effect	  of	  task	  relevance	  on	  mean	  amplitudes	  (F(3,57)	  =	  2.84,	  p	  =	  .054;	  see	  Figure	  3.6).	  Post-­‐hoc	   t-­‐tests	   revealed	   significantly	   higher	   mean	   amplitudes	   for	   high	   distracting	   task	  irrelevant	   stimuli	   compared	   to	   task	   relevant	   stimuli	   (p	  =	  .02)	   and	   compared	   to	  passively	  viewed	   stimuli	   (p	  =	  .046).	  Amplitudes	   for	  high	  and	   low	  distracting	   task	  irrelevant	  stimuli	  were	  not	  significantly	  different	  (p	  =	  .35).	  	  	  
	  Figure	  3.6:	  Grand	  average	  time	  courses	  over	  electrodes	  T7/T8	  for	  the	  different	  conditions.	  The	  grey	  shaded	   area	   marks	   the	   time	   window	   of	   the	   analysed	   mean	   amplitudes.	   High	   distracting	   task	  irrelevant	  stimuli	   led	   to	  significantly	  higher	  mean	  amplitudes	   than	   task	  relevant	  stimuli	  and	   than	  passively	  viewed	  stimuli.	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For	   the	   F-­‐channel	   group,	   there	   was	   a	   significant	   main	   effect	   of	   task	  relevance	  on	  mean	  amplitudes	  (F(3,57)	  =	  10.90,	  p	  <	  .001;	  see	  Figure	  3.7).	  Post-­‐hoc	  t-­‐tests	   revealed	  significantly	   lower	  mean	  amplitudes	   for	   task	   relevant	   stimuli	   than	  for	   high	   distracting	   task	   irrelevant	   stimuli	   (p	  <	  .001),	   for	   low	   distracting	   task	  irrelevant	  stimuli	  (p	  =	  .04),	  and	  for	  passively	  viewed	  stimuli	  (p	  =	  .008).	  In	  addition,	  high	  distracting	  task	  irrelevant	  stimuli	  showed	  a	  trend	  for	  higher	  mean	  amplitudes	  than	  passively	  viewed	  stimuli	  (p	  =	  .051).	  	  	  
	  Figure	  3.7:	  Grand	  average	  time	  courses	  over	  electrodes	  F7/F8	  for	  the	  different	  conditions.	  The	  grey	  shaded	  area	  marks	  the	  time	  window	  of	  the	  analysed	  mean	  amplitudes.	  Task	  relevant	  stimuli	  led	  to	  significantly	   lower	   mean	   amplitudes	   than	   all	   other	   stimuli	   and	   high	   distracting	   task	   irrelevant	  stimuli	  showed	  a	  trend	  for	  higher	  mean	  amplitudes	  than	  passively	  viewed	  stimuli.	  	  	  In	   addition,	   mean	   frontal	   amplitudes	   across	   all	   channels	   and	   conditions	  correlated	   significantly	   with	   N170	   suppression	   efficiency	   (i.e.	   the	   difference	  amplitude	   of	   task	   relevant	   minus	   high	   distracting	   task	   irrelevant	   stimuli):	   The	  higher	   overall	   mean	   frontal	   amplitudes,	   the	   lower	   the	   suppression	   for	   high	  distracting	   task	   irrelevant	   stimuli	   compared	   to	   task	   relevant	   stimuli	   (r(18)	  =	  .45,	  
p	  =	  .048).	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3.5 Discussion	  
We	   found	   a	  modulation	   of	   N170	   amplitudes	   by	   the	   task	   relevance	   of	   the	  presented	  stimuli.	  Since	  our	  paradigm	  enabled	  us	  to	  vary	  the	  degree	  of	  distraction	  caused	   by	   the	   task	   irrelevant	   stimuli,	   we	   found	   an	   interesting	   dissociation	   that	  clearly	   extends	   previous	   findings:	   Peak	   amplitudes	  were	   significantly	   higher	   for	  task	   relevant	   than	   for	   high	   distracting	   task	   irrelevant	   and	   for	   passively	   viewed	  stimuli,	  while	   there	  was	   no	   difference	   for	   task	   relevant	   and	   low	  distracting	   task	  irrelevant	  stimuli.	  In	  addition,	  peak	  amplitudes	  for	  low	  distracting	  task	  irrelevant	  stimuli	  were	  significantly	  higher	  than	  for	  high	  distracting	  task	  irrelevant	  stimuli.	  At	  the	  same	  time,	  peak	  amplitudes	  for	  all	  distracting	  task	  irrelevant	  stimuli	  were	  not	  different	   from	   peak	   amplitudes	   for	   passively	   viewed	   stimuli.	   Amplitudes	   of	   the	  P100,	  however,	  were	  not	  significantly	  influenced	  by	  stimulus	  relevance.	  Our	  pattern	  of	  results	  for	  the	  N170	  points	  to	  a	  processing	  enhancement	  for	  task	   relevant	   stimuli	   compared	   to	   a	   passive	   viewing	  baseline.	   This	   enhancement	  seemed	  to	  be	  absent	  for	  low	  distracting	  task	  irrelevant	  stimuli,	  which	  did	  not	  differ	  from	   passively	   viewed	   stimuli.	   For	   the	   processing	   of	   high	   distracting	   stimuli,	  however,	  there	  seemed	  to	  be	  an	  additional	  processing	  suppression,	  as	  amplitudes	  for	   these	   stimuli	  were	   significantly	   lower	   than	   for	   low	  distracting	   stimuli.	   Visual	  inspection	   of	   the	   grand	   average	  waveforms	   suggests	   that	   the	   processing	   of	   high	  distracting	   stimuli	  might	   even	   have	   been	   suppressed	   below	   the	   passive	   viewing	  baseline,	   and	   the	   post-­‐hoc	   t-­‐test	   revealed	   that	   this	   suppression	   was	   indeed	  significant	  but	  did	  not	  pass	  correction	  for	  multiple	  testing.	  	  The	   suppression	   of	   processing	   for	   high	   distracting	   task	   irrelevant	   stimuli	  compared	   to	   task	   relevant	   stimuli	   appeared	   to	   be	   directly	   related	   to	   task	  performance:	  Small	  N170	  difference	  amplitudes	  for	  these	  stimuli	  –	  indicating	  less	  effective	   suppression	   –	   correlated	   negatively	   with	   an	   accuracy	   index	   that	   takes	  both	  correct	  (non-­‐)responses	  and	  false	  alarm	  responses	  into	  account.	  Participants	  with	   less	   effective	   processing	   suppression	  were	   possibly	  more	   distracted	   by	   the	  task	   irrelevant	   stimuli,	   which	   then	   interfered	   with	   successful	   working	   memory	  maintenance	   of	   the	   task	   relevant	   1-­‐back	   picture	   and	   led	   to	   less	   accurate	  performance.	   In	   fact,	  a	  paired	  t-­‐test	  yielded	  significantly	  higher	  mean	  amplitudes	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for	  task	  irrelevant	  stimuli	  followed	  by	  false	  alarms	  than	  for	  task	  irrelevant	  stimuli	  not	   followed	  by	   false	   alarms.	  Although	  only	   few	   trials	   could	  be	   entered	   into	   this	  analysis	   because	   the	   number	   of	   false	   alarms	   across	   participants	  was	   rather	   low,	  this	  difference	  could	  support	   two	  different	  explanations:	  Either	   the	  processing	  of	  the	  distracting	  stimuli	  was	  generally	  suppressed,	  and	  when	  it	  was	  not	  participants	  were	   distracted	   enough	   to	   make	   a	   false	   alarm	   response	   to	   the	   following	   task	  relevant	   stimulus.	   Or	   the	   processing	   of	   these	   task	   irrelevant	   stimuli	   was	  “accidentally”	   enhanced,	   which	   made	   these	   stimuli	   more	   distracting	   and	   then	  caused	  false	  alarms	  later	  on.	  The	  pattern	  found	  for	  the	  frontal	  components	  points	  to	  a	  role	  of	  the	  DLPFC	  in	   processing	   suppression	   and/or	   enhancement.	   While	   Schreppel	   et	   al.	   (2008)	  found	   an	   enhancement	   of	   frontal	   processing	   for	   task	   relevant	   stimuli,	   we	   found	  enhanced	   frontal	   processing	   for	   (high)	   distracting	   task	   irrelevant	   stimuli.	   Our	  results	  are	   in	   line	  with	  the	   findings	  of	  Kessler	  et	  al.	   (2005),	  who	  found	  enhanced	  frontal	   amplitudes	   at	   around	   1000	  ms	   after	   the	   presentation	   of	   high	   distracting	  (interfering)	  stimuli	  during	  a	  working	  memory	  task.	  This	  enhancement	  of	   frontal	  activity	  was	   interpreted	  as	   the	  DLPFC	   trying	   to	   recover	   the	  memory	   trace	  of	   the	  originally	  maintained	  stimulus	  after	  a	  high	  interfering	  task	  irrelevant	  stimulus	  had	  been	  presented.	  This	   interpretation	  could	  be	  transferred	  to	  our	  working	  memory	  paradigm	  with	   the	  distracting	   task	   irrelevant	   stimulus	  disrupting	  and	   interfering	  with	   the	  maintenance	   of	   the	   task	   relevant	   stimulus,	   leading	   to	   increased	   DLPFC	  activity	  and	  thereby	  enhanced	  frontal	  EEG	  components.	  Interestingly,	  mean	  frontal	  amplitudes	  across	  both	   investigated	  electrode	  pairs	  and	  all	   conditions	  correlated	  significantly	   with	   N170	   suppression	   efficiency.	   Higher	   mean	   amplitudes	   were	  associated	  with	  less	  efficient	  suppression	  of	  high	  distracting	  task	  irrelevant	  stimuli	  compared	   to	   task	  relevant	   stimuli.	  This	   finding	   is	  difficult	   to	   interpret	  and	  might	  indicate	   a	   role	   of	   the	  observed	   low	   frontal	   activity	  during	   the	  processing	  of	   task	  relevant	   stimuli	   for	   overall	   processing	  modulation.	   It	   has	   to	   be	   noted,	   however,	  that	  the	  analysed	  time	  window	  was	  quite	  restricted,	  since	  we	  chose	  not	  to	  analyse	  any	   frontal	   EEG	   data	   acquired	   after	   the	   end	   of	   the	   presented	   stimulus	   and	   the	  onset	   of	   the	   fixation	   cross.	   In	   addition,	   the	   frontal	   electrodes	   entered	   into	   the	  analysis	   are	   not	   identical	   to	   the	   ones	   selected	   by	   previous	   studies	   (K.	   Kessler	  &	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Kiefer,	   2005;	   Schreppel	   et	   al.,	   2008)	   and	   are	   more	   posterior	   and	   more	   dorsal,	  respectively.	   They	   might	   thus	   not	   optimally	   reflect	   task-­‐related	   DLPFC	   activity.	  Nevertheless,	  we	  found	  some	  indication	  that	  the	  DLPFC	  central	  executive	  might	  be	  involved	   in	   the	   processing	   modulation	   of	   the	   high	   distracting	   task	   irrelevant	  stimuli	  and	  the	  task	  relevant	  stimuli.	  	  However,	   another	   possible	   explanation	   for	   the	   lower	   amplitudes	   to	   high	  distracting	  stimuli	  might	  be	  that	  each	  high	  distracting	  stimulus	  had	  to	  compete	  for	  processing	  resources	  with	  the	  task	  relevant	  stimulus	  that	  was	  being	  maintained	  in	  working	   memory.	   Several	   studies	   showed	   that	   simultaneous	   presentation	   of	  stimuli	   that	   activate	   the	   same	   neural	   populations	   led	   to	   decreased	   ERPs	   for	   the	  stimuli	   that	  were	   not	   directly	   task	   relevant	   (Ranganath	  &	   Paller,	   1999;	   Rossion,	  Kung,	   &	   Tarr,	   2004).	   In	   addition,	   the	   ERPs	   to	   task	   relevant	   target	   stimuli	   were	  found	  to	  be	  reduced	  when	  working	  memory	  load	  was	  increased	  from	  maintaining	  one	   face	   to	   maintaining	   two	   or	   more	   faces	   (Morgan,	   Klein,	   Boehm,	   Shapiro,	   &	  Linden,	   2008).	   Since	   task	   relevant	   and	  high	   distracting	   task	   irrelevant	   stimuli	   in	  our	   study	   were	   from	   the	   same	   category,	   they	   likely	   activated	   the	   same	   neural	  networks,	   which	  might	   have	   caused	   the	   high	   distracting	   stimuli	   to	   evoke	   lower	  event-­‐related	   potentials.	   However,	   stimuli	   in	   our	   study	   were	   subsequently	   (and	  not	   simultaneously)	   presented	   and	  working	  memory	   load	   consisted	   of	   only	   one	  task	  relevant	  stimulus	  at	  a	  time.	  	  Another	   possible	   explanation	   for	   the	   increased	   N170	   amplitudes	   to	   task	  relevant	  stimuli	  might	  be	  the	  need	  for	  stimulus	  discrimination	  when	  viewing	  these	  stimuli.	  Discriminating	  between	  stimuli	  has	  been	  shown	  to	  increase	  the	  posterior	  N1	  (Vogel	  &	  Luck,	  2000).	  Since	  discriminative	  demands	  in	  our	  task	  were	  high,	  this	  might	  have	  influenced	  the	  obtained	  amplitudes.	  In	  addition,	  since	  task	  relevant	  and	  task	  irrelevant	  stimuli	  alternated	  in	  our	  paradigm,	  it	  was	  possible	  for	  participants	  to	   know	   in	   advance	   if	   the	   next	   stimulus	   would	   be	   relevant	   or	   irrelevant	   for	  successful	   task	   performance.	   This	   temporal	   expectation	   might	   have	   led	  participants	   to	  modulate	   their	   attention	   before	   the	   task	   irrelevant	   stimulus	  was	  actually	   presented.	   The	   enhanced	   amplitudes	   to	   task	   relevant	   stimuli	   might	  therefore	  represent	  the	  effect	  of	  a	  more	  general	  attentional	  modulation	  induced	  by	  the	   structure	   of	   stimulus	   presentation	   instead	   of	   a	   specific	   effect	   of	   selective	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attention.	   This	   does	   not,	   however,	   explain	   the	  modulation	   observed	   for	   the	   task	  irrelevant	  stimuli.	  Amplitudes	  differed	  significantly	  depending	  on	  how	  distracting	  a	  task	  irrelevant	  stimulus	  was	  to	  successful	  task	  performance.	  Since	  the	  degree	  of	  distractibility	  of	  the	  task	  irrelevant	  stimuli	  varied	  randomly	  across	  trials,	  selective	  attention	  processes	  must	  indeed	  have	  induced	  this	  modulation.	  	  We	   furthermore	   found	   significant	   correlations	   of	   CAARS	   DSM-­‐IV	  Hyperactive/	   Impulsive	  Symptoms	  and	  Total	  ADHD	  Symptoms	  scores	  with	  N170	  amplitudes	   for	   low	   distracting	   task	   irrelevant	   stimuli	   and	   for	   passively	   viewed	  stimuli,	   which	   are	   difficult	   to	   explain.	   It	   is	   important	   to	   remember	   that	   all	  participants	  were	  highly	  functioning	  and	  without	  clinical	  impairments	  in	  daily	  life.	  One	  possibility	   to	   interpret	   these	   correlations	   is	   therefore	   that	   participants	  with	  higher	  symptoms	  might	  have	  been	  more	  easily	  bored	  by	  the	  less	  demanding	  task	  conditions,	   leading	   to	   lower	   amplitudes	   during	   the	   presentation	   of	   passively	  viewed	  and	   low	  distracting	   task	   irrelevant	  stimuli.	   In	  contrast,	   these	  participants	  might	   have	   been	   able	   to	  maintain	   focus	   during	   the	  more	   demanding	   conditions	  (task	   relevant	   and	   high	   distracting	   task	   irrelevant	   stimuli),	   which	   is	   why	   no	  correlations	  were	  found	  for	  these	  conditions.	  However,	  the	  task	  still	  appears	  to	  tap	  some	  ADHD	   symptoms	   that	   cannot	   clearly	   be	   connected	   to	   the	   investigated	  EEG	  components,	   as	   increased	  ADHD	  symptoms	  were	   associated	  with	   a	   less	   accurate	  behavioural	   performance,	   in	   particular	   with	   a	   lower	   amount	   of	   detected	   target	  trials.	  One	  possible	  additional	   limitation	  of	   this	   study	   is	   that	   the	  passive	  viewing	  control	  condition	  might	  have	  been	  less	  arousing	  than	  the	  experimental	  conditions	  which	  might	  have	  impacted	  on	  N170	  amplitudes	  (Egner	  &	  Gruzelier,	  2001,	  2004;	  Fekete,	   Pitowsky,	   Grinvald,	   &	   Omer,	   2009;	   Howells,	   Stein,	   &	   Russell,	   2010),	  although	   Vogel	   and	   Luck	   (2000)	   did	   not	   find	   increased	   arousal	   to	   enhance	  posterior	  N1	  amplitudes.	  	  In	   addition	   to	   replicating	   previous	   studies	   that	   showed	   early	   visual	  processing	   enhancement	   of	   task	   relevant	   and	   suppression	   of	   task	   irrelevant	  stimuli,	   this	  study	  could	  extend	  and	  clarify	  these	  findings.	  The	  results	  point	  to	  an	  enhancement	   of	   early	   visual	   processing	   of	   task	   relevant	   stimuli	   and	   to	   a	  suppression	   of	   task	   irrelevant	   stimuli	   –	   if	   these	   stimuli	   are	   high	   distracting	   to	  successful	   task	   completion.	   The	   efficiency	   of	   this	   processing	   modulation	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furthermore	   seemed	   to	   have	   direct	   behavioural	   consequences.	   In	   addition,	   the	  investigation	   of	   frontal	   EEG	   components	   showed	   a	   potential	   involvement	   of	   the	  DLPFC	   in	   the	   processing	   of	   high	   distracting	   task	   irrelevant	   and	   of	   task	   relevant	  stimuli.	   The	   connection	   of	   the	   different	   EEG	   components	   to	   symptoms	   of	  ADHD,	  however,	   did	   not	   yield	   the	   hypothesised	   results,	   possibly	   because	   overall	   ADHD	  symptomatology	  in	  the	  investigated	  sample	  was	  rather	  low.	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4 Study	  2:	  fMRI	  Parameters	  of	  Selective	  Attention	  
4.1 Introduction	  
The	  main	  goal	  of	   the	   first	   (EEG)	  study	  was	   to	   test	   the	  refined	  version	  of	  a	  previously	   used	   experimental	   paradigm	   (Schreppel	   et	   al.,	   2008)	   that	   taxed	  selective	   attention	   properties	   of	   the	   central	   executive	   component	   of	   Baddeley’s	  (2012)	   working	   memory	   model.	   The	   study	   could	   successfully	   replicate	   N170	  amplitude	   differences	   for	   task	   relevant	   versus	   distracting	   task	   irrelevant	   stimuli	  (Gazzaley	  et	  al.,	  2005;	  Schreppel	  et	  al.,	  2008)	  and	   for	  high	  distracting	  versus	   low	  distracting	   task	   irrelevant	   stimuli	   (Sreenivasan	   &	   Jha,	   2007).	   In	   addition,	   a	  modulation	   of	   frontal	   components	   linked	   to	   DLPFC	   functioning	   (K.	   Kessler	   &	  Kiefer,	   2005;	   Schreppel	   et	   al.,	   2008)	   was	   found.	   The	   ability	   of	   the	   EEG	   to	   show	  DLPFC	  functioning,	  however,	   is	   limited	  by	  the	  inverse	  problem	  (Helmholtz,	  1853;	  Michel	  et	  al.,	  2004),	  which	  does	  not	  allow	  definitive	  statements	  about	  the	  origin	  of	  a	  measured	  scalp	  potential.	  Therefore,	  the	  second	  study	  now	  aimed	  to	  transfer	  this	  experimental	  paradigm	  to	  fMRI.	  	  Previous	   studies	   already	   used	   fMRI	   to	   investigate	   the	   impact	   of	   task	  relevance	   on	   stimulus	   processing	   as	  well	   as	   the	   potential	   involvement	   of	   frontal	  areas	  during	  these	  tasks	  (see	  also	  1.3.2.).	  A	  study	  using	  a	  delayed	  recognition	  task	  investigated	   early	   visual	   processing	   in	   pre-­‐specified	   ROIs	   during	   stimulus	  encoding	   and	   found	   a	   suppression	   of	   activation	   during	   the	   processing	   of	  distracting	   task	   irrelevant	   stimuli	   and	   an	   enhancement	   of	   activation	   during	   the	  processing	   task	   relevant	   stimuli	   relative	   to	   a	   passive	   viewing	   control	   condition	  (Gazzaley	   et	   al.,	   2005).	   Another	   study	   also	   used	   a	   delayed	   recognition	   task,	   but	  presented	   high	   and	   low	   distracting	   task	   irrelevant	   stimuli	   from	   the	   same	   or	   a	  different	  category	  as	   the	   to-­‐be-­‐remembered	  stimulus	  during	   the	  delay	   (Jha	  et	  al.,	  2004).	   The	   authors	   found	   increased	   left	   PFC	   activity	   during	   the	   delay	   if	   high	  distracting	  compared	  to	  low	  distracting	  task	  irrelevant	  stimuli	  were	  presented.	  In	  addition,	  activation	  in	  the	  fusiform	  face	  area	  (FFA)	  during	  the	  delay	  was	  increased	  if	  the	  task	  relevant	  as	  well	  as	  the	  distracting	  stimulus	  were	  faces.	  This	  increase	  in	  activation	   could	   be	   interpreted	   as	   increased	   maintenance	   efforts	   during	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distraction,	   but	   it	   could	   also	   be	   construed	   as	   the	   additional	   processing	   of	  distracting	   faces	   while	   a	   task	   relevant	   face	   was	   already	   being	   maintained	   in	  working	  memory.	  However,	   it	   has	   to	  be	  noted	   that	   this	   increased	  activation	  was	  visible	   only	   for	   correct	   trials,	   supporting	   the	   potential	   role	   of	   increased	  maintenance-­‐related	  activation	  in	  successful	  working	  memory	  performance.	  Further	  analyses	  of	  the	  data	  set	  discussed	  above	  (Gazzaley	  et	  al.,	  2005)	  also	  showed	  increased	  activation	  in	  the	  left	  DLPFC	  in	  the	  encoding	  period,	  during	  which	  participants	   viewed	   task	   relevant	   and	   task	   irrelevant	   stimuli	   compared	   to	   a	  passive	   viewing	   control	   condition	   (Gazzaley	   et	   al.,	   2007).	   The	   authors	   also	  performed	  a	  functional	  connectivity	  analysis	  using	  a	  seed	  region	  in	  the	  left	  scene-­‐selective	  visual	   association	   cortex	  of	   the	  parahippocampal	   gyrus	   that	  had	   shown	  the	  most	  robust	  effects	  of	  top-­‐down	  modulation	  in	  the	  previous	  analyses	  (Gazzaley	  et	   al.,	   2005).	   They	   found	   a	   significant	   correlation	   of	   activation	   in	   the	   left	  parahippocampal	   gyrus	   and	   in	   the	   left	   PFC,	   with	   increased	   correlation	   when	  stimuli	   were	   task	   relevant	   and	   decreased	   correlation	   when	   stimuli	   were	   task	  irrelevant,	   relative	   to	   the	   passive	   viewing	   condition.	   The	   authors	   furthermore	  found	   that	   connectivity	   correlated	   significantly	   with	   the	   amount	   of	   relevance-­‐induced	  processing	  modulation	  in	  the	  parahippocampal	  gyrus.	  	  As	   mentioned	   above,	   the	   first	   goal	   of	   this	   study	   was	   the	   transfer	   of	   the	  experimental	   paradigm	   established	   in	   the	   previous	   EEG	   study	   to	   fMRI.	   This	  transfer	   necessitated	   some	   changes	   to	   the	   experimental	   paradigm	   described	   in	  3.3.1,	   which	   were	   mainly	   related	   to	   stimulus	   timing.	   FMRI	   relies	   on	   the	   blood	  oxygenation	   level-­‐dependent	   (BOLD)	   response.	   This	   is	   based	   on	   the	   fact	   that	  increased	   blood	   flow	   caused	   by	   neuronal	   activation	   leads	   to	   decreased	  concentrations	   of	   deoxygenated	   haemoglobin	   and	   that	   oxygenated	   and	  deoxygenated	   haemoglobin	   have	   differential	   magnetic	   properties,	   allowing	   the	  inference	  of	  neuronal	  activity	  from	  recorded	  changes	  in	  haemoglobin	  oxygenation	  (Hu,	  Le,	  &	  Ugurbil,	  1997).	  The	  BOLD	  signal	  has	  been	  hypothesised	   to	  reflect	   “the	  input	   and	   intracortical	   processing	   of	   a	   given	   area”	   (Logothetis,	   Pauls,	   Augath,	  Trinath,	   &	   Oeltermann,	   2001,	   p.150)	   and	   was	   found	   to	   be	   related	   to	   local	   field	  potentials.	  The	  temporal	  resolution	  of	  the	  BOLD	  signal	  is	  rather	  low,	  with	  an	  initial	  dip	  followed	  by	  a	  signal	  increase	  after	  two	  to	  three	  seconds	  and	  the	  peak	  response	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after	  eight	   to	   fifteen	  seconds	  (Hu	  et	  al.,	  1997;	  Logothetis,	  Guggenberger,	  Peled,	  &	  Pauls,	   1999;	   Logothetis	   et	   al.,	   2001;	   Malonek	   &	   Grinvald,	   1996).	   This	   delayed	  response	  puts	  restraints	  on	  stimulus	   timing	   in	  experimental	  paradigms,	  although	  studies	   suggest	   that	   interstimulus	   intervals	   of	   2.5	   seconds	  might	   be	   possible	   for	  random	  designs	  with	   two	   conditions	   and	   a	   repetition	   time	   (TR)	   of	   two	   seconds,	  meaning	   that	   trials	   of	   the	   same	   condition	  would	   –	   on	   average	   –	   be	   five	   seconds	  apart	  from	  each	  other	  (Wager	  &	  Nichols,	  2003).	  	  As	   a	   second	   goal,	   the	   continuous	   nature	   of	   our	   paradigm	   should	   allow	   a	  replication	   of	   Jha	   et	   al.’s	   (2004)	   results	   of	   increased	   left	   PFC	   and	   FFA	   activation	  during	  the	  presentation	  of	  high	  distracting	  task	  irrelevant	  stimuli,	  as	  their	  delayed	  recognition	   task	   also	   involved	   the	   sequential	   presentation	   of	   task	   relevant	   and	  distracting	  task	  irrelevant	  stimuli	  spanning	  several	  seconds.	  A	  further	  goal	  of	  this	  study	  was	   to	   investigate	   the	   impact	  of	   the	  COMT	   val158met	  polymorphism	  on	   the	  hypothesised	  elicited	  prefrontal	  activation	  during	  this	   task.	  As	  described	   in	  1.2.2,	  this	   polymorphism	  was	   consistently	   linked	   to	   efficiency	   of	   prefrontal	   functional	  activation	   during	   working	   memory	   tasks,	   with	   met/met	   carriers	   showing	   less	  activation	  at	  equal	  behavioural	  performance	  levels	  and	  thereby	  presumably	  more	  efficient	   functioning	   than	   val/val	   carriers	   (Egan	   et	   al.,	   2001;	  Mattay	   et	   al.,	   2003;	  Mier	  et	  al.,	  2010).	  	  	  
4.2 Hypotheses	  
1.	   We	  expected	  high	  distracting	  task	  irrelevant	  stimuli	  to	  lead	  to	  increased	  activation	   in	   the	  PFC	   as	  well	   as	   in	  ROIs	   related	   to	   the	   visual	   stimulus	  processing	   when	   compared	   to	   activation	   for	   task	   relevant	   stimuli	  (Gazzaley	  et	  al.,	  2005;	  Jha	  et	  al.,	  2004).	  	  2.	   In	  line	  with	  previous	  results,	  the	  task-­‐related	  increase	  in	  PFC	  activation	  should	  be	  particularly	  pronounced	   in	   the	   left	  hemisphere	  (Gazzaley	  et	  al.,	  2007;	  Jha	  et	  al.,	  2004).	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3.	   In	   addition,	   we	   hypothesised	   that	   task-­‐induced	   prefrontal	   cortex	  activation	   would	   correlate	   with	   suppression	   efficiency	   in	   the	   visual	  ROIs	  (Gazzaley	  et	  al.,	  2007).	  	  4.	   Regarding	   the	   COMT	   genotype,	   we	   expected	   val/val	   carriers	   to	   show	  increased	   activation	   in	   prefrontal	   ROIs	   indicating	   less	   efficient	  functioning	   than	   met/met	   carriers	   (Egan	   et	   al.,	   2001;	   Mattay	   et	   al.,	  2003).	  	  5.	   Behavioural	  performance	  between	  the	  two	  genotype	  groups	  should	  not	  be	  different	  (Barnett	  et	  al.,	  2008).	  	  	  
4.3 Methods	  
 Experimental	  Paradigm	  4.3.1
As	   the	   goal	   of	   this	   study	   was	   the	   transfer	   of	   the	   experimental	   paradigm	  established	  in	  the	  EEG	  study	  (see	  3.3.1	  for	  a	  description	  of	  this	  paradigm)	  to	  fMRI,	  the	   task	   parameters	   remained	   unchanged.	   However,	   given	   the	   low	   temporal	  resolution	   of	   fMRI	   (see	   3.1)	   compared	   to	   EEG,	   interstimulus	   intervals	   were	  increased	   and	   now	   lasted	   2,500	  ms	   to	   4,500	  ms.	   In	   addition,	   8	   scans	   at	   the	  beginning	  of	  the	  paradigm	  were	  included	  to	  allow	  for	  saturation	  of	  the	  signal	  and	  to	   serve	  as	   a	  baseline,	   respectively.	  Task	  duration	  was	  about	  34	  minutes,	   during	  which	  673	  fMRI	  volumes	  were	  acquired.	  	  Since	   this	   study	   aimed	   to	   investigate	   frontal	   contributions	   to	   processing	  modulation	  as	  well	  as	   the	  processing	  modulation	   itself,	  a	   functional	   localiser	  was	  included	   to	   enable	   an	   analysis	   of	   individual	   ROIs	   in	   the	   FFA	   and	   in	   the	  parahippocampal	   place	   area	   (PPA).	   This	   localiser	   consisted	   of	   twelve	   20-­‐second	  blocks,	  during	  which	  either	  20	  pictures	  of	  faces,	  20	  pictures	  of	  houses,	  or	  a	  fixation	  cross	   were	   presented.	   Each	   picture	   was	   presented	   for	   750	  ms	   with	   250	  ms	  interstimulus	   interval.	   Participants	   were	   instructed	   to	   look	   at	   all	   pictures	  attentively.	  The	  total	  duration	  of	  this	  localiser	  was	  about	  five	  minutes,	  allowing	  for	  the	  acquisition	  of	  97	  fMRI	  volumes.	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 Participants	  4.3.2
Twenty-­‐six	  subjects	  (14	  men)	  participated	   in	   this	  study.	  Participants	  were	  mostly	   students	   and	   were	   recruited	   from	   a	   previously	   established	   subject	   pool	  (see	  also	  Biehl	  et	  al.,	  2013;	  Gschwendtner	  et	  al.,	  2012)	   to	  be	  homozygous	   for	   the	  
COMT	   genotype.	   All	   subjects	   were	   right-­‐handed,	   with	   normal	   or	   corrected-­‐to-­‐normal	   vision	   and	   free	   of	   neurological	   or	   psychiatric	   diseases.	   Ethical	   approval	  was	   obtained	   through	   the	   Ethical	   Review	   Board	   of	   the	   medical	   faculty	   of	   the	  University	  of	  Würzburg;	  all	  procedures	  involved	  were	  in	  accordance	  with	  the	  2008	  Declaration	   of	   Helsinki.	   Participants	   gave	   written	   informed	   consent	   after	   full	  explanation	  of	  the	  procedures.	  	  Five	  subjects	  had	  to	  be	  excluded	  due	   to	  hardware	  and	  software	  problems,	  respectively.	  Two	  subjects	  were	  excluded	  because	  they	  identified	  less	  than	  40	  %	  of	  target	   trials	   and	   their	   understanding	   of	   the	   experimental	   task	   was	   therefore	  doubtful.	  One	  subject	  was	  excluded	  after	  data	  preprocessing	  because	  of	  excessive	  movement	  in	  the	  scanner	  (sudden	  movement	  of	  more	  than	  2	  mm),	  so	  that	  the	  final	  sample	  included	  18	  participants	  (see	  Table	  4.1	  for	  sample	  characteristics).	  	  
Table	  4.1:	  Overview	  of	  mean	  demographic	  data	  for	  both	  COMT	  groups.	  Standard	  deviation	  is	  noted	  in	  
parentheses	  unless	  stated	  otherwise.	  	   met/met	   val/val	  
	  




	  Participants	  (male)	   9	  (4)	   9	  (3)	  Mean	  age	   22.3(2.4)	   23.6(4.4)	  Mean	  school	  years	  	   12.7(1.0)	   12.7(1.0)	  MWST	  IQ	  estimate	   112.4(10.7)	   117.6(15.2)	  Mean	  inattention1	   12.2(3.6)	   13.9(5.5)	  Mean	  hyperactivity	   8.9(4.7)*	   13.2(3.7)*	  
Note.	   1	   Symptoms	   of	   inattention	   and	   hyperactivity/	   impulsivity	   as	   assessed	   with	   the	   ASRS;	   *	  denotes	  significant	   between-­‐group	   differences	   (p	  <	  .05);	   there	   were	   no	   between-­‐group	   differences	   on	   the	  questionnaires	  not	  listed	  here	  (all	  p	  >	  .1).	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 Psychological	  Assessment	  4.3.3
As	   in	   the	   previous	   EEG	   study,	   participants	   completed	   three	   ADHD	  questionnaires	  to	  assess	  individual	  symptoms	  of	  both	  childhood	  and	  adult	  ADHD:	  The	   ASRS	   (R.	   C.	   Kessler	   et	   al.,	   2005),	   the	   CAARS	   (Christiansen	   et	   al.,	   2012;	  Christiansen	  et	  al.,	  2011;	  Conners	  et	  al.,	  1999),	  and	  the	  WURS	  (Ward	  et	  al.,	  1993).	  To	   control	   for	   affect	   and	   depressive	   symptoms,	   subjects	   furthermore	   completed	  the	  Positive	  and	  Negative	  Affect	  Schedule	  (PANAS)	  (Krohne	  et	  al.,	  1996;	  Watson	  et	  al.,	  1988)	  and	  the	  Beck	  Depression	  Inventory	  (BDI-­‐II)	  (Hautzinger	  et	  al.,	  2006).	  In	  addition,	   participants	   completed	   the	   Mehrfachwahl-­‐Wortschatz-­‐Intelligenztest 
(MWT-­‐B),	   a	   short	   verbal	   screening	   measure	   that	   estimates	   IQ	   (Blaha	   &	   Pater,	  1979).	  	  	  
 fMRI	  Data	  Acquisition	  and	  Analysis	  	  4.3.4
Imaging	   data	   were	   acquired	   at	   the	   Research	   Center	   for	   Magnetic-­‐Resonance-­‐Bavaria	   (MRB)	   in	   Würzburg	   using	   a	   Siemens	   MAGNETOM®	   Avanto	  MRI	   scanner	  with	   a	  magnetic	   field	   strength	   of	   1.5	   Tesla	   (Siemens	   AG,	   Erlangen,	  Germany)	   and	   a	   twelve	   channel	   head	   coil.	   The	   TR	   of	   the	   T2*-­‐weighted	   gradient	  echo	   planar	   imaging	   (EPI)	   sequence	  was	   three	   seconds;	   the	   echo	   time	   (TE)	  was	  50	  ms.	  Further	  parameters	  were	  flip	  angle	  90°,	  in-­‐plane	  resolution	  4	  ×4	  mm2,	  field	  of	  view	  (FOV)	  255	  ×255	  mm2.	  One	  TR	  allowed	  for	  the	  interleaved	  acquisition	  of	  32	  axial	   slices	   of	   4	  mm	   thickness	   in	   ascending	   order	   (no	   gap	   between	   slices).	   Slice	  acquisition	   was	   aligned	   to	   be	   parallel	   to	   the	   AC-­‐PC	   line,	   which	   runs	   along	   the	  anterior	  and	  the	  posterior	  commissure.	  The	  first	  three	  volumes	  of	  each	  sequence	  were	   discarded	   to	   allow	   for	   signal	   saturation.	   In	   addition,	   a	   high-­‐resolution	  structural	   MPRAGE	   scan	   was	   obtained	   for	   each	   participant	   with	   the	   following	  parameters:	   TR	   1870	  ms,	   TE	   3.74	  ms,	   flip	   angle	   15°,	   in-­‐plane	   resolution	  1.4	  ×1	  mm2,	  FOV	  250	  ×250	  mm2,	  slice	  thickness	  1	  mm.	  The	  experimental	  task	  was	  presented	  via	  MRI	  compatible	  goggles	  (VisuaStim	  Digital,	  Resonance	  Technologies,	  Inc.,	   Northridge,	   USA)	   using	   Presentation®	   (version	   11.3,	   Neurobehavioral	  Systems,	  Inc.,	  Albany,	  USA).	  In	  order	  to	  minimize	  head	  movement,	  participants	  lay	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on	   a	   polyurethane	   foam	   head	   cushion	   with	   additional	   movement	   restraints	  mounted	  to	  the	  sides	  of	  the	  head	  coil.	  	  All	   fMRI	   data	  were	   analysed	  with	   Statistical	   Parametric	  Mapping	   (SPM)	   8	  (Wellcome	  Trust,	  2009),	  which	  uses	  a	  voxel	  based	  approach	  (2007;	  spm,	  2013).	  In	  this	  software,	  a	  general	  linear	  model	  in	  combination	  with	  a	  temporal	  convolution	  model	  is	  used	  to	  describe	  the	  obtained	  fMRI	  data	  and	  hypotheses	  are	  tested	  using	  statistical	  inference	  with	  correction	  for	  multiple	  comparisons	  based	  on	  continuous	  random	  field	  theory.	  For	  all	  fMRI	  studies	  described	  in	  this	  thesis,	  EPI	  images	  were	  realigned	  to	  correct	  for	  movement	  during	  scanning	  and	  the	  MPRAGE	  scan	  was	  co-­‐registered	   to	   the	  mean	  EPI	   image	   and	   segmented	   into	   grey	   and	  white	  matter	   as	  well	  as	  cerebrospinal	  fluid.	  These	  parameters	  were	  then	  applied	  to	  the	  EPI	  images,	  which	  were	  normalized	  to	  3	  mm3	  voxel	  size	  and	  smoothed	  with	  a	  9	  mm3	  full-­‐width	  at	   half	   maximum	   (FWHM)	   Gaussian	   smoothing	   kernel.	   Subsequently,	   stimulus	  onsets	   were	   extracted	   from	   participants’	   logfiles	   and	   first	   level	   analyses	   were	  computed	   for	  each	  participant	   incorporating	   the	  conditions	  of	   interest	  as	  well	  as	  the	   movement	   parameters	   obtained	   during	   data	   preprocessing.	   Contrasts	   of	  interest	  were	   calculated	   for	   every	  participant	   and	   further	   analysed	  using	   second	  level	   analyses	   as	   specified	   below.	   Results	   were	   whole-­‐brain	   FWE	   (family-­‐wise	  error)	  corrected	  with	  p	  <	  .05	  unless	  specified	  otherwise.	  The	  extent	  threshold	  for	  a	  given	  cluster	  was	  set	  at	  a	  minimum	  of	  five	  voxels.	  Peak	  voxels	  were	  anatomically	  located	   using	   WFU	   PickAtlas	   Toolbox	   version	   2.4	   (Maldjian,	   Laurienti,	   Kraft,	   &	  Burdette,	  2003).	  For	  this	  study,	  a	  whole	  brain	  analysis	  was	  carried	  out	  across	  all	  participants	  by	   performing	   a	   one-­‐sample	   t-­‐test	   with	   pFWE	  <	  .05	   for	   the	   contrasts	   of	   interest.	  Further	   analyses	   were	   then	   carried	   out	   by	   using	   two-­‐sample	   t-­‐tests	   as	  implemented	  in	  SPM8	  to	  test	  for	  differences	  between	  COMT	  met/met	  carriers	  and	  val/val	  carriers	  using	  small	  volume	  correction	  (spheres	  with	  9	  mm	  radius	  placed	  around	  the	  MNI	  transformed	  coordinates	  of	  the	  peak	  voxels	  specified	  by	  Mattay	  et	  al.,	  2003).	  For	  all	  analyses,	  peak	  voxels	  with	  pFWE	  ≤	  .05	  were	  considered	  significant	  and	   peak	   voxels	   with	   pFWE	  ≤	  .1	   were	   considered	   trends.	   If	   the	   small	   volume	  correction	  showed	  a	  significant	  between-­‐group	  difference	  or	  trend	  for	  a	  peak	  voxel	  of	   a	   given	   cluster,	   the	   contrast	   estimates	   of	   this	   cluster	   were	   exported	   for	   each	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participant	  using	  Region	  of	  Interest	  Extraction	  (REX)	  Toolbox	  (Whitfield-­‐Gabrieli,	  2009).	   These	  mean	   cluster	   activations	  were	   then	   entered	   into	   SPSS	   Statistics	   20	  (IBM®,	  New	  York,	  USA)	   for	   further	  analysis5.	   For	   illustration	  purposes,	   the	   fMRI	  data	  below	  are	  rendered	  using	  MRIcron	  (Rorden,	  2010)	  by	  overlaying	  the	  clusters	  on	  a	  template	  with	  16mm	  search	  depth.	  	  In	  addition,	  individual	  activation	  of	  the	  FFA	  for	  high	  and	  for	  low	  distracting	  task	  irrelevant	  face	  stimuli	  minus	  the	  face	  stimuli	  from	  the	  passive	  viewing	  control	  condition	  as	  well	  as	  for	  task	  relevant	  face	  stimuli	  minus	  the	  face	  stimuli	  from	  the	  passive	   viewing	   condition	   was	   extracted	   using	   REX	   Toolbox	   (Whitfield-­‐Gabrieli,	  2009).	   Furthermore,	   individual	   activation	   of	   a	   cluster	   in	   the	   left	   middle	   frontal	  gyrus	   (MFG)	  was	   extracted	   for	   high	   distracting	   task	   irrelevant	   faces	  minus	   task	  relevant	   faces.	   The	   FFA	   was	   determined	   in	   each	   participant	   by	   examining	   the	  individual	   first-­‐level	   results	   of	   the	   contrast	   ‘faces	   minus	   houses’	   from	   the	  functional	  localiser	  (see	  4.3.1	  for	  a	  description	  of	  this	  localiser).	  Anatomical	  masks	  of	  the	  left	  and	  the	  right	  fusiform	  gyrus,	  respectively,	  were	  overlaid	  over	  the	  first-­‐level	  results.	  The	  significance	  threshold	  was	  adjusted	  individually	  in	  order	  to	  yield	  a	  maximally	  activated	  contiguous	  cluster	  of	  10	  voxels	  in	  either	  the	  right	  or	  the	  left	  fusiform	   gyrus	   for	   each	   participant.	   Unfortunately,	   the	   activation	   yielded	   by	   the	  house	  stimuli	  in	  the	  functional	  localiser	  was	  not	  consistent	  enough	  to	  analyse	  task-­‐induced	  PPA	  activation	  in	  the	  same	  way.	  	  	  
 Statistical	  Analysis	  4.3.5
For	   the	   behavioural	   data,	   the	   percentage	   of	   correctly	   identified	   target	  stimuli	  (hits),	  the	  number	  of	  false	  alarms,	  reaction	  time,	  and	  overall	  accuracy	  were	  entered	   into	   separate	   mixed	   model	   ANOVAs	   with	   the	   between-­‐subjects	   factor	  
COMT	  genotype	  (val/val,	  met/met)	  and	  the	  within-­‐subjects	  factor	  stimulus	  category	  (face,	   house).	   For	   the	   fMRI	   data,	   two-­‐sample	   t-­‐tests	  with	  COMT	   genotype	   as	   the	  between-­‐subjects	   factor	   were	   used	   to	   compare	   the	   exported	   mean	   cluster	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  Mean	  cluster	  activation	  was	  used	  for	  further	  analyses	  as	  a	  more	  robust	  measure	  of	  regional	  activation.	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activations.	   FFA	   activation	   was	   analysed	   using	   a	   mixed	   model	   ANOVA	   with	   the	  between-­‐subjects	  factor	  COMT	  genotype	  (met/met	  versus	  val/val)	  and	  the	  within-­‐subjects	   factor	   task	   relevance	   (task	   relevant,	   high	  distracting	   task	   irrelevant,	   low	  distracting	  task	  irrelevant).	  Hypotheses-­‐driven	  one-­‐sided	  t-­‐tests	  were	  used	  for	  the	  factor	   task	   relevance,	   two-­‐tailed	   t-­‐tests	   were	   used	   for	   all	   other	   post-­‐hoc	  comparisons.	  To	  control	  for	  multiple	  comparisons,	  all	  post-­‐hoc	  t-­‐tests	  were	  Šidák-­‐corrected.	   If	   assumptions	   of	   sphericity	   were	   violated,	   degrees	   of	   freedom	   were	  adjusted	   according	   to	   Greenhouse-­‐Geisser	   (Greenhouse	   &	   Geisser,	   1959).	  However,	  to	  facilitate	  understanding	  only	  full	  degrees	  of	  freedom	  are	  reported.	  In	  addition,	   correlations	   between	   cluster	   activations	   and	   performance	   data	   were	  computed.	  For	  these	  analyses,	  p-­‐values	  of	  α	  ≤	  .05	  were	  considered	  significant.	  	  	  
4.4 Results	  
(1) Behavioural	  Data	  
Mixed	  model	  ANOVAs	  with	  the	  between-­‐subjects	  factor	  COMT	  genotype	  and	  the	  within-­‐subjects	  factor	  stimulus	  category	  for	  the	  percentage	  of	  hits,	  the	  number	  of	   false	   alarms,	   reaction	   time,	   and	   overall	   accuracy	   showed	   no	   significant	   main	  effect	  of	  COMT	   genotype	  or	   stimulus	   category	  nor	  a	   significant	   interaction	  of	   the	  two	  factors	  for	  any	  of	  the	  investigated	  parameters	  (all	  p	  >	  .1).	  Both	  groups	  had	  an	  overall	  accuracy	  index	  of	  around	  .98	  and	  detected	  around	  80	  %	  of	  the	  target	  trials	  with	  an	  average	  reaction	  time	  of	  around	  800	  ms	  while	  committing	  around	  4	  false	  alarms	  (see	  Table	  4.2	  for	  the	  performance	  parameters	  of	  the	  two	  groups).	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Table	  4.2:	  Overview	  of	  mean	  performance	   for	  met/met	   carriers	  and	  val/val	   carriers	   in	   the	   selective	  
attention	  task.	  The	  standard	  deviation	  is	  noted	  in	  parentheses.	  	   met/met	   val/val	  
	  




	  	  %	  hits	  	   84.9(10.4)	   81.3(12.2)	  Reaction	  time1	  	   777(140)	   847(154)	  False	  alarms	   4.1(2.9)	   4.1(2.1)	  Accuracy	  index	   .98(.01)	   .98(.01)	  
Note.	   1	   Reaction	   time	   is	   reported	   in	   milliseconds	   (ms).	   There	   were	   no	   significant	   between-­‐group	  differences	  (all	  p	  >	  .1).	  	  	  
(2) fMRI	  Data	  
Based	  on	  the	  results	  of	   the	  EEG	  study	  the	  contrast	  of	  high	  distracting	  task	  irrelevant	   stimuli	  minus	   task	   relevant	   stimuli	  was	   examined,	   as	   high	   distracting	  task	   irrelevant	   stimuli	   were	   hypothesised	   to	   be	   most	   taxing	   on	   the	   central	  executive	   and	   should	   thereby	   yield	   the	   highest	   DLPFC	   activation.	   Whole	   brain	  FWE-­‐corrected	  data	  showed	  significantly	  more	  activation	  in	  the	  left	  precuneus,	  the	  left	  MFG,	  the	  right	  superior	  frontal	  gyrus	  (SFG),	  the	  left	  inferior	  parietal	  lobule,	  and	  the	  left	  superior	  temporal	  gyrus	  for	  this	  contrast.	  Based	  on	  the	  literature	  (Gazzaley	  et	   al.,	   2007)	   the	   cluster	   in	   the	   left	   MFG/DLPFC	   was	   chosen	   as	   a	   ROI	   that	   was	  potentially	   involved	   in	   the	   modulation	   of	   visual	   processing,	   and	   individual	  activation	   for	   high	   distracting	   task	   irrelevant	   minus	   task	   relevant	   faces	   in	   this	  region	   was	   extracted	   for	   each	   participant.	   Since	   an	   additional	   goal	   of	   this	   pilot	  study	  was	  to	  detect	  activation	  foci	  caused	  by	  the	  experimental	  paradigm,	  fMRI	  data	  were	  also	  examined	  with	  a	  significance	  threshold	  of	  p	  <	  .0001	  (uncorrected).	  This	  analysis	  showed	  significant	  activation	  in	  the	  structures	  mentioned	  above	  as	  well	  as	  in	  the	  right	  middle	  and	  inferior	  frontal	  gyri,	  the	  bilateral	  fusiform	  gyrus,	  the	  right	  inferior	   parietal	   lobule,	   the	   left	   superior	   parietal	   gyrus,	   the	   left	  middle	   occipital	  gyrus,	  and	  the	  right	  superior	  occipital	  gyrus	  (see	  Figure	  4.1).	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  Figure	   4.1:	   Significant	   voxels	   found	   in	   the	   whole	   brain	   analysis	   with	   p	  <	  .0001	   (unc.,	   five	   voxels	  extent	   threshold)	   for	   the	   contrast	   high	   distracting	   task	   irrelevant	   stimuli	   minus	   task	   relevant	  stimuli	  across	  all	  participants.	  Clusters	  of	  activation	  can	  be	  seen	  in	  frontal	  and	  parietal	  areas	  as	  well	  as	  in	  the	  bilateral	  fusiform	  gyrus.	  	  	  Comparisons	  between	  COMT	  met/met	  carriers	  and	  val/val	  carriers	  showed	  no	  significant	  whole	  brain	  differences.	  However,	  ROI	  analyses	  yielded	  a	  significant	  peak	   voxel	   difference	   for	   one	   of	   the	   three	   examined	   coordinates	   specified	   by	  Mattay	   and	   colleagues	   (2003):	   Val/val	   carriers	   showed	   significantly	   higher	  activation	   than	   met/met	   carriers	   in	   the	   right	   medial	   frontal	   gyrus	   (t(16)	  =	  3.87,	  
pFWE	  =	  .03,	  cluster	  size:	  28	  voxels;	  see	  Figure	  4.2)6.	  	  	  
	  
	   A	   two	   sample	   t-­‐test	   of	   the	   contrast	   estimates	   for	   the	   entire	   cluster	   also	  yielded	   a	   significant	   between-­‐group	   difference	   with	   val/val	   carriers	   showing	  significantly	   greater	   activation	   than	   met/met	   carriers	   (t(16)	  =	  3.05,	   p	  =	  .01;	  met/met:	   M	  =	  -­‐0.22,	   SD	  =	  0.42;	   val/val:	   M	  =	  0.70,	   SD	  =	  0.80).	   Correlations	   of	   the	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  See	  Table	  8.1	  (appendix)	  for	  MNI	  coordinates	  of	  the	  significant	  between-­‐group	  peak	  voxel	  difference.	  	  
Figure	   4.2:	   Cluster	   found	   in	   the	   ROI	   analyses	   with	  significantly	   greater	   peak	   voxel	   activation	   for	   the	  contrast	   high	   distracting	   task	   irrelevant	   minus	   task	  relevant	  stimuli	   in	  the	  val/val	  group	  compared	  to	  the	  met/met	  group	  in	  the	  right	  medial	  frontal	  gyrus.	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contrast	  estimates	  for	  this	  cluster	  showed	  no	  association	  of	  mean	  activity	  with	  any	  of	  the	  performance	  parameters.	  Given	   the	  bilateral	   activation	  of	   the	   fusiform	  gyrus	   across	   all	   participants,	  individually	  determined	  activation	  of	  each	  participant’s	  FFA	  was	  extracted	  for	  task	  relevant	   faces	  minus	   the	  passive	   viewing	   control	   condition,	   high	  distracting	   task	  irrelevant	   faces	  minus	   the	  passive	  viewing	  control	   condition,	  and	   low	  distracting	  task	  irrelevant	  faces	  minus	  the	  passive	  viewing	  control	  condition.	  A	  mixed	  model	  ANOVA	  with	   the	  between-­‐subjects	   factor	  COMT	  genotype	  and	   the	  within-­‐subjects	  factor	   task	   relevance	   yielded	   a	   significant	   main	   effect	   of	   task	   relevance	  (F(2,32)	  =	  4.35,	   p	  =	  .02;	   see	   Figure	   4.3)	   with	   high	   distracting	   task	   irrelevant	   faces	  leading	   to	   significantly	   higher	   mean	   contrast	   estimates	   than	   task	   relevant	   faces	  (p	  =	  .01).	  Low	  distracting	  task	  irrelevant	  faces	  showed	  intermediate	  activation,	  not	  being	  significantly	  different	  from	  either	  task	  relevant	  (p	  =	  .14)	  or	  high	  distracting	  task	  irrelevant	  faces	  (p	  =	  .33).	  	  	  
	  	   There	  was	  no	  significant	  main	  effect	  of	  group	  and	  no	  significant	  interaction	  of	   group	   and	   task	   relevance	   (both	   p	  >	  .1),	   and	   there	   were	   no	   significant	  correlations	   of	   mean	   FFA	   contrast	   estimates	   and	   any	   of	   the	   performance	  parameters	   (all	   p	  >	  .1).	   In	   addition,	   there	   was	   no	   correlation	   between	   left	   MFG	  activation	   for	   high	   distracting	   task	   irrelevant	  minus	   task	   relevant	   faces	   and	   FFA	  activation	  for	  the	  same	  contrast.	  	  	  
Figure	   4.3:	   Mean	   FFA	   contrast	   estimates	   for	   face	  stimuli	   in	   the	   different	   conditions	   minus	   the	   passive	  viewing	   condition.	   For	   the	   graph,	   data	   were	  normalised	  using	  the	  normalisation	  method	  described	  in	   Franz	   and	   Loftus	   (2012)	   to	   remove	   irrelevant	  between-­‐subjects	   differences.	   Error	   bars	   denote	  standard	   error	   of	   the	   mean	   for	   the	   normalised	   data	  (SEMnorm).	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4.5 Discussion	  
The	   main	   goal	   of	   this	   study	   was	   to	   transfer	   the	   experimental	   paradigm	  established	   in	   the	   first	   (EEG)	   study	   to	   fMRI.	   Although	   stimulus	   timing	   had	   to	   be	  adjusted	  to	  accommodate	  for	  the	  lower	  temporal	  resolution	  afforded	  by	  fMRI,	  this	  transfer	  was	  generally	  successful	  and	  produced	  an	  analysable	  data	  set.	  	  As	   expected	   based	   on	   previous	   studies	   (Gazzaley	   et	   al.,	   2007;	   Jha	   et	   al.,	  2004)	   our	   task	   produced	   robust	   activation	   in	   the	   left	   MFG/DLPFC	   when	   high	  distracting	   task	   irrelevant	   and	   task	   relevant	   stimuli	  were	   compared.	   In	   addition,	  activation	   could	  be	   found	   in	   left	  parietal	   and	   temporal	   as	  well	   as	   in	   right	   frontal	  areas,	   which	   is	   also	   consistent	   with	   previous	   results	   (Gazzaley	   et	   al.,	   2007).	  Furthermore,	  existing	  problems	  of	  previous	  paradigms	  could	  be	  avoided:	  Gazzaley	  et	  al.’s	  (2005;	  2007)	  experimental	  paradigm	  presented	  two	  task	  relevant	  and	  two	  low	   distracting	   task	   irrelevant	   stimuli	   within	   four	   seconds.	   For	   this	   reason,	   all	  analyses	  had	   to	  be	   conducted	  on	   the	   combined	   task	   relevant	   and	   task	   irrelevant	  stimuli,	   and	   it	   was	   not	   possible	   to	   disentangle	   the	   activation	   caused	   by	   either	  stimulus	   class.	   In	   contrast,	   the	   continuous	   design	   of	   our	   study	   allowed	   us	   to	  contrast	   task	   relevant	   and	   high	   distracting	   task	   irrelevant	   stimuli,	   thereby	  disentangling	  activation	  related	  to	  the	  encoding	  of	  task	  relevant	  stimuli	  and	  to	  the	  suppression	  of	  distracting	  task	  irrelevant	  stimuli.	  	  Our	  design	  furthermore	  enabled	  us	  to	  compare	  the	  obtained	  results	  to	  those	  reported	  by	  Jha	  et	  al.	  (2004).	  Although	  the	  underlying	  task	  was	  different,	  this	  study	  could	  contrast	  task	  relevant	  and	  high	  distracting	  task	  irrelevant	  stimuli	  as	  well.	  It	  also	   reports	   increased	   activation	   in	   the	   left	   PFC,	   although	   in	   a	   possibly	   more	  ventral	   area.	   In	   addition,	   we	   could	   replicate	   their	   finding	   of	   increased	   FFA	  activation	   during	   high	   distracting	   compared	   to	   low	   distracting	   task	   irrelevant	  stimuli.	   While	   FFA	   activation	   in	   our	   study	   was	   higher	   for	   high	   distracting	   task	  irrelevant	  stimuli	  compared	  to	  task	  relevant	  stimuli,	  activation	  for	  low	  distracting	  task	  irrelevant	  stimuli	  was	  intermediate	  and	  not	  significantly	  different	  from	  either	  of	  the	  other	  two	  stimulus	  classes.	  This	  finding	  is	  in	  line	  with	  and	  extends	  previous	  reports	   (Jha	   et	   al.,	   2004).	   In	   these	   reports,	   the	   increased	   activation	   during	   the	  presentation	   of	   high	   distracting	   task	   irrelevant	   stimuli	   could	   signify	   either	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inhibitory	  processes	  or	  increased	  maintenance	  efforts	  during	  high	  distraction	  or	  a	  combination	   of	   both.	   However,	   it	   could	   also	   just	   reflect	   the	   additive	   effect	   of	  processing	   a	   distracting	   stimulus,	   with	   a	   stimulus	   from	   the	   same	   category	   that	  activated	   the	   same	   neural	   population	   already	   being	   maintained	   in	   working	  memory	  (Ranganath	  &	  Paller,	  1999;	  Rossion	  et	  al.,	  2004).	  Our	  paradigm	  allowed	  us	  to	  replicate	  these	  results,	  but	  we	  could	  also	  further	  extend	  the	  findings	  of	  Jha	  et	  al.	  (2004)	   by	   showing	   increased	   activation	   for	   the	   low	   distracting	   task	   irrelevant	  stimuli,	   which	   were	   from	   another	   category	   than	   the	   maintained	   task	   relevant	  stimuli.	   This	   supports	   the	   interpretation	   of	   increased	   activation	   as	   possibly	  reflecting	   inhibitory	  processes	   in	   the	   face	  of	   distraction.	  However,	  while	   the	   low	  distracting	   task	   irrelevant	   stimuli	   in	   our	   study	   showed	   intermediate	   activation,	  this	   activation	   was	   not	   significantly	   different	   from	   the	   activation	   for	   both	   task	  relevant	   and	  high	   distracting	   task	   irrelevant	   stimuli.	   Furthermore,	   our	   paradigm	  did	  not	   include	  a	   “pure”	  maintenance	  condition,	   thereby	   limiting	   the	   conclusions	  that	  can	  be	  drawn	  from	  these	  results.	  Nevertheless,	  this	  finding	  for	  the	  FFA	  mimics	  the	   results	   from	   the	   EEG	   study,	   where	   low	   distracting	   task	   irrelevant	   stimuli	  elicited	   intermediate	   N170	   amplitudes	   when	   compared	   to	   high	   distracting	   task	  irrelevant	   and	   task	   relevant	   stimuli.	  Unfortunately,	   a	   comparable	  analysis,	  which	  might	  have	  clarified	   the	  FFA	   findings,	  was	  not	  possible	   for	  PPA	  activation,	  as	   the	  functional	   localiser	   failed	   to	  elicit	   the	  necessary	   consistent	  PPA	  activation	  across	  participants.	  	  Unlike	   hypothesised	   this	   study	   did	   not	   show	   an	   association	   of	   FFA	  activation	  and	  activation	  of	  a	  cluster	  in	  the	  left	  MFG	  that	  was	  assumed	  to	  be	  most	  likely	  responsible	  for	  producing	  task-­‐induced	  modulation	  in	  stimulus	  processing.	  It	  has	  to	  be	  pointed	  out,	  however,	  that	  while	  Gazzaley	  et	  al.	  (2007)	  found	  activation	  of	   a	   similar	   cluster	   when	   they	   examined	   task-­‐related	   activity	   in	   a	   univariate	  analysis,	  the	  reported	  correlations	  were	  only	  visible	  when	  the	  connectivity	  indices	  of	   this	   region	   and	   visual	   association	   areas	   were	   correlated	   with	   task-­‐induced	  processing	  suppression.	  As	  we	  did	  not	  analyse	  connectivity	  between	   these	  areas,	  our	   lack	   of	   a	   significant	   association	   is	   not	   entirely	   surprising.	   In	   addition,	   as	   the	  DLPFC	   was	   previously	   found	   to	   possess	   greatly	   differentiated	   responsivity	  (Goldman-­‐Rakic,	  1995),	  it	  is	  possible	  that	  the	  MFG	  cluster	  in	  our	  study	  was	  simply	  
Study	  2:	  fMRI	  Parameters	  of	  Selective	  Attention	  –	  Discussion	   75	  	  
	   	  
not	   subserving	  modulatory	   functions	   leading	   to	   processing	   consequences	   in	   the	  FFA.	  	   A	  further	  goal	  of	  this	  study	  was	  to	  investigate	  the	  impact	  of	  COMT	  genotype	  on	   behavioural	   performance	   and	   on	   the	   elicited	   prefrontal	   activation.	   Since	   past	  reports	   of	  worse	   performance	   of	   val/val	   carriers	   compared	   to	  met/met	   carriers	  analysed	  very	   large	  samples	  and	  found	  only	  small	   to	  moderate	  effect	  sizes	  (Diaz-­‐Asper	  et	  al.,	  2008),	   the	   finding	  of	  no	  behavioural	  performance	  differences	   for	  the	  two	  COMT	  groups	  was	  expected	  and	  is	  also	  in	  line	  with	  previous	  studies	  (Barnett	  et	  al.,	  2008;	  Egan	  et	  al.,	  2001).	  It	  has	  to	  be	  noted	  that	  performance	  data	  in	  this	  study	  indicated	  high	  performance	  accuracy	  with	  a	  target	  detection	  rate	  of	  around	  80	  %	  indicating	   that	   the	   task	   was	   sufficiently	   difficult	   to	   prevent	   participants	   from	  performing	  at	  ceiling	  level.	  With	  regard	  to	  the	  functional	  activation	  elicited	  by	  the	  task,	  we	  could	  replicate	  some	  of	  the	  previous	  findings	  (Egan	  et	  al.,	  2001;	  Mattay	  et	  al.,	  2003;	  Mier	  et	  al.,	  2010)	  with	  significantly	  higher	  activation	  of	  val/val	  carriers	  compared	  to	  met/met	  carriers	  in	  one	  of	  three	  examined	  ROIs	  in	  the	  frontal	  cortex.	  The	   task	   thus	   apparently	   taxes	   some	   of	   the	   frontal	   lobe	   functions	   vulnerable	   to	  activation	  efficiency	  differences	  caused	  by	  the	  COMT	  genotype,	  although	  to	  a	  lesser	  extent	  than	  expected.	  While	  previous	  studies	  used	  the	  modified	  n-­‐back	  task	  up	  to	  a	  difficulty	   level	   of	   3-­‐back	   (Mattay	   et	   al.,	   2003),	   the	   high	   performance	   accuracy	   in	  our	  study	  possibly	  indicates	  that	  this	  task	  might	  not	  have	  been	  difficult	  enough	  to	  produce	  the	  necessary	  effort	  for	  observing	  frontal	  efficiency	  differences.	  	  To	   conclude,	   our	   experimental	   paradigm	   enabled	   us	   to	   replicate	   previous	  results	   linked	   to	   both	   the	   processing	   of	   (high)	   distracting	   task	   irrelevant	   stimuli	  and	  to	  the	  impact	  of	  the	  COMT	  genotype.	  In	  addition	  to	  yielding	  frontal	  activation	  consistent	   with	   the	   literature,	   whole-­‐brain	   results	   furthermore	   showed	  widespread	   frontal	   and	   parietal	   activation	   when	   results	   were	   examined	   with	   a	  more	   liberal	   statistical	   threshold,	   making	   this	   paradigm	   suited	   for	   further	  investigations	  using	  fMRI.	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5 Study	  3:	  Double-­‐Blind	  Placebo-­‐Controlled	  Trial	  	  
5.1 Introduction	  
This	  third	  study	  comprised	  a	  medium-­‐sized	  sample	  of	  unmedicated	  aADHD	  patients	   and	  matched	  healthy	   controls,	  whose	  performance	  on	   a	   variety	  of	   tasks	  was	   compared.	   In	  addition,	   the	   study	   included	  a	  double-­‐blind	  placebo-­‐controlled	  clinical	   trial	   of	  MPH	   versus	   placebo	   for	   the	   participating	   aADHD	   patients	   (study	  code:	  W004PS0108_1,	   EudraCT:	   2008-­‐006242-­‐26).	   This	   study	   therefore	  pursued	  several	   goals:	   First,	   as	   all	   participants	   completed	   three	   different	  neuropsychological	   tests,	   the	   performance	   of	   aADHD	   patients	   compared	   to	   a	  matched	   control	   group	   and	   the	   possible	   impact	   of	   COMT	   genotype	   on	   this	  performance	  was	   investigated.	   In	   addition,	   the	   effect	   of	   MPH	  medication	   versus	  placebo	   in	   the	   patients	   was	   evaluated	   by	   examining	   their	   performance	   at	   the	  beginning	  and	  at	  the	  end	  of	  the	  clinical	  trial.	  	  As	  previous	  studies	  have	  shown	  the	  feasibility	  of	  transferring	  investigations	  from	   participants	   with	   subclinical	   ADHD	   symptoms	   to	   patient	   samples	   (e.g.	  Herrmann	  et	  al.,	  2010;	  Herrmann	  et	  al.,	  2009),	  a	  second	  focus	  of	  this	  study	  was	  the	  assessment	  of	  behavioural	  performance	  and	  functional	  brain	  activation	  in	  aADHD	  patients	   and	   healthy	   controls	   during	   the	   selective	   attention	   task.	   In	   addition,	   a	  possible	   effect	   of	   MPH	  medication	   on	   these	   parameters	   in	   aADHD	   patients	   was	  examined.	   The	   first	   (EEG)	   study	   provided	   some	   indication	   of	   subclinical	   ADHD	  symptoms	  impacting	  on	  processing	  modulation	  as	  well	  as	  on	  target	  detection	  rates	  and	  performance	  accuracy.	  The	  performance	  profiles	  of	  aADHD	  patients	  compared	  to	   the	   sample	  with	   subclinical	   symptoms	   should	   be	   similar	   but	   potentially	  more	  strongly	   impaired.	   We	   therefore	   expected	   to	   replicate	   and	   extend	   our	   previous	  findings	   from	   the	   selective	   attention	   task	   with	   the	   sample	   of	   aADHD	   patients	  compared	  to	  a	  matched	  healthy	  control	  group.	  	  The	   third	   goal	   of	   this	   study	  was	   the	   investigation	  of	   the	   effects	   of	   a	  more	  classic	  working	  memory	  paradigm	  in	  aADHD	  patients	  and	  healthy	  controls	  as	  well	  as	  the	  examination	  of	  the	  impact	  of	  MPH	  on	  the	  investigated	  parameters	  in	  aADHD	  patients.	   While	   the	   selective	   attention	   task	   showed	   good	   results	   for	   the	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investigation	  of	  the	  central	  executive	  component	  of	  working	  memory,	  the	  design	  of	  the	   task	   did	   not	   allow	   the	   investigation	   of	   more	   global	   working	   memory	  functioning.	   Although	   a	   meta-­‐analysis	   found	   some	   indication	   for	   EF	   deficits	   in	  aADHD	  (Boonstra	  et	  al.,	  2005),	   functional	   imaging	  studies	  of	  working	  memory	   in	  aADHD	   patients	   are	   still	   scarce	   with	   most	   of	   the	   existing	   studies	   focusing	   on	  behaviour	   inhibition	   as	   the	   EF	   of	   interest	   (Cortese	   et	   al.,	   2012).	   One	   of	   the	   few	  existing	   studies	   that	   investigated	  adults	  with	  ADHD	  using	   the	  classic	  n-­‐back	   task	  reports	   an	   overall	   decreased	   activation	   pattern	   in	   the	   attention/	   task-­‐positive	  network.	   Although	   this	   decreased	   activation	   was	   evident	   when	   task-­‐related	  activation	  of	  the	  aADHD	  group	  was	  compared	  to	  a	  matched	  control	  group,	  only	  few	  significant	  differences	  were	  found	  in	  the	  whole-­‐brain	  between-­‐group	  comparison	  (Bayerl	  et	  al.,	  2010).	  Furthermore,	  the	  meta-­‐analysis	  mentioned	  above	  (Cortese	  et	  al.,	   2012)	   reports	   hypoactivation	   in	   the	   frontoparietal	   network	   in	   adults	   with	  ADHD,	  with	  some	  hyperactivation	  in	  the	  visual,	  dorsal	  attention,	  and	  default	  mode	  networks.	  However,	   the	   lack	  of	  results	   for	   the	  dorsal	  attention	  network	  might	  be	  caused	  by	  most	  studies	  investigating	  inhibition	  processes	  subserved	  by	  the	  ventral	  attention	  network	  instead	  of	  working	  memory.	  	  So	   far,	   there	   are	   no	   studies	   investigating	   the	   effects	   of	   six	  weeks	   of	  MPH	  versus	  placebo	  medication	  on	  the	  activation	  of	  these	  networks	  in	  aADHD	  patients	  using	  a	  measure	  of	  working	  memory.	  However,	  a	  placebo-­‐controlled	  clinical	  study	  of	   aADHD	  patients	   using	   a	  modified	   version	   of	   the	   Stroop	   reports	   increased	   left	  DLPFC	   and	   bilateral	   parietal	   lobe	   activation	   after	   six	   weeks	   of	   MPH	  medication	  (Bush	   et	   al.,	   2008).	   In	   addition,	   working	   memory	   studies	   with	   children	   and	  adolescents	  found	  a	  down-­‐regulation	  of	  the	  task-­‐negative/	  default	  mode	  network	  and	  an	  up-­‐regulation	  of	  the	  task-­‐positive	  network/	  frontoparietal	  network	  through	  MPH	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	  Stevens,	  2012).	   Importantly,	   there	   is	  a	   lack	  of	  investigations	  using	  placebo-­‐controlled	  designs	  that	  span	  several	  weeks,	  with	  most	  studies	   investigating	   children	   and	   adolescents	   and	   relying	   on	   dispensing	   single	  doses	  of	  medication	  or	  using	  a	  naturalistic	  on/off	  design.	  To	   investigate	   working	   memory	   functioning	   in	   general,	   we	   decided	   to	  employ	  the	  modified	  n-­‐back	  task.	  The	  classic	  n-­‐back	  task	  was	  previously	  shown	  to	  be	  sensitive	   for	   functional	  activation	  differences	   in	  both	  children	  and	  adults	  with	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ADHD	   compared	   to	   healthy	   controls	   as	   well	   as	   for	   stimulant	   medication	   effects	  (Kobel	  et	  al.,	  2009;	  Valera,	  Faraone,	  Biederman,	  Poldrack,	  &	  Seidman,	  2005).	  The	  classic	  n-­‐back	  task	  usually	  consists	  of	  the	  sequential	  presentation	  of	  letters	  on	  the	  screen,	  and	  the	  participant	  is	  instructed	  to	  respond	  if	  the	  presented	  letter	  and	  the	  letter	  shown	   ‘n’	   trials	  earlier	  are	   identical	  (J.	  D.	  Cohen	  et	  al.,	  1994).	   In	  contrast,	  a	  frequently	   used	   modification	   of	   this	   task	   uses	   numbers	   instead	   of	   letters	   and	  requires	   the	   participant	   to	   respond	   on	   every	   trial	   by	   indicating	   the	   number	  (numbers	  1	  to	  4)	  shown	  ‘n’	  trials	  earlier	  (Goldberg	  et	  al.,	  2003).	  We	  decided	  to	  use	  this	   modified	   version	   of	   the	   n-­‐back	   task,	   as	   it	   was	   previously	   successfully	  employed	   to	   assess	   the	   effects	   of	  COMT	  genotype	   on	   functional	   activation	   in	   the	  frontal	  lobes,	  yielding	  significant	  differences	  between	  the	  three	  allele	  groups	  (Diaz-­‐Asper	  et	  al.,	  2008;	  Egan	  et	  al.,	  2001).	  Moreover,	  this	  task	  was	  shown	  to	  be	  sensitive	  to	   interactions	   of	   COMT	   genotype	   and	   amphetamine	   intake	   in	   healthy	   controls	  (Mattay	  et	  al.,	  2003).	  	  The	   goal	   of	   this	   study	   was	   to	   compare	   behavioural	   performance	   and	  functional	   activation	   of	   aADHD	   patients	   and	   healthy	   controls	   as	   well	   as	   to	  investigate	  the	  effect	  of	  stimulant	  medication	  on	  several	  neuropsychological	  tests,	  the	  previously	  established	  selective	  attention	  task,	  and	  the	  modified	  n-­‐back	  task.	  In	  addition,	  this	  study	  tried	  to	  explore	  possible	  interactive	  effects	  of	  COMT	  genotype	  and	  aADHD.	  Throughout	  the	   investigation	  of	  task-­‐induced	  functional	  activation,	  a	  particular	  focus	  was	  placed	  on	  the	  attention/	  task-­‐positive	  network.	  	  	  
5.2 Methods	  
 ADHD	  Patient	  Sample	  and	  Healthy	  Control	  Sample	  5.2.1
A	   total	   of	   41	   adult	   patients	   with	   ADHD	   were	   recruited	   from	   the	   ADHD	  outpatient	   clinic	   at	   the	   Department	   of	   Psychiatry,	   Psychosomatics,	   and	  Psychotherapy	   of	   the	   University	   of	   Würzburg.	   Diagnoses	   were	   made	   by	   an	  experienced	  psychiatrist	  according	   to	  DSM-­‐IV-­‐TR	   (2000)	  criteria.	  Patients	  had	   to	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testing.	  Three	  of	  the	  recruited	  aADHD	  patients	  did	  not	  meet	  full	  inclusion	  criteria7.	  Three	  more	  patients	  decided	  not	  to	  proceed	  with	  the	  study	  after	  inclusion	  and	  one	  patient	   decided	   to	   discontinue	   the	   study	   after	   the	   first	   fMRI	   appointment	   for	  unknown	  reasons.	  No	  or	  only	  one	  set	  of	  fMRI	  data	  was	  obtained	  from	  two	  patients	  who	   worked	   in	   metal	   processing	   and	   were	   excluded	   from	   further	   fMRI	   data	  collection	  in	  accordance	  with	  MRB	  safety	  requirements.	  This	  resulted	  in	  a	  total	  of	  35	  data	  sets	   from	  patients	  with	  ADHD,	  of	  whom	  34	  participated	   in	   the	   first	   fMRI	  appointment	   and	   32	   participated	   in	   the	   first	   as	   well	   as	   in	   the	   second	   fMRI	  appointment.	  Of	  the	  35	  patients	  who	  participated	  in	  the	  study,	  19	  patients	  (54	  %)	  were	   classified	   as	   predominantly	   inattentive	   (based	   on	   CAARS	   DSM-­‐IV	   T-­‐scores	  >	  60	   on	   the	   Inattentive	   Symptoms	   scale),	   15	   patients	   (43	  %)	   were	   classified	   as	  combined	  type	  (based	  on	  CAARS	  DSM-­‐IV	  T-­‐scores	  >	  60	  on	  the	  Inattentive	  as	  well	  as	  on	  the	  Hyperactive/	  Impulsive	  Symptoms	  scale),	  and	  one	  patient	  was	  classified	  as	  predominantly	  hyperactive/	  impulsive	  (based	  on	  CAARS	  DSM-­‐IV	  T-­‐scores	  >	  60	  on	  the	  Hyperactive/	  Impulsive	  Symptoms	  scale).	  The	  patient	  classified	  as	  suffering	  from	   ADHD	   of	   the	   predominantly	   hyperactive/	   impulsive	   type	   discontinued	   the	  study	  after	  the	  first	  fMRI	  appointment.	  	  After	   inclusion	   in	   the	  study,	  all	  patients	  were	  randomly	  assigned	   to	  either	  IR-­‐MPH	   or	   placebo	   treatment	   in	   a	   double-­‐blind	   design.	   Neither	   the	   patients	   nor	  any	  researcher	   involved	   in	  data	  collection	  were	  aware	  of	   the	  assigned	  treatment.	  Medication	   was	   dispensed	   in	   a	   free	   titration	   design.	   The	   medication	   schedule	  started	  with	  a	  daily	  dose	  of	  10	  mg,	  which	  was	  increased	  by	  10mg	  every	  week	  up	  to	  a	   maximum	   daily	   dose	   of	   60	  mg.	   Medication	   was	   only	   increased	   as	   long	   as	   the	  patient	   subjectively	   benefitted	   from	   the	   increase	   without	   suffering	   from	   any	  disturbing	  side	  effects.	  A	  psychiatrist	  saw	  each	  participating	  patient	  at	  least	  every	  two	  weeks	   to	   assess	   symptom	   response	   and	   side	   effects,	   and	   adjust	  medication	  dosage	   if	   necessary.	   Patients	  were	   debriefed	   after	   the	   second	   fMRI	   appointment	  following	  six	  weeks	  of	  MPH	  medication	  or	  placebo	  and	  could	  subsequently	  begin	  or	  continue	  with	  MPH	  medication	  (depending	  on	  their	  previous	  treatment),	  if	  they	  wished.	  Furthermore,	  all	  patients	  were	  seen	  by	  a	  psychiatrist	  for	  a	  final	  follow-­‐up	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  See	  Table	  8.2	  and	  below	  (appendix)	  for	  the	  full	  list	  of	  inclusion	  and	  exclusion	  criteria,	  and	  for	  characteristics	  of	  the	  dispensed	  MPH	  and	  placebo	  medication.	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assessment	   four	  weeks	   after	   the	   end	   of	   the	   double-­‐blind	  medication	   phase	   (see	  Figure	  5.1).	  	  
	  Figure	   5.1:	   Schematic	   diagram	   illustrating	   the	   time	   profile	   of	   the	   clinical	   trial.	   For	   a	   detailed	  description	  of	  the	  employed	  clinical	  and	  neuropsychological	  measures	  see	  5.2.2.	  	  	   In	   addition,	   47	   healthy	   control	   participants	   without	   a	   past	   or	   present	  diagnosis	  of	  ADHD	  were	  recruited	   from	  a	  previously	  established	  participant	  pool	  (see	   also	   Biehl	   et	   al.,	   2013;	   Gschwendtner	   et	   al.,	   2012)	   as	   well	   as	   through	  university	   advertisement.	   A	   varying	   subset	   of	   healthy	   control	   participants	   was	  chosen	   as	   a	   most	   closely	   matched	   control	   group	   for	   the	   experimental	   tasks	  following	   a	   case-­‐control	   design	   (p	  >	  .2	   for	   age,	   gender,	   and	   number	   of	   school	  years).	  All	  control	  participants	  had	  normal	  or	  corrected-­‐to-­‐normal	  vision	  and	  were	  free	  of	  neurological	  or	  psychiatric	  diseases.	  Furthermore,	   all	   participants	   were	   genotyped	   for	   the	   COMT	   val158met	  polymorphism.	   Blood	   was	   taken	   and	   DNA	   was	   extracted	   using	   a	   standard	   de-­‐salting	  procedure.	  A	  standard	  PCR	  procedure	  (slightly	  modified	  from	  the	  protocol	  used	  by	  Egan	  et	  al.,	  2001)	  was	  used	  to	  determine	  COMT	  genotypes,	  which	  did	  not	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deviate	  from	  Hardy-­‐Weinberg	  equilibrium.	  Ethical	  approval	  was	  obtained	  through	  the	  Ethical	  Review	  Board	  of	  the	  medical	  faculty	  of	  the	  University	  of	  Würzburg;	  all	  procedures	  involved	  were	  in	  accordance	  with	  the	  2008	  Declaration	  of	  Helsinki.	  All	  participants	   gave	   written	   informed	   consent	   after	   full	   explanation	   of	   the	  procedures.	  	  	  
 Psychological	  Assessment	  5.2.2
Patients	  were	  administered	  the	  Wender-­‐Reimherr-­‐Interview	  (WRI),	  a	  semi-­‐structured	   interview	   to	   aid	   the	   diagnosis	   of	   aADHD	   (Corbisiero,	   Buchli-­‐Kammermann,	   &	   Stieglitz,	   2010).	   In	   addition,	   patients	   completed	   the	   CAARS	  (Conners	   et	   al.,	   1999),	   which	   is	   a	   more	   refined	   questionnaire	   of	   aADHD	  (Christiansen	   et	   al.,	   2012;	   Christiansen	   et	   al.,	   2011)	   and	   the	  WURS	   (Ward	   et	   al.,	  1993),	   which	   assesses	   childhood	   symptoms	   of	   ADHD.	   To	   exclude	   possible	  comorbid	  axis	   I	  disorders,	  all	  patients	  were	  assessed	  with	  the	  Structured	  Clinical	  Interview	   for	  DSM-­‐IV	   (SCID-­‐I)	   (Wittchen,	  Zaudig,	  &	  Fydrich,	  1997),	   the	  Hamilton	  Depression	   Rating	   Scale	   (HAM-­‐D)	   (Hamilton,	   1960),	   and	   the	   Hamilton	   Anxiety	  Rating	   Scale	   (HAM-­‐A)	   (Hamilton,	   1959).	  With	   exception	   of	   the	  WURS,	   all	   of	   the	  questionnaires	   were	   administered	   before	   the	   first	   and	   the	   second	   fMRI	  appointment	   in	   order	   to	   track	   possible	   treatment-­‐related	   changes	   in	  symptomatology.	  	  Patients	  as	  well	  as	  healthy	  controls	  completed	  the	  ASRS	  (R.	  C.	  Kessler	  et	  al.,	  2005),	   an	   18-­‐item	   screening	   questionnaire	   assessing	   ADHD	   symptoms	   based	   on	  the	  DSM-­‐IV-­‐TR	  (2000),	  and	  the	  PANAS	  (Krohne	  et	  al.,	  1996;	  Watson	  et	  al.,	  1988)	  to	  control	  for	  positive	  and	  negative	  affectivity	  at	  the	  time	  of	  the	  fMRI	  appointments.	  In	   addition,	   the	   following	   neuropsychological	   data	   were	   obtained	   from	   all	  participants	   during	   the	   first	   (and	   for	   patients	   also	   during	   the	   second)	   fMRI	  appointment:	  The	  Digit	  Span	  subtest	  from	  the	  German	  version	  of	  the	  WAIS	  (Aster,	  Neubauer,	  &	  Horn,	  2006)	  as	  a	  measure	  of	  verbal	  short-­‐term	  memory	  (Digit	  Span	  
Forward)	   and	   verbal	   working	   memory	   (Digit	   Span	   Backward),	   the	   Stroop	   Color	  
Word	   Test	   (Bäumler,	   1985)	   as	   a	   measure	   of	   inhibition,	   and	   the	   Standard	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Progressive	  Matrices	  (StPM)8	  (Kratzmeier	  &	  Horn,	  1988)	  to	  obtain	  an	  estimate	  of	  intellectual	   functioning.	   The	   StPM	  was	   administered	   only	   once	   since	   it	   assesses	  fluid	   intelligence,	   which	   should	   not	   vary	   as	   a	   result	   of	   stimulant	   medication	  treatment.	  	  	  
 fMRI	  Data	  Acquisition	  and	  Analysis	  	  5.2.3
As	   for	   the	   pilot	   study,	   imaging	   data	   were	   acquired	   at	   the	   MRB	   using	   a	  Siemens	  MAGNETOM®	  Avanto	  MRI	  scanner	  with	  a	  magnetic	   field	  strength	  of	  1.5	  Tesla	   (Siemens	   AG,	   Erlangen,	   Germany)	   and	   a	   twelve	   channel	   head	   coil.	   The	  presentation	  and	  response	  equipment	  were	   identical	   to	   the	  equipment	  described	  in	   4.3.4.	   For	   all	   paradigms,	   TR	   of	   the	   T2*-­‐weighted	   gradient	   EPI	   sequence	   was	  three	  seconds;	  the	  echo	  time	  (TE)	  was	  50	  milliseconds.	  Further	  parameters	  were	  flip	   angle	   (90°),	   in-­‐plane	   resolution	   3.6	  ×	   3.6	  mm2,	   field	   of	   view	   (FOV)	   230	  ×	  230	  mm2.	   One	   TR	   allowed	   for	   the	   serial	   acquisition	   of	   32	   axial	   slices	   of	   4	  mm	  thickness	  in	  descending	  order	  (1	  mm	  gap	  between	  slices).	  Slices	  were	  aligned	  to	  be	  parallel	   to	   the	   AC-­‐PC	   line,	   which	   runs	   along	   the	   anterior	   and	   the	   posterior	  commissure.	  The	  first	  three	  volumes	  of	  each	  sequence	  were	  discarded	  to	  allow	  for	  signal	   saturation.	   In	   addition,	   a	   high-­‐resolution	   structural	   MPRAGE	   scan	   was	  acquired	  for	  every	  participant	  as	  described	  above.	  All	   fMRI	   data	   were	   analysed	   using	   SPM8	   (Wellcome	   Trust,	   2009)	   as	  described	  in	  4.3.4.	  As	  described	  in	  5.2,	  a	  separate	  subgroup	  of	  healthy	  participants	  was	   chosen	   for	   each	   task	   to	  match	   the	  ADHD	  patients	  most	   closely.	   To	   examine	  task-­‐induced	  activation,	  whole	  brain	  analyses	  were	  carried	  out	  across	  both	  groups	  by	   performing	   one-­‐sample	   t-­‐tests	   with	   pFWE	  <	  .05	   for	   the	   contrasts	   of	   interest.	  These	  results	  were	  subsequently	  examined	  for	  activation	  at	  peak	  voxels	  of	  interest	  belonging	   to	   the	   task-­‐positive	  network	  as	  specified	  by	  Fox	  and	  colleagues	  (2006;	  2005).	  To	  reduce	  the	  number	  of	  tests,	  further	  analyses	  were	  only	  conducted	  if	  the	  examined	   contrast	   caused	   significant	   activation	   of	   the	   peak	   voxel	   across	   all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  The	  abbreviation	  StPM	  was	  chosen	  to	  avoid	  confusion	  with	  the	  fMRI	  analysis	  software	  Statistical	  Parametric	  Mapping	  (SPM).	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participants.	  To	  investigate	  differences	  between	  the	  aADHD	  and	  the	  control	  group,	  whole	   brain	   analyses	   were	   carried	   out	   by	   performing	   two-­‐sample	   t-­‐tests	   with	  
pFWE	  <	  .05	   for	   the	   contrasts	   of	   interest.	   Medication	   effects	   were	   examined	   using	  mixed	  model	  ANOVAs	   implemented	  as	   flexible	   factorial	  models	   in	  SPM8	  with	  the	  between-­‐subjects	  factor	  medication	  (MPH	  versus	  placebo)	  and	  the	  within-­‐subjects	  factor	   time	   of	   measurement	   (first	   fMRI	   appointment	   versus	   second	   fMRI	  appointment).	  	  Further	   analyses	   were	   carried	   out	   by	   testing	   for	   differences	   between	  aADHD	  patients	  and	  healthy	  controls	  as	  well	  as	  between	  MPH-­‐	  and	  placebo-­‐treated	  aADHD	  patients	  using	  small	  volume	  correction	  (spheres	  with	  9	  mm	  radius	  placed	  around	  the	  MNI	  transformed	  coordinates	  of	  the	  peak	  voxels	  from	  Fox	  et	  al.,	  2005,	  2006).	   For	   all	   analyses,	   peak	   voxels	   with	   pFWE	  ≤	  .05	   were	   considered	   significant	  and	   peak	   voxels	   with	   pFWE	  ≤	  .1	   were	   considered	   trends.	   If	   the	   small	   volume	  correction	   showed	   a	   significant	   between-­‐group	   difference	   or	   trend	   for	   the	   peak	  voxel	   of	   a	   given	   cluster,	   the	   contrast	   estimates	   of	   this	   cluster	  were	   exported	   for	  each	  participant	  using	  REX	  Toolbox	  (Whitfield-­‐Gabrieli,	  2009).	  These	  mean	  cluster	  activations	  were	  then	  entered	   into	  SPSS	  Statistics	  20	  (IBM®,	  New	  York,	  USA)	   for	  further	   analysis	   and	   correlations	   between	   cluster	   activations	   and	   behavioural	   as	  well	   as	   questionnaire	   data	   were	   computed9.	   For	   illustration	   purposes,	   the	   fMRI	  data	  below	  are	  rendered	  using	  MRIcron	  (Rorden,	  2010)	  by	  overlaying	  the	  clusters	  on	  a	  template	  with	  16	  mm	  search	  depth.	  	  For	  the	  selective	  attention	  task,	  individual	  FFA	  activation	  was	  extracted	  for	  high	   distracting	   task	   irrelevant	   face	   stimuli	  minus	   face	   stimuli	   from	   the	   passive	  viewing	   control	   condition	   as	   well	   as	   for	   task	   relevant	   face	   stimuli	   minus	   face	  stimuli	  from	  the	  passive	  viewing	  control	  condition	  using	  REX	  Toolbox	  (Whitfield-­‐Gabrieli,	  2009)	  as	  described	  in	  4.3.4.	  FFA	  ROIs	  were	  created	  for	  each	  participant	  by	  examining	   individual	   first-­‐level	   results	  of	   the	  contrast	   ‘faces	  minus	  swirled	   faces’	  from	  the	  functional	  localiser	  (see	  4.3.1	  and	  5.5.2	  for	  a	  description	  of	  this	  localiser).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9	   As	   in	   the	   previous	   fMRI	   study,	   mean	   cluster	   activation	   was	   used	   for	   further	   analyses	   as	   a	   more	   robust	  measure	  of	  regional	  activation.	  Correlations	  and	  COMT	  genotype	  analyses	  using	  peak	  voxel	  activation	  instead	  of	  cluster	  activation	  yielded	  similar	  results	  and	  are	  reported	  in	  the	  appendix	  (see	  Table	  8.4	  and	  8.3.3).	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 Statistical	  Analysis	  5.2.4
Potential	  differences	  in	  behavioural	  performance	  and/or	  the	  exported	  mean	  cluster	  activations	  between	  the	  aADHD	  group	  and	  the	  healthy	  control	  group	  were	  investigated	   using	   two-­‐sample	   t-­‐tests	   with	   the	   between-­‐subjects	   factor	   group	  (aADHD	   versus	   healthy	   controls)	   for	   the	   selective	   attention	   task.	   For	   the	   n-­‐back	  task,	  mixed	  model	  ANOVAs	  with	  the	  between-­‐subjects	  factor	  group	  (aADHD	  versus	  healthy	  controls)	  and	   the	  within-­‐subjects	   factor	   task	  difficulty	   (0-­‐back,	  1-­‐back,	  2-­‐back)	   were	   computed.	   To	   investigate	   medication	   effects	   on	   behavioural	  performance	   and/or	   mean	   cluster	   activation,	   mixed	   model	   ANOVAs	   with	   the	  between-­‐subjects	  factor	  medication	  (MPH	  versus	  placebo)	  and	  the	  within-­‐subjects	  factor	   time	   of	   measurement	   (first	   fMRI	   appointment	   versus	   second	   fMRI	  appointment)	  were	  computed	  for	  the	  selective	  attention	  task.	  For	  the	  n-­‐back	  task,	  mixed	  model	  ANOVAs	  with	   the	   between-­‐subjects	   factor	  medication	   (MPH	  versus	  placebo)	   and	   the	   within-­‐subjects	   factors	   time	   of	   measurement	   (first	   fMRI	  appointment	  versus	  second	  fMRI	  appointment)	  and	  task	  difficulty	  (0-­‐back,	  1-­‐back,	  2-­‐back)	  were	  computed.	  	  Furthermore,	   FFA	   activation	   in	   the	   selective	   attention	   task	   was	   analysed	  using	   a	   mixed	   model	   ANOVA	   with	   the	   between-­‐subjects	   factor	   group	   (ADHD	  patients	   versus	   healthy	   controls)	   and	   the	   within-­‐subjects	   factor	   task	   relevance	  (high	   distracting	   task	   irrelevant	   versus	   task	   relevant).	   Hypotheses-­‐driven	   one-­‐sided	  t-­‐tests	  were	  used	  for	  the	  factor	  task	  relevance	  in	  the	  selective	  attention	  task;	  two-­‐tailed	   t-­‐tests	   were	   used	   for	   all	   other	   post-­‐hoc	   comparisons.	   To	   control	   for	  multiple	  comparisons,	  all	  post-­‐hoc	  t-­‐tests	  were	  Šidák-­‐corrected.	  If	  assumptions	  of	  sphericity	   were	   violated,	   degrees	   of	   freedom	   were	   adjusted	   according	   to	  Greenhouse-­‐Geisser	   (Greenhouse	   &	   Geisser,	   1959).	   However,	   to	   facilitate	  understanding	  only	  full	  degrees	  of	  freedom	  are	  reported.	  In	  addition,	  correlations	  between	  cluster	  activations	  and	  performance	  data	  as	  well	  as	  CAARS	  scores	  (for	  the	  patient	  group)	  were	  computed.	  	  For	  all	  behavioural	  data,	  outliers	  were	  identified	  using	  z-­‐transformation	  of	  the	   data.	   Participants	   with	   any	   value	   exceeding	   z	  =	  ±3.29	   were	   excluded	   from	  further	  data	  analysis.	  For	  the	  selective	  attention	  task,	  an	  additional	  accuracy	  index	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incorporating	  both	   the	  number	  of	   correctly	   identified	   targets	   and	   the	  number	  of	  false	  alarms	  was	  calculated	  as	  described	  above.	  	  The	   interaction	   of	   COMT	   genotype	   and	   ADHD	   diagnosis	   was	   investigated	  whenever	   the	   number	   of	   participants	   allowed	   meaningful	   exploratory	   analyses.	  Unfortunately,	   this	  was	  not	   the	   case	   for	   the	   selective	   attention	   task	   (n	  =	  4	   in	   the	  smallest	   cell).	   Unlike	   originally	   intended,	   the	   interaction	   of	   COMT	   genotype	   and	  medication	  response	  in	  the	  ADHD	  sample	  could	  also	  not	  be	  investigated,	  with	  the	  smallest	  cells	  ranging	  from	  n	  =	  1	  to	  n	  =	  3	  for	  the	  different	  tasks.	  Given	  the	  unequal	  and	   partially	   rather	   small	   cell	   sizes	   caused	   by	   the	   distribution	   of	   the	   COMT	  genotype	  in	  the	  general	  population,	  all	  COMT	  genotype	  data	  were	  analysed	  using	  a	  non-­‐parametric	   equivalent	   of	   the	   two-­‐way	  ANOVA	  which	   ranks	   observations	   for	  the	   levels	  of	  one	  factor	  within	  the	   levels	  of	  the	  other	  factor	  (Prescott	  &	  Shahlaee,	  1999;	   Shirley,	   1987),	  with	  ADHD	  diagnosis	   and	  COMT	   genotype	   entered	   as	   fixed	  factors	  in	  all	  analyses.	  Mann-­‐Whitney-­‐U	  tests	  for	  independent	  samples	  were	  used	  for	   post-­‐hoc	   comparisons.	   For	   all	   analyses,	   p-­‐values	   of	   α	  ≤	  .05	   were	   considered	  significant	  and	  p-­‐values	  of	  α	  ≤	  .1	  were	  considered	  trends.	  	  	  
5.3 Clinical	  Outcomes	  	  
As	   mentioned	   above,	   patients	   were	   randomly	   assigned	   to	   either	   MPH	   or	  placebo	   treatment	   in	   a	   double-­‐blind	   design.	  Medication	  was	   dispensed	   in	   a	   free	  titration	   design	   meaning	   that	   dosage	   was	   only	   increased	   as	   long	   as	   the	   patient	  reported	  beneficial	  effects	  without	  suffering	  from	  any	  disturbing	  side	  effects.	  After	  six	  weeks	  of	  medication,	   the	  average	  daily	  medication	  dose	  was	  49	  mg	  (SD	  =	  15).	  Medication	   doses	   were	   significantly	   lower	   for	   patients	   in	   the	   MPH	   (M	  =	  44	  mg,	  
SD	  =	  18)	  compared	  to	  patients	  in	  the	  placebo	  group	  (M	  =	  55	  mg,	  SD	  =	  8;	  t(32)	  =	  2.48,	  
p	  =	  .02).	  	  In	   line	  with	  previous	   studies	   (Biederman,	  Mick,	   et	   al.,	   2010;	  Medori	   et	   al.,	  2008;	  Rösler	  et	  al.,	  2009),	  clinically	  significant	  treatment	  response	  was	  defined	  as	  a	  fixed	   minimum	   reduction	   in	   T-­‐scores,	   in	   this	   case	   on	   the	   CAARS	   DSM-­‐IV	   Total	  ADHD	   Symptoms	   scale	   as	   well	   as	   on	   the	   CAARS	   DSM-­‐IV	   Inattentive	   Symptoms	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scale	   and/or	   the	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	   scale,	   from	  day	  1	   to	   day	  42.	   Given	   that	   the	   CAARS	   scores	   in	   this	   study	   were	   based	   on	   self-­‐report,	  we	  deemed	  a	  minimum	  reduction	  of	  20	  %	  sufficient	  to	  classify	  patients	  as	  responders.	  Across	  both	  the	  MPH	  and	  the	  placebo	  group,	  18	  patients	  (53	  %)	  were	  classified	  as	  responders.	  Six	  patients	  (40	  %)	  in	  the	  placebo	  group	  and	  12	  patients	  (63	  %)	  in	  the	  MPH	  group	  responded	  to	  treatment,	  yielding	  a	  trend	  for	  a	  significant	  between-­‐group	  difference	  (t(32)	  =	  1.34,	  pone-­‐sided	  =	  .095).	  	  These	  results	  were	  similar	  when	  absolute	  CAARS	  DSM-­‐IV	  T-­‐scores	   instead	  of	   response	   rates	   based	   on	   symptom	   reduction	  were	   compared,	   although	  mixed	  model	   ANOVAs	   with	   the	   between-­‐subjects	   factor	   medication	   and	   the	   within-­‐subjects	   factor	   time	   of	   measurement	   showed	   no	   significant	   interaction	   of	   these	  factors	  for	  any	  of	  the	  ASRS	  or	  the	  CAARS	  DSM-­‐IV	  subscales	  (all	  p	  >	  .1).	  There	  was,	  however,	   a	   significant	  main	   effect	   of	   time	  of	  measurement	   on	  both	  ASRS	   and	   all	  three	   CAARS	   DSM-­‐IV	   subscales	   (ASRS	   inattention:	   F(1,32)	  =	  14.91,	   p	  =	  .001;	   ASRS	  hyperactivity/	   impulsivity:	   F(1,32)	  =	  16.34,	   p	  <	  .001;	   CAARS	   DSM-­‐IV	   Inattentive	  Symptoms:	   F(1,32)	  =	  29.90,	   p	  <	  .001;	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	  Symptoms:	   F(1,32)	  =	  17.14,	   p	  <	  .001;	   CAARS	   DSM-­‐IV	   Total	   ADHD	   Symptoms:	  
F(1,32)	  =	  32.49,	  p	  <	  .001;	  see	  Table	  5.1)	  with	  both	  groups	  reporting	  more	  symptoms	  before	   the	   first	   fMRI	   appointment	   than	   after	   six	   weeks	   of	   MPH	   medication	   or	  placebo.	  In	  addition,	  there	  was	  a	  significant	  main	  effect	  of	  medication	  on	  the	  ASRS	  inattention	  score	  (F(1,32)	  =	  5.09,	  p	  =	  .03)	  and	  a	  trend	  for	  a	  main	  effect	  of	  medication	  on	   the	   ASRS	   hyperactivity/	   impulsivity	   score	   (F(1,32)	  =	  3.78,	   p	  =	  .06)	   and	   on	   the	  CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	   score	   (F(1,32)	  =	  3.50,	   p	  =	  .07),	  with	   the	   placebo	   group’s	   score	   across	   both	   appointments	   being	   higher	   than	   the	  MPH	  group’s.	  	  This	  pattern	  of	  results	  became	  even	  clearer	  when	  the	  individual	  percentage	  of	   score	   reduction	   for	   each	   patient	   was	   compared	   for	   the	   two	   groups	   using	  hypothesis-­‐driven	  one-­‐sided	  independent	  sample	  t-­‐tests.	  As	  suggested	  by	  the	  two	  previous	  analyses,	  the	  MPH	  group	  showed	  a	  trend	  for	  a	  more	  pronounced	  decrease	  in	  CAARS	  DSM-­‐IV	  Inattentive	  Symptoms	  scores	  than	  the	  placebo	  group	  (t(32)	  =	  1.38,	  
p	  =	  .09).	   Findings	   were	   similar	   albeit	   less	   pronounced	   for	   CAARS	   DSM-­‐IV	   Total	  ADHD	  Symptoms	  scores	  (t(32)	  =	  1.15,	  p	  =	  .13),	  whereas	  no	  probable	  differences	   in	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symptom	   reduction	   between	   the	   two	   groups	   could	   be	   surmised	   for	   the	   CAARS	  DSM-­‐IV	  Hyperactive/	  Impulsive	  Symptoms	  scores	  (t(32)	  =	  0.39,	  p	  =	  .35).	  Potential	  explanations	  for	  these	  findings	  are	  discussed	  in	  6.2	  below.	  	  
Table	  5.1:	  Overview	  of	  mean	  ASRS	  and	  mean	  CAARS	  DSM-­‐IV	  scores	  as	  well	  as	  mean	  percentage	  CAARS	  
T-­‐score	   reduction	   for	   the	   ADHD	   group.	   Standard	   deviation	   is	   noted	   in	   parentheses	   unless	   stated	  
otherwise.	  	  	   1st/2nd	  appointment	  (ADHD)	  	   Placebo	   MPH	  Participants	  (male)	   15	  (9)	   19	  (10)	  
	  
ASRS	  (raw-­‐scores)	  
	   	  Inattention	   25.0(4.5)/21.2(8.5)	   23.6(5.4)/15.3(7.0)	  Hyperactivity/Impulsivity	   20.1(5.7)/16.5(7.4)	   18.2(7.5)/11.1(5.9)	  
	  
CAARS	  (T-­‐scores)	  
	   	  Inattentive	  Symptoms	   79.1(8.9)/67.1(14.7)	  	   80.1(9.6)/61.2(13.3)	  	  Reduction	  (percentage)	   13.8(21.7)	   23.0(17.1)	  Hyperactive/Impulsive	  Symptoms	   65.9(15.0)/54.9(13.6)	  	   58.2(14.9)/46.6(15.0)	  	  Reduction	  (percentage)	   14.5(19.8)	   17.5(24.6)	  Total	  ADHD	  Symptoms	   76.7(11.7)/62.9(14.9)	  	   73.0(11.7)/54.9(14.6)	  	  Reduction	  (percentage)	   16.3(21.4)	   24.1(18.0)	  
Note.	  Both	  groups	  reported	  significantly	  more	  symptoms	  before	  the	  first	  fMRI	  appointment	  than	  after	  six	  weeks	  of	  MPH	  medication	  or	  placebo	  (all	  p	  <	  .001).	  	  	  
5.4 Neuropsychology	  and	  Questionnaires10	  
As	  detailed	   in	  1.1.3	   (3),	   studies	  with	   children	  and	  adolescents	  with	  ADHD	  report	   a	   beneficial	   effect	   of	   MPH	   on	   working	   memory	   measures	   requiring	   a	  manipulation	   of	   maintained	   material	   as	   well	   as	   on	   working	   memory	   measures	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  Results	  from	  the	  following	  study	  are	  currently	  submitted	  for	  publication.	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requiring	   simple	   information	   storage	   and	   reproduction	   (Coghill	   et	   al.,	   2013).	   In	  addition,	   one	   study	   investigating	   adults	   with	   ADHD	   found	   a	   significant	  improvement	  of	  test	  scores	  on	  the	  Stroop	  as	  well	  as	  on	  a	  working	  memory	  index	  comprising	  arithmetic	  and	  digit	  span	  subtests	  (Fallu	  et	  al.,	  2006).	  Furthermore,	  several	  studies	  investigated	  the	  impact	  of	  COMT	  genotype	  on	  neuropsychological	  endophenotypes	  in	  ADHD	  (see	  also	  1.2.3).	  So	  far,	  four	  studies	  investigating	   children	   and	   adolescents	   provided	   some	   evidence	   that	   val/val	  carriers	   might	   perform	   worse	   on	   tasks	   taxing	   short-­‐term	   information	   storage	  while	   met-­‐allele	   carriers	   might	   be	   impaired	   on	  measures	   of	   sustained	   attention	  (Bellgrove	  et	  al.,	  2005;	  Matthews	  et	  al.,	  2012;	  Mills	  et	  al.,	  2004;	  Taerk	  et	  al.,	  2004).	  Crucially,	   it	   should	   be	   noted	   that	   the	   importance	   of	   COMT	   increases	   with	  increasing	  age	  (Barnett	  et	  al.,	  2008;	  Levy,	  2007),	  meaning	  its	  functional	  impact	  on	  PFC	  mediated	  higher	  cognitive	  functions	  should	  be	  more	  visible	  in	  adults	  than	  it	  is	  in	   children	   (Taerk	   et	   al.,	   2004).	   However,	   there	   is	   only	   one	   study	   with	   aADHD	  patients	   to	   date	   (Boonstra	   et	   al.,	   2008).	   While	   this	   study	   found	   a	   positive	  association	   for	  the	  val/met	  genotype	  and	  full-­‐scale	  IQ	  on	  the	  WAIS,	   there	  was	  no	  effect	   of	   COMT	   genotype	   on	   the	   subtests	   Digit	   Span	   Forward	   or	   Digit	   Span	  
Backward	  or	  on	  the	  Stroop	  Color	  Word	  Test.	  Unfortunately,	  none	  of	   these	  studies	  used	   a	   healthy	   control	   group,	   thereby	   potentially	   missing	   differential	   effects	   of	  
COMT	  in	  ADHD	  patients	  compared	  to	  healthy	  controls.	  	  The	   aim	  of	   this	   study	  was	   therefore	   to	   investigate	   the	  neuropsychological	  performance	  of	  aADHD	  patients	  compared	  the	  healthy	  controls.	  In	  a	  second	  step,	  a	  possible	   interactive	   impact	   of	   COMT	   genotype	   and	   ADHD	   diagnosis	   as	   well	   as	  possible	  effects	  of	  stimulant	  treatment	  on	  neuropsychological	  task	  performance	  in	  aADHD	  patients	  was	  examined.	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 Hypotheses	  5.4.1
1.	  	   In	  line	  with	  previous	  studies	  (Boonstra	  et	  al.,	  2005;	  Martinussen	  et	  al.,	  2005;	  Willcutt	  et	  al.,	  2005),	  aADHD	  patients	  should	  perform	  worse	  on	  the	   investigated	  neuropsychological	  EF	  measures	  of	  verbal	   short-­‐term	  memory	   (Digit	   Span	   Forward),	   verbal	   working	   memory	   (Digit	   Span	  
Backward),	   and	   inhibition	   (Stroop	   Color	   Word	   Test)	   than	   healthy	  controls.	  	  2.	   Regarding	   a	   possible	   medication	   effect	   in	   the	   aADHD	   group,	   we	  expected	  a	  positive	  impact	  of	  MPH	  on	  the	  examined	  measures,	  with	  the	  MPH	  group	  performing	  better	  than	  the	  placebo	  group	  after	  six	  weeks	  of	  treatment	  (Coghill	  et	  al.,	  2013;	  Fallu	  et	  al.,	  2006).	  	  3.	   Based	  on	  the	  tonic-­‐phasic	  model	  of	  dopaminergic	  functioning	  (Arnsten,	  2006;	   Bilder	   et	   al.,	   2004;	   Grace,	   1991;	   Pliszka,	   2005),	   the	   COMT	   val-­‐allele	  should	  furthermore	  be	  more	  detrimental	  to	  aADHD	  patients	  than	  to	   healthy	   controls	   in	   a	   gene-­‐dosage	   fashion,	   with	   val/val	   aADHD	  patients	  showing	  the	  worst	  performance.	  	  
 Participants	  5.4.2
Neuropsychological	   and	   questionnaire	   data	   were	   obtained	   from	   35	   adult	  patients	   with	   ADHD	   and	   35	   healthy	   controls	   comparable	   with	   regard	   to	   age,	  gender,	  and	  school	  years	  (all	  p>.2,	  with	   the	  exception	  of	  school	  years	  p	  =	  .15;	  see	  Table	  5.2	  for	  sample	  characteristics).	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Table	   5.2:	   Overview	   of	   mean	   demographic	   data,	   ASRS	   and	   StPM	   scores,	   and	   distribution	   of	   COMT	  
genotype	   for	   the	   neuropsychological	   tasks	   for	   healthy	   controls	   (HC)	   and	   patients	   with	   ADHD.	  









	  Participants	  (male)	   35	  (16)	   35	  (20)	   15	  (9)	   19	  (10)	  Mean	  age	   33.6(9.6)	   36.0(9.9)	   35.3(10.2)	   37.2(9.7)	  Mean	  school	  years	   11.2(1.8)	   10.6(1.6)	   10.4(1.4)	   10.8(1.8)	  StPM	  raw	  score	   49.0(7.8)	   49.1(6.9)	   49.6(7.7)	   48.8(6.5)	  Mean	  inattention1	   11.5(4.7)*	   23.9(5.2)*	   25.0(4.5)/21.2(8.5)	   23.6(5.4)/15.3(7.0)	  Mean	  hyperactivity	   9.7(5.8)*	   19.1(6.6)*	   20.1(5.7)/16.5(7.4)	   18.2(7.5)/11.1(5.9)	  
	  
COMT	  genotype	  
	   	   	   	  met/met	  (male)	   8	  (3)	   10	  (8)	   	   	  val/met	  (male)	   17	  (9)	   18	  (8)	   	   	  val/val	  (male)	   10	  (4)	   7	  (4)	   	   	  
Note.	   1	   Symptoms	   of	   inattention	   and	   hyperactivity/	   impulsivity	   as	   assessed	   with	   the	   ASRS;	   *	  denotes	  significant	  between-­‐group	  differences	  (p	  <	  .001).	  	  	  
 Results	  5.4.3
5.4.3.1 Patients	  with	  ADHD	  versus	  Healthy	  Controls	  
As	   would	   be	   expected,	   patients	   with	   ADHD	   had	   significantly	   more	  symptoms	   of	   inattention	   and	   hyperactivity/	   impulsivity	   compared	   to	   healthy	  controls	  as	  assessed	  with	  the	  ASRS	  before	  the	  first	  fMRI	  appointment	  (inattention:	  
t(68)	  =	  10.48,	   p	  <	  .001;	   hyperactivity/	   impulsivity:	   t(68)	  =	  6.25,	   p	  <	  .001;	   see	   Table	  5.2).	  There	  were	  no	  significant	  between-­‐group	  differences	  on	  the	  StPM	  or	  on	  any	  of	  the	  other	  neuropsychological	  measures	  (all	  p	  >	  .1).	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5.4.3.2 ADHD	  Patients	  with	  MPH	  Medication	  versus	  Placebo	  	  
Mixed	  model	  ANOVAs	  with	  the	  between-­‐subjects	  factor	  medication	  and	  the	  within-­‐subjects	   factor	   time	  of	  measurement	   yielded	  no	  significant	  main	  effects	  or	  interactions	   for	   the	   Digit	   Span	   Forward	   and	   Digit	   Span	   Backward	   subtests	   (all	  
p	  >	  .1).	  For	  the	  Stroop	  Color	  Word	  Test,	  results	  showed	  no	  significant	  interaction	  of	  medication	   and	   time	   of	   measurement,	   but	   a	   significant	   main	   effect	   of	   time	   of	  measurement	   (F(1,32)	  =	  28.45,	   p	  <	  .001)	   with	   all	   participants	   performing	  significantly	   better	   on	   the	   second	   (M	  =	  67.8	  s,	   SD	  =	  14.5)	   than	   on	   the	   first	  appointment	  (M	  =	  74.8	  s,	  SD	  =	  16.4).	  	  
5.4.3.1 Interaction	  of	  COMT	  Genotype	  and	  ADHD	  Diagnosis	  
For	  the	  Digit	  Span	  Forward	  subtest	  (verbal	  short-­‐term	  memory),	  there	  was	  no	  significant	  main	  effect	  of	  ADHD	  diagnosis	  (p	  =	  .16)	  or	  COMT	  genotype	  (p	  =	  .28).	  There	   was,	   however,	   a	   trend	   for	   an	   interaction	   of	   ADHD	   diagnosis	   and	   COMT	  genotype	   (F(2,64)	  =	  2.81,	   p	  =	  .07).	   Post-­‐hoc	   Mann-­‐Whitney-­‐U	   tests	   revealed	   a	  significant	  difference	  between	  the	  two	  groups	  for	  the	  met/met	  genotype	  (p	  =	  .03),	  with	   the	   ADHD	   group	   performing	   significantly	   worse	   than	   the	   healthy	   control	  group	   (see	   Figure	   5.2).	   Within	   the	   patient	   group,	   val/met	   carriers	   performed	  significantly	  better	  than	  met/met	  carriers	  (p	  =	  .01),	  while	  there	  were	  no	  significant	  differences	  within	  the	  healthy	  control	  group.	  	  For	   the	   Digit	   Span	   Backward	   subtest	   (verbal	   working	   memory),	   there	  similarly	   was	   no	   significant	   main	   effect	   of	   ADHD	   diagnosis	   (p	  =	  .24)	   or	   COMT	  genotype	  (p	  =	  .85).	  However,	  there	  was	  a	  significant	  interaction	  of	  ADHD	  diagnosis	  and	   COMT	   genotype	   (F(2,64)	  =	  3.27,	   p	  =	  .04).	   Post-­‐hoc	   Mann-­‐Whitney-­‐U	   tests	  revealed	  a	  significant	  difference	  between	  the	  two	  groups	  for	  the	  val/val	  genotype	  (p	  =	  .03)	   with	   the	   group	   with	   ADHD	   performing	   significantly	   worse	   than	   the	  healthy	   control	   group	   (see	   Figure	   5.2).	   In	   addition,	   val/val	   carriers	   performed	  significantly	   better	   than	   val/met	   carriers	   (p	  =	  .02)	   within	   the	   healthy	   control	  group.	  There	  were	  no	  significant	  differences	  within	  the	  patient	  group.	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  Figure	   5.2:	   Mean	   number	   of	   repeated	   digits	   in	   the	   Digit	   Span	   Forward	   and	   in	   the	   Digit	   Span	  
Backward	   subtest	   for	   patients	   with	   ADHD	   and	   healthy	   controls	   (HC)	   and	   the	   different	   COMT	  genotypes.	   Error	   bars	   denote	   standard	   error	   of	   the	   mean	   (SEM).	   Significant	   between-­‐group	  differences	  (p	  <	  .05)	  are	  marked	  by	  *.	  	  For	   the	  Stroop	  Color	  Word	  Test	  (inhibition),	   there	  was	  no	  significant	  main	  effect	  of	  ADHD	  diagnosis	  or	  COMT	  genotype	  as	  well	  as	  no	  significant	  interaction	  of	  the	  two	  (all	  p	  >	  .1).	  	  	  
 Discussion	  5.4.4
Contrary	   to	  our	  hypotheses,	  healthy	  controls	  did	  not	  perform	  significantly	  better	   than	   aADHD	   patients	   on	   the	   examined	   neuropsychological	   measures	   of	  verbal	  working	  memory,	  verbal	  short-­‐term	  memory,	  and	   inhibition.	   Investigation	  of	   the	  medication	   effects	   in	   aADHD	   patients	   also	   did	   not	   yield	   the	   hypothesised	  results.	  Patients	  in	  the	  MPH	  group	  did	  not	  show	  an	  improved	  performance	  after	  six	  weeks	   of	   treatment	   on	   any	   of	   the	   examined	   neuropsychological	  measures	  when	  compared	  to	  the	  placebo	  group.	  	  In	   contrast,	   measures	   of	   verbal	   short-­‐term	   memory	   and	   verbal	   working	  memory	   showed	   interaction	   effects	   of	   COMT	   genotype	   and	   ADHD	   diagnosis.	  Interestingly,	  the	  results	  showed	  a	  differential	  effect	  of	  COMT	  genotype	  and	  ADHD	  depending	  on	  the	  nature	  of	  the	  task:	  While	  met/met	  carriers	  with	  ADHD	  seemed	  to	  be	  at	  a	  disadvantage	  on	  the	  measure	  of	  verbal	  short-­‐term	  memory	  compared	  to	  the	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other	  genotypes	  and	  healthy	  controls,	  the	  measure	  of	  verbal	  working	  memory	  did	  not	  seem	  to	  benefit	  val/val	  carriers	  with	  ADHD	  in	  the	  same	  way	  as	  healthy	  val/val	  carriers.	   These	   results	   can	   be	   interpreted	   in	   terms	   of	   the	   tonic-­‐phasic	  model	   of	  increased	  stability	  or	  flexibility	  depending	  on	  COMT	  genotype	  (Barnett	  et	  al.,	  2008;	  Bilder	   et	   al.,	   2004;	   Durstewitz	   &	   Seamans,	   2008;	   Matthews	   et	   al.,	   2012):	   The	  measure	   of	   verbal	   short-­‐term	   memory	   (Digit	   Span	   Forward)	   required	   the	  reproduction	   on	   increasingly	   long	   lists	   of	   numbers.	   It	   would	   therefore	   seem	  reasonable	   for	  met/met	   carriers	   to	   show	   better	   performance	   as	   increased	   tonic	  dopamine	   –	   and	   thereby	   increased	   representational	   stability	   –	   would	   be	  advantageous	   in	   this	   task.	   However,	   compared	   to	   the	   healthy	   control	   group,	  met/met	   carriers	  with	  ADHD	   showed	  worse	   performance.	   This	   finding	   is	   in	   line	  with	   another	   study	   that	   reports	   worse	   performance	   for	  met-­‐allele	   carriers	   with	  ADHD	  on	  a	  measure	  of	  sustained	  (i.e.	  stable)	  attention	  (Bellgrove	  et	  al.,	  2005).	   In	  contrast,	  the	  measure	  of	  verbal	  working	  memory	  (Digit	  Span	  Backward)	  required	  the	  retention	  of	  lists	  of	  numbers	  as	  well	  as	  the	  internal	  manipulation	  of	  these	  lists	  before	   reproduction.	   It	   could	   therefore	   be	   expected	   that	   val/val	   carriers	   show	  better	   performance	   as	   this	   genotype	   affords	   increased	   phasic	   dopamine	   and	  thereby	  increased	  mental	  flexibility.	  Again,	  patients	  with	  ADHD	  did	  not	  show	  this	  expected	  advantage	  compared	  to	  healthy	  controls.	  	  As	   overall	   sample	   size	   for	   the	   analysis	   of	   a	   medication	   effect	   was	   rather	  small,	   interaction	   effect	   sizes	   (Cohen’s	  f)	   were	   calculated	   for	   the	   non-­‐significant	  results	  based	  on	  partial	  η²	  and	  corrected	  for	  correlation	  among	  repeated	  measures	  using	  G*Power	  3.0.3	  (Faul,	  Erdfelder,	  Lang,	  &	  Buchner,	  2007)	  to	  explore	  whether	  sample	   size	  was	   sufficient	   to	  detect	   significant	   interactions	  of	   the	   factors	   time	  of	  
measurement	   and	  medication.	   Unlike	   effect	   sizes	   for	   the	   better	   known	  Cohen’s	  d,	  effect	  sizes	  for	  Cohen’s	  f	  are	  considered	  as	  small	  if	  they	  exceed	  .1,	  medium	  if	  they	  exceed	   .25,	   and	   large	   if	   they	   exceed	   .4	   (J.	   Cohen,	   1988;	   UCRegents,	   2013).	  Interaction	  effect	  size	  for	  the	  Digit	  Span	  Forward	  subtest	  was	  below	  .001	  and	  hence	  no	   power	   calculation	   was	   performed.	   Achieved	   power	   was	   high	   for	   the	   Stroop	  
Color	  Word	   Test	   (Cohen’s	   f	  =	  .13,	   power	  =	  .89)	   as	   the	   two	   Stroop	  measurements	  correlated	  substantially,	  and	  it	  should	  therefore	  be	  assumed	  that	  sample	  size	  was	  sufficient	   for	   statistical	   analysis	   to	   detect	   any	   truly	   existing	   interaction	   effect.	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Power	   was	   considerably	   lower,	   however,	   for	   the	   Digit	   Span	   Backward	   subtest	  (f	  =	  .11,	  power	  =	  .27)	  allowing	  for	  the	  possibility	  that	  a	  potential	  interaction	  effect	  was	   missed	   due	   to	   insufficient	   sample	   size.	   Still,	   it	   should	   be	   noted	   that	   the	  interaction	   effect	   sizes	   for	   both	   neuropsychological	   tests	   were	   relatively	   small	  pointing	  to	  only	  a	  minor	  effect	  of	  medication	  on	  test	  performance.	  	  In	  addition,	  although	  the	  data	  yielded	  no	  main	  effects	  of	  COMT	  genotype	  or	  ADHD	   on	   the	   investigated	   neuropsychological	   measures,	   two	   of	   the	   three	   tasks	  showed	  interactions	  of	  COMT	  genotype	  and	  ADHD	  diagnosis.	  The	  results	  therefore	  point	   to	   a	   possible	   differential	   impact	   of	   COMT	   genotype	   in	   adults	   with	   ADHD	  compared	  to	  healthy	  controls.	  However,	  given	  the	  relatively	  small	  overall	  sample	  size,	  these	  results	  should	  be	  interpreted	  with	  caution	  and	  more	  research	  is	  clearly	  necessary.	  	  	  
5.5 Selective	  Attention	  Task	  
As	  the	  experimental	  paradigm	  of	  this	  task	  was	  successfully	  transferred	  from	  EEG	   to	   fMRI	   in	   the	  previous	   study	   (see	  4.5),	   the	  goal	  of	   this	   study	  was	   to	  assess	  behavioural	   performance	   and	   functional	   brain	   activity	   in	   aADHD	   patients	   and	  healthy	   controls,	   and	   to	   examine	   possible	   effects	   of	   MPH	   medication	   on	   these	  parameters	   in	   aADHD	   patients.	   As	   stated	   above,	   the	   first	   (EEG)	   study	   provided	  some	   indication	   of	   subclinical	   ADHD	   symptoms	   impacting	   on	   processing	  modulation	  as	  well	  as	  on	  target	  detection	  rates	  and	  performance	  accuracy.	  Based	  on	   previous	   studies	   which	   successfully	   transferred	   investigations	   from	  participants	   with	   subclinical	   ADHD	   symptoms	   to	   ADHD	   patient	   samples	   (e.g.	  Herrmann	   et	   al.,	   2010;	   Herrmann	   et	   al.,	   2009),	   we	   expected	   the	   performance	  profiles	   of	   aADHD	   patients	   to	   be	   similar	   to	   those	   of	   the	   participants	   with	  subclinical	  ADHD	  symptoms,	  but	  potentially	  more	  strongly	   impaired.	  Our	  second	  (fMRI)	  study	  furthermore	  showed	  activation	  of	  participants’	  task-­‐positive	  network	  including	   the	   left	   MFG/DLPFC	   when	   high	   distracting	   task	   irrelevant	   and	   task	  relevant	  stimuli	  were	  compared.	  Since	  previous	  studies	  report	  a	  hypoactivation	  of	  the	  DLPFC	  and	   the	   frontoparietal/	   task-­‐positive	  network	   in	  ADHD	   (Banich	  et	   al.,	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2009;	  Cortese	  et	  al.,	  2012;	  Valera	  et	  al.,	  2010)	  as	  well	  as	  a	  possible	  up-­‐regulation	  of	  frontoparietal/	  task-­‐positive	  network	  activation	  through	  MPH	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	  Stevens,	   2012),	   a	   particular	   focus	  of	   this	   study	  was	  on	   the	   activation	  of	  these	   networks	   as	   well	   as	   potential	   medication-­‐induced	   changes	   in	   network	  activation.	  	  	  
 Hypotheses	  5.5.1
1.	   Based	  on	  the	  previous	  fMRI	  results	  for	  this	  paradigm,	  we	  hypothesised	  that	   high	   distracting	   task	   irrelevant	   stimuli	   would	   lead	   to	   increased	  activation	   of	   frontal	   nodes	   of	   the	   attention/	   task-­‐positive	   network	  compared	   to	   task	   relevant	   stimuli	   (Gazzaley	   et	   al.,	   2005;	   Jha	   et	   al.,	  2004).	  	  2.	   This	  activation	  should	  be	  lower	  in	  aADHD	  patients	  compared	  to	  healthy	  controls	   (Cortese	  et	   al.,	   2012),	   and	   it	   should	   correlate	  negatively	  with	  symptoms	  of	   hyperactivity/	   impulsivity	   and	   inattention	   in	   the	  patient	  sample.	  	  3.	   At	   the	   end	   of	   the	   clinical	   trial,	   patients	  who	   received	  MPH	   treatment	  should	  show	  increased	  network	  activation	  both	  compared	  to	  their	  first	  measurement	   and	   compared	   to	   patients	   who	   received	   placebo	  treatment	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	  Stevens,	  2012).	  	  4.	   With	   regard	   to	   individually	   determined	   FFA	   activation,	   we	   again	  expected	   high	   distracting	   task	   irrelevant	   stimuli	   to	   lead	   to	   increased	  activation	  compared	   to	   task	  relevant	  stimuli	   (Jha	  et	  al.,	  2004),	  and	  we	  expected	   frontal	   activation	   for	   high	   distracting	   task	   irrelevant	   stimuli	  minus	   to	   task	   relevant	   stimuli	   to	   correlate	   positively	   with	   FFA	  activation	  for	  the	  same	  contrast	  (Gazzaley	  et	  al.,	  2007).	  	  5.	   In	   addition,	   we	   hypothesised	   that	   differential	   FFA	   activation	   for	   high	  distracting	   task	   irrelevant	   stimuli	   minus	   task	   relevant	   stimuli	   would	  correlate	  negatively	  with	  ADHD	  symptoms	  as	  reported	  on	  the	  CAARS.	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6.	   Given	   the	   results	   obtained	   in	   the	   first	   (EEG)	   study,	   we	   furthermore	  expected	  the	  percentage	  of	  detected	  targets	  and	  the	  accuracy	   index	   to	  correlate	   negatively	   with	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	  Symptoms	  as	  well	  as	  CAARS	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scores.	  	  	  
 Experimental	  Paradigm	  5.5.2
The	   experimental	   paradigm	   was	   a	   modification	   of	   the	   selective	   attention	  tasks	  used	  in	  the	  first	  (EEG)	  and	  in	  the	  second	  (fMRI)	  study	  (see	  3.3.1	  and	  4.3.1).	  Following	  the	  results	  of	  the	  second	  study,	  task	  relevant	  house	  stimuli	  were	  omitted	  from	   the	   paradigm	   and	   the	   occurrence	   probability	   of	   passively	   viewed	   house	  stimuli	   was	   reduced.	   The	   modified	   experimental	   paradigm	   therefore	   comprised	  only	   two	  conditions:	  One	  experimental	  condition	  (“faces	  relevant”)	  and	  a	  passive	  viewing	  control	  condition.	  Each	  condition	  was	  presented	  twice,	  yielding	  a	  total	  of	  four	   blocks	   containing	   80	   stimuli	   each.	   Of	   the	   80	   stimuli	   presented	   in	   the	  experimental	   condition,	   40	   (i.e.	   50	  %	   of	   all	   stimuli	   presented	   in	   the	   block)	  were	  task	   relevant	  and	  40	   (i.e.	   another	  50	  %)	  were	   task	   irrelevant	  distractors.	  The	  40	  task	  relevant	  stimuli	  were	  all	  face	  stimuli.	  In	  contrast,	  the	  40	  task	  irrelevant	  stimuli	  were	   split	   evenly	   to	   be	   either	   face	   stimuli	   (yielding	   20	   high	   distracting	   task	  irrelevant	   stimuli)	   or	   house	   stimuli	   (yielding	   20	   low	   distracting	   task	   irrelevant	  stimuli).	  The	  passive	  viewing	  control	  condition	  contained	  30	  face	  stimuli	  (i.e.	  75	  %	  of	   all	   presented	   stimuli)	   and	   10	   house	   stimuli	   (i.e.	   25	  %),	   which	   –	   only	   in	   this	  condition	  –	  were	  presented	  in	  random	  order.	  Every	  picture	  was	  shown	  only	  once	  in	  one	  of	  the	  two	  conditions.	  	  The	   occurrence	   probability	   of	   1-­‐back	   and	   2-­‐back	   repetitions	   remained	  unchanged	   from	   the	  original	   task.	  However,	   interstimulus	   intervals	  were	   further	  increased	  to	  improve	  the	  detection	  of	  potential	  effects,	  and	  now	  lasted	  3,000	  ms	  to	  6,000	  ms.	  On	  a	  behavioural	   level,	   reaction	   times	   for	   correct	   responses	  as	  well	   as	  number	   of	   false	   alarms	   and	   number	   of	   correctly	   identified	   target	   stimuli	   were	  recorded.	   In	   addition,	   the	   functional	   localiser	   was	  modified	   to	   include	   only	   face	  pictures.	   Half	   of	   these	   face	   pictures	   were	   made	   unrecognisable	   by	   using	   a	   600	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degree	   swirl	   filter	   as	   implemented	   in	   Adobe®	   Photoshop®	   CS4	   (version	   11.0,	  Adobe	  Systems,	  Inc.,	  San	  Jose,	  USA).	  As	  some	  participants	  had	  shown	  difficulties	  in	  task	  understanding	   in	   the	  previous	   fMRI	   study,	   all	  participants	  now	  completed	  a	  computerised	   explanation	   of	   all	   tasks	   with	   subsequent	   supervised	   practice	  sessions	  to	  ensure	  a	  good	  understanding	  of	  task	  requirements.	  	  	  
 Participants	  5.5.3
At	   the	   first	   fMRI	   appointment,	   fMRI	   data	   of	   33	   patients	  with	   ADHD	  were	  obtained.	  Two	  data	  sets	  were	  lost	  because	  of	  technical	  problems.	  Two	  patients	  had	  to	  be	  excluded	  after	  preprocessing	  of	   the	  data	  because	  of	  excessive	  movement	   in	  the	   scanner	   (continuous	   repetitive	   movements	   and	   sudden	   movement	   of	   more	  than	  2	  mm,	  respectively).	  Three	  patients	  were	  excluded	  because	  their	  behavioural	  data	   showed	   extreme	   outlier	   values	   for	   false	   alarms,	   and	   another	   two	   patients	  were	  excluded	  because	  they	  detected	  less	  than	  40	  %	  of	  the	  target	  trials	  and	  their	  understanding	  of	  the	  experimental	  task	  was	  therefore	  doubtful.	  This	  resulted	  in	  a	  total	  of	  24	  patient	  data	  sets	  for	  this	  task	  at	  the	  first	  appointment.	  The	  control	  group	  was	   chosen	   from	   the	   total	   sample	   of	   healthy	   participants	   to	   be	   comparable	   (all	  
p	  ≥	  .2)	  to	  the	  aADHD	  group	  with	  regard	  to	  age,	  gender,	  and	  years	  of	  schooling	  (see	  Table	  5.3	  for	  sample	  characteristics).	  	  Three	  more	   patient	   data	   sets	   were	   lost	   at	   the	   second	   fMRI	   appointment:	  One	  patient	  discontinued	  the	  study	  after	  the	  first	  fMRI	  appointment	  for	  unknown	  reasons,	   while	   a	   second	   patient	   could	   not	   participate	   in	   the	   second	   fMRI	  appointment	  due	   to	  MRB	   safety	   requirements	   (work	   in	  metal	   processing),	   and	   a	  third	   patient	   showed	   poor	   target	   detection	   (<	  40	  %)	   at	   the	   second	   fMRI	  appointment.	  This	  resulted	   in	  a	   total	  of	  21	  patient	  data	  sets	   that	  comprised	  both	  the	  first	  fMRI	  appointment	  without	  medication	  and	  the	  second	  fMRI	  appointment	  after	  6	  weeks	  of	  MPH	  or	  placebo	  treatment	  (see	  Table	  5.3).	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Table	  5.3:	  Overview	  of	  mean	  demographic	  data	  and	  ASRS	  scores	  for	  healthy	  controls	  and	  patients	  with	  
ADHD	  as	  well	  as	  ADHD	  placebo	  and	  MPH	  groups	  for	  the	  selective	  attention	  task.	  Standard	  deviation	  is	  









	  Participants	  (male)	   24	  (12)	   24	  (13)	   11	  (6)	   10	  (4)	  Mean	  age	   34.4(9.0)	   37.4(8.9)	   38.5(9.2)	   39.2(8.4)	  Mean	  school	  years	  	   10.9(1.8)	   10.7(1.5)	   10.5(1.3)	   11.0(1.8)	  StPM	  raw	  score	   49.8(5.8)	   50.3(6.6)	   49.4(7.7)	   50.6(5.7)	  Mean	  inattention1	   11.3(4.9)*	   24.0(5.1)*	   25.4(4.4)/21.7(7.9)	   23.2(5.5)/15.2(6.5)	  Mean	  hyperactivity	   9.5(5.9)*	   19.3(6.1)*	   19.5(5.2)/15.5(5.7)	   17.7(6.9)/11.6(6.3)	  
Note.	   1	   Symptoms	   of	   inattention	   and	   hyperactivity/	   impulsivity	   as	   assessed	   with	   the	   ASRS;	   *	  denotes	  significant	  between-­‐group	  differences	  (p	  <	  .001).	  	  	  
 Results	  5.5.4
5.5.4.1 Patients	  with	  ADHD	  versus	  Healthy	  Controls	  
(1) Behavioural	  Data	  
Two-­‐sample	   t-­‐tests	   with	   the	   between-­‐subjects	   factor	   group	   for	   the	  percentage	  of	  correctly	  identified	  target	  stimuli	  (hits),	  the	  number	  of	  false	  alarms,	  reaction	   time,	   and	   overall	   accuracy	   showed	   no	   behavioural	   differences	   between	  the	  two	  groups	  (all	  p	  >	  .1).	  Both	  groups	  had	  an	  overall	  accuracy	  index	  of	  around	  .95	  and	   detected	   around	   80	  %	   of	   the	   target	   trials	   with	   an	   average	   reaction	   time	   of	  around	   960	  ms	   and	   committed	   around	   5	   false	   alarms	   (see	   Table	   5.4	   for	   the	  performance	  parameters	  of	  the	  different	  groups).	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Table	  5.4:	  Overview	  of	  mean	  performance	  parameters	  for	  healthy	  controls	  and	  patients	  with	  ADHD	  as	  
well	  as	  ADHD	  placebo	  and	  MPH	  groups	  in	  the	  selective	  attention	  task.	  The	  standard	  deviation	  is	  noted	  










	  	  %	  hits	  	   80.8(19.1)	   82.5(16.7)	   83.6(15.7)/	  85.5(15.1)	   84.0(19.6)/	  78.0(11.4)	  Reaction	  time1	   951(278)	   969(363)	   895(261)/	  998(440)	   1047(408)/	  1184(481)	  False	  alarms	   6.3(6.2)	   4.9(5.6)	   4.4(4.8)/3.5(3.6)	   3.9(3.6)/1.5(1.4)	  Accuracy	  index	   .95(.04)	   .96(.04)	   .96(.04)/.97(.03)	   .97(.03)/.98(.01)	  
Note.	   1	   Reaction	   time	   is	   reported	   in	   milliseconds	   (ms).	   There	   were	   no	   significant	   between-­‐group	  differences	  (all	  p	  >	  .1).	  	  
(2) fMRI	  Data	  
As	   in	   the	   previous	   fMRI	   study,	   the	   contrast	   of	   high	   distracting	   task	  irrelevant	   stimuli	   minus	   task	   relevant	   stimuli	   was	   examined	   to	   investigate	  selective	  attention	  processes.	  Across	  all	  participants,	  the	  whole	  brain	  analysis	  with	  
pFWE	  <	  .05	  for	  this	  contrast	  showed	  significant	  activation	  in	  some	  of	  the	  frontal	  and	  parietal	   areas	   associated	  with	   the	   attention/	   task-­‐positive	   network	   as	  well	   as	   in	  the	   ACC	   and	   in	   the	   bilateral	   fusiform	   gyrus	   (see	   Figure	   5.3).	   An	   examination	   of	  attention/	   task-­‐positive	   network	   peak	   voxels	   as	   specified	   by	   Fox	   and	   colleagues	  (2006;	  2005)	  revealed	  task-­‐induced	  bilateral	  activation	  in	  the	  intraparietal	  sulcus	  (IPS)	  as	  well	  as	  significant	  unilateral	  activation	   in	   the	  right	  superior,	  middle,	  and	  inferior	   frontal	   gyri,	   the	   right	   DLPFC,	   the	   right	   supramarginal	   gyrus,	   the	   right	  precuneus,	  and	  the	  right	  middle	  temporal	  region.	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  Figure	  5.3:	  Significant	  voxels	   found	   in	   the	  whole	  brain	  analysis	  with	  pFWE	  <	  .05	  (five	  voxels	  extent	  threshold)	   for	   the	   contrast	   high	   distracting	   task	   irrelevant	   stimuli	   minus	   task	   relevant	   stimuli	  across	  all	  participants	  (24	  patients	  and	  24	  healthy	  controls).	  Clusters	  of	  activation	  can	  be	  seen	   in	  some	   areas	   of	   the	   attention/	   task-­‐positive	   network	   as	   well	   as	   in	   the	   ACC	   and	   in	   the	   bilateral	  fusiform	  gyrus.	  	  	   Comparisons	  between	  the	  group	  with	  ADHD	  and	  the	  healthy	  control	  group	  showed	   no	   significant	  whole	   brain	   differences.	   However,	   ROI	   analyses	   yielded	   a	  trend	  for	  greater	  activation	   in	  the	  healthy	  control	  group	  compared	  to	  the	  patient	  group	  in	  the	  right	  DLPFC	  (t(46)	  =	  2.77,	  pFWE	  =	  .08,	  cluster	  size:	  64	  voxels;	  see	  Figure	  5.4)11.	  No	  other	  ROI	  showed	  significant	  or	  trend	  level	  between-­‐group	  differences.	  A	  two	   sample	   t-­‐test	   of	   the	   contrast	   estimates	   for	   this	   cluster	   showed	   a	   significant	  between-­‐group	   difference,	   with	   the	   healthy	   controls	   showing	   greater	   activation	  than	  the	  ADHD	  patients	  (t(46)	  =	  2.57,	  p	  =	  .01;	  healthy	  controls:	  M	  =	  0.92,	  SD	  =	  0.79;	  ADHD:	  M	  =	  0.36,	  SD	  =	  0.71).	  Correlations	  of	   the	  contrast	  estimates	   for	  this	  cluster	  showed	  no	   association	  of	  mean	  activity	   and	   any	  of	   the	  performance	  parameters.	  For	  the	  patient	  group,	  there	  were	  no	  significant	  correlations	  of	  mean	  activation	  of	  this	  cluster	  and	  any	  of	  the	  CAARS	  subscales.12	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  See	  Table	  8.3	  (appendix)	  for	  MNI	  coordinates	  of	  the	  significant	  between-­‐group	  peak	  voxel	  difference.	  12	  These	  results	  remained	  unchanged	  when	  contrast	  estimates	  for	  the	  peak	  voxel	  instead	  of	  the	  cluster	  were	  entered	  into	  the	  analyses.	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   Given	   the	  bilateral	   activation	  of	   the	   fusiform	  gyrus	   across	   all	   participants,	  individual	  activation	  of	   the	  FFA	  was	  extracted	  for	  high	  distracting	  task	   irrelevant	  stimuli	  minus	   the	   passive	   viewing	   control	   condition	   as	  well	   as	   for	   task	   relevant	  stimuli	  minus	  the	  passive	  viewing	  control	  condition.	  A	  mixed	  model	  ANOVA	  with	  the	   between-­‐subjects	   factor	   group	   and	   the	   within-­‐subjects	   factor	   task	   relevance	  yielded	   a	   significant	   main	   effect	   of	   task	   relevance	   (F(1,46)	  =	  20.62,	   p	  <	  .001)	   with	  high	   distracting	   task	   irrelevant	   stimuli	   leading	   to	   significantly	   higher	   contrast	  estimates	   than	   task	   relevant	   stimuli	   (high	   distracting	   task	   irrelevant	   stimuli:	  
M	  =	  0.48,	   SD	  =	  1.82.;	   task	   relevant	   stimuli:	   M	  =	  -­‐0.25,	   SD	  =	  1.45).	   There	   was	   no	  significant	  main	   effect	   of	   group	   and	   no	   significant	   interaction	   of	   group	   and	   task	  relevance	   (both	   p	  >	  .1).	   Interestingly,	   FFA	   effect	   sizes	   for	   high	   distracting	   task	  irrelevant	   stimuli	  minus	   task	   relevant	   stimuli	   correlated	   significantly	  with	  mean	  contrast	   estimates	   for	   the	   right	  DLPFC	   for	   the	   same	  contrast	   (r(46)	  =	  .35,	  p	  =	  .02):	  The	   more	   activation	   in	   the	   right	   DLPFC	   for	   high	   distracting	   task	   irrelevant	  compared	  to	  task	  relevant	  stimuli,	  the	  more	  FFA	  activation	  was	  found	  for	  the	  same	  contrast.	  	  Correlations	  of	  FFA	  contrast	  estimates	  and	  ADHD	  symptoms	  in	  the	  patient	  group	  showed	  a	   trend	   level	   correlation	  of	   contrast	  estimates	   for	  high	  distracting	  task	   irrelevant	   minus	   task	   relevant	   stimuli	   and	   scores	   on	   the	   CAARS	   DSM-­‐IV	  Hyperactive/	   Impulsive	  Symptoms	   subscale	   (r(22)	  =	  -­‐.39,	  p	  =	  .06):	  The	  higher	   self-­‐reported	   symptoms	   of	   hyperactivity/	   impulsivity,	   the	   lower	   the	   differential	   FFA	  activation	   for	   task	   irrelevant	  minus	   task	   relevant	   stimuli.	   In	   contrast,	   there	  were	  no	  correlations	  of	  the	  CAARS	  scales	  and	  any	  of	  the	  performance	  parameters.	  	  	  
Figure	  5.4:	  Cluster	   found	  in	  the	  ROI	  analyses	  with	  the	  trend	  for	  greater	  peak	  voxel	  activation	  for	  the	  contrast	  high	   distracting	   task	   irrelevant	   minus	   task	   relevant	  stimuli	   in	   the	  healthy	   control	   group	   compared	   to	   the	  patient	  group	  in	  the	  right	  DLPFC.	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5.5.4.2 Patients	  with	  ADHD:	  MPH	  Medication	  versus	  Placebo	  	  
(1) Behavioural	  Data	  
A	  mixed	  model	  ANOVA	  with	  the	  between-­‐subjects	  factor	  medication	  and	  the	  within-­‐subjects	  factor	  time	  of	  measurement	  showed	  no	  main	  effect	  of	  medication	  or	  of	   time	   of	   measurement	   and	   no	   interaction	   of	   medication	   and	   time	   of	  measurement	   for	   any	  of	   the	  behavioural	  parameters	   (all	  p	  >	  .1;	   see	  Table	  5.4	   for	  performance	  parameters	  of	  the	  two	  groups).	  	  	  
(2) fMRI	  Data	  
The	  peak	  voxels	  described	  under	  5.5.4.1	   (2)	  were	  used	   for	   the	  analysis	  of	  medication-­‐induced	  between-­‐group	  differences	   in	   the	  patient	   group.	  The	   flexible	  factorial	   model	   as	   implemented	   in	   SPM8	   with	   the	   between-­‐subjects	   factor	  
medication	   and	   the	   within-­‐subjects	   factor	   time	   of	   measurement	   yielded	   no	  significant	   interactions	  between	  medication	  and	   time	  of	  measurement	   for	   any	  of	  the	  investigated	  peak	  voxels.	  A	  mixed	  model	  ANOVA	  for	  individual	  activation	  of	  the	  FFA	  with	   the	   between-­‐subjects	   factor	  medication	   and	   the	  within-­‐subjects	   factors	  
time	   of	  measurement	   and	   task	   relevance	   yielded	   a	   significant	  main	   effect	   of	   task	  relevance	   (F(1,19)	  =	  8.95,	   p	  =	  .007)	   with	   high	   distracting	   task	   irrelevant	   stimuli	  leading	  to	  significantly	  higher	  contrast	  estimates	  than	  task	  relevant	  stimuli	  across	  all	   participants	   and	   both	   appointments	   (high	   distracting	   task	   irrelevant	   stimuli:	  
M	  =	  0.46,	   SD	  =	  1.61;	   task	   relevant	   stimuli:	   M	  =	  -­‐0.22,	   SD	  =	  1.24).	   There	   were	   no	  other	  significant	  main	  effects	  or	  interactions	  (all	  p	  >	  .1).	  	  	  
 Discussion	  5.5.5
Consistent	  with	  the	  results	  from	  the	  previous	  fMRI	  study,	  the	  experimental	  task	  led	  to	  bilateral	  activation	  of	  frontal	  and	  parietal	  lobe	  regions.	  As	  expected,	  the	  obtained	   fMRI	   data	   showed	   activation	   patterns	   that	   were	   very	   similar	   to	   those	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obtained	   in	   the	   previous	   fMRI	   study.	   In	   addition,	   the	   results	   from	   this	   larger	  sample	   showed	   significant	   activation	   of	   the	   ACC.	   Given	   the	   need	   to	   control	   the	  interference	  possibly	   caused	  by	  distracting	   stimuli,	   this	   activation	   is	   not	   entirely	  surprising	   and	   consistent	  with	   previously	   reported	   ACC	   functions	   (Bush,	   Luu,	   &	  Posner,	   2000).	   However,	   while	   the	   overall	   frontal	   and	   parietal	   activation	   was	  bilateral,	  active	  nodes	  of	   the	  task-­‐positive/	  attention	  network	  were	   found	  mainly	  in	  the	  right	  hemisphere.	  This	  conflicts	  with	  our	  previous	  results	  as	  well	  as	  with	  the	  literature	   (Gazzaley	  et	   al.,	   2007;	   Jha	  et	   al.,	   2004),	  where	   the	  main	  activation	  was	  found	   to	   be	   in	   the	   left	   hemisphere,	   and	   cannot	   be	   satisfactorily	   explained	   at	   the	  moment.	  As	   hypothesised,	   the	   task-­‐induced	   network	   activation	   was	   lower	   in	   the	  aADHD	  group	  than	  in	  the	  control	  group,	  although	  this	  was	  found	  only	  for	  a	  cluster	  in	   the	   right	   DLPFC.	   Contrary	   to	   the	   hypothesis	   that	   task-­‐positive	   network	  hypoactivation	  in	  aADHD	  might	  be	  linearly	  related	  to	  ADHD	  symptoms,	  we	  found	  no	  correlation	  of	  mean	  contrast	  estimates	   for	   this	  cluster	  and	  T-­‐scores	  on	  any	  of	  the	  CAARS	   scales.	   In	   addition,	  we	   could	  not	   replicate	   findings	   that	  pointed	   to	   an	  up-­‐regulation	  of	  the	  task-­‐positive	  network	  through	  MPH	  treatment	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	   Stevens,	   2012).	   Importantly,	   there	   are	   some	   differences	   between	  the	  studies	  reporting	  these	  findings	  and	  our	  study.	  First,	  these	  studies	  investigated	  children	  and	  adolescents,	   respectively,	  and	  there	  are	  so	   far	  no	  reports	   that	  allow	  conclusions	  about	  the	  transferability	  of	  these	  findings	  to	  adult	  patients.	  In	  addition,	  both	   studies	   used	   single	   dose	   MPH	   trials	   or	   an	   on/off	   design,	   which	   makes	  comparisons	  of	  the	  results	  even	  more	  difficult.	  It	  furthermore	  has	  to	  be	  noted	  that	  we	  only	  investigated	  the	  network	  nodes	  that	  showed	  significant	  activation	  across	  all	   participants	   in	   order	   to	   restrict	   the	   number	   of	   statistical	   tests.	   It	   is	   therefore	  possible	  albeit	  unlikely	  that	  medication	  effects	  for	  some	  of	  the	  network	  nodes	  were	  missed.	  	  As	   in	   the	   previous	   study,	  we	   also	   found	   significantly	   increased	   individual	  FFA	   activation	   for	   high	   distracting	   task	   irrelevant	   compared	   to	   task	   relevant	  stimuli,	  which	  is	  consistent	  with	  the	  literature	  (Jha	  et	  al.,	  2004).	  Interestingly,	  the	  differential	   FFA	   activation	   for	   high	  distracting	   task	   irrelevant	   stimuli	  minus	   task	  relevant	   stimuli	   correlated	   significantly	   with	   the	   activation	   of	   the	   right	   DLPFC	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cluster	  for	  the	  same	  contrast.	  This	  is	  comparable	  to	  the	  results	  from	  our	  first	  (EEG)	  study,	  although	  we	  did	  not	   find	  a	  corresponding	  correlation	  in	  the	  second	  (fMRI)	  study,	  when	  an	  activation	  cluster	  in	  the	  left	  DLPFC	  was	  examined13.	  Furthermore	  and	  in	  contrast	  to	  the	  findings	  from	  the	  EEG	  study,	  we	  found	  a	  negative	  association	  of	  FFA	  contrast	  estimates	   for	  high	  distracting	  task	   irrelevant	  minus	  task	  relevant	  stimuli	   and	   T-­‐scores	   on	   the	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	  subscale	  for	  the	  patient	  group,	  where	  higher	  symptom	  scores	  were	  associated	  with	  reduced	   differences	   between	   task	   relevant	   and	   task	   irrelevant	   stimuli.	   Although	  the	  exact	  meaning	  of	  these	  reduced	  differences	  is	  unclear	  (Jha	  et	  al.,	  2004),	  these	  results	   still	   point	   to	   an	   impact	   of	   aADHD	   symptoms	   of	   visual	   processing	  modulation	   depending	   on	   task	   relevance.	   Since	   the	   sample	   in	   the	   EEG	   study	  reported	   only	   subclinical	   ADHD	   symptoms	   and	   overall	   hyperactive/	   impulsive	  symptoms	  were	  in	  the	  low	  normal	  range	  (mean	  T-­‐score:	  42.1,	  standard	  deviation:	  9.7),	   this	   effect	  might	   likely	   be	   only	   visible	   in	   a	   clinical	   sample.	  On	   a	   similar	   but	  opposite	  note,	  ADHD	  symptoms	  as	  assessed	  with	  the	  CAARS	  did	  not	  correlate	  with	  any	  of	  the	  performance	  parameters	  in	  this	  study.	  Although	  this	  is	  contrary	  to	  our	  hypotheses	  and	  to	  the	  results	  of	  the	  EEG	  study,	  these	  correlations	  might	  only	  have	  been	  visible	  for	  the	  lower	  overall	  symptoms	  of	  a	  non-­‐clinical	  sample.	  	  To	   conclude,	   although	   the	   experimental	   task	   clearly	   activated	   the	   task-­‐positive/	  attention	  network,	  this	  activation	  might	  not	  have	  been	  strong	  enough	  to	  yield	  widespread	  activation	  differences	  between	  the	  well-­‐matched	  aADHD	  patient	  and	   healthy	   control	   groups	   and	   between	   the	   ADHD	   MPH	   and	   placebo	   groups,	  respectively.	   Nevertheless,	   the	   difference	   between	   aADHD	   patients	   and	   healthy	  controls	  in	  the	  right	  DLPFC	  seems	  to	  be	  directly	  related	  to	  the	  requirements	  of	  the	  experimental	   task.	   In	  addition,	  while	  we	  could	  replicate	  some	  of	   the	  results	   from	  the	   first	  (EEG)	  study,	  which	  examined	  a	  subclinical	  sample,	  some	  of	   the	  obtained	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  13	  When	  this	  right	  DLPFC	  peak	  voxel	  was	  used	  to	  re-­‐examine	  the	  data	  from	  the	  previous	  fMRI	  study,	  we	  found	  a	  comparable	  cluster	  of	  activation	  in	  the	  associated	  9	  mm	  spherical	  ROI,	  which	  also	  correlated	  very	  strongly	  with	   individual	   FFA	   activation	   in	   this	   sample	   (cluster	   size:	   110	   voxels;	   peak	   voxel:	   t(17)	  =	  5.30,	   pFWE	  =	  .003;	  
r(16)	  =	  .62,	  p	  =	  .01).	  This	  provides	  further	  support	  for	  the	  assumption	  that	  frontal	  activation	  in	  this	  area	  might	  be	   directly	   related	   to	   differences	   in	   the	   visual	   processing	   of	   the	   presented	   stimuli.	   However,	   given	   the	  correlational	  nature	  of	  these	  results	  no	  conclusions	  about	  causality	  can	  be	  made.	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results	  were	  contrary	  to	  our	  previous	  findings.	  Nevertheless,	  the	  main	  findings	  of	  task-­‐related	   frontal	   and	   FFA	   activation	   could	   be	   replicated	   and	   even	   extended.	  Correlations	   furthermore	   point	   to	   the	   importance	   of	   frontal	   regions	   in	   the	   task-­‐induced	  modulation	  of	  visual	  processing	  as	  well	  as	  to	  a	  possible	  impact	  of	  clinically	  important	   hyperactive/	   impulsive	   symptoms	   on	   this	  modulation.	   These	   findings	  underscore	   the	   importance	   to	  not	   rely	  on	   findings	   from	  samples	  with	  subclinical	  symptoms,	   but	   to	   transfer	   established	   paradigms	   to	   investigations	   with	   clinical	  populations.	  	  	  
5.6 N-­‐Back	  Task	  
As	   detailed	   in	   5.1,	   this	   study’s	   goal	   was	   the	   assessment	   of	   functional	  activation	  during	  more	  global	  working	  memory	  demands	   in	  aADHD	  patients	  and	  healthy	  controls	  as	  well	  as	  the	  examination	  of	  MPH	  effects	  in	  aADHD	  patients	  using	  an	   established	   modification	   of	   the	   classic	   n-­‐back	   working	   memory	   paradigm	  (Goldberg	   et	   al.,	   2003).	   This	   is	   particularly	   interesting,	   as	   one	  of	   the	   few	   studies	  that	   investigated	   working	   memory	   functioning	   using	   the	   classic	   n-­‐back	   task	  reports	  overall	  decreased	  activation	  in	  the	  attention/	  task-­‐positive	  network	  when	  activation	  of	  an	  aADHD	  group	  was	  compared	  to	  a	  matched	  control	  group	  (Bayerl	  et	  al.,	  2010).	  Importantly,	  very	  few	  between-­‐group	  differences	  were	  visible	  when	  the	  two	  groups	  were	  compared	  using	  whole	  brain	  analyses.	  	  We	  decided	   to	   employ	   a	  modified	   variant	   of	   this	   task,	  which	   should	   yield	  activation	  patterns	   similar	   to	   and	  possibly	  more	   pronounced	   than	   the	   activation	  patterns	   found	   with	   the	   classic	   n-­‐back	   task.	   This	   modified	   n-­‐back	   task	   had	  previously	  been	  shown	  to	  be	  sensitive	  to	  effects	  of	  the	  COMT	  genotype	  on	  frontal	  lobe	  activation	  (Diaz-­‐Asper	  et	  al.,	  2008;	  Egan	  et	  al.,	  2001)	  as	  well	  as	  to	  interactions	  of	   COMT	   genotype	   and	   amphetamine	   intake	   in	   healthy	   controls	   (Mattay	   et	   al.,	  2003).	   It	   therefore	   seemed	   very	   well	   suited	   for	   the	   investigation	   of	   healthy	  controls	  and	  aADHD	  patients,	  the	  effect	  of	  MPH	  medication	  and	  placebo	  in	  aADHD	  patients,	   and	  possible	   interactive	  effects	  of	  COMT	   genotype	  and	  ADHD	  diagnosis.	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As	  described	  above	  (see	  5.1	  and	  5.5),	  the	  focus	  in	  data	  analysis	  was	  again	  placed	  on	  activation	  of	  the	  task-­‐positive	  network	  (Banich	  et	  al.,	  2009;	  Cortese	  et	  al.,	  2012;	  M.	  D.	  Fox	  et	  al.,	  2006;	  M.	  D.	  Fox	  et	  al.,	  2005;	  Valera	  et	  al.,	  2010)	  and	  on	  its	  possible	  up-­‐regulation	  after	  stimulant	  medication	  intake	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	  Stevens,	  2012).	  	  	  
 Hypotheses	  5.6.1
1.	   We	   expected	   the	   2-­‐back	   condition	   of	   this	   task	   to	   lead	   to	   increased	  activation	  of	   frontal	   and	  parietal	  nodes	  of	   the	   attention/	   task-­‐positive	  network	  compared	  to	  the	  0-­‐back	  control	  condition	  (Egan	  et	  al.,	  2001).	  	  2.	   ADHD	   patients	   should	   show	   hypoactivation	   in	   these	   network	   nodes	  (Cortese	  et	  al.,	  2012;	  Cubillo	  et	  al.,	  2013),	  and	  network	  activation	  should	  correlate	  negatively	  with	  ADHD	  symptoms	  as	  reported	  on	  the	  CAARS.	  	  3.	   Across	   all	   participants,	  we	   expected	   activation	   in	   the	   attention/	   task-­‐positive	  network	  to	  correlate	  positively	  with	  behavioural	  performance.	  	  4.	   In	   addition,	   ADHD	   patients	   treated	   with	   MPH	   were	   hypothesised	   to	  show	   higher	   activation	   of	   the	   attention/	   task-­‐positive	   network	   at	   the	  second	   fMRI	   appointment	   compared	   to	   their	   first	   appointment	   and	   to	  placebo-­‐treated	  patients	  (Cubillo	  et	  al.,	  2013;	  Wong	  &	  Stevens,	  2012).	  5.	   Based	  on	  previous	  findings	  from	  this	  task	  (Mattay	  et	  al.,	  2003;	  Mier	  et	  al.,	   2010),	   we	   furthermore	   expected	   COMT	   val/val	   carriers	   to	   show	  inefficient	   (i.e.	   increased)	   frontal	   activation	   compared	   to	   val/met	   and	  met/met	  carriers	  across	  all	  participants.	  	  6.	   As	   in	   5.4,	   we	   additionally	   expected	   the	   COMT	   val-­‐allele	   to	   be	   more	  detrimental	  to	  ADHD	  patients	  than	  to	  healthy	  controls	  in	  a	  gene-­‐dosage	  fashion,	   with	   patient	   val/val	   carriers	   showing	   the	   most	   inefficient	  activation	  patterns.	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 Experimental	  Paradigm	  5.6.2
This	  modified	  version	  of	  the	  n-­‐back	  task	  is	  well	  established	  in	  the	  literature	  (Diaz-­‐Asper	  et	  al.,	  2008;	  Egan	  et	  al.,	  2001;	  Goldberg	  et	  al.,	  2003;	  Mattay	  et	  al.,	  2003)	  and	   was	   obtained	   in	   2010	   by	   contacting	   Professor	   Weinberger	   at	   the	   National	  Institute	   of	  Mental	  Health	   (NIMH).	   It	   is	   a	  modification	  of	   the	   classic	   n-­‐back	   task,	  where	  participants	  have	  to	  press	  a	  response	  button	  whenever	  a	  stimulus	  from	  “n”	  trials	  back	  is	  repeated	  (J.	  D.	  Cohen	  et	  al.,	  1994).	  In	  Weinberger’s	  version	  of	  the	  task,	  participants	   are	   required	   to	   respond	   on	   every	   trial	   by	   indicating	   the	   number	  (numbers	  range	  from	  1	  to	  4)	  shown	  “n”	  trials	  earlier.	  The	  task	  comprised	  a	  0-­‐back,	  a	  1-­‐back,	  and	  a	  2-­‐back	  condition,	  presented	   in	  blocks	  of	  30	  seconds	  each.	  The	  0-­‐back	  condition	  serves	  as	  control	  condition	  as	   it	  constitutes	  a	  motor	  equivalent	  to	  the	  1-­‐back	  and	  2-­‐back	  conditions,	  but	  does	  not	  require	  higher	  cognitive	  functions	  of	   working	   memory	   and	   interference	   inhibition.	   Numbers	   were	   presented	   for	  500	  ms	   with	   1,500	  ms	   interstimulus	   interval,	   leading	   to	   a	   total	   of	   15	   number	  presentations	   per	   block.	   Fifteen	   blocks	   (i.e.	   five	   blocks	   per	   condition)	   were	  presented	  in	  pseudo-­‐randomised	  order	  with	  the	  entire	  experiment	  lasting	  around	  8	  minutes,	  during	  which	  170	  fMRI	  volumes	  were	  acquired.	  	  	  
 Participants	  5.6.3
At	   the	   first	   fMRI	   appointment,	   fMRI	   data	   of	   34	   patients	  with	   ADHD	  were	  obtained.	  Two	  data	  sets	  were	  lost	  because	  of	  technical	  problems.	  Two	  patients	  had	  to	  be	  excluded	  after	  preprocessing	  of	   the	  data	  because	  of	  excessive	  movement	   in	  the	   scanner	   (continuous	   repetitive	   movements	   and	   sudden	   movement	   of	   more	  than	   2	  mm,	   respectively).	   One	   patient	   was	   excluded	   because	   her	   behavioural	  performance	  showed	  extreme	  outlier	  values,	  resulting	  in	  a	  total	  of	  29	  patient	  data	  sets	   for	  this	   task.	  The	  control	  group	  was	  chosen	  from	  the	  total	  sample	  of	  healthy	  participants	   to	  be	  comparable	  (all	  p	  ≥	  .2)	   to	   the	  group	  with	  ADHD	  with	  regard	  to	  age,	  gender,	  and	  years	  of	  schooling	  (see	  Table	  5.5	  for	  sample	  characteristics).	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Two	  more	  patient	  data	  sets	  were	  lost	  at	  the	  second	  fMRI	  appointment:	  One	  patient	   discontinued	   the	   study	   after	   the	   first	   fMRI	   appointment	   for	   unknown	  reasons,	   while	   a	   second	   patient	   could	   not	   participate	   in	   the	   second	   fMRI	  appointment	   due	   to	   MRB	   safety	   requirements	   (work	   in	   metal	   processing).	   This	  resulted	   in	   a	   total	   of	   27	   patient	   data	   sets	   that	   comprised	   both	   the	   first	   fMRI	  appointment	  without	  medication	  and	  the	  second	  fMRI	  appointment	  after	  6	  weeks	  of	  MPH	  or	  placebo	  treatment	  (see	  Table	  5.5).	  	  	  
Table	  5.5:	  Overview	  of	  mean	  demographic	  data,	  ASRS	  scores,	  and	  distribution	  of	  COMT	  genotype	  for	  









	  Participants	  (male)	   29	  (13)	   29	  (18)	   13	  (7)	   14	  (9)	  Mean	  age	   33.3(9.3)	   36.1(9.9)	   36.4(9.9)	   37.3(10.1)	  Mean	  school	  years	  	   11.1(1.8)	   10.8(1.6)	   10.5(1.5)	   11.4(1.7)	  StPM	  raw	  score	   50.7(4.9)	   49.4(7.0)	   49.2(8.2)	   49.6(6.3)	  Mean	  inattention1	   11.2(4.6)*	   24.0(4.8)*	   25.3(4.0)/22.5(7.4)	   23.4(4.9)/15.9(7.2)	  Mean	  hyperactivity	   9.7(5.4)*	   18.7(6.2)*	   20.5(5.3)/17.5(7.2)	   16.3(6.3)/11.4(6.3)	  
	  
COMT	  genotype	  
	   	   	   	  met/met	  (male)	   7	  (3)	   6	  (6)	   	   	  val/met	  (male)	   14	  (7)	   17	  (8)	   	   	  val/val	  (male)	   6	  (3)	   6	  (4)	   	   	  
Note.	   1	   Symptoms	   of	   inattention	   and	   hyperactivity/	   impulsivity	   as	   assessed	   with	   the	   ASRS;	   *	  denotes	  significant	  between-­‐group	  differences	  (p	  <	  .001).	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 Results	  5.6.4
5.6.4.1 Patients	  with	  ADHD	  versus	  Healthy	  Controls	  
(1) Behavioural	  Data	  
Mixed	   model	   ANOVAs	   for	   correct	   responses,	   incorrect	   responses,	   and	  missed	  trials	  with	  the	  between-­‐subjects	  factor	  group	  and	  the	  within-­‐subjects	  factor	  
task	   difficulty	   yielded	   no	   significant	   main	   effect	   of	   group	   and	   no	   significant	  interaction	  of	   group	  and	   task	  difficulty	   for	   correct	   responses	   (both	  p	  >	  .1).	  There	  was,	  however,	  a	  significant	  main	  effect	  of	   task	  difficulty	   (F(2,112)	  =	  99.37,	  p	  <	  .001)	  with	  participants	   indicating	  significantly	   fewer	  correct	  responses	  with	   increasing	  task	   difficulty	   (p	  <	  .001	   for	   all	   post-­‐hoc	   comparisons).	   The	   same	   was	   true	   for	  missed	   trials	   (F(2,112)	  =	  52.22,	   all	   p	  <	  .001)	   and	   for	   incorrect	   responses	  (F(2,112)	  =	  47.75,	   all	  p	  <	  .001,	   except	  p	  =	  .01	   for	   the	   post-­‐hoc	   comparison	   of	   the	   0-­‐back	   and	   the	  1-­‐back	   condition;	   see	  Table	  5.6	   for	   performance	  parameters	   of	   the	  different	  groups).	  As	  responses	   in	   this	  paradigm	  were	  given	  simultaneously	  with	  the	  continuous	  appearance	  of	  the	  number	  stimuli,	  reaction	  times	  do	  not	  represent	  meaningful	  performance	  indicators	  and	  were	  therefore	  not	  analysed.	  	  	  
Table	  5.6:	  Overview	  of	  mean	  performance	  for	  healthy	  controls	  and	  ADHD	  patients	  as	  well	  as	  the	  ADHD	  




















	  	  %	  correct	  	   83.4(16.6)	   81.2(17.0)	   79.1(19.7)/86.2(13.2)	   82.1(15.9)/84.3(17.0)	  	  %	  incorrect	  	   8.7(8.8)	   7.1(6.1)	   7.3(6.8)/6.3(5.3)	   6.9(6.1)/8.6(12.0)	  	  %	  missed	  trials	   7.9(11.9)	   11.7(14.9)	   13.6(16.2)/7.6(12.6)	   11.0(14.9)/7.1(12.0)	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  %	  correct	  	   65.4(21.3)	   60.8(20.7)	   63.5(21.6)/70.9(17.0)	   59.3(21.7)/69.8(18.0)	  	  %	  incorrect	  	   18.3(14.3)	   17.0(12.0)	   16.4(9.8)/20.0(24.7)	   16.0(13.8)/15.0(11.2)	  	  %	  missed	  trials	   16.3(14.7)	   22.2(19.2)	   20.1(20.7)/13.7(17.9)	   24.8(19.6)/15.2(16.6)	  
Note.	   There	   were	   no	   significant	   between-­‐group	   differences	   (all	   p	  >	  .1).	   All	   participants	   indicated	  significantly	   fewer	   correct	   and	  more	   incorrect	   responses	   and	  missed	  more	   trials	  with	   increasing	   task	  difficulty	   (all	   p	  ≤	  .01).	   ADHD	   patients	   indicated	   significantly	   more	   correct	   responses	   and	   missed	  significantly	  fewer	  trials	  (for	  the	  1-­‐back	  and	  2-­‐back	  conditions	  only)	  at	  the	  second	  compared	  to	  the	  first	  appointment	  (all	  p	  <	  .05).	  	  	  
(2) fMRI	  Data	  
Across	   all	   participants,	   whole	   brain	   analyses	   with	   pFWE	  <	  .05	   for	   the	  contrasts	   1-­‐back	   minus	   0-­‐back	   and	   2-­‐back	   minus	   0-­‐back	   showed	   very	   similar	  activation	   patterns	   of	   the	   attention/	   task-­‐positive	   network	   as	   well	   as	   of	   the	  cerebellum	  and	   the	   caudate	  nuclei	   (see	  Figure	  5.5).	  This	   activation	  was	   lower	   in	  the	  1-­‐back	  contrast	  than	  in	  the	  2-­‐back	  contrast	  and	  the	  contrast	  2-­‐back	  minus	  1-­‐back	   showed	   increased	   activation	   in	   frontal	   and	   parietal	   areas	   for	   the	   2-­‐back	  condition.	  Therefore,	  only	  the	  contrast	  of	  the	  most	  demanding	  condition	  (2-­‐back)	  minus	  the	  control	  condition	  (0-­‐back)	  was	  further	  analysed.	  	  An	  examination	  of	  attention/	  task-­‐positive	  network	  peak	  voxels	  as	  specified	  by	  Fox	  and	  colleagues	   (2006;	  2005)	   revealed	   task-­‐induced	  bilateral	   activation	   in	  the	  IPS,	  the	  inferior	  parietal	  lobule,	  and	  the	  DLPFC	  as	  well	  as	  significant	  unilateral	  activation	   in	   the	   right	   superior,	   middle,	   and	   inferior	   frontal	   gyri,	   the	   right	  supramarginal	   gyrus,	   the	   right	   precuneus.	   These	   peak	   voxels	  were	   subsequently	  examined	  for	  between	  group	  differences	  as	  specified	  in	  5.2.3.	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  Figure	  5.5:	  Significant	  voxels	   found	   in	   the	  whole	  brain	  analysis	  with	  pFWE	  <	  .05	  (five	  voxels	  extent	  threshold)	   for	   the	   contrast	   1-­‐back	  minus	   0-­‐back	   (A.)	   and	   the	   contrast	   2-­‐back	  minus	   0-­‐back	   (B.)	  across	  all	  participants	  (29	  patients	  and	  29	  healthy	  controls).	  Clusters	  of	  activation	  can	  be	  seen	   in	  areas	   of	   the	   attention/	   task-­‐positive	   network	   as	   well	   as	   in	   the	   cerebellum	   and	   in	   the	   caudate	  nucleus.	  	  	  Comparisons	  between	  the	  group	  with	  ADHD	  and	  the	  healthy	  control	  group	  showed	   no	   significant	   whole	   brain	   differences,	   but	   ROI	   analyses	   yielded	  significantly	  greater	  peak	  voxel	  activation	   in	  ADHD	  patients	  compared	  to	  healthy	  controls	  in	  the	  left	  anterior	  IPS	  (pFWE	  =	  .02),	  the	  right	  inferior/middle	  frontal	  gyrus	  (IFG/MFG;	  pFWE	  =	  .050),	   and	   the	   left	  DLPFC	   (pFWE	  =	  .03;	   see	   Figure	   5.6	   and	  Table	  5.7).	   In	   addition,	   we	   found	   trends	   for	   greater	   activation	   in	   the	   patient	   group	  compared	  to	  the	  healthy	  controls	  in	  the	  right	  posterior	  IPS	  and	  the	  right	  anterior	  IPS	  (pFWE	  =	  .06	  and	  pFWE	  =	  .09,	  respectively;	  see	  Table	  5.7	  for	  cluster	  sizes).	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  Figure	  5.6:	  Clusters	   found	   in	   the	  ROI	  analyses	  with	  significantly	  greater	  peak	  voxel	  activation	   for	  the	  contrast	  2-­‐back	  minus	  0-­‐back	  in	  the	  patient	  group	  compared	  to	  the	  healthy	  controls	  in	  the	  left	  anterior	  IPS	  (A.),	  the	  right	  IFG/MFG	  (B.),	  and	  the	  left	  DLPFC	  (C.).	  	  	  Two	  sample	  t-­‐tests	  of	  the	  contrast	  estimates	  for	  the	  clusters	  that	  contained	  a	  trend	  level	  or	  significant	  peak	  voxel	  difference	  also	  showed	  significant	  between-­‐group	  differences	  with	  the	  ADHD	  patients	  showing	  consistently	  greater	  activation	  than	   the	   healthy	   controls	   (see	   Table	   5.7	   for	   relevant	   statistics	   by	   anatomical	  region).	  	  
Table	   5.7:	   Anatomical	   regions	   with	   significant	   peak	   voxel	   between-­‐group	   differences	   with	  
corresponding	  cluster	  sizes	  (in	  voxels)	  and	  pFWE-­‐values	  of	  the	  peak	  voxel	  difference,	  as	  well	  as	  means	  
and	  standard	  deviations	  (SD)	  of	  the	  contrast	  estimates	  for	  the	  respective	  clusters	  for	  the	  two	  groups	  
(healthy	  controls	  (HC)	  and	  ADHD	  patients),	  and	  the	  t-­‐	  and	  p-­‐values	  of	  the	  corresponding	  uncorrected	  
two-­‐sample	  t-­‐tests.	  	  
Anatomical	  region	   Cluster	  size	   pFWE	   	  Mean	  contrast	  estimates	  (SD)	   t-­‐value1	  	   p	  HC	   ADHD	  Left	  anterior	  IPS	   43	   .02	   0.44(0.29)	   0.66(0.35)	   2.51	   .02	  Right	  IFG/MFG	   41	   .050	   0.33(0.28)	   0.53(0.28)	   2.68	   .01	  Left	  DLPFC	   86	   .03	   0.28(0.26)	   0.49(0.37)	   2.72	   .009	  Right	  posterior	  IPS	   19	   .06	   0.19(0.50)	   0.47(0.41)	   2.31	   .03	  Right	  anterior	  IPS	   57	   .09	   0.51(0.32)	   0.73(0.39)	   2.37	   .02	  
Note.	  1	  degrees	  of	  freedom	  (df)	  =	  56.	  	   To	   compute	  meaningful	   correlations	  with	   performance	   data,	   performance	  indices	   were	   calculated	   as	   the	   ratio	   of	   2-­‐back	   %	  correct	   responses	   to	   0-­‐back	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%	  correct	  responses.	  To	  avoid	  missing	  values	  for	  the	  incorrect	  response	  ratios	  due	  to	  no	  incorrect	  responses	  in	  any	  of	  the	  two	  conditions,	  %	  incorrect	  responses	  was	  transformed	   into	   its	   corresponding	   negative	   %	  not	   incorrect	   responses	   (100	  %	  minus	  %	  incorrect	   responses).	   This	   procedure	   yielded	   two	   different	   performance	  indices,	  one	  based	  on	  the	  number	  of	  correct	  responses	  and	  the	  other	  based	  on	  the	  number	  of	  incorrect	  responses	  in	  the	  two	  examined	  conditions.	  The	  index	  based	  on	  correct	   responses	   should	   be	   seen	   as	   indicating	  performance	  quality,	  with	   higher	  values	  reflecting	  better	  behavioural	  performance.	   In	  contrast,	   the	   index	  based	  on	  incorrect	  responses	  should	  be	  understood	  as	   indicating	  performance	  monitoring,	  since	   it	   signals	  how	  many	   incorrect	   responses	  were	   given	  before	   the	  participant	  realised	   that	   he	   or	   she	   was	   making	   a	   mistake.	   As	   the	   percentage	   of	   incorrect	  responses	  was	   transformed	   to	   its	   negative	   for	   the	   following	   calculations,	   higher	  values	   reflect	   better	   behavioural	   performance	   for	   this	   index.	   Correlations	   were	  calculated	  for	  these	  performance	  ratios	  and	  the	  contrast	  estimates	  for	  the	  clusters	  specified	  above.	  	  These	  calculations	  revealed	  significant	  or	  trend	  level	  associations	  between	  correct	  response	  performance	  and	  activation	  in	  the	  left	  anterior	  IPS,	  as	  well	  as	  the	  right	  anterior	  and	  posterior	  IPS:	  The	  higher	  the	  activation	  in	  these	  areas,	  the	  better	  performance	   with	   regard	   to	   correct	   responses.	   Similarly,	   incorrect	   response	  performance	  correlated	  significantly	  with	  activation	  in	  the	  right	  IFG/MFG	  as	  well	  as	  the	  right	  anterior	  and	  posterior	  IPS:	  The	  higher	  the	  activation	  in	  these	  areas,	  the	  fewer	   incorrect	   responses	  were	   given	   (see	   Table	   5.8	   for	   all	   correlations).	   There	  were	   no	   significant	   correlations	   for	   the	   left	   DLPFC	   (both	   p	  >	  .1).	   For	   the	   patient	  sample,	   activation	   in	   some	  of	   the	   investigated	  areas	   furthermore	  correlated	  with	  symptom	  severity	  as	  measured	  with	  the	  CAARS.	  Higher	  fMRI	  contrast	  estimates	  in	  the	   left	   anterior	   IPS,	   the	   right	   IFG/MFG,	   and	   the	   right	   posterior	   IPS	   correlated	  significantly	  with	  scores	  on	  the	  CAARS	  DSM-­‐IV	  Hyperactive/	  Impulsive	  Symptoms	  scale.	  In	  addition,	  these	  areas	  also	  showed	  significant	  correlations	  with	  the	  CAARS	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scale	  (see	  Table	  5.8	  for	  all	  correlations).	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Table	  5.8:	  Correlation	  coefficients	  (r)	  and	  p-­‐values	  for	  the	  contrast	  estimates	  and	  the	  two	  performance	  
indices	   for	   the	   entire	   sample,	   as	   well	   as	   correlation	   coefficients	   (r)	   and	   p-­‐values	   for	   the	   contrast	  
estimates	   in	   these	   clusters	   and	   T-­‐scores	   for	   CAARS	  DSM-­‐IV	  Hyperactive/	   Impulsive	   Symptoms	   scale	  
and	  CAARS	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scale	  for	  the	  patient	  sample.	  	  
	  Anatomical	  region	  
Performance	  (correct)	   Performance	  (incorrect)	   CAARS	  Hyper./Impuls.	   CAARS	  Total	  Sympt.	  	  
r	  (p-­‐value)1	  	   r	  (p-­‐value)1	  	   r	  (p-­‐value)2	  	   r	  (p-­‐value)2	  	  Left	  anterior	  IPS	   .25	  (.06)	   .22	  (n.s.)	   .46	  (.01)	   .54	  (.002)	  Right	  IFG/MFG	   .20	  (n.s.)	   .32	  (.01)	   .41	  (.03)	   .44	  (.02)	  Right	  posterior	  IPS	   .35	  (.01)	   .48	  (<.001)	   .46	  (.01)	   .40	  (.03)	  Right	  anterior	  IPS	   .24	  (.07)	   .37	  (.004)	   .28	  (n.s.)	   .40	  (.03)	  
Note.	  1	  df	  =	  56;	  2	  df	  =	  27.	  	  	  
5.6.4.2 Patients	  with	  ADHD:	  MPH	  Medication	  versus	  Placebo	  	  
(1) Behavioural	  Data	  
Mixed	   model	   ANOVAs	   for	   correct	   responses,	   incorrect	   responses,	   and	  missed	  trials	  with	  the	  between-­‐subjects	  factor	  medication	  and	  the	  within-­‐subjects	  factors	  time	  of	  measurement	  and	  task	  difficulty	   showed	  significant	  main	  effects	  of	  time	   of	   measurement	   (F(1,25)	  =	  9.14,	   p	  =	  .01)	   and	   task	   difficulty	   (F(2,50)	  =	  59.41,	  
p	  <	  .001)	   for	   correct	   responses:	   All	   participants	   indicated	   significantly	   fewer	  correct	   responses	   with	   increasing	   task	   difficulty	   (p	  <	  .001	   for	   all	   post-­‐hoc	  comparisons)	  and	  showed	  better	  performance	  at	  the	  second	  compared	  to	  the	  first	  fMRI	  appointment	  (p	  =	  .01).	  The	  same	  was	  true	  for	  missed	  trials	  (main	  effect	  time	  of	  measurement:	  F(1,25)	  =	  12.67,	  p	  =	  .002;	  main	  effect	   task	  difficulty:	  F(2,50)	  =	  23.52,	  
p	  <	  .001),	  which	  also	  showed	  a	  significant	  interaction	  of	  time	  of	  measurement	  and	  task	  difficulty	  (F(2,50)	  =	  8.65,	  p	  =	  .001):	  Paired	  t-­‐tests	  showed	  a	  significant	  decrease	  of	  missed	  trials	  at	  the	  second	  compared	  to	  the	  first	   fMRI	  measurement	  for	  the	  1-­‐back	  condition	  (p	  =	  .02)	  and	  the	  2-­‐back	  condition	  (p	  <	  .001),	  but	  not	  for	  the	  0-­‐back	  condition	   (p	  =	  .14).	   In	  contrast,	   for	   incorrect	   responses	  only	  a	  main	  effect	  of	   task	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difficulty	   could	   be	   found	   (F(2,50)	  =	  24.45,	   p	  <	  .001):	   Participants	   gave	   significantly	  fewer	   incorrect	   responses	   in	   the	   0-­‐back	   condition	   compared	   to	   the	   1-­‐back	  condition	   (p	  =	  .01)	   and	   the	   2-­‐back	   condition	   (p	  <	  .001),	   which	   were	   also	  significantly	   different	   (p	  =	  .001).	   There	  were	   no	   other	   significant	  main	   effects	   or	  interactions	  (all	  p	  >	  .1;	  see	  Table	  5.6	  for	  performance	  parameters	  of	  the	  two	  groups	  at	  the	  second	  appointment).	  	  	  
(2) fMRI	  Data	  
The	  peak	  voxels	  described	  under	  5.6.4.1	   (2)	  were	  used	   for	   the	  analysis	  of	  medication-­‐induced	  between-­‐group	  differences	  in	  the	  patient	  group.	  Comparisons	  between	   the	   MPH	   and	   the	   placebo	   group	   yielded	   no	   significant	   whole	   brain	  differences.	  However,	  ROI	  analyses	  showed	  a	  significant	  interaction	  of	  medication	  and	   time	   of	  measurement	   for	   the	   contrast	   2-­‐back	  minus	   0-­‐back	   in	   the	   right	   SFG	  (F(1,25)	  =	  14.14,	  pFWE	  =	  .04,	  cluster	  size:	  12	  voxels;	  see	  Figure	  5.7).	  	  	  
	  	  Subsequent	  two-­‐sample	  t-­‐tests	  as	  implemented	  in	  SPM8	  showed	  a	  trend	  for	  greater	   activation	  of	   the	  MPH	  group	   compared	   to	   the	  placebo	  group	   (t(25)	  =	  2.81,	  
pFWE	  =	  .09,	  cluster	  size	  15	  voxels)	  at	  the	  second	  fMRI	  appointment,	  which	  was	  not	  present	   (p	  >	  .1)	   at	   the	   first	   appointment.	   A	  mixed	  model	   ANOVA	   of	   the	   contrast	  estimates	   for	   this	   cluster	   also	   yielded	  a	   significant	   interaction	  of	  medication	   and	  time	   of	   measurement	   (F(1,25)	  =	  11.25,	   p	  =	  .003).	   Post-­‐hoc	   t-­‐tests	   showed	  significantly	  higher	  activation	  for	  the	  MPH	  group	  compared	  to	  the	  placebo	  group	  at	  
Figure	   5.7:	   Cluster	   found	   in	   the	   ROI	   analyses	   for	   the	  interaction	   of	   medication	   and	   time	   of	   measurement	  for	   the	   contrast	   2-­‐back	   minus	   0-­‐back	   in	   the	   right	  superior	  frontal	  gyrus.	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the	   second	   fMRI	   appointment	   (t(25)	  =	  2.18,	   p	  =	  .04)	   with	   no	   significant	   between-­‐group	  difference	  at	  the	  first	  appointment	  (p	  >	  .1).	  In	  addition,	  paired-­‐sample	  t-­‐tests	  showed	   a	   trend	   for	   an	   activation	   decrease	   in	   the	   placebo	   group	   (t(12)	  =	  2.06,	  
p	  =	  .06),	   while	   the	   MPH	   group	   showed	   a	   significant	   increase	   in	   activation	  (t(13)	  =	  2.97,	  p	  =	  .01)	  between	  the	  two	  fMRI	  appointments	  (see	  Figure	  5.8).	  	  	  
	  	  
5.6.4.3 Interaction	  of	  COMT	  Genotype	  and	  ADHD	  Diagnosis	  
(1) Behavioural	  Data	  
Two	  healthy	  control	  participants	  had	  to	  be	  excluded	  from	  this	  investigation	  because	  the	  analysis	  of	  their	  DNA	  yielded	  inconclusive	  findings	  for	  COMT	  genotype.	  The	   non-­‐parametric	   equivalents	   of	   the	   two-­‐way	   ANOVA	   (as	   described	   in	   5.2.4)	  with	   the	   between-­‐subjects	   factors	   ADHD	   and	   COMT	   genotype	   showed	   no	  significant	  main	  effects	  of	  ADHD	  or	  COMT	  genotype	  and	  no	  significant	  interaction	  for	   correct	   responses,	   incorrect	   responses,	   or	  missed	   trials	   for	   any	   of	   the	   three	  conditions	  (all	  p	  >	  .1).	  The	  effect	  of	   task	  difficulty	  could	  not	  be	   investigated	  using	  non-­‐parametric	   methods.	   However,	   parametric	   mixed	   model	   ANOVAs	   which	  included	   task	   difficulty	   as	   a	   within-­‐subjects	   factor	   showed	   no	   significant	  interactions	   involving	  COMT	  genotype	   for	  correct	  responses,	   incorrect	  responses,	  or	  missed	  trials	  (all	  p	  >	  .1).	  	  	  
Figure	   5.8:	   Mean	   contrast	   estimates	   for	   the	  cluster	  with	   peak	   voxel	   interaction	   for	   the	   two	  groups	  (MPH	  and	  placebo)	  by	  group	  and	  time	  of	  measurement	   for	   the	   contrast	   2-­‐back	  minus	   0-­‐back.	  Note.	  *p	  ≤	  .05,	  **p	  ≤	  .01;	  #p	  ≤	  .1.	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(2) fMRI	  Data	  
We	  exploratorily	   examined	   the	   contrast	   estimates	  of	   the	   clusters	   showing	  between-­‐group	  differences	   for	  possible	   interaction	  effects	  of	  COMT	  genotype	  and	  ADHD	   diagnosis	   using	   the	   non-­‐parametric	   equivalent	   of	   the	   two-­‐way	   ANOVA	  described	   in	   5.2.4.	   For	   the	   contrast	   2-­‐back	   minus	   0-­‐back,	   activation	   in	   the	   left	  anterior	   IPS	   showed	   a	   significant	   main	   effect	   of	   COMT	   genotype	   (F(2,50)	  =	  4.44,	  
p	  =	  .02)	   with	   val/val	   carriers	   displaying	   significantly	   greater	   activation	   than	  val/met	   carriers	   across	   all	   participants	   (p	  =	  .01;	   val/met:	   M	  =	  0.48,	   SD	  =	  0.33;	  val/val:	   M	  =	  0.74,	   SD	  =	  0.31).	   In	   addition,	   there	   was	   a	   significant	   interaction	   of	  
COMT	   genotype	   and	   ADHD	   (F(2,50)	  =	  4.88,	   p	  =	  .01):	   ADHD	   patients	   with	   val/met	  genotype	  showed	  significantly	  greater	  contrast	  estimates	   in	  the	   investigated	  area	  than	  healthy	  controls	  with	  this	  genotype	  (p	  =	  .001)	  and	  ADHD	  patients	  with	  val/val	  genotype	  also	  showed	  a	  trend	  for	  greater	  activation	  than	  healthy	  val/val	  controls	  (p	  =	  .07;	  see	  Figure	  5.9).	  	  	  
	  Figure	  5.9:	  Mean	  contrast	  estimates	  for	  the	  left	  anterior	  IPS	  and	  in	  the	  right	  IFG/MFG	  for	  patients	  with	   ADHD	   and	   healthy	   controls	   and	   the	   different	   COMT	   genotypes.	   Error	   bars	   denote	   standard	  error	  of	   the	  mean	  (SEM).	  Significant	  between-­‐group	  differences	   (p	  ≤	  .05)	  are	  marked	  by	  *,	   trends	  (p	  ≤	  .1)	  are	  marked	  by	  #.	  	  Contrast	   estimates	   for	   the	   right	   IFG/MFG	   also	   showed	   a	   significant	   main	  effect	   of	   COMT	   genotype	   for	   the	   contrast	   2-­‐back	   minus	   0-­‐back	   (F(2,50)	  =	  4.11,	  
p	  =	  .02),	   with	   val/val	   carriers	   displaying	   significantly	   greater	   activation	   than	  val/met	   carriers	   (p	  =	  .03)	   and	   than	   met/met	   carriers	   across	   all	   participants	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(p	  =	  .04;	   val/val:	   M	  =	  0.62,	   SD	  =	  0.25;	   val/met:	   M	  =	  0.39,	   SD	  =	  0.30;	   met/met:	  
M	  =	  0.36,	   SD	  =	  0.31).	   In	   addition,	   there	   was	   a	   significant	   interaction	   of	   COMT	  genotype	  and	  ADHD	  (F(2,50)	  =	  3.65,	  p	  =	  .03):	  ADHD	  patients	  with	  val/met	  genotype	  showed	   significantly	   greater	   contrast	   estimates	   in	   the	   investigated	   area	   than	  healthy	   controls	   with	   this	   genotype	   (p	  =	  .01).	   In	   addition,	   ADHD	   patients	   with	  val/val	   genotype	   showed	   a	   trend	   for	   greater	   activation	   than	   healthy	   val/val	  controls	  (p	  =	  .07;	  see	  Figure	  5.9).	  	  Within-­‐groups,	   ADHD	   met/met	   carriers	   displayed	   significantly	   or	   trend	  level	   lower	   activation	   in	   both	   areas	   compared	   to	   ADHD	   val/val	   carriers	   (left	  anterior	  IPS:	  p	  =	  .07;	  right	  IFG/MFG:	  p	  =	  .009),	  while	  activation	  in	  these	  two	  COMT	  groups	  was	  the	  same	  in	  the	  healthy	  control	  group	  (both	  p	  >	  .1).	  There	  was	  no	  main	  effect	  of	  COMT	  genotype	  or	  interaction	  of	  COMT	  genotype	  and	  ADHD	  for	  any	  of	  the	  other	  investigated	  areas.	  	  
 Discussion	  	  5.6.5
The	  results	  from	  this	  study	  extend	  the	  findings	  from	  the	  selective	  attention	  task	  and	  from	  the	  literature	  in	  an	  interesting	  and	  unexpected	  way.	  First	  of	  all,	  the	  most	  demanding	  2-­‐back	  condition	  was	  hypothesised	  to	  cause	  increased	  activation	  of	   the	  attention/	   task-­‐positive	  network	  compared	   to	   the	  0-­‐back	  condition,	  which	  served	  as	   a	  motor	   control	   condition.	  This	  hypothesis	  was	   confirmed,	  with	   the	  1-­‐back	   and	   the	   2-­‐back	   task	   showing	   a	   substantial	   and	   parametric	   increase	   in	  network	  activation	  over	  the	  0-­‐back	  condition.	  However,	  based	  on	  a	  meta-­‐analysis	  of	   fMRI	   studies	   investigating	  EF	   (Cortese	  et	  al.,	   2012),	  we	  hypothesised	   to	   find	  a	  hypoactivation	   of	   these	   network	   nodes	   in	   aADHD	   patients	   compared	   to	   healthy	  controls.	  This	  was	  not	  the	  case	  and	  the	  data	  did	  indeed	  show	  a	  hyperactivation	  of	  several	  network	  nodes	  in	  the	  frontal	  and	  parietal	  lobes	  when	  the	  ADHD	  group	  was	  compared	  to	  the	  control	  group.	  	  In	  order	  to	  interpret	  this	  finding,	  the	  results	  from	  the	  meta-­‐analysis	  as	  well	  as	   from	   two	   other	   similar	   studies	   need	   to	   be	   re-­‐examined.	   One	   similar	   study	  employed	   a	   classic	   n-­‐back	   task	   and	   reports	   hypoactivation	   particularly	   in	   the	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DLPFC	  in	  a	  group	  of	  children	  with	  ADHD	  compared	  to	  healthy	  controls	  (Cubillo	  et	  al.,	   2013).	   These	   two	   groups	   showed	   behavioural	   performance	   differences,	   with	  the	  ADHD	  group	  performing	  significantly	  worse	  than	  the	  healthy	  control	  group	  in	  the	  more	  demanding	  conditions.	  The	  same	  is	  true	  for	  a	  study	  with	  aADHD	  patients,	  which	  reports	   less	  network	  activation	  but	  also	  worse	  performance	   in	   the	  patient	  group	   (Bayerl	   et	   al.,	   2010).	   Interestingly,	   the	  meta-­‐analysis	   of	   fMRI	   studies	  with	  children	   and	   adolescents	   reports	   hypoactivation	   in	   the	   frontoparietal/	   task-­‐positive	  network	  with	  hyperactivation	  only	  in	  not	  task-­‐related	  networks	  (Cortese	  et	   al.,	   2012).	   In	   contrast,	   the	   fMRI	   studies	   of	   adults	   showed	   hypo-­‐	   as	   well	   as	  hyperactivation	   in	   attention/	   task-­‐positive	   networks,	   which	   the	   authors	  interpreted	   as	   possibly	   reflecting	   compensatory	   efforts	   in	   the	   affected	  networks.	  This	   interpretation	   is	   very	   compatible	   with	   our	   own	   data:	   While	   the	  hyperactivation	   of	   the	   task-­‐positive	   network	   in	   the	   aADHD	   patients	   was	  unexpected,	   network	   activation	   correlated	   positively	   with	   behavioural	   task	  performance	  based	  on	  both	  correct	  and	  incorrect	  responses	  across	  all	  participants.	  This	   supports	   the	   interpretation	   of	   the	   ADHD	   group’s	   hyperactivation	   serving	  compensatory	   purposes	   since	   increased	   activation	   was	   indeed	   associated	   with	  better	  performance	  and	  –	   importantly	   –	   there	  were	  no	  behavioural	  performance	  differences	   between	   the	   two	   groups.	   In	   addition,	   network	   activation	   correlated	  positively	   with	   the	   CAARS	   Hyperactive/	   Impulsive	   and	   Total	   ADHD	   Symptoms	  scales	   in	   aADHD	   patients.	   This	   might	   indicate	   that	   aADHD	   patients	   with	   more	  severe	  symptoms	  had	  to	  apply	  more	  effort	  to	  successfully	  complete	  the	  task,	  which	  would	   further	   support	   the	   interpretation	   of	   increased	   functional	   activation	  reflecting	  compensatory	  efforts.	  	  Furthermore,	   we	   found	   a	   hypothesised	   increase	   of	   activation	   in	   the	   right	  SFG	   of	   patients	   treated	  with	  MPH,	  which	  was	   significant	   compared	   to	   their	   first	  fMRI	  measurement	  without	  medication	  as	  well	  as	  to	  placebo-­‐treated	  patients.	  This	  is	  in	  line	  with	  previous	  reports	  of	  MPH	  up-­‐regulating	  network	  activity	  and	  frontal	  activation	   (Cubillo	   et	   al.,	   2013;	   Wong	   &	   Stevens,	   2012).	   The	   investigation	   of	  possible	   effects	   of	   COMT	   genotype	   and	   ADHD	   diagnosis	   on	   the	   network	   nodes	  showing	   between-­‐group	   differences	   moreover	   yielded	   main	   effects	   of	   COMT	   in	  frontal	  as	  well	  as	  parietal	  regions	  of	   interest,	  with	  val/val	  carriers	  showing	  more	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inefficient	  activation	  than	  the	  other	  genotype	  groups.	  While	  the	  effect	  of	  COMT	  on	  frontal	   lobe	   functioning	   is	   in	   line	  with	  many	  previous	   findings	  (Egan	  et	  al.,	  2001;	  Mattay	  et	  al.,	  2003;	  Mier	  et	  al.,	  2010),	  less	  is	  know	  about	  its	  impact	  on	  parietal	  lobe	  functioning.	   There	   is,	   however,	   some	   indication	   that	   COMT	   might	   similarly	   be	  linked	  to	  activation	  changes	  in	  the	  posterior	  parietal	  cortex	  as	  in	  the	  frontal	  cortex	  if	  a	  task	  requires	  rapid	  updating	  of	  information	  (Tan	  et	  al.,	  2007).	  Interestingly,	  the	  two	   regions	   with	   main	   effects	   of	   COMT	   genotype	   on	   activation	   also	   showed	   an	  interactive	   effect	   of	   COMT	   genotype	   and	   ADHD	   diagnosis.	   Contrary	   to	   previous	  results,	   healthy	   controls	   showed	  no	   differences	   between	   the	   genotype	   groups	   in	  the	   frontal	   ROI	   and	   val/met	   carriers	   showed	   the	  most	   efficient	   activation	   in	   the	  parietal	  ROI.	   In	  contrast,	  ADHD	  patients	  with	   two	  met-­‐alleles	  displayed	   the	  most	  efficient	   activation	   in	   both	   ROIs	   and	   efficiency	   showed	   a	   linear	   decrease	   with	  val/val	  carriers	  being	  the	  most	  inefficient.	  This	  is	   in	  line	  with	  our	  hypothesis	  and	  might	  point	  to	  a	  left	  shift	  in	  the	  cortical	  dopaminergic	  response	  function	  caused	  by	  the	  combined	  effects	  of	  COMT	  genotype	  and	  ADHD	  (Arnsten,	  2006;	  Pliszka,	  2005).	  Still,	  it	  should	  be	  kept	  in	  mind	  that	  cell	  sizes	  for	  the	  investigation	  of	  this	  interactive	  effect	   were	   rather	   small	   and	   further	   important	   differences	   might	   have	   been	  missed.	  Nevertheless,	   the	   preliminary	   results	   obtained	   in	   this	   study	   point	   to	   the	  possibility	   of	   an	   interesting	   interaction	   of	   COMT	   genotype	   and	   ADHD	   diagnosis,	  which	  warrants	  further	  investigation.	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6 Concluding	  Discussion	  
6.1 Selective	  Attention	  and	  Working	  Memory	  
A	   main	   focus	   of	   the	   studies	   presented	   in	   this	   dissertation	   was	   the	  investigation	   of	   selective	   attention	   functions	   mediated	   by	   the	   working	   memory	  central	  executive	  (Baddeley,	  2012;	  J.	  D.	  Cohen	  et	  al.,	  2000;	  Postle,	  2006).	  Similar	  to	  previous	   studies,	  we	   found	   support	   for	   the	  hypothesis	   that	   the	   central	   executive	  modulates	   early	   visual	   processing	   based	   on	   how	   relevant	   a	   stimulus	   is	   for	  successful	  task	  completion	  (Egner	  &	  Hirsch,	  2005;	  Gazzaley	  et	  al.,	  2005;	  Polk	  et	  al.,	  2008;	  Rutman	  et	  al.,	  2010;	  Schreppel	  et	  al.,	  2008;	  Sreenivasan	  &	  Jha,	  2007;	  Zanto	  &	  Gazzaley,	  2009)	   in	  both	   the	   first	   (EEG),	   and	   the	  second	  and	   third	   (fMRI)	   studies.	  Our	   results	   also	   support	   previous	   investigations	   that	   took	   the	   degree	   of	  distractibility	   of	   the	   task	   irrelevant	   stimulus	   into	   consideration	   (Jha	   et	   al.,	   2004;	  Sreenivasan	  &	  Jha,	  2007).	  	  Both	   EEG	   and	   fMRI	   showed	   differential	   visual	   processing	   of	   stimuli	   that	  were	   high	   distracting	   compared	   to	   stimuli	   that	  were	   low	  distracting.	  While	   high	  distracting	   task	   irrelevant	   stimuli	   led	   to	   reduced	   N170	   amplitudes	   compared	   to	  low	  distracting	  task	  irrelevant	  stimuli	  and	  compared	  to	  task	  relevant	  stimuli	  in	  the	  EEG	  study,	  FFA	  activation	  for	  high	  distracting	  task	  irrelevant	  stimuli	  was	  found	  to	  be	   increased	   in	   the	   fMRI	  studies.	  This	   increase	   is	  more	  difficult	   to	   interpret	   than	  the	  decreased	  amplitudes	  in	  the	  EEG	  study,	  as	  it	  might	  reflect	  inhibitory	  processes,	  increased	  maintenance	  efforts,	  or	  simply	  additive	  presentation	  effects	  in	  this	  area	  (Jha	   et	   al.,	   2004;	   Ranganath	   &	   Paller,	   1999;	   Rossion	   et	   al.,	   2004).	   However,	   the	  results	   of	   the	   second	   (fMRI)	   study	   also	   showed	   possibly	   increased	   activation	   –	  achieving	   trend	   level	   significance	   before	   correcting	   for	   multiple	   comparisons	   –	  when	  the	  low	  distracting	  task	  irrelevant	  stimulus	  was	  from	  another	  category	  than	  the	   task	   relevant	   stimulus.	   As	   FFA	   activation	   was	   still	   increased	   when	   the	  maintained	   task	  relevant	  stimulus	  was	   from	  another	  category	  (house)	   in	   the	   low	  distracting	  task	  irrelevant	  condition,	  this	  most	  likely	  supports	  the	  interpretation	  of	  the	   increased	   BOLD	   response	   reflecting	   inhibitory	   processes	   in	   the	   FFA.	   It	  furthermore	   contradicts	   additive	   effects	   caused	   by	   the	   presentation	   of	   a	   high	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distracting	  task	   irrelevant	   face	  stimulus	  while	  a	  relevant	   face	  stimulus	  was	  being	  maintained	   in	   working	   memory.	   However,	   to	   further	   disentangle	   possible	  interpretations	   of	   the	   differential	   processing	   observed	   in	   both	   EEG	   and	   fMRI,	   it	  would	  be	  necessary	  to	  try	  to	  include	  high	  distracting	  task	  irrelevant	  stimuli	  from	  a	  separate	   category	   in	   the	   experimental	   paradigm,	   although	   that	  might	   admittedly	  be	  difficult	  to	  accomplish.	  	  In	   addition,	   previous	   reports	   of	   frontal	   involvement	   in	   processing	  modulation	   and	   recovery	   from	   interference	   could	   be	   replicated	   (Gazzaley	   et	   al.,	  2007;	  Jha	  et	  al.,	  2004;	  K.	  Kessler	  &	  Kiefer,	  2005).	  Both	  EEG	  and	  fMRI	  data	  showed	  a	  processing	   enhancement	   for	  high	  distracting	   task	   irrelevant	   stimuli	   compared	   to	  task	  relevant	   stimuli	   in	   frontal	  areas.	  While	   the	  EEG	  results	   showed	  no	   laterality	  effects,	   fMRI	  data	   from	   the	   third	   study	   strongly	   implicated	   the	   right	  hemisphere.	  Differential	   activation	   for	   task	   relevant	   minus	   high	   distracting	   task	   irrelevant	  stimuli	  in	  a	  right	  DLPFC	  cluster	  belonging	  to	  the	  task-­‐positive	  network	  (M.	  D.	  Fox	  et	  al.,	  2006;	  M.	  D.	  Fox	  et	  al.,	  2005)	  correlated	  significantly	  with	  FFA	  activation	  for	  the	  same	  contrast.	  This	  might	  be	  further	   indication	  of	   inhibitory	  processes	   in	  the	  FFA	  being	  coordinated	  by	  the	  DLPFC,	  especially	  as	  a	  cluster	  in	  the	  same	  region	  of	  interest	  was	  found	  to	  show	  comparable	  correlations	  in	  a	  post-­‐hoc	  analysis	  of	  data	  from	  the	  second	  (fMRI)	  study.	  	  The	   selective	   attention	   paradigm	   furthermore	   proved	   sensitive	   to	   the	  detection	  of	  both	  aADHD	  and	  COMT	   effects	   in	   the	  research	  presented	  above.	  The	  ADHD	   effects,	   however,	   did	   not	   transfer	   as	   expected	   from	   participants	   with	  subclinical	  ADHD	  symptoms	   to	  patients	  meeting	   full	  diagnostic	  criteria	  of	  ADHD:	  While	  participants’	  scores	  on	  the	  CAARS	  Hyperactive/	  Impulsive	  and	  Total	  ADHD	  Symptoms	   scales	   correlated	   negatively	   with	   performance	   accuracy	   in	   the	   first	  (EEG)	  study	  –	  which	  was	  caused	  by	  lower	  target	  detection	  rates	  –	  no	  comparable	  correlations	   were	   found	   for	   the	   patient	   sample	   in	   the	   third	   study.	   Although	  performance	  was	  generally	  high	  in	  both	  of	  these	  studies,	  a	  closer	  inspection	  of	  the	  behavioural	  data	  showed	  significantly	  higher	  accuracy,	  target	  detection,	  and	  faster	  reaction	  times	  in	  participants	  from	  the	  first	  compared	  to	  the	  third	  study,	  with	  only	  the	  number	  of	   false	  alarms	  being	  comparable.	  This	  might	  be	  due	   to	  a	  number	  of	  factors.	   The	  most	   likely	   explanation	   for	   this	   difference	   concerns	   the	   investigated	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samples:	  While	  ADHD	  patients	  and	  their	  matched	  healthy	  controls	  were	  recruited	  from	   a	   wide	   range	   of	   age	   and	   educational	   backgrounds,	   the	   participants	   with	  subclinical	   ADHD	   symptoms	   in	   the	   first	   study	   were	   mainly	   students	   in	   their	  twenties.	   It	   is	   therefore	  possible	   that	   the	   task	  was	  only	  able	   to	   tax	   the	   impact	  of	  ADHD	   symptoms	   on	   performance	   in	   the	   first	   sample,	   where	   the	   overall	   level	   of	  cognitive	  functioning	  was	  very	  high.	  Participants	  in	  the	  fMRI	  study	  may	  also	  have	  been	   more	   fatigued	   as	   they	   had	   already	   completed	   another	   task	   when	   they	  performed	   the	  selective	  attention	   task.	   It	   is	   furthermore	  possible	   that	   the	  supine	  position	  in	  the	  fMRI	  scanner	  might	  have	  contributed	  to	  increased	  drowsiness	  and	  thereby	  worse	  performance	  than	  the	  seated	  position	  in	  the	  EEG.	  The	  different	  sample	  characteristics	  might	  furthermore	  have	  influenced	  the	  correlations	   between	   task-­‐related	   activation	   and	   ADHD	   symptoms	   that	   were	  observed	  in	  the	  two	  studies.	  As	  ADHD	  had	  previously	  been	  connected	  to	  impaired	  distractor	   suppression	   and	   executive	   control	   (Dramsdahl	   et	   al.,	   2011;	   Friedman-­‐Hill	   et	   al.,	   2010),	   it	   was	   hypothesised	   that	   participants	  with	   higher	   (subclinical)	  ADHD	  symptoms	  would	  show	  less	  differential	  processing	  of	  task	  relevant	  and	  high	  distracting	   task	   irrelevant	   stimuli.	   This	   was	   not	   found	   in	   the	   first	   (EEG)	   study,	  where	  ADHD	  symptoms	  on	   the	  CAARS	  DSM-­‐IV	  Hyperactive/	   Impulsive	  and	  Total	  ADHD	  Symptoms	  scales	  correlated	  negatively	  only	  with	   the	  N170	  amplitudes	   for	  the	   less	   demanding	   conditions	   (low	   distracting	   task	   irrelevant	   and	   passively	  viewed	  stimuli).	  In	  contrast,	  ADHD	  patients	  in	  the	  third	  study	  showed	  the	  expected	  correlation	  when	  FFA	  activation	  was	  examined:	  The	  higher	  patients	  scored	  on	  the	  CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	   scale,	   the	   lower	   their	  differential	  FFA	  activation	  for	  high	  distracting	  task	  irrelevant	  minus	  task	  relevant	  stimuli.	  As	  with	  the	  behavioural	  data	  above,	  the	  high-­‐functioning	  participants	  with	  subclinical	  ADHD	  symptoms	  in	  the	  first	  study	  might	  have	  been	  able	  to	  completely	  compensate	   for	   their	   symptoms	   in	   the	   two	   most	   demanding	   conditions	   (task	  relevant	  and	  high	  distracting	  task	  irrelevant	  stimuli,	  respectively).	  In	  contrast,	  the	  patient	   sample	   in	   the	   third	   study	   reported	   much	   higher	   overall	   symptoms	   and	  although	  behavioural	  performance	  was	  still	  comparable	  to	  that	  of	  healthy	  controls,	  a	  complete	  compensation	  of	  their	  deficits	  might	  not	  have	  been	  possible.	  This	  lack	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of	   compensation	   seems	   to	   be	   especially	   true	   for	   those	   patients	   with	   high	  hyperactive/	  impulsive	  symptoms	  of	  ADHD.	  	  	  	  
6.2 Adult	  ADHD,	  Methylphenidate,	  and	  COMT	  Genotype	  
A	   second	   focus	   of	   this	   dissertation	  was	   the	   investigation	   of	   the	   effects	   of	  MPH	  on	  several	  parameters	  of	  EF	  and	  working	  memory.	  The	  medication	  effect	  on	  ADHD	   symptoms	   found	   in	   the	   third	   (double-­‐blind	   placebo-­‐controlled)	   study	  corresponded	  to	  what	  would	  be	  expected	  based	  on	  previous	  research.	  There	  was	  only	   a	   trend	   level	   effect	   of	  MPH	  when	   response	   rates	   and	  mean	   score	   reduction	  percentages	   were	   analysed,	   which	   is	   likely	   attributable	   to	   the	   size	   of	   the	  investigated	   sample.	   Notably,	   the	   effect	   size	   for	   between-­‐group	   differences	   in	  response	  rate14	  was	  small	  to	  medium	  (d	  =	  .46).	  This	  is	  comparable	  to	  the	  results	  of	  a	   larger	   study,	  which	   reports	   effect	   sizes	   between	   .38	   and	   .62	   for	   different	  MPH	  doses	   (Medori	   et	   al.,	   2008).	   However,	   compared	   to	   studies	   solely	   investigating	  medication	  response	  (Biederman,	  Mick,	  et	  al.,	  2010;	  Medori	  et	  al.,	  2008;	  Spencer	  et	  al.,	   2005),	   the	   sample	   size	   of	   our	   much	   more	   time-­‐consuming	   combined	   fMRI	  medication	  study	  was	  necessarily	  relatively	  small.	  Correspondingly,	   the	  power	  to	  detect	  a	  truly	  existing	  difference	  in	  response	  rates	  was	  only	  36	  %.	  	  The	   obtained	   results	   were	   similar	   when	   questionnaire	   scores	   instead	   of	  response	   rates	  were	   considered:	  Both	   the	  MPH	  and	   the	  placebo	  group	  showed	  a	  decrease	   in	   self-­‐reported	  ADHD	   symptoms	  before	   the	   second	   fMRI	   appointment.	  Although	   the	   MPH	   group	   reported	   trend	   level	   lower	   hyperactivity/	   impulsivity	  scores	  than	  the	  placebo	  group,	  this	  was	  significant	  across	  both	  appointments	  and	  did	   not	   interact	   with	   the	   time	   of	   measurement.	   Inspection	   of	   the	   questionnaire	  scores,	   however,	   again	   points	   to	   medication	   effects	   in	   the	   expected	   direction.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	  As	  described	  above,	  medication	  response	  was	  defined	  as	  a	  minimum	  reduction	  of	  20	  %	  in	  T-­‐scores	  on	  the	  CAARS	  DSM-­‐IV	   Total	   ADHD	   Symptoms	   scale	   as	  well	   as	   on	   either	   the	   CAARS	  DSM-­‐IV	   Inattentive	   Symptoms	  scale	  and/or	  the	  CAARS	  DSM-­‐IV	  Hyperactive/	  Impulsive	  Symptoms	  scale	  from	  day	  1	  to	  day	  42.	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Therefore,	  interaction	  effect	  sizes	  (Cohen’s	  f)	  were	  calculated	  as	  described	  in	  5.4.4	  to	   explore	  whether	   the	   sample	   size	  was	   sufficient	   to	   detect	   significant	   effects	   of	  MPH	   treatment	   compared	   to	   placebo	   over	   time.	   Unfortunately,	   achieved	   power	  was	  low	  for	  the	  CAARS	  DSM-­‐IV	  Inattentive	  (f	  =	  .21,	  power	  =	  .42)	  and	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scales	  (f	  =	  .14,	  power	  =	  .25).	  It	  is	  therefore	  possible	  that	  small	  to	  moderate	   interaction	   effects	   for	   these	   scales	  were	  missed	  due	   to	   the	   insufficient	  sample	  size.	  Estimated	  effect	  size	  was	  too	  small	  to	  accurately	  investigate	  achieved	  power	   for	   the	  CAARS	  DSM-­‐IV	  Hyperactive/	   Impulsive	  Symptoms	  scale	  and	  hence	  no	  power	  calculation	  could	  be	  performed.	  However,	  patients’	  initial	  scores	  on	  the	  Hyperactive/	   Impulsive	   Symptoms	   scale	   were	   substantially	   lower	   than	   for	   the	  other	  two	  CAARS	  scales	  and	  mean	  T-­‐scores	  on	  this	  scale	  were	  in	  the	  normal	  range	  for	   all	   patients	   at	   the	   end	   of	   the	   trial.	   In	   contrast,	   power	  was	   high	   for	   the	   ASRS	  inattention	  subscale	  (f	  =	  .25,	  power	  =	  .97),	  with	  slightly	  lower	  power	  for	  the	  ASRS	  hyperactivity/	   impulsivity	   subscale	   (f	  =	  .23,	   power	  =	  .65).	   It	   can	   therefore	   be	  assumed	   that	   sample	   size	   was	   sufficient	   for	   these	   questionnaires	   and	   statistical	  analyses	  should	  have	  detected	  any	  truly	  existing	  interaction	  effects.	  To	  summarise,	  a	  placebo	  effect	  on	  all	  symptoms	  of	  ADHD	  was	   found,	  with	  patients	  reporting	  a	  significant	  improvement	  of	  their	  symptoms	  irrespective	  of	  the	  actual	  pharmacological	   treatment	   they	  had	  received.	  This	  placebo	  effect	  might	   in	  part	   be	   attributable	   to	   the	   extensive	   clinical	   care	   all	   patients	   were	   engaged	   in	  during	   the	   course	   of	   the	   study.	   Furthermore,	   the	   sample	   size	  was	   unfortunately	  insufficient	   to	   detect	   any	   significant	   interaction	   effects	   for	   the	   CAARS	   DSM-­‐IV	  Inattentive	  and	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scales.	  It	  might	  therefore	  be	  quite	  possible	  to	  find	  effects	  for	  these	  subscales	  with	  a	  substantially	  larger	  sample	  (e.g.	  84	  participants	  would	  be	  necessary	   to	   achieve	   an	   experimental	   power	  of	   .80	   for	  the	  CAARS	  DSM-­‐IV	  Inattentive	  Symptoms	  scale).	  It	  should	  be	  noted,	  however,	  that	  the	   achieved	   response	   rates	   of	   40	  %	   (placebo	   group)	   versus	   63	  %	   (MPH	   group)	  were	  very	  comparable	  to	  those	  reported	  by	  much	  larger	  clinical	  trials	  (Biederman,	  Mick,	   et	   al.,	   2010;	  Medori	   et	   al.,	   2008;	   Rösler	   et	   al.,	   2009).	   Unlike	   hypothesized,	  performance	   on	   the	   neuropsychological	   tests	   (particularly	   on	   the	   Stroop	   Color	  
Word	   Test	   and	   the	   Digit	   Span	   Forward	   subtest)	   was	   also	   not	   influenced	   by	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medication	   in	   the	   patient	   sample,	   which	   might	   mainly	   be	   attributable	   to	   the	  characteristics	  of	  these	  tests.	  	  Several	   additional	   points	   need	   to	   be	   considered	   when	   evaluating	   the	  response	   to	   stimulant	   medication.	   First,	   many	   studies	   defined	   response	   rates	  based	   on	   symptoms	   ratings	   provided	   by	   clinically	   trained	   investigators	   (e.g.	  Biederman,	  Mick,	  et	  al.,	  2010;	  Medori	  et	  al.,	  2008;	  Spencer	  et	  al.,	  2005).	  A	  recent	  meta-­‐analysis	   identified	   this	   practice	   as	   problematic	   due	   to	   the	   risk	   of	   blinding	  failures,	   caused	   by	   trained	   clinicians’	   ability	   to	   deduce	   patients’	   true	  medication	  from	   the	   behavioural	   and	   hemodynamic	   effects	   of	   MPH	   much	   better	   than	   the	  patients	  themselves	  (Castells	  et	  al.,	  2013).	   In	  contrast,	   the	  described	  results	   from	  our	  study	  rely	  on	  patient	  self-­‐report,	  which	  is	  known	  to	  lead	  to	  less	  robust	  effects	  (Medori	  et	  al.,	  2008).	  It	  should	  be	  noted,	  however,	  that	  we	  defined	  response	  rates	  as	   a	  minimum	   reduction	   of	   20	  %	   in	   T-­‐scores	   on	   the	   CAARS	  DSM-­‐IV	  Total	   ADHD	  Symptoms	   scale	   as	   well	   as	   on	   either	   the	   CAARS	   DSM-­‐IV	   Inattentive	   Symptoms	  scale	   and/or	   the	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	   Symptoms	   scale	   from	  day	  1	   to	   day	  42.	   This	   definition	   is	   rather	   liberal,	   as	   other	   studies	   assumed	   a	  minimum	   reduction	   of	   30	  %	   (in	   observer	   ratings)	   to	   classify	   responders	   (e.g.	  Biederman,	  Mick,	  et	  al.,	  2010).	  Another	  potential	  difference	  in	  our	  study	  pertains	  to	  the	   titration	   and	   dose	   of	   the	   dispensed	   medication.	   While	   many	   of	   the	   studies	  mentioned	   above	   use	   daily	   MPH	   doses	   up	   to	   the	   maximum	   specified	   by	   the	  manufacturer,	   medication	   was	   titrated	   more	   clinically	   valid	   and	   thereby	   more	  conservatively	   in	   our	   study,	   with	   a	  maximum	  weekly	   increase	   of	   10	  mg	   up	   to	   a	  maximum	   daily	   dose	   of	   60	  mg.	   This	   is	   well	   below	   the	   maximum	   recommended	  daily	   dose	   of	   1	  mg/kg	   and	   80	  mg,	   respectively,	   for	   adults	   (MEDICE	   Arzneimittel	  Pütter	  GmbH	  &	  Co.	  KG).	   It	   is	   therefore	  possible	   that	  a	   further	   increase	  of	  dosage	  might	   have	   improved	   eventual	   response	   rates	   –	   although	   possibly	   at	   the	   cost	   of	  increased	  side	  effects.	  	  The	   fact	   that	  medication	  doses	  were	  significantly	   lower	   for	  patients	   in	   the	  MPH	  compared	  to	  the	  placebo	  group	  in	  our	  study	  might	  be	  potentially	  problematic.	  This	  difference	  might	  have	  provided	  the	  psychiatrists	  responsible	  for	  the	  titration	  of	   the	  medication	  with	  some	  clues	  regarding	  the	  assigned	  treatment	  condition.	   It	  should	   be	   pointed	   out,	   however,	   that	   –	   contrary	   to	   other	  medication	   trials	   –	   no	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medically	   responsible	   personnel	   was	   involved	   in	   the	   collection	   of	   any	  neuropsychological	  or	  fMRI	  data,	  thereby	  limiting	  any	  impact	  on	  the	  collected	  data	  which	  might	  have	  been	  caused	  by	  blinding	  failures.	  Although	   the	   selective	   attention	   task	   showed	   some	   sensitivity	   to	   both	  aADHD	   and	   COMT,	   these	   effects	   were	  more	   pronounced	   in	   the	  modified	   n-­‐back	  task,	  a	  more	  traditional	  measure	  of	  working	  memory	  functioning.	  Like	  the	  selective	  attention	   task,	   this	   task	   caused	   a	   pronounced	   activation	   of	   the	   task-­‐positive	  network.	  We	  detected	  robust	  activation	  increases	  in	  frontal	  and	  parietal	  areas,	  but	  also	   in	   the	   cerebellum	   and	   in	   the	   caudate	   nucleus,	   when	   the	   most	   demanding	  condition	  was	   compared	   to	   the	   control	   condition.	   However,	   none	   of	   these	   areas	  showed	  any	  significant	  activation	  differences	  between	  aADHD	  patients	  and	  healthy	  participants	  when	  univariate	  whole	  brain	  analyses	  were	  examined.	  This	   is	   in	   line	  with	   previous	   reports	   (Bayerl	   et	   al.,	   2010)	   and	   points	   to	   rather	   subtle	   between-­‐group	  differences	  on	  a	  network	  level	  (Cortese	  et	  al.,	  2012;	  Cubillo	  et	  al.,	  2013).	  	  Contrary	   to	   our	   hypotheses,	   we	   found	   increased	   task-­‐positive	   network	  activation	  in	  the	  aADHD	  patients	  when	  frontal	  and	  parietal	  nodes	  of	  this	  network	  were	  analysed.	  Nonetheless,	  a	  closer	  examination	  of	   the	  obtained	  results	  showed	  some	   noteworthy	   properties	   of	   our	   data.	   Contrary	   to	   a	   comparable	   study	   that	  reports	   network	   hypoactivation	   in	   the	   aADHD	   sample	   (Bayerl	   et	   al.,	   2010),	   we	  found	   no	   behavioural	   performance	   differences	   between	   the	   two	   groups.	   In	  addition,	   task-­‐positive	   network	   activation	   showed	   a	   positive	   correlation	   with	  behavioural	   performance,	   and	   activation	   correlated	   positively	   with	   CAARS	  Hyperactive/	   Impulsive	   and	  Total	  ADHD	  Symptoms	  within	   the	  patient	   sample	   in	  our	  study.	  This	  combination	  of	  results	  led	  us	  to	  interpret	  the	  increased	  activation	  in	   the	   aADHD	   patients	   as	   compensatory	   efforts	   compared	   to	   healthy	   controls,	   a	  possibility	  that	  was	  also	  raised	  by	  a	  previous	  meta-­‐analysis,	  which	  found	  increased	  activation	  of	  aADHD	  patients	  in	  some	  of	  the	  investigated	  network	  nodes	  (Cortese	  et	   al.,	   2012).	   Interestingly,	   the	   ability	   to	   compensate	   for	   deficits	   by	   increasing	  network	   activation	   seems	   to	   be	   typical	   in	   adult	   patients,	   as	   studies	   with	   ADHD	  children	  consistently	  showed	  hypoactivation	  in	  task-­‐related	  networks	  (Cortese	  et	  al.,	   2012;	   Cubillo	   et	   al.,	   2013).	   In	   addition,	   we	   found	   MPH	   to	   further	   increase	  frontal	   activation	   during	   task	   performance,	   which	   is	   also	   in	   line	   with	   previous	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reports	   (Cubillo	   et	   al.,	   2013;	  Wong	  &	   Stevens,	   2012).	   These	   results	   indicate	   that	  future	   studies	   should	  place	   a	   stronger	   focus	  on	  behavioural	   task	  performance	  of	  the	   investigated	   groups,	   as	   this	   could	   be	   the	   key	   to	   whether	   hypo-­‐	   or	  hyperactivation	   of	   the	   investigated	   networks	   will	   be	   observed	   when	   the	   two	  groups	  are	  compared.	  	  We	   also	   found	   a	   noteworthy	   interaction	   of	   COMT	   genotype	   and	   ADHD	  diagnosis	  in	  both	  the	  imaging	  and	  the	  neurophysiological	  data,	  which	  pointed	  to	  an	  additional	   negative	   impact	   of	   ADHD	   on	   the	   typical	   neuropsychological	   and	  functional	   activation	   profiles	   associated	   with	   the	   COMT	   genotype:	   Contrary	   to	  healthy	  controls,	  patients	  with	  aADHD	  showed	  no	  advantage	  for	  met/met	  carriers	  on	  a	  stable	  neuropsychological	  measure	  of	  working	  memory	  and	  no	  advantage	  for	  val/val	   carriers	   on	   a	   flexible	   neuropsychological	   measure	   of	   working	   memory.	  When	  functional	  activation	  was	  examined	  during	  the	  modified	  n-­‐back	  task,	  aADHD	  patients	   showed	   a	   more	   pronounced	   negative	   effect	   of	   the	   COMT	   val-­‐allele	   on	  activation	   efficiency	   than	   the	   healthy	   control	   group.	   These	   results	   point	   to	   a	  possible	   left	   shift	   in	   the	   inverted	   U-­‐shaped	   cortical	   dopaminergic	   response	  function	  (Bellgrove	  et	  al.,	  2005;	  Cools	  &	  D'Esposito,	  2011;	  Mattay	  et	  al.,	  2003)	   in	  aADHD:	   While	   healthy	   controls	   showed	   no	   genotype	   differences	   or	   a	   slight	  advantage	  for	  the	  val/met	  genotype	  (in	  the	  IPS),	  effects	  were	  more	  pronounced	  in	  the	  aADHD	  group	  with	   the	  most	  efficient	   functioning	  visible	   in	  met/met	  carriers.	  This	   finding	   has	   notable	   implications	   for	   research	   on	   the	   response	   to	   stimulant	  medication	   in	   aADHD	   (which	   could	   not	   be	   investigated	   here	   due	   to	   insufficient	  participant	  numbers	  per	  cell).	  Since	  some	  of	  the	  investigated	  parameters	  showed	  most	   efficient	   functioning	   in	   met/met	   aADHD	   patients	   but	   in	   val/met	   healthy	  controls,	   this	   left	   shift	   in	   the	   response	   function	   of	   aADHD	   patients	   might	   cause	  met/met	   patients	   to	   be	   even	   more	   sensitive	   to	   pharmacologically	   induced	  increases	   of	   cortical	   and	   subcortical	   dopamine	   than	   healthy	   controls.	   As	   a	  consequence,	  this	  group	  might	  show	  a	  more	  unfavourable	  response	  to	  stimulants	  than	   what	   was	   previously	   observed	   in	   healthy	   met/met	   carriers	   (Mattay	   et	   al.,	  2003).	   This	   is	   in	   line	   with	   pharmacogenetic	   studies,	   which	   report	   a	   reduced	  response	  to	  stimulant	  medication	  in	  ADHD	  children	  with	  two	  met-­‐alleles	  (Cheon	  et	  al.,	  2008;	  Kereszturi	  et	  al.,	  2008;	  McGough	  et	  al.,	  2009).	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It	   should	  be	  noted,	  however,	   that	  contrary	   to	  previous	  research	  using	   this	  paradigm	  (Barnett	  et	  al.,	  2008;	  Egan	  et	  al.,	  2001;	  Goldberg	  et	  al.,	  2003)	  we	  did	  not	  find	  differences	   in	   frontal	   cortical	   activation	   for	   the	  different	  COMT	   genotypes	   in	  healthy	   controls.	   This	   discrepancy	  might	   have	   been	   caused	   by	   the	   small	   sample	  size,	   or	   it	  might	   be	  due	   to	   the	   fact	   that	   the	   investigated	  ROIs	  were	  pre-­‐specified	  based	  on	  task-­‐positive	  network	  nodes	  that	  had	  shown	  between-­‐group	  differences	  for	  healthy	   controls	  and	  aADHD	  patients.	  Most	   importantly,	   these	  ROIs	  were	  not	  selected	  based	  on	  previous	   investigations	  of	   the	  COMT	   genotype.	   Still,	   this	  might	  make	  the	  findings	  even	  more	  relevant,	  as	  they	  indicate	  an	  adverse	  effect	  of	  the	  val-­‐allele	  on	  task-­‐positive	  network	  nodes	  that	  are	  also	  affected	  by	  ADHD.	  	  	  	  
6.3 Limitations	  	  
There	  are	   several	   limitations	   to	   the	   studies	  presented	   in	   this	  dissertation.	  One	  important	  limitation	  concerns	  the	  design	  of	  the	  selective	  attention	  task.	  While	  this	  design	  was	  well	  suited	   for	   investigation	  with	  EEG	  and	  yielded	  robust	  results	  with	   this	   method,	   it	   might	   have	   been	   too	   restrictive	   for	   application	   in	   an	   fMRI	  study.	  The	  necessary	  alternating	  presentation	  of	  task	  relevant	  and	  task	  irrelevant	  stimuli	   considerably	   reduced	   the	   efficiency	   of	   this	   design	   for	   the	   fMRI	   studies.	  Combined	   with	   the	   comparably	   short	   interstimulus	   intervals,	   this	   alternating	  presentation	  contributed	  to	  a	  reduced	  orthogonality	  of	  several	  of	  the	  regressors	  in	  the	  general	  linear	  model,	  thereby	  limiting	  the	  contrasts	  that	  could	  be	  meaningfully	  investigated.	  	  For	  future	  studies,	  the	  design	  might	  be	  improved	  in	  one	  of	  two	  ways:	  First,	  it	  might	  be	  advisable	  to	  abandon	  the	  strictly	  alternating	  stimulus	  presentation	  and	  to	  possibly	   further	   increase	   the	   interstimulus	   intervals	  between	  stimuli	   from	  the	  same	   condition.	   However,	   these	   modifications	   would	   increase	   task	   difficulty	  considerably,	   as	  participants	  would	  have	   to	  maintain	   the	   task	   relevant	   stimuli	   in	  working	   memory	   for	   very	   long	   durations.	   A	   second	   –	   and	   probably	   preferable	  option	  –	  would	  be	  to	  change	  the	  experimental	  design	  from	  event-­‐related	  to	  block	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design.	   This	   design	   would	   permit	   a	   comparison	   between	   blocks	   with	   only	   task	  relevant	   and	   passively	   viewed	   stimuli	   as	   well	   as	   between	   blocks	   with	   high	   and	  with	   low	   distracting	   task	   irrelevant	   and	   alternatingly	   presented	   task	   relevant	  stimuli.	   However,	   this	   block	   design	   would	   require	   finding	   solutions	   for	   the	  differences	  in	  presentation	  rate	  and/or	  spacing	  for	  the	  blocks	  with	  and	  the	  blocks	  without	  interspersed	  task	  irrelevant	  stimuli,	  thereby	  potentially	  over-­‐complicating	  the	  original	  design.	  Furthermore,	  it	  might	  be	  advisable	  to	  use	  an	  FFA	  localiser	  with	  moving	   instead	  of	  static	   faces,	  as	  moving	   faces	  have	  been	  reported	  to	  yield	  more	  robust	   activation	   (C.	   J.	   Fox,	   Iaria,	   &	   Barton,	   2009;	   Schultz	   &	   Pilz,	   2009).	  Nonetheless,	  although	  the	  design	  for	  the	  fMRI	  studies	  was	  not	  optimal,	   it	  allowed	  us	   to	   investigate	   the	  most	  notable	  contrast	   (task	  relevant	  versus	  high	  distracting	  task	   irrelevant	  stimuli)	  both	  with	  regard	  to	  the	  task	  as	  such	  and	  to	  the	   impact	  of	  
COMT	  genotype	  and	  aADHD	  on	  task-­‐related	  activation.	  	  Another	  way	   the	   fMRI	  studies	  could	  potentially	  be	   improved	  concerns	   the	  relatively	  long	  TR	  of	  three	  seconds.	  Although	  a	  long	  TR	  was	  necessary	  since	  dorsal	  as	   well	   as	   ventral	   structures	   were	   of	   interest	   here,	   the	   field	   of	   view	   in	   the	  presented	   studies	   also	   included	   the	   cerebellum.	   While	   this	   is	   of	   potential	  importance	   in	   the	   investigation	   of	   ADHD,	   it	   was	   not	   the	   focus	   of	   the	   research	  presented	   here	   and	   the	   recording	   of	   its	   activation	   unnecessarily	   prolonged	   the	  total	   recording	   time.	  Given	   the	  relatively	   long	  TRs,	   it	  was	  not	  possible	   to	   include	  temporal	   interpolation	   to	  partly	   correct	   for	   the	  different	  acquisition	   times	  of	   the	  individual	  slices	  during	  data	  analysis15.	  	  Another	  limitation	  concerns	  the	  aADHD	  patients	  included	  in	  the	  third	  study.	  Since	   inclusion	   and	   exclusion	   criteria	   for	   this	   study	  were	   very	   strict,	   it	   was	   not	  possible	   to	   select	   participants	   based	   on	   their	   ADHD	   subtype.	   This	   is	   especially	  important,	   as	   there	   is	   some	  evidence	   that	   the	   inattentive	   type	  might	   represent	   a	  disorder	  that	  is	  aetiologically	  and	  neurobiologically	  distinct	  from	  the	  hyperactive/	  impulsive	   and	   the	   combined	   type	   (Diamond,	   2005;	   Goodyear	  &	  Hynd,	   1992).	   As	  Barkley	   pointed	   out	   several	   years	   ago	   (Barkley,	   1997;	   Barkley,	   Dupaul,	   &	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  15	  Although	   the	  usefulness	   of	   slice-­‐timing	   correction	   is	   under	   debate	   (Friston	   et	   al.,	   2007;	  Henson,	  Buechel,	  Josephs,	  &	  Friston,	  1999),	  its	  use	  might	  nevertheless	  have	  been	  advantageous	  in	  the	  analysis	  of	  the	  presented	  fMRI	  data.	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McMurray,	  1990),	  patients	  with	  the	  inattentive	  type	  might	  be	  deficient	  in	  selective	  attention	   and	  be	   characterised	  by	   a	   slower	   cognitive	   speed.	   In	   contrast,	   patients	  with	  the	  combined	  type	  might	  be	  easily	  distracted	  and	  more	  deficient	  in	  the	  area	  of	  sustained	   attention.	   It	   would	   therefore	   not	   be	   unexpected,	   should	   these	   two	  subtypes	   show	   different	   performance	   profiles	   in	   our	   selective	   attention	   and	  working	  memory	  tasks.	  	  Further	   analyses	   addressing	   this	   issue,	   however,	   would	   need	   to	   take	  patients’	   childhood	   ADHD	   diagnoses	   into	   consideration:	   Although	   19	   of	   the	   35	  patients	   who	   participated	   in	   the	   third	   study	   were	   classified	   as	   predominantly	  inattentive	  and	  15	  patients	  were	  classified	  as	  combined	  type,	  we	  were	  not	  able	  to	  account	  for	  symptom	  changes	  over	  the	  lifespan.	  There	  is	  some	  evidence	  that	  ADHD	  symptom	  profiles	  change	  with	  increasing	  age	  (Barkley,	  1997;	  Biederman,	  Mick,	  &	  Faraone,	  2000).	  As	  hyperactivity	  declines,	  patients	  who	  would	  have	  met	  diagnostic	  criteria	  for	  the	  combined	  type	  as	  children,	  only	  meet	  criteria	  for	  the	  predominantly	  inattentive	   type	   in	   adulthood.	  These	  adults’	   inattention,	  however,	   is	   qualitatively	  different	   from	   that	   of	   adults	  who	  met	   criteria	   for	   the	   predominantly	   inattentive	  type	   throughout	  development	   (Barkley,	  1997).	  Studies	   involving	  aADHD	  patients	  would	  therefore	  need	  to	  retrospectively	  determine	  the	  patients’	  childhood	  ADHD	  subtype	   and	   then	   split	   the	   patients	   now	  meeting	   criteria	   for	   the	   predominantly	  inattentive	   type	   into	   patients	   who	   originally	  met	   criteria	   for	   the	   combined	   type	  and	   patients	  who	   ‘truly’	   have	   ADHD	   of	   the	   inattentive	   type.	   This	   is	   –	   at	   least	   at	  present	  –	  highly	   impracticable.	   Including	   ‘truly’	   inattentive,	  adult	  age	   inattentive,	  and	   combined	   type	   ADHD	   patients	   in	   our	   investigated	   sample	   increased	   the	  variance	   within	   that	   sample,	   thereby	   reducing	   the	   probability	   to	   find	   any	  significant	  differences	  between	  this	  sample	  and	  healthy	  controls.	  While	  we	  found	  correlations	  for	  the	  CAARS	  Hyperactive/	  Impulsive	  Symptoms	  as	  well	  as	  the	  Total	  ADHD	  Symptoms	  scales	  with	  performance	  and/or	  activation	  parameters	   for	  both	  the	  selective	  attention	  and	  the	  working	  memory	  task,	  no	  correlations	  were	  found	  for	   the	   CAARS	   Inattentive	   Symptoms	   scale,	   further	   underscoring	   the	   above	  argument.	  	  With	  regard	  to	  the	  investigated	  MPH	  effects,	  only	  limited	  conclusions	  can	  be	  drawn	   from	   our	   study	   due	   to	   the	   low	   achieved	   power.	   Future	   studies	   should	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therefore	   aim	   to	   investigate	   larger	   samples	   in	   comparable	  medication	   trials	   and	  consider	  both	  response	  rates	  and	  medication	  effects	  on	  neuropsychological	  as	  well	  as	   neurophysiological	   functioning,	   despite	   the	   substantial	   resources	   this	   would	  necessitate.	  While	   this	   is	   already	   done	  with	   small	   samples	   in	   some	   studies	   (e.g.	  Bush	  et	  al.,	  2008),	  many	  investigations	  still	  focus	  on	  either	  one	  or	  the	  other	  aspect,	  thereby	   limiting	   the	   knowledge	   that	   can	   be	   attained	   from	   these	   studies.	   In	  addition,	  much	  information	  could	  be	  gained	  by	  splitting	  the	  examined	  patients	  into	  responders	   and	   non-­‐responders	   based	   on	   an	   a	   priori	   criterion,	   and	   by	  investigating	  the	  obtained	  neuropsychological	  and	  fMRI	  data	  separately	   for	   these	  two	  groups.	  However,	  the	  sample	  size	  in	  our	  study	  was	  not	  sufficient	  to	  allow	  any	  meaningful	  analyses	  of	  this	  kind.	  	  Another	   possible	   limitation	   involves	   the	   conclusions	   that	   can	   be	   drawn	  from	   the	   investigations	   of	  COMT	   genotype	   and	  MPH	  medication.	  While	   the	  main	  focus	  of	  the	  literature	  in	  these	  two	  areas	  is	  still	  on	  dopamine,	  both	  COMT	  genotype	  and	  MPH	  also	  impact	  on	  norepinephrine	  to	  a	  yet	  unknown	  extent	  (Arnsten,	  2011;	  Berridge	  et	  al.,	  2006;	  Bilder	  et	  al.,	  2004).	  This	  is	  especially	  important	  with	  regard	  to	   the	   selective	   attention	   task,	   as	   norepinephrine	   has	   been	   hypothesised	   to	  improve	   the	   signal-­‐to-­‐noise	   ratio	   by	   suppressing	   task	   irrelevant	   and	   enhancing	  task	   relevant	   stimuli	   (Pliszka,	   2005).	   While	   this	   does	   not	   change	   the	   main	  conclusions	   drawn	   from	   our	   studies,	   it	   should	   be	   kept	   in	   mind	   that	   both	   the	  reported	  COMT	  genotype	  and	  the	  MPH	  effects	  might	  be	  attributable	  to	  an	  unknown	  degree	  to	  the	  action	  of	  norepinephrine	  instead	  of	  dopamine.	  	  In	   addition,	   previous	   findings	   suggest	   that	   COMT	   might	   have	   a	   sexually	  dimorphic	   effect	   (Barnett	   et	   al.,	   2008;	   Gogos	   et	   al.,	   1998;	  Harrison	  &	  Tunbridge,	  2008)	  and	  Barnett	  et	  al.’s	  (2008)	  meta-­‐analysis	  of	  performance	  on	  the	  n-­‐back	  task	  found	   that	   effect	   sizes	   increased	   with	   the	   number	   of	   female	   participants	   in	   the	  sample.	  This	  limitation	  should	  be	  kept	  in	  mind	  with	  regard	  to	  the	  COMT	  genotype	  analyses	  in	  the	  above	  studies,	  as	  cell	  sizes	  were	  small	  and	  only	  here	  did	  not	  allow	  for	  a	  precise	  balancing	  of	  male	  and	  female	  participants.	  This	  especially	  applies	  to	  met/met	  carriers,	  as	  the	  aADHD	  group	  was	  clearly	  composed	  of	  more	  men	  than	  the	  healthy	   control	   group.	   However,	   with	   the	   exception	   of	   the	   Digit	   Span	   Forward	  subtest,	   the	  between-­‐group	  effects	   in	   the	  COMT	   analyses	  did	  not	   incorporate	   the	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met/met	   group.	   Consequently,	   the	   impact	   of	   this	   gender	   imbalance	   might	   be	  negligible.	   Still,	   as	   research	   also	   points	   to	   potential	   interactive	   effects	   of	   gender	  and	  aADHD,	  with	  male	  patients	  showing	  more	  pronounced	  activation	  changes	  than	  female	   patients	   during	   a	   working	   memory	   task	   (Valera	   et	   al.,	   2010),	   a	   more	  detailed	  consideration	  of	  this	  issue	  might	  be	  desirable	  in	  future	  studies.	  	  A	   final	   potential	   criticism	   pertains	   to	   the	   modified	   n-­‐back	   task.	   Although	  this	   task	   allows	   for	   a	   parametric	  manipulation	   of	   load	   and	   thereby	  maintenance	  demands	  (Goldberg	  et	  al.,	  2003),	  critics	  point	  out	  that	  it	  confounds	  these	  demands	  with	  information	  updating	  demands	  (Bilder	  et	  al.,	  2004).	  This	  is	  problematic,	  since	  increased	  maintenance	  demands	  should	  favour	  met/met	  carriers,	  while	  increased	  updating	  demands	  should	  favour	  val/val	  carriers.	  Since	  the	  task	  does	  not	  allow	  for	  a	  separate	  increase	  of	  these	  demands,	   it	  could	  actually	  be	  hypothesised	  to	  favour	  val/met	   carriers,	   who	   should	   be	   able	   to	   fulfil	   both	   demands	   to	   an	   intermediate	  degree.	   However,	   while	   this	   hypothesis	   might	   be	   supported	   based	   on	   the	   fMRI	  activation	  found	  in	  the	  healthy	  control	  participants	  in	  the	  third	  study,	  this	  finding	  is	  not	  in	  line	  with	  the	  literature	  (Egan	  et	  al.,	  2001;	  Mattay	  et	  al.,	  2003;	  Mier	  et	  al.,	  2010)	  and	  more	  likely	  due	  to	  the	  small	  sample	  size	  of	  our	  study.	  	  	  	  
6.4 Summary	  and	  Outlook	  
As	   stated	   above,	   this	   dissertation	   pursued	   several	   goals.	   The	   first	   study	  investigated	   selective	   attention	   properties	   of	   the	   central	   executive	   component	  during	   a	   working	   memory	   task.	   This	   study	   replicated	   and	   extended	   previous	  research	  by	  showing	  that	  both	  the	  task	  relevance	  and	  the	  degree	  of	  distraction	  of	  an	  irrelevant	  stimulus	  impacted	  on	  early	  visual	  processing	  as	  measured	  with	  EEG.	  The	   study	   furthermore	   confirmed	   the	   influence	   of	   stimulus	   relevance	   on	   frontal	  EEG	   components	   and	   demonstrated	   a	   connection	   of	   overall	   activation	   in	   frontal	  areas	  to	  suppression	  efficiency	   in	  posterior	  visual	  processing	  areas.	  Although	  the	  impact	   of	   (subclinical)	   symptoms	   of	   ADHD	   on	   the	   efficiency	   of	   processing	  modulation	  could	  not	  be	  confirmed,	  ADHD	  symptoms	  were	  associated	  with	  worse	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task	   performance,	   indicating	   some	   sensitivity	   of	   this	   task	   for	   the	   hyperactive/	  impulsive	  symptoms	  associated	  with	  ADHD.	  	  The	  goal	  of	   the	  second	  study	  was	   to	   transfer	   this	   task	   to	   fMRI,	   in	  order	   to	  replicate	  and	  possibly	  extend	  previous	  findings	  as	  well	  as	  to	  assess	  its	  sensitivity	  to	   changes	   in	   neural	   activation	   efficiency	   associated	   with	   the	   COMT	   genotype.	  These	   three	   goals	   were	   achieved	   and	   we	   successfully	   replicated	   findings	   of	  increased	   frontal	   and	   FFA	   activation	   during	   the	   processing	   of	   task	   irrelevant	  stimuli	   compared	   to	   task	   relevant	   stimuli.	   In	   addition,	   results	   of	   differential	   FFA	  activation	   for	   task	   irrelevant	   stimuli	   depending	   on	   how	  distracting	   these	   stimuli	  were	  could	  meaningfully	  extend	  previous	  findings.	  The	  task	  also	  proved	  sensitive	  to	   the	   effects	   of	   the	   COMT	   genotype	   and	   showed	   more	   inefficient	   activation	   of	  val/val	   compared	   to	  met/met	   carriers	   in	   one	   of	   the	   three	   examined	   frontal	   lobe	  areas.	  	  The	   third	   study	  was	   the	  most	   complex	   and	   extensive	   of	   this	   dissertation,	  and	   investigated	   the	   effects	   of	   aADHD,	   MPH,	   and	   COMT	   genotype	   on	   working	  memory	   in	   a	   sample	   of	   rigorously	   selected	   patients	   and	   healthy	   controls.	   Since	  previous	   studies	  had	  shown	  whole	  brain	  between-­‐group	  differences	   to	  be	   rather	  small,	  a	  particular	  focus	  in	  the	  analysis	  of	  the	  fMRI	  data	  was	  placed	  on	  activity	  in	  the	   task-­‐positive/	   attention	   network.	   A	   clinical	   effect	   of	  MPH	  was	   visible	   in	   this	  study,	  but	  the	  symptom	  improvement	  of	  aADHD	  patients	  taking	  MPH	  compared	  to	  placebo	  was	  non-­‐significant	  on	  the	  investigated	  scales	  or	  with	  regard	  to	  response	  rates.	  These	  non-­‐significant	  findings	  have	  to	  be	  attributed	  to	  insufficient	  power	  of	  this	   study.	   As	   noted	   above	   and	   in	   spite	   of	   the	   low	   power,	   however,	   a	   beneficial	  effect	  of	  MPH	  was	  clearly	  visible.	  	  This	   study	   is	   one	   of	   the	   first	   investigations,	   which	   explored	   the	  neuropsychological	  effects	  COMT	  in	  a	  sample	  of	  aADHD	  patients	  and	  a	  comparable	  healthy	  control	  group,	  and	  showed	  an	  interactive	  effect	  of	  these	  two	  factors.	  While	  there	  was	   no	  main	   effect	   of	   COMT	   on	   the	   investigated	   neuropsychological	   tests,	  aADHD	   patients	   did	   not	   seem	   to	   be	   able	   to	   profit	   from	   task	   characteristics	  benefitting	  a	  particular	  genotype	  in	  the	  same	  way	  healthy	  controls	  did.	  	  The	   fMRI	   data	   in	   this	   study	   showed	   that	   the	   selective	   attention	   task	  successfully	   activated	   the	   task-­‐positive	   network	   when	   h
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irrelevant	   and	   task	   relevant	   stimuli	   were	   compared.	   In	   addition,	   ROI	   analyses	  yielded	  decreased	  activation	   in	   the	  right	  DLPFC	  of	   the	  patient	  group.	  Contrary	  to	  the	  second	  (fMRI)	  study,	  this	  third	  study	  also	  showed	  an	  association	  of	  activation	  in	   this	   cluster	   and	   FFA	   suppression	   efficiency,	   and	   suppression	   efficiency	   was	  significantly	  worse	   in	  patients	  with	  higher	  hyperactive/	   impulsive	  symptoms.	  No	  significant	  effect	  of	  MPH	  could	  be	  found	  in	  this	  study.	  	  In	   contrast,	   the	   n-­‐back	   task,	   which	   concentrated	   more	   exclusively	   on	  working	   memory	   without	   a	   specific	   focus	   on	   selective	   attention,	   showed	   more	  activation	   in	  nodes	  of	   the	   task-­‐positive	  network	   in	   the	  group	  with	  aADHD	   in	   the	  absence	  of	  behavioural	  performance	  differences.	  Furthermore,	  more	  hyperactive/	  impulsive	  symptoms	  were	  associated	  with	  stronger	  network	  activation	  and	  more	  activation	   was	   also	   correlated	   with	   better	   performance.	   This	   pattern	   of	   results	  supports	   the	   conclusion	   of	   compensatory	   activation	   in	   the	   aADHD	   group.	   In	  addition,	  activation	  in	  the	  SFG	  was	  increased	  in	  patients	  taking	  MPH	  compared	  to	  placebo,	  which	  is	  in	  line	  with	  previous	  reports	  of	  MPH	  up-­‐regulating	  frontal	  nodes	  of	   the	   task-­‐positive	  network.	  Furthermore,	  we	  could	  replicate	   the	  COMT	   effect	  of	  more	   inefficient	   frontal	   activation	   in	   val/val	   carriers	   across	   all	   participants.	   In	  addition,	  we	   found	  an	   interaction	  effect	  of	  COMT	  genotype	  and	  aADHD.	  Based	  on	  this	   finding,	   we	   propose	   a	   left	   shift	   of	   aADHD	   patients	   on	   the	   hypothesised	  inverted	  U-­‐shaped	   cortical	   response	   function	   to	   dopamine,	   as	   aADHD	   seemed	   to	  exacerbate	   the	   hypothesised	   negative	   impact	   of	   two	   val-­‐alleles	   on	   cortical	  efficiency.	  	  It	   should	  be	  noted	   that	   the	  number	  of	   fMRI	  data	  analyses,	  which	  could	  be	  reported	  in	  this	  dissertation	  was	  naturally	  limited	  and	  that	  consequently	  only	  the	  broadest	   and	   most	   comprehensive	   analyses	   could	   be	   described	   here.	   It	   might	  therefore	  prove	  beneficial	  to	  exploratorily	  analyse	  further	  aspects	  of	  the	  data	  using	  more	  liberal	  methods	  and	  statistical	  thresholds.	  	  Still,	  future	  studies	  that	  include	  larger	  sample	  sizes	  are	  clearly	  needed.	  Such	  studies	   could	   build	   on	   our	   findings	   by	   investigating	   the	   complexity	   of	   the	  interactive	   impact	   of	   COMT	   genotype	   and	   aADHD	   on	   neuropsychological	   test	  results.	   These	   studies	   should	   also	   consider	   the	   impact	   on	   cortical	   activation	  measured	  with	  fMRI,	  but	  also	  on	  medication	  response	  and	  adverse	  effects.	  It	  might	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also	  be	  advisable	  to	  investigate	  COMT	  haplotypes	  (Nackley	  et	  al.,	  2006)	  instead	  of	  single	  SNPs,	  as	  this	  might	  provide	  further	  differentiation	  of	  the	  obtained	  results.	  In	  addition,	   research	   on	   ADHD	   might	   benefit	   from	   adopting	   a	   stronger	   network	  perspective.	  Whole	  brain	  between-­‐group	  comparisons	  almost	  always	  yield	  small	  –	  if	   any	   –	   differences.	   In	   contrast,	   the	   network	   perspective	   seems	   much	   more	  promising.	  While	  several	   studies	  already	   investigated	  activation	  and	  connectivity	  of	   the	   default	  mode	   network	   at	   rest	   (e.g.	   Fair	   et	   al.,	   2010),	  more	   research	   using	  multivariate	  analysis	  methods	  could	  still	  be	  done	  on	  the	  activation	  of	  task-­‐positive	  networks	  and	   the	  deactivation	  of	   task-­‐negative	  networks	  during	   task	  completion	  (Liddle	  et	  al.,	  2011).	  In	  addition,	  the	  interaction	  of	  cortical	  and	  subcortical	  network	  structures	   as	   well	   as	   possible	   abnormal	   connectivity	   in	   ADHD	   require	   more	   in-­‐depth	   investigations	   (Castellanos	  &	  Proal,	   2012;	  De	  La	  Fuente,	   Xia,	  Branch,	  &	  Li,	  2013;	  Sun	  et	  al.,	  2012;	  Wolf	  et	  al.,	  2009).	  The	  inspired	  meta-­‐analysis	  by	  Cortese	  et	  al.	  (2012),	  which	  connected	  the	  results	  from	  previous	  fMRI	  studies	  to	  hypothesised	  network	   activation	   in	  ADHD	   and	   healthy	   controls	   is	   certainly	   a	   step	   in	   the	   right	  direction	  and	  provides	  many	  interesting	  suggestions	  for	  future	  research.	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8 Appendix	  
	  
8.1 Study	  1:	  EEG	  Parameters	  of	  Selective	  Attention	  
	  
	  Figure	   8.1:	   Scatter	   plots	   and	   linear	   regression	   lines	   for	   N170	   amplitudes	   and	   CAARS	   DSM-­‐IV	  Hyperactive/	  Impulsive	  and	  Total	  Symptoms	  subscales.	  Each	  dot	  represents	  one	  participant.	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8.2 Study	  2:	  fMRI	  Parameters	  of	  Selective	  Attention	  
	  
Table	   8.1:	   MNI	   coordinates	   of	   significant	   between-­‐group	   peak	   voxel	   difference	   for	   the	   selective	  
attention	  task.	  	  Anatomical	  region	   MNI	  coordinates	  	  
	  
Selective	  attention	  task:	  val/val	  versus	  met/met	  carriers	  
-­‐ Right	  medial	  frontal	  gyrus	   	  12	  	  	  2	  	  	  	  64	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8.3 Study	  3:	  Double-­‐Blind	  Placebo-­‐Controlled	  Trial	  
	  
Table	  8.2:	  Inclusion	  and	  exclusion	  criteria	  for	  ADHD	  patients	  	  Inclusion	  criteria	  
	  
Participants	  must	  fulfil	  all	  of	  the	  following	  criteria:	  
	  1. Only	   participants	   will	   be	   included	   who	   (1)	   fulfil	   the	   diagnostic	   criteria	   defined	   in	   the	  guidelines	  for	  the	  diagnosis	  of	  ADHD	  in	  childhood	  and	  adulthood,	  and	  who	  (2)	  would	  be	  treated	  with	  MPH	  also	  for	  clinical	  indications	  outside	  the	  study.	  2. Provision	  of	  written	  informed	  consent.	  	  3. A	  diagnosis	  of	  aADHD	  by	  Diagnostic	  and	  Statistical	  Manual	  of	  Mental	  Disorders	  –	  Fourth	  Edition	  (DSM-­‐IV).	  4. Females	  and	  males	  aged	  18	  to	  50	  years.	  5. Female	   patients	   of	   childbearing	   potential	   must	   be	   using	   a	   reliable	   method	   of	  contraception	   and	   have	   a	   negative	   urine	   human	   chorionic	   gonadotropin	   (HCG)	   test	   at	  enrolment.	  6. Able	  to	  understand	  and	  comply	  with	  the	  requirements	  of	  the	  study.	  	  7. Right-­‐handed	  according	  to	  Edinburgh	  Handedness	  Inventory	  (Oldfield,	  1971).	  8. German	  as	  first	  language.	  9. Caucasian	  ethnicity.	  	  	  	  Exclusion	  criteria	  
	  
Any	  of	  the	  following	  is	  regarded	  as	  a	  criterion	  for	  exclusion	  from	  the	  study:	  	  
	  1. Pregnancy	   or	   lactation;	   women	   capable	   of	   childbearing	   are	   required	   to	   use	   a	   reliable	  method	   (Pearl-­‐index	   <	  1%)	   of	   contraception	   (e.g.	   hormonal	   treatment,	   intrauterine	  device,	  vasoligation	  in	  the	  partner,	  sexual	  abstinent).	  2. Any	  current	  DSM-­‐IV	  Axis	  I	  disorder	  not	  defined	  in	  the	  inclusion	  criteria	  requiring	  current	  additional	  treatment.	  3. Motor	  tics,	  siblings	  with	  tics,	  or	  positive	  family	  history	  or	  diagnosis	  of	  Tourette	  syndrome.	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4. Patients	   who,	   in	   the	   opinion	   of	   the	   investigator,	   pose	   an	   imminent	   risk	   of	   suicide	   or	   a	  danger	  to	  self	  or	  others.	  5. Known	  intolerance	  or	  lack	  of	  response	  to	  MPH,	  as	  judged	  by	  the	  investigator.	  	  6. Present	  pre-­‐treatment	  with	  MPH	  (within	  the	  last	  three	  months	  prior	  to	  study	  treatment).	  7. Intake	  of	  MAO-­‐inhibitors	  within	  the	  last	  14	  days	  prior	  to	  study	  treatment.	  8. Medical	  conditions	  that	  would	  affect	  absorption,	  distribution,	  metabolism,	  or	  excretion	  of	  study	  treatment.	  	  9. Unstable	   or	   inadequately	   treated	   medical	   illness	   (e.g.	   Congestive	   Heart	   Failure/	   CHF,	  angina	   pectoris,	   hypertension,	   narrow	   angle	   glaucoma,	   hyperthyroidism,	   thyrotoxicosis,	  cardiac	  arrhythmia,	  cardiac	  infarction)	  as	  judged	  by	  the	  investigator.	  	  10. Epilepsy.	  11. An	  absolute	  neutrophil	  count	  (ANC)	  of	  ≤	  1.5	  x	  109	  per	  litre.	  12. Involvement	  in	  the	  planning	  and	  conduct	  of	  the	  study.	  13. Previous	  enrolment	  or	  randomisation	  of	  treatment	  in	  the	  present	  study.	  14. Participation	  in	  another	  drug	  trial	  within	  4	  weeks	  prior	  to	  enrolment	  into	  this	  study.	  	  15. Moderate,	  severe,	  or	  profound	  mental	  retardation.	  16. Heart	  pacemakers,	  cochlea	  implants,	  other	  metal	  parts	  in	  the	  head	  outside	  the	  mouth.	  	  	  	  The	   dispensed	   MPH	   and	   placebo	   medication	   consisted	   of	   lactose	   monohydrate,	  magnesiumstearat,	   cellulose	   powder,	   and	   microcristalline	   cellulose	   and	   was	  provided	  by	  MEDICE	  Pharma	  GMBH	  &	  Co.	  KG,	  Iserlohn,	  Germany.	  It	  was	  labeled	  as	  follows:	  	  Methylphenidat-­‐HCl	  10	  mg	  Tabletten	  oder	  Placebo-­‐Tabletten	  180	  Tabletten	  zum	  Einnehmen	  Woche	  1-­‐6	  Patienten-­‐Nr.:	  Studien-­‐Nr.:	  W004PS0108_1	  Ch.-­‐B.:	  Verwendbar	  bis:	  Zur	  klinischen	  Prüfung	  bestimmt	  Dosierung	  gemäß	  der	  Anweisung	  des	  Prüfarztes	  Außerhalb	  der	  Reichweite	  von	  Kindern	  lagern	  Nicht	  über	  25°C	  lagern	  Nicht	  verbrauchte	  Tabletten	  an	  den	  Arzt	  zurückgeben!	  Klinik	  und	  Poliklinik	  für	  Psychiatrie,	  Psychosomatik	  und	  Psychotherapie,	  Würzburg,	  Telefon:	  0931	  –	  201	  77000	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Table	   8.3:	  MNI	   coordinates	   of	   significant	   or	   trend	   level	   between-­‐group	   differences	   for	   the	   different	  
tasks.	  	  Anatomical	  region	   MNI	  coordinates	  	  	   	  
Selective	  attention	  task:	  healthy	  controls	  versus	  patients	  with	  ADHD	  
-­‐ Right	  DLPFC	   	  42	  	  	  44	  	  	  31	  
	  
N-­‐back	  task:	  healthy	  controls	  versus	  patients	  with	  ADHD	  	  
-­‐ Left	  anterior	  IPS	   -­‐36	  	  -­‐49	  	  	  40	  
-­‐ Right	  inferior/middle	  frontal	  gyrus	   	  45	  	  	  11	  	  	  37	  
-­‐ Left	  DLPFC	   -­‐39	  	  	  35	  	  	  25	  
-­‐ Right	  posterior	  IPS	   	  15	  	  -­‐76	  	  	  46	  
-­‐ Right	  anterior	  IPS	   	  39	  	  -­‐49	  	  	  49	  	  
N-­‐back	  task:	  ADHD	  patients	  with	  MPH	  versus	  placebo	  
-­‐ Right	  superior	  frontal	  gyrus	   	  24	  	  	  50	  	  	  37	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 Selective	  Attention	  Task	  8.3.1
	  
	  Figure	   8.2:	   Scatter	   plots	   and	   linear	   regression	   lines	   for	   contrast	   estimates	   (high	   distracting	   task	  irrelevant	  minus	  task	  relevant	  condition)	  in	  the	  right	  DLPFC	  and	  the	  FFA	  as	  well	  as	  CAARS	  DSM-­‐IV	  T-­‐scores	  and	  FFA	  contrast	  estimates	  for	  the	  patient	  group.	  Each	  dot	  represents	  one	  participant.	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 N-­‐Back	  Task	  8.3.2
	  
Table	   8.4:	   Correlation	   coefficients	   (r)	   and	  p-­‐values	   of	   peak	   voxel	   contrast	   estimates	  with	   correct	   as	  
well	  as	  incorrect	  performance	  for	  the	  entire	  sample,	  as	  well	  as	  correlation	  coefficients	  (r)	  and	  p-­‐values	  
of	   contrast	   estimates	   in	   these	   clusters	  with	   T-­‐scores	   for	   the	   CAARS	   DSM-­‐IV	   Hyperactive/	   Impulsive	  
Symptoms	  and	  CAARS	  DSM-­‐IV	  Total	  ADHD	  Symptoms	  scales	  for	  the	  patient	  sample.	  	  
	  Anatomical	  region	  
Performance	  (correct)	   Performance	  (incorrect)	   CAARS	  hyper./impuls.	   CAARS	  total	  symptoms	  	  
r	  (p-­‐value)1	  	   r	  (p-­‐value)1	  	   r	  (p-­‐value)2	  	   r	  (p-­‐value)2	  	  Left	  anterior	  IPS	   .13	  (n.s.)	   .19	  (n.s.)	   .46	  (.01)	   .51	  (.01)	  Right	  IFG/MFG	   .22	  (n.s.)	   .34	  (.01)	   .38	  (.04)	   .41	  (.03)	  Right	  posterior	  IPS	   .32	  (.02)	   .47	  (<.001)	   .42	  (.02)	   .32	  (.09)	  Right	  anterior	  IPS	   .20	  (n.s.)	   .36	  (.01)	   .20	  (n.s.)	   .27	  (n.s.)	  
Note.	  1	  degrees	  of	  freedom	  (df)	  =	  56;	  2	  df	  =	  27.	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  Figure	   8.3:	   Scatter	   plots	   and	   linear	   regression	   lines	   for	   contrast	   estimates	   (2-­‐back	  minus	   0-­‐back	  condition)	   and	   task	   performance.	   Each	   dot	   represents	   one	   participant.	   Correlations	   for	   the	   right	  posterior	  IPS	  (B.	  and	  E.)	  retained	  significance	  after	  the	  extreme	  outlier	  (in	  grey	  box)	  was	  excluded.	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  Figure	   8.4:	   Scatter	   plots	   and	   linear	   regression	   lines	   for	   contrast	   estimates	   (2-­‐back	  minus	   0-­‐back	  condition)	  and	  CAARS	  DSM-­‐IV	  T-­‐values	  for	  the	  patient	  group.	  Each	  dot	  represents	  one	  participant.	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 Interaction	  of	  COMT	  Genotype	  and	  ADHD	  	  8.3.3
	  Peak	  voxel	  contrast	  estimates	  
	  1. Left	  anterior	  IPS:	  	  
" Significant	  interaction	  of	  COMT	  genotype	  and	  ADHD	  (F(2,50)	  =	  4.21,	  p	  =	  .02).	  
o Significantly	  higher	  activation	  of	  ADHD	  val/met	  carriers	   (p	  <	  .001)	  and	  ADHD	  val/val	  carriers	  (p	  =	  .03)	  compared	  to	  healthy	  controls.	  	  	  2. Right	  IFG/MFG:	  	  
" Significant	  interaction	  of	  COMT	  genotype	  and	  ADHD	  (F(2,50)	  =	  4.64,	  p	  =	  .02).	  
o Significantly	  higher	  activation	  of	  ADHD	  val/met	  carriers	   (p	  =	  .003)	  and	  ADHD	  val/val	  carriers	  (p	  =	  .04)	  compared	  to	  healthy	  controls.	  	  
Affidavit	   168	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  Erklärung	  
	  
Affidavit	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  my	   thesis	   entitled	   “The	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   Adult	   Attention	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